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Abstract 
 
Lantibiotics are ribosomally-synthesised peptide antibiotics that are post-translationally 
modified to introduce (methyl)lanthionine bridges. The increasing prevalence of antibiotic 
resistance in bacterial pathogens has renewed focus on the discovery of natural products 
with antimicrobial properties. The Actinomycetales are renowned for their ability to 
produce a large variety of antimicrobials, yet of these, very few lantibiotics have been 
described. Planosporicin is a lantibiotic produced by the actinomycete Planomonospora 
alba that inhibits cell wall biosynthesis in Gram-positive pathogens.  
During this work, the structure of planosporicin was refined and reclassified as a type AI 
lantibiotic with a strong resemblance to those which bind lipid II. The biosynthetic gene 
cluster responsible for planosporicin biosynthesis was identified by genome scanning and 
subsequently isolated from a P. alba cosmid library. A minimal gene cluster for 
planosporicin production was defined by heterologous expression in Nonomuraea sp. 
ATCC 39727. Deletion of the gene encoding the prepropeptide abolished planosporicin 
production in P. alba, further confirming the identity of the cluster. Further deletion 
analyses of likely biosynthetic and processing enzymes identified through bioinformatics 
revealed they too are essential for planosporicin production. 
The planosporicin gene cluster was shown to encode several putative regulatory proteins 
including an extracytoplasmic function (ECF) σ factor, a likely cognate anti-σ factor and a 
potential helix-turn-helix DNA binding protein. Further deletion analyses, combined with 
quantitative RT-PCR, revealed insights into the mechanism of regulation of planosporicin 
biosynthesis. A model for the pathway-specific regulation of a lantibiotic biosynthetic gene 
cluster by a master regulator and an ECF σ factor–anti-σ factor complex that responds to 
sub-inhibitory concentrations of planosporicin is proposed.   
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Chapter 1 : Introduction 
 
 
1.1 Actinobacteria 
The phylum Actinobacteria consists of 39 families and 130 genera, making it one of the 
largest lineages within the domain Bacteria (Figure 1.1) (Ventura et al. 2007; Miao and 
Davies 2010). Actinobacteria are Gram-positive bacteria with a high genomic GC content; 
ranging from 51 mol% GC in some Corynebacterium to more than 70 mol% GC in 
Streptomyces and Frankia (Ventura et al. 2007). The sequencing of many actinobacterial 
genomes revealed vast genomic diversity within this phylum. Sequenced genomes to date 
range from the 2.50 Mb Micrococcus luteus circular chromosome predicted to encode 
2,403 proteins (Young et al. 2010), to the 9.67 Mb Rhodococcus jostii linear chromosome 
predicted to encode 9,145 proteins (McLeod et al. 2006). 
Actinobacteria exhibit a wide variety of morphologies, but many, such as the 
Streptomycetaceae family, have a highly differentiated, branched mycelium. This 
superficially resembles the mycelium of fungi, which they were originally classified as 
under the older name actinomycetes (mycet is derived from the Greek mukēt meaning 
fungus), referred to in subsequent Chapters. Unusual developmental features are 
displayed by many actinobacterial genera, such as formation of sporulating aerial 
mycelium in many members of the Actinomycetales order. These features are linked to 
the variety of lifestyles exhibited by different genera. Many Streptomyces species are soil 
inhabitants where they play a crucial role in the decomposition of organic matter to recycle 
nutrients back into the ecosystem. However, other Actinobacteria are plant commensals 
(Leifsonia), nitrogen-fixing symbionts (Frankia), gastrointestinal tract inhabitants 
(Bifidobacterium) and even pathogens, such as some Mycobacterium species (Ventura et 
al. 2007). 
 
1.1.1 Phylogeny 
Among Actinobacteria, the Streptomycetaceae are the dominant family, with non-
streptomycetes referred to as ‘rare actinomycetes’ due to their low isolation frequency. 
The family Streptosporangiaceae was first proposed over 20 years ago (Goodfellow et al. 
1990). This family initially consisted of the genera Streptosporangium, Microbispora, 
Microtetraspora, Planobispora and Planomonospora. Subsequently, further genera have 
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been added, such as Nonomuraea (Zhang et al. 1998), to form a family of nine related 
genera with Streptosporangium as the type genus. Together, the family 
Streptosporangiaceae forms a distinct clade on the basis of 16S rRNA gene sequence 
data (Figure 1.2), but display a range of morphologies. Genera such as Planomonospora 
form spore vesicles containing single spores, whereas other genera form spore chains. 
Microbispora has spores in characteristic longitudinal pairs while Nonomuraea displays 
spore chains on aerial hyphae (Dworkin 1996). 
 
 
  
 
Figure 1.1 : Phylogenetic tree of the class Actinobacteria.  
Taxonomy is based on 1,500 nucleotides of 16S rRNA. Families containing members 
subjected to complete genome sequencing (as of August 2010) are depicted in bold. Scale 
bar, 5 nucleotides. Adapted from Miao and Davies 2010. 
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The Planomonospora genus was initially proposed in 1967 with Planomonospora 
parontospora as the type species (Thiemann et al. 1967). The genus now contains five 
validly described species; Planomonospora alba (Mertz 1994), Planomonospora 
parontospora subsp. antibiotica (Thiemann et al. 1967), Planomonospora parontospora 
subsp. parontospora (Thiemann et al. 1967), Planomonospora sphaerica (Mertz 1994) 
and Planomonospora venezuelensis (Thiemann 1970). P. venezuelensis was first 
identified from soil in Venezuela, whereas P. alba was identified from the Sudan, 
 
Figure 1.2 : A phylogenetic tree based on partial 16S rRNA sequences from 
representative members of the Streptosporangiaceae family.  
Type species are in bold and 
T
 indicates type strain. The numbers at the nodes indicate the 
percentage of bootstrap support and an asterisk indicates the branch was also found using 
other tree-making algorithms. Figure from Dworkin 1996. 
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indicating a wide geographical distribution. A subsequent study isolated 246 
Planomonospora strains from 137 of the 1200 soil samples examined (Suzuki et al. 2001). 
Strains of the P. parontospora group were recovered from 131 of these soil samples, 
while strains assigned to the P. venezuelensis group were isolated from 13 soil samples. 
It is now clear that Planomonospora strains have a worldwide distribution in soils of arid, 
temperate and tropical regions. 
P. alba is an aerobic, Gram-positive, chemo-organotrophic actinomycete that forms 
branched, non-fragmenting substrate hyphae and sparsely branched aerial hyphae (Mertz 
1994). Clavate spore vesicles each contain a single spore, which become motile in water 
due to peritrichous flagella (Mertz 1994). The cell membrane contains a number of 
glycerol-based phospholipids such as phosphatidylethanolamine, phosphatidylinositol and 
phosphatidylglycerol as well as glucosamine-containing phospholipids (Mertz 1994). 
 
1.1.2 Secondary metabolites 
Actinobacteria exhibit diverse physiological and metabolic properties in order to adapt to 
changing environments. Many produce so-called ‘secondary metabolites’, defined as 
metabolites that are not essential for growth under laboratory conditions. These include 
pigments, such as the brightly coloured actinorhodin and prodiginines from Streptomyces 
coelicolor and many antibiotics (Wright and Hopwood 1976a; Rudd and Hopwood 1980). 
The first actinomycete antibiotic to be discovered was actinomycin, produced by 
Actinomyces antibioticus (Waksman and Woodruff 1941). Subsequently hundreds of 
secondary metabolites with potent antimicrobial activity have been discovered, primarily 
from the Streptomyces genus. For example, S. coelicolor produces both methylenomycin 
and the calcium-dependent antibiotic (Wright and Hopwood 1976b; Lakey et al. 1983). 
However, other actinomycetes genera also have the capacity to produce antimicrobials of 
pharmacological and commercial interest. 
The term ‘secondary metabolites’ implies inferiority to primary metabolites, but non-
essentiality for growth under controlled lab conditions has no bearing on their important 
roles in the environment. Moreover, there is increasing evidence that many secondary 
metabolites may play roles as signalling molecules at low concentrations (Goh et al. 2002; 
Yim et al. 2007). Surfactin originally drew attention due to its antimicrobial activity but has 
recently been shown to stimulate biofilm development in Bacillus subtilis through a 
mechanism that triggers K+ leakage resulting in the elevated production of extracellular 
matrix components (Lopez et al. 2009). This may be a common theme in which secondary 
metabolites act as intra- and inter-specific signals, cues or chemical manipulators at one 
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concentration, and have a second role as antibiotics, toxins, or ionophores at higher 
concentrations (Keller and Surette 2006; Shank and Kolter 2009). 
The secondary metabolites of the Antibiotic Literature Database (ABL) are mostly 
produced by the bacterial order Actinomycetales (57 %) with 13 % made up by other 
bacteria and the remaining 30 % produced by fungi1. More than 20,000 microbial 
secondary metabolites possessing some bioactivity in vitro have been discovered 
(Marinelli 2009). Many were initially studied as potential anti-infectives (antibacterials, 
antifungals, antivirals, and antiparasitics) but eventually developed into leading anticancer 
drugs, immunosuppressive agents for organ transplantation, or pharmaceuticals targeting 
metabolic and cardiovascular diseases (Marinelli 2009). 
The bioactive molecules produced by actinomycetes belong to a range of chemical 
classes. Of most relevance to this thesis are the peptide antibiotics. Thiopeptides contain 
a characteristic macrocyclic core consisting of multiple thiazoles, dehydroamino acids, 
and a 6-membered nitrogen heterocycle (Velasquez and van der Donk 2011). Recently 
the thiostrepton biosynthetic gene cluster was identified from whole-genome scanning of 
Streptomyces laurentii demonstrating thiopeptides are ribosomally-synthesised then post-
translationally modified (Kelly et al. 2009). There are also many non-ribosomally produced 
peptides which exhibit bioactivity. Non-ribosomal peptides are synthesised by non-
ribosomal peptide synthetases (NRPSs) through the sequential condensation of amino 
acid monomers. Unlike ribosomes, NRPSs can incorporate a range of non-proteogenic 
amino acids, leading to unusual chemical properties and structures that can be further 
modified by specific tailoring enzymes to add additional functional groups (Walsh et al. 
2001; Lautru and Challis 2004). Several of these peptide-based natural products are 
currently used in the clinic to treat serious Gram-positive infections. For example, the 
glycopeptide vancomycin is synthesised by an NRPS as a linear heptapeptide which is 
further modified by tailoring enzymes to glycosylate and introduce oxidative cross-links 
(van Wageningen et al. 1998). The cyclic lipopeptide daptomycin consists of thirteen 
amino acids, ten of which form a ring, while three form an exocyclic tail with decanoic acid 
attached to the N-terminus (Miao et al. 2005). Daptomycin was the second member of this 
class to be discovered but its bactericidal activity against vancomycin resistant Gram-
positive pathogens ensured that it was the first to be marketed for commercial use 
(Steenbergen et al. 2005). However, this thesis focuses on one particular group of 
ribosomally synthesised and post-translationally modified peptides, the lantibiotics 
(introduced in Section 1.3). 
 
                                                
1 www.ricercaperlavita.it/en/patrimonio_fiirv/abl_database.htm (updated until 2006) 
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1.1.3 Regulation of secondary metabolism 
The regulation of secondary metabolism occurs at two levels, it can be pathway-specific 
and/ or mediated through pleiotropic regulatory genes (Bibb 2005). The use of multiple 
regulators gives the scope for different signals to influence the production of secondary 
metabolites. Therefore it is not uncommon to observe conditional phenotypes where the 
wild type (WT) phenotype can be restored if the growth conditions are altered (Rigali et al. 
2008).  
The highly phosphorylated nucleotide ppGpp (guanosine 5′-diphosphate 3′-diphosphate) 
mediates the stringent response under conditions of amino acid starvation in bacteria. 
This response modulates transcription to divert resources away from growth and division 
in order to adapt until nutrient conditions improve. In actinomycetes these adaptive 
responses include the induction of antibiotic production, and there is increasing evidence 
that ppGpp plays a direct role in transcriptional activation (rather than this activation being 
an indirect consequence of a growth rate reduction). A modified ppGpp synthetase gene, 
relA, was used to induce ppGpp synthesis without a detectable reduction in growth and 
was shown to elicit the transcription of actII-ORF4 and the consequent production of 
actinorhodin in S. coelicolor (Hesketh et al. 2001). The global role of ppGpp synthesis in 
S. coelicolor was demonstrated through the use of Affymetrix microarrays and revealed an 
influence on the expression of antibiotic gene clusters, conservons, and morphogenetic 
proteins (Hesketh et al. 2007). 
In actinomycetes, the developmental regulation of secondary metabolite production is 
well-documented and commonly linked to the presence of regulatory metabolites, such as 
A-factor (the auto-regulatory-factor 2-isocapryloyl-3R-hydroxymethyl-γ-butyrolactone) 
which induces morphological and chemical differentiation in Streptomyces griseus, 
resulting in sporulation and the production of streptomycin and grixazone (Horinouchi and 
Beppu 1994). A-factor binds the receptor protein ArpA and prompts its dissociation from 
the adpA promoter resulting in transcription of adpA (Kato et al. 2004). AdpA consists of 
an N-terminal dimerisation domain and a C-terminal DNA-binding domain, and is the key 
transcriptional activator of a regulon that includes genes required for secondary 
metabolism and morphological differentiation (Yamazaki et al. 2004). In contrast to other 
γ-butyrolactone regulatory systems, disruption of arpA had no effect on A-factor 
production, which is instead repressed by AdpA in a two-step regulatory feedback loop 
(Kato et al. 2004). However, A-factor may well be the exception among γ-butyrolactones 
as a pleiotropic regulator. Other γ-butyrolactones only regulate secondary metabolism and 
the frequent location of genes for their biosynthesis and receptor proteins within 
secondary metabolite gene clusters implies that their regulatory role may be pathway-
specific. For example, the jadomycin gene cluster of Streptomyces venezuelae encodes 
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JadR2, a γ-butyrolactone receptor homologue which functions with JadR1 in stress-
induced activation of jadomycin B biosynthesis (Wang and Vining 2003).  
Other regulators include the SARP (Streptomyces Antibiotic Regulatory Protein) family 
and the LAL (Large ATP-binding regulators of the LuxR family) family, responsible for the 
transcriptional activation of specific secondary metabolic pathways in many 
actinomycetes. To take a recent example, Aur1PR3 is a transcriptional activator of the 
SARP family which forms a regulatory cascade along with the TetR family negative 
regulator Aur1R to control expression of the aur1 polyketide gene cluster involved in 
biosynthesis of the angucycline-like antibiotic auricin in Streptomyces aureofaciens CCM 
3239 (Novakova et al. 2011). 
However, the regulation of lantibiotic gene clusters is best characterised in low-GC 
organisms. In several systems, lantibiotics have been shown to induce their own 
synthesis. The first insight into the mechanism of nisin autoregulation in Lactococcus 
lactis came from the demonstration that the sensor histidine kinase NisK and the 
response regulator NisR transduced signals resulting in the transcriptional autoregulation 
of nisA which encodes the nisin precursor peptide (Kuipers et al. 1995). Subsequently 
nisF, which encodes part of the immunity ABC transporter, was also demonstrated to be 
nisin inducible (de Ruyter et al. 1996). The SpaRK two-component system regulating 
subtilin production in B. subtilis ATCC 6633 is itself under control by two independent 
regulatory systems. These are autoinduction via subtilin and transcriptional regulation via 
σH (Stein et al. 2002b). In contrast, the deletion of spo0H (encoding σH) had no significant 
effect on mersacidin production and immunity in Bacillus sp. strain HIL Y-85,54728 
(Schmitz et al. 2006). Instead mersacidin functions as an autoinducer, promoting 
transcription of mrsA, the gene encoding the precursor peptide, resulting in earlier 
production of mersacidin (Schmitz et al. 2006). Two-component regulatory systems are 
not exclusive to low-GC lantibiotic clusters. The cinnamycin gene cluster encodes the two-
component regulatory system CinRK. However this cluster also contains one further 
regulator, a SARP (CinR1) (Widdick et al. 2003). Thus the biosynthesis of lantibiotics is 
often regulated in a cell density dependent manner in which the lantibiotic acts as a 
signalling molecule in an autoinduction mechanism. 
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1.2 Antibiotics 
1.2.1 The rise in antibiotic resistance 
It is more than sixty years since clinical implementation of the first natural product 
antibiotic. Yet infectious disease remains a global problem. It is now understood that use 
(and misuse) of an antibiotic selects for bacteria that are resistant to the drug. Thus 
clinically significant resistance commonly arises within a couple of decades after the 
introduction of a new antibiotic. In the case of penicillin, pathogen resistance through the 
acquisition of a single hydrolytic enzyme occurred less than one year after clinical 
introduction of the drug in 1945 (Walsh 2003). In contrast, vancomycin resistance did not 
emerge until 30 years after its first clinical use, due to its initially infrequent use and the 
fact that resistance required the assembly of a five-gene resistance cassette (Walsh 
2003). 
The prevalence of hospital-acquired (nosocomial) infections caused by Gram-positive 
pathogens such as Staphylococcus aureus, Streptococcus pneumoniae, enterrococci and 
Clostridium difficile has increased due to the acquisition of multidrug resistance. S. aureus 
most commonly causes infections of the skin and bloodstream (bacteraemia), as well as 
pneumonia, which can be severe or fatal. The number of cases of methicillin-resistant S. 
aureus (MRSA) bacteraemia in the UK increased from 2 % in 1990 to 43 % in 2002 
(Johnson et al. 2005). In recent years an improvement in cleaning regimes has decreased 
the number of deaths attributed to MRSA2, however there is no indication of a decrease in 
virulence, and a more lethal strain may subsequently develop. Recently, new strains of 
MRSA have emerged that cause infections in the community. In 2009 it was estimated 
that approximately 30 % of the UK population were colonised with S. aureus, and 1-3 % of 
the total population colonised with MRSA3. Community-associated (CA)-MRSA strains are 
genetically and phenotypically distinct from Hospital-acquired (HA)-MRSA. For example, 
many CA-MRSA strains are producers of the lantibiotic Bsa (bacteriocin of S. aureus), 
presumably conferring a competitive ecological advantage (Daly et al. 2010). HA-MRSA is 
resistant to fluoroquinolones, macrolides, lincosamides, streptogramins, aminoglycosides, 
rifampin and tetracyclines whereas CA-MRSA is susceptible to many non-β-lactam 
antibiotics (Van Bambeke et al. 2008). Treatment of MRSA with vancomycin led to the 
acquisition of the VanA determinant from vancomycin-resistant enterococci (VRE) to 
                                                
2 MRSA deaths continue to decrease (August 2011) Office for National Statistics 
http://www.statistics.gov.uk/cci/nugget.asp?id=1067 
 
3 MRSA in primary care (January 2009) Clinical Knowledge Summaries  
www.cks.nhs.uk/mrsa_in_primary_care 
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generate vancomycin-resistant S. aureus (VRSA) (Van Bambeke et al. 2008). VRE are a 
cause of surgical infections and infections of the urinary tract (Appelbaum and Jacobs 
2005). However, the worldwide spread of Enterococcus faecium (complex-17) is 
characterised primarily through their resistance to ampicillin rather than vancomycin 
(Willems et al. 2005). Multidrug-resistant S. pneumonia continues to cause acute 
respiratory diseases and meningitis in many parts of the world, although the use of protein 
conjugated vaccines has reduced the number of new infections (Rice 2009). 
Epidemiological studies of isolates of one multidrug-resistant lineage of S. pneumoniae 
showed how genomic plasticity permitted the evolution of resistance to fluoroquinolones, 
rifampicin, and macrolides on multiple occasions over just 40 years (Croucher et al. 2011). 
This insight into the evolution of such pathogens may aid the design of future control 
strategies and vaccines (Woodford and Livermore 2009).  
 
1.2.2 The decline in antibiotic discovery 
Although there are a number of new antibacterial agents active against multi-drug 
resistant pathogens, only one, daptomycin, has a novel mechanism of action 
(Steenbergen et al. 2005). Daptomycin is proposed to undergo a primary structural 
change due to an interaction with calcium which facilitates a secondary structural change 
due to an interaction with the cell membrane, leading to membrane penetration (Jung et 
al. 2004). The insertion of daptomycin into the membrane creates a pore through which 
potassium ions are released, resulting in depolarisation and cell death (Muthaiyan et al. 
2008; Van Bambeke et al. 2008). Other antibacterials recently approved for clinical use 
include linezolid (the first oxazolidinone in clinical use), telithromycin (a ketolide derived 
from clarithromycin), tigecycline (a broad-spectrum intravenous tetracycline) and 
ceftobiprole (a fifth generation cephalosporin). Other agents in preclinical development 
include the new glycopeptides oritavancin and dalbavancin, and the diaminopyrimidine 
iclaprim (Appelbaum and Jacobs 2005). So far, there is no widespread resistance to these 
newer antimicrobials, but occasional reports of therapeutic failure due to resistance (e.g. 
linezolid, daptomycin, telithromycin, or newer fluoroquinolones) means the development of 
new antimicrobials remains a high priority (Woodford and Livermore 2009). As well as 
glycopeptides, there are several other peptide antibiotics with potential as antibacterial 
agents. Although host-derived antimicrobial peptides (AMPs) such as pexiganan (a 
magainin), omiganan (an indolicidin), and iseganan (a protegrin) suffer from weak activity, 
nonspecific cytotoxicity, and apparent susceptibility to proteolysis, bacterial peptides such 
as the lantibiotics show more promise and are discussed in detail in Section 1.3 (Vaara 
2009). 
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The need for further antimicrobial agents can be addressed through two strategies. Novel 
natural products can be discovered either by screening extracts in a whole-cell assay, or 
potentially through genome scanning. Alternatively, vast libraries of chemicals can be 
screened in vitro to identify novel scaffolds. Compounds discovered through either route 
are frequently subject to subsequent modification by medicinal chemists to ensure 
appropriate levels of stability, toxicity, distribution and elimination.  
A change in emphasis between natural products and chemical libraries as the key source 
of new antimicrobial agents has occurred several times over the past seventy years. The 
development of penicillin as a medicine by Florey and Chain in the 1940’s resulted in the 
first mass-produced antibiotic. This heralded the start of the ‘golden age’ of antibiotic 
discovery, lasting over fifty years (Newman et al. 2000). The main strategy during this time 
relied on the detection of bioactive natural products and their purification. The purification 
and structural elucidation of these compounds often posed technical challenges, adding to 
the financial cost of new natural product discovery. As technology improved, purification 
became less challenging, but despite the addition of multiple screening steps, 
dereplication (the rediscovery of known antibiotics) became a problem.  
Medicinal chemistry improved existing activities through the synthetic tailoring of known 
molecular scaffolds, but in the long-term new lead compounds are needed (Fischbach and 
Walsh 2009). Combinatorial chemistry enabled the synthesis of new structural classes 
within the chemical space to form vast libraries of compounds that were then subjected to 
high-throughput screening (HTS) against drug targets to identify structures to take forward 
as lead compounds. Although there has been a lot of investment in HTS, only one de 
novo combinatorial compound was approved as a drug during the 25 years from 1981 to 
2006 (Newman and Cragg 2007). This was the biaryl urea sorafenib, a multikinase 
inhibitor for the treatment of advanced renal cancer (Newman and Cragg 2007).  
The main issue is that lead compounds identified through in vitro screens against specific 
targets need subsequent modification to improve permeability. Whereas whole-cell 
screening simultaneously tests for the ability to enter the pathogen as well as activity, 
leading more quickly to biologically active compounds (Baltz 2007). What has also 
become clear is that the choice of target to screen against is critical (Payne et al. 2007). 
The search for novel targets by a genomic approach has been unsuccessful and instead 
agents against under-exploited old targets may provide the answer. 
More than two-thirds of clinically used antibiotics are natural products or their 
semisynthetic derivatives (Newman and Cragg 2007). The success of natural products 
can be no surprise when millions of years of evolution have selected for structures with 
biological activity. Natural products achieve structural complexity and bioactivity that are 
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unlikely to be achieved by combinatorial chemistry. The failure of high-throughput target-
based screening of chemical libraries to discover new antibiotics has prompted a return to 
the discovery of new natural products with antimicrobial properties. There are now two 
additional methods of accessing novel natural products; metagenomics and genome 
scanning (Davies 2011). However the proof of principle of metagenomics as a validated 
method of discovery has not yet been established (Baltz 2007). Thus the latest strategy is 
a return to the search for natural products through genome mining in combination with the 
search for novel biodiversity (Zerikly and Challis 2009).  
Genome mining is possible due to the fact that biosynthetic genes are clustered. This was 
first discovered in S. coelicolor where all the biosynthetic genes for the polyketide 
antibiotic actinorhodin were found to be clustered in a chromosomal region of 
approximately 26 kb (Malpartida and Hopwood 1986). The sequencing of S. coelicolor 
revealed many more biosynthetic gene clusters where the product has not yet been 
identified, referred to as cryptic gene clusters (Bentley et al. 2002). The Streptomyces 
genus is predicted to be capable of producing hundreds of thousands of antibiotics, of 
which <5 % have been discovered so far (Watve et al. 2001). The identification of cryptic 
gene clusters combined with genetic manipulation can be used in principle to stimulate the 
production of novel natural products from known species through heterologous 
expression, gene-targeting and ribosome engineering (Chiang et al. 2011; Winter et al. 
2011). For example, genetic manipulation enabled the expression of the 150 kb type I 
modular polyketide synthase (PKS) cryptic gene cluster from Streptomyces ambofaciens 
ATCC 23877. The constitutive expression of a LAL regulator encoded within the cluster 
triggered expression of the biosynthetic genes, which lead to the identification of the 
stambomycins (Laureti et al. 2011).  
The actinomycetes have proven themselves to be an important source of antibiotics in the 
past, and the use of new techniques such as high-throughput fermentation, the isolation of 
little-studied marine actinomycetes and the mining of genomes for cryptic pathways may 
facilitate the discovery of further antimicrobials (Baltz 2008; Nett et al. 2009). It has been 
noted that of the actinomycetes, the fragmenting forms are not such prolific producers, so 
focus has fallen on those whose morphology is characterised by a stable differentiated 
mycelium (F. Marinelli, personal communication). In particular, there is increasing 
emphasis on the isolation and screening of rare actinomycetes from under-explored 
ecological niches (Tiwari and Gupta 2011). The main problem with screening for novel 
anti-infectives is dereplication. In order to circumvent this, there has also been a drive to 
re-evaluate ‘neglected’ molecules through screening for other activities. 
The use of novel biosynthetic pathways for natural products in combination with chemistry 
creates the opportunity for combinatorial biosynthesis as a source of further novel 
  
30 
30 Chapter 1 : Introduction 
compounds (Baltz 2007). There are other combinations of microbial genetics and 
synthetic chemistry that can yield new compounds. For example, mutasynthesis is where 
a mutant is fed a synthetic analogue that can be utilised by the biosynthetic enzymes to 
obtain a new product, while chemoenzymatic synthesis is where the enzyme that will 
synthesise the analogue is expressed in the deletion mutant to obtain the new product. 
Over the past 15 years, pharmaceutical industry research into natural products has 
declined (Li and Vederas 2009). Although natural product anti-infective research still 
exists, generally in smaller companies, and is supported by government funded research, 
it is clear that the ‘golden age’ of discovery is over. As antibiotic treatments last for at most 
a couple of weeks, their profit-making potential is limited. Consequently, many companies 
have shut down their antimicrobial discovery and development groups in favour of 
investment in potential treatments for chronic/terminal illnesses. 
 
1.3 Lantibiotics 
Lantibiotics are a distinct class of antimicrobial compounds, characterised by the presence 
of unusual post-translational modifications. They are typified by the presence of the ring-
forming thioether amino acids lanthionine (Lan) and/or 3-methyl lanthionine (MeLan) (Sahl 
et al. 1995). These non-proteogenic amino acids constrain the molecule into a defined 
structural conformation that serves the dual purpose of ensuring functional biological 
activity and resisting proteolytic degradation (Sahl and Bierbaum 1998). As more 
lantibiotics are characterised, the range of observed post-translational modifications has 
expanded, but can be classified into those linking two residues within the peptide to form 
a bridge and those modifications on the α-carbon of a single amino acid (Figure 1.3). By 
definition, lantibiotics are lanthionine-containing peptides with antibiotic activity.  However, 
some lanthionine-containing peptides have been discovered that do not appear to have 
antibiotic activity.  Thus the term lantipeptides was recently coined to describe such 
compounds (Goto et al. 2010). 
 
1.3.1 Classification 
The bacteriocins were originally defined half a century ago to describe colicin-like 
antimicrobials produced by bacteria (Jacob et al. 1953). A classification scheme for the 
bacteriocins of lactic-acid bacteria was first put forward in 1993 but has subsequently 
been revised and simplified to form a scheme which incorporates bacteriocins regardless 
of the Gram-status of the producing organism (Klaenhammer 1993; Cotter et al. 2005a). 
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In both schemes the lantibiotics are class I bacteriocins, distinguished from other 
bacterially produced antimicrobial peptides on the basis of their extensive post-
translational modifications (Klaenhammer 1993; Cotter et al. 2005a).  
 
Figure 1.3 : Structural motifs introduced into lantibiotics by post-translational modification. 
Also shown is the schematic notation used in other figures, which includes the abbreviation 
for amino butyric acid (Abu). 
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Various lantibiotic subdivisions have been implemented over the years. Initially lantibiotics 
were assigned into two subclasses on the basis of structure: type A lantibiotics have an 
elongated shape, while type B lantibiotics are more globular in conformation (Jung and 
Sahl 1991). An alternative interpretation of structural features divides class I bacteriocins 
into seven subgroups. Each subgroup assumes the name of the most renowned member; 
nisin A, epidermin, Pep5, lacticin 481, mersacidin, cinnamycin and lacticin 3147 (Xie and 
van der Donk 2004). Other classification schemes have been proposed which are based 
on primary rather than tertiary structure. One such scheme focuses on the composition of 
the leader sequence present at the N-terminus of the precursor peptide (prepropeptide) 
that includes the future mature peptide sequence (propeptide) at its C-terminus. 
Lantibiotics modified by individual modification enzymes to produce (Me)Lan bridges 
typically have a conserved FNLD motif in the leader peptide, whereas lantibiotics modified 
by bifunctional modification enzymes typically have a GG or GA cleavage site and contain 
multiple Asp and Glu residues in the leader peptide (Chatterjee et al. 2005). However the 
steady discovery of lantibiotics with novel structures and functions demands a 
classification scheme with inherent flexibility. One such scheme primarily emphasises the 
amino acid sequence of enzymes and substrates involved in the post-translational 
modification of lantibiotics. In this scheme, class I lantibiotics such as nisin use distinct 
enzymes for the individual reactions involved in (Me)Lan formation, while class II, such as 
mersacidin, use dual-function enzymes. Class III lantipeptides are characterised by overt 
antimicrobial activity (Willey and van der Donk 2007). Another unifying feature of class III 
is the use of a dual-function enzyme with homology to the C-terminus of class II enzymes 
but with a Ser/Thr kinase domain (Goto et al. 2010). These classification systems are 
commonly used in conjunction with each other. Type AI lantibiotics are those which are 
elongated and use individual modification enzymes to produce (Me)Lan bridges, whilst 
type AII and type B use bifunctional modification enzymes and are elongated or globular 
respectively. 
 
1.3.2 Lantibiotic producers 
The first lantibiotic was discovered over eighty years ago (Rogers 1928). This was nisin, 
produced by the low-GC organism L. lactis and subsequently used as a preservative in 
the food industry (Chatterjee et al. 2005). Since then more than 60 lantibiotic peptides 
have been described (Field et al. 2010). Many are produced by other low-GC Gram-
positive bacteria from which the biosynthetic gene cluster has been identified (Figure 1.4). 
For many, the structure and mode of action of the lantibiotic has been investigated 
(Section 1.3.3) and the function of genes encoded within the biosynthetic gene cluster 
studied (Section 1.3.4).  
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A smaller number of lantibiotic biosynthetic gene clusters have been sequenced in high-
GC organisms (Figure 1.5). The cinnamycin gene cluster from Streptomyces 
cinnamoneus cinnamoneus DSM 40005 provided the first insight into the differences 
between gene clusters from high-GC as opposed to low-GC clusters (Widdick et al. 2003). 
Cinnamycin is a type B lantibiotic which is closely related to duramycin, duramycin B, 
duramycin C, and ancovenin, all of which are produced by actinomycetes as 19 residue 
propeptides which are post-translationally modified to introduce Lan residues in similar 
positions (Figure 1.6) (Widdick et al. 2003). 
 
Actagardine was initially named gardimycin (Somma et al. 1977). This lantibiotic is 
produced as a 19 residue propeptide from Actinoplanes garbadinensis and post-
translationally modified to introduce one Lan and three MeLan bridges (Figure 1.6) 
(Zimmermann et al. 1995). Deoxyactagardine B (DAB) is a 19 residue type B lantibiotic 
structurally similar to actagardine (Figure 1.6). The gar gene cluster from A. garbadinensis 
ATCC 31049, and the lig gene cluster from Actinoplanes liguriae NCIMB41362 have been 
 
Figure 1.4 : A schematic of seven representative lantibiotic gene clusters from low-GC 
Gram-positive bacteria.  
The gene clusters for type AI lantibiotics nisin, subtilin, epidermin and Pep5, the type AII 
lantibiotic lacticin 481, the type B lantibiotic mersacidin and the two-component lantibiotic 
lacticin 3147 are depicted. Several genes are represented in all the displayed gene 
clusters; i.e. the prepropeptide (A, S), the dehydratase and cylcase (B, C, M) and the ABC 
transporter (T). Promoter position and direction (where known) are indicated with red 
arrows. Figure adapted from Willey and van der Donk et al. 2007. 
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cloned and sequenced (Figure 1.5) (Boakes et al. 2009; Boakes et al. 2010). Despite the 
presence of a GarO-like mono-oxygenase, DAB lacks the sulfoxide bond seen in 
actagardine. The only other difference between DAB and actagardine are two amino acids 
at positions 15 and 16 (Figure 1.6). 
The biosynthetic gene clusters of cinnamycin, actagardine and DAB share common 
features, identifying key differences between high-GC as opposed to low-GC clusters 
(Widdick et al. 2003; Boakes et al. 2009; Boakes et al. 2010). All lack the typical LanT-
type lantibiotic exporter, instead encoding a two-component ABC transporter (Section 
1.3.4.2). Also missing is a LanP-type protease to cleave the leader peptide; instead the 
protease is likely encoded elsewhere in the genome (Section 1.3.4.3.1). 
Michiganin A has been purified and characterised from the tomato pathogen Clavibacter 
michiganensis subsp. michiganensis and resembles actagardine. Michiganin A is a type B 
lantibiotic produced as a 21 residue propeptide into which three MeLan bridges are 
introduced (Figure 1.6) (Holtsmark et al. 2006). 
A screen of extracts from uncommon actinomycetes by Vicuron Pharmaceuticals 
identified five potentially novel lantibiotics. Two of these lantibiotics were identified from 
members of the Streptosporangiaceae; planosporicin from Planomonospora sp. DSM 
14920 and microbisporicin from Microbispora sp. ATCC PTA-5024 (Castiglione et al. 
2007; Castiglione et al. 2008). Planosporicin is discussed in detail in Section 1.3.5. The 
gene cluster for microbisporicin biosynthesis was subsequently cloned and characterised 
from Microbispora corallina (Figure 1.5) (Foulston and Bibb 2010). The cluster revealed a 
typical actinomycete lantibiotic exporter (MibTU) but also several enzymes not previously 
observed in any lantibiotic gene clusters. In particular, a tryptophan halogenase (MibH) is 
proposed to be responsible for the chlorination of tryptophan observed in microbisporicin, 
and the cluster appears to be regulated through a combination of an extracytoplasmic 
function sigma factor (MibX) and anti-sigma factor (MibW) as well as a helix-turn-helix 
DNA binding protein (MibR) (Foulston and Bibb 2011).  
SapB is a lantipeptide encoded by ramS in the ram operon which is regulated by RamR 
(Figure 1.5). RamS is subject to post-translational modification to introduce four 
dehydroalanine (Dha) residues and two Lan bridges to create SapB (Figure 1.6). This 
lantipeptide does not possess antimicrobial activity but is instead a morphogenetic peptide 
important for aerial mycelium formation in S. coelicolor (Kodani et al. 2004). Similarly, 
Streptomyces tendae produces SapT, a lantipeptide with three MeLan bridges and one 
Lan bridge (Figure 1.6). SapB and SapT are both amphiphilic peptides which serve as 
biosurfactants to facilitate the emergence of newly formed aerial hyphae (Kodani et al. 
2005). 
  
35 
35 Chapter 1 : Introduction 
Figure 1.5 : A schematic of actinomycete lantibiotic biosynthetic gene clusters.  
Shown are genes encoding the prepropeptide (purple), modification enzymes (pink), two-
component ABC export systems (dark blue), putative regulators (light blue) and genes of 
unknown function (green) as described in the text. 
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Figure 1.6 : Representatives of lantibiotics produced by actinomycetes. 
Cinnamycin (Kaletta et al. 1991), actagardine (Zimmermann and Jung 1997), 
Deoxyactagardine B (Boakes et al. 2010), michiganin A (predicted) (Holtsmark et al. 
2006), sapB (Kodani et al. 2004), sapT (Kodani et al. 2005), cypemycin (Claesen and 
Bibb 2010), grisemycin (Claesen and Bibb 2011) and labyrinthopeptins A1, A2 and A3 
(Meindl et al. 2010). Residues are; unmodified (white), dehydrated (purple), dehydrated 
and cyclised residues (blue), other modifications (green). The same shorthand notation 
is used as defined in Figure 1.3. Abbreviations refer to; amino butyric acid (Abu), 
dehydroalanine (Dha), lanthionine (Ala-S-Ala), dehydrobutyrine (Dhb), methyl 
lanthionine (Abu-S-Ala), L-allo-isoleucine (aIle) and labionin (Lab). (Me)Lan rings of 
lantibiotics with structural  similarity to mersacidin are labelled in grey. 
 
 
 
 
  
37 
37 Chapter 1 : Introduction 
 
Figure 1.6 : Representatives of lantibiotics produced by actinomycetes (continued). 
 
Genome scanning identified a gene cluster from S. venezuelae that encoded a putative 
prepropeptide (VenA) and an unusual lanthionine synthetase (VenL) (Figure 1.5) (Goto et 
al. 2010). Homologues to this lanthionine synthetase, generically termed LanL, were 
identified in other gene clusters and are discussed further in Section 1.3.4.1.4. In vitro 
enzyme activity of VenL was used to produce venezuelin through the introduction of one 
Dha and three dehydrobutyrine (Dhb) residues; a Cys residue located in the nascent 
peptide chain was added to one of the Dhb residues to form a Lan bridge (Goto et al. 
2010). Venezuelin has a globular structure, but its biological activity and function remain 
to be determined (Goto et al. 2010). 
Cypemycin is a peptide antibiotic produced by Streptomyces sp. OH-4156 (Komiyama et 
al. 1993). Although it displays some antimicrobial activity against M. luteus, it also 
possesses significant cytocidal activity against P388 leukemia cells. The cloning and 
characterisation of the cypemycin gene cluster (Figure 1.5), led to the identification of a 
new class of modified peptide natural products, the linaridins (Claesen and Bibb 2010). 
These peptides are ribosomally synthesised and post-translationally modified to introduce 
a number of lantibiotic-like structural features, notably the dehydration of serine and 
threonine residues. However, the characteristic (Me)Lan bridges of lantibiotics are not 
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observed (Figure 1.6). Indeed the enzyme(s) responsible for dehydration are completely 
different to those of lantibiotic clusters (Section 1.4.3.1.5). Other members of this class 
have subsequently been identified and characterised, such as grisemycin produced by 
Streptomyces griseus IFO 13350 (Figure 1.5 and 1.6) (Claesen and Bibb 2011). 
The labyrinthopeptins were identified recently as a product of the actinomycete 
Actinomadura namibiensis DSM 6313 (Meindl et al. 2010). These ribosomally synthesised 
peptides are post-translationally modified to introduce the amino acid labionin, described 
in Section 1.3.4.3.5.3 (Figure 1.3). The sequencing of the gene cluster revealed a protein 
kinase-cyclase (LabKC) that phosphorylates serines then dehydrates these 
phosphoserines to Dha residues which are subsequently cyclised to form the labionin 
(Figure 1.5) (Meindl et al. 2010). Although labyrinthopeptins A1, A2 and A3 are structurally 
very different to other type III lantipeptides (Figure 1.6), the presence of a kinase-cyclase 
modification enzyme assigns it as a member of the type III class. 
The thiopeptides are a class of ribosomally synthesised, heterocycle-containing peptides 
produced by a range of phyla, including some actinomycetes. One striking example is 
goadsporin produced by Streptomyces sp. TP-A0584 (Onaka et al. 2005). This 
polypeptide antibiotic contains thiazole and oxazole rings introduced through enzymes 
which appear either similar to lanthionine synthetases or enzymes involved in microcin 
biosynthesis. The microcins are a class of ribosomal peptides, some of which are 
extensively post-translationally modified to create a range of structures cidal to other 
enterobacteria. GodE bears resemblence to McbC involved in Microcin B17 formation, 
while GodF and GodE are more similar to LanB-type dehydratases of lantibiotic gene 
clusters (Onaka et al. 2005). 
 
1.3.3 Lantibiotic mode of action 
The two main methods through which antibiotics target bacteria are the inhibition of either 
cell wall biosynthesis or protein synthesis. Both these targets involve molecules which are 
not found in eukaryotes so are also used widely in clinical treatments of bacterial 
infections. The most commonly used antibacterials are the β-lactam antibiotics such as 
the penicillins, aminopenicillins and cephalosporins. Other chemical classes of secondary 
metabolites with antibiotic properties are the aminocoumarins, tetracyclines, macrolides, 
aminoglycosides, lincosamides and the polyene antibiotics as well as peptide, 
glycopeptide and lipopeptide antibiotics. There are also a number of synthetic 
antibacterials which include the fluoroquinolones, oxalidinones, sulfonamides and 
nitroimidazoles.  
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Although the range of organisms inhibited by different lantibiotics varies, all lantibiotics are 
primarily active against Gram-positive species. However, if the outer membrane of Gram-
negatives is disrupted, then some activity can be observed (Stevens et al. 1991). Many 
lantibiotics act through the inhibition of cell wall biosynthesis. Lipid II is a membrane-
bound monomeric cell wall precursor that delivers cell wall monomers to the membrane 
for polymerisation into the cell wall (Figure 1.7). Inhibition of cell wall biosynthesis 
effectively inhibits cell division and increases likelihood of cell lysis due to internal osmotic 
pressure (Bauer and Dicks 2005; Breukink and de Kruijff 2006). Lipid II is a complex 
biosynthetic intermediate biosynthesised from UDP-GlcNAc in eight successive enzyme-
catalysed steps (van Heijenoort 2001). Therefore, targeting lipid II poses a more difficult 
problem to pathogens than targeting a single enzyme whose active site could be modified 
more easily. The effectiveness of targeting lipid II as an antibacterial strategy is 
highlighted by the fact that it is targeted by several different classes of antibiotic (Figure 
1.7). While other antimicrobial classes often target protein synthesis, lantibiotics are 
mainly cell wall synthesis inhibitors or pore formers. The formation of pores in the 
cytoplasmic membrane dissipates the proton motive force (PMF). The PMF is a 
combination of the chemical potential energy (the difference in concentration of the 
protons on each side of the membrane) and the electrical potential energy (a 
consequence of the charge separation across the membrane). These gradients drive ATP 
synthesis, so the collapse of the PMF means the cell cannot power energy-requiring 
reactions and consequently dies. 
Nisin is the most extensively characterised of all lantibiotics and its mode of action is well 
understood. To date, six naturally occurring variants have been described, four from 
different strains of L. lactis and two from Streptococcus species. The efficacy of nisin and 
the absence of resistance despite over 40 years of use in the food industry as a 
preservative is thought to be due to a dual mechanism of cell killing. Nisin Z has been 
shown through confocal fluorescence microscopy to sequester lipid II from sites of cell 
wall biosynthesis such as the cell division septum (Hasper et al. 2006). The addition of 
nisin to Bacillus sp. and susceptible L. lactis was observed to perturb the normal 
distribution of lipid II, preventing its accumulation at specific sites. Thus the peptidoglycan 
units carried by lipid II are not available, uncoupling cell wall synthesis from membrane 
synthesis, and causing bacterial lysis (Hasper et al. 2006). The N-terminus of nisin 
consists of two thioether crosslinks referred to as the A and B rings (Figure 1.8). Nuclear 
magnetic resonance (NMR) studies have revealed these rings wrap around the 
pyrophosphate group of lipid II, allowing the formation of five intermolecular hydrogen 
bonds (Figure 1.9). These rings form a cage encapsulating the pyrophosphate moiety of 
lipid II (Hsu et al. 2004). The binding of lipid II by the N-terminus is a key step in the 
second mode of action mediated through the C-terminus. The recruitment of nisin 
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monomers to the membrane facilitates oligomerisation to form trans-membrane pores, 
leading to osmotic shock and cell lysis (Hasper et al. 2004). The region between the third 
and fourth (Me)Lan rings in nisin acts as a hinge and is essential for pore formation. Site-
specific mutations to the nisin hinge region prevent pore formation without affecting the 
bacteriocidal activity of nisin (Hasper et al. 2004). Thus the hinge allows insertion of nisin 
molecules into the membrane where four nisin molecules form a complex with eight lipid II 
molecules to form a stable structure resistant to disruption by mild detergents (Hasper et 
al. 2004). 
 
 
 
Figure 1.7 : The structure of lipid II.  
The N-acetylglucosamine-β-1,4-N-acetylmuramic acid disaccharide (GlcNAc–MurNAc) is 
attached by a pyrophosphate to a membrane anchor of 11 isoprenoid units 
(undecaprenylpyrophosphate). The muramic acid bears a pentapeptide that contains a Lys 
residue for later cross-linking. The binding site of the glycopeptide vancomycin and the 
lantibiotic nisin are indicated in red. 
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Figure 1.8 : Lantibiotics with N-terminal structural similarity to nisin.  
Nisin, subtilin (Gross et al. 1973), microbisporicin (Castiglione et al. 2008), epidermin 
(Allgaier et al. 1985), gallidermin (Kellner et al. 1988), clausin (Bressollier et al. 2007) and 
mutacin 1140 (Smith et al. 2000). Residues are; unmodified (white), dehydrated (purple), 
dehydrated and cyclised residues (blue).  The same shorthand notation is used as defined 
in Figure 1.3. The N-terminal A and B rings proposed to bind lipid II are labelled in grey. 
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Crucially, it is the backbone of the nisin peptide chain which forms five hydrogen bonds to 
the pyrophosphate, with no involvement of the specific side-chains of each amino acid 
residue. Consequently, other lantibiotics with nisin-like A and B rings at the N-terminus are 
bacteriocidal due to their ability to bind lipid II (Bonelli et al. 2006; Hasper et al. 2006). 
Epidermin and gallidermin share a high degree of homology with the A and B rings of 
nisin and have been shown to bind lipid II (Figure 1.8). One key difference is at position 4 
which is a lysine in epidermin and gallidermin, compared to isoleucine in nisin. The 
change in charge of the side-chain, from neutral to positive, may increase affinity to the 
pyrophosphate of lipid II, and it is interesting to note that gallidermin and epidermin have 
10-20 times the bacteriocidal activity of nisin, perhaps due a higher efficacy of binding 
increasing the efficiency of cell wall inhibition (Bonelli et al. 2006; Rink et al. 2007b). 
Alternatively, there is some evidence to suggest that the C-termini of epidermin and 
gallidermin are able to interact with the prenyl chain of lipid II as a second mechanism of 
inhibition which could account for its increased binding efficacy (Hans-Jorg Sahl, personal 
communication). However there is also some evidence that like nisin, epidermin and 
gallidermin may also form pores, although the shorter length (22 amino acids, compared 
to 34 in nisin) means that the efficiency of lipid II-mediated pore formation by gallidermin 
appears to vary with the thickness of model membranes (Bonelli et al. 2006). Assays with 
intact cells, indicated that the pore-forming ability of gallidermin did not significantly 
 
Figure 1.9 : NMR resolved solution structure of nisin in complex with the lipid II variant 3LII 
(shortened prenyl tail of 3 isoprene units instead of 11 in full-length lipid II).  
A; Ensemble of the 20 lowest-energy NMR structures. The backbone of nisin (residues 1-
19) is blue with the (Me)Lan rings A-C labelled, 3LII is green. B; The N-terminus of nisin 
(residues 1-12) encage the pyrophosphate moiety of 3LII. Nisin is shown as a space-filled 
model with side chains in green and labelled. 3LII is shown as a skeletal model with C, N, 
O and P in white, blue, red and cyan respectively. Figures from Hsu et al. 2004.  
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contribute to killing (Bonelli et al. 2006). Thus the high potency of epidermin and 
gallidermin is likely due to a higher affinity for lipid II. 
Other lantibiotics sharing similarity to nisin at the N-terminus include clausin and mutacin 
1140 (Figure 1.8). Clausin has been shown to interact with lipid II (Wiedemann et al. 
2006a). Similarly, mutacin 1140 (also known as mutacin III) has demonstrated inhibition of 
cell wall synthesis (Smith et al. 2008). 
The structure-activity relationships of most lantibiotics are poorly defined due to the lack of 
molecular detail elucidated from antibiotic-target interactions. The existence of unrelated 
compounds possessing similar mechanisms of action often means that conclusions drawn 
from structure-activity studies on one lantibiotic cannot readily be applied to another. For 
example mersacidin is a type B lantibiotic with no structural similarity to nisin, yet it inhibits 
cell wall biosynthesis through an interaction with lipid II. Mersacidin acts by inhibiting the 
transglycosylation reaction of bacterial cell wall biosynthesis via interaction with the 
disaccharide-pyrophosphate region of lipid II (Brotz et al. 1998). This interaction relies on 
the highly flexible Ala12-Abu13 region and the flexible glycine rich region (Figure 1.10) (Hsu 
et al. 2003). The removal of Glu17 (located in the C-ring) inactivated mersacidin, implying 
that it may be involved in the Lipid II interaction (Szekat et al. 2003). A more extensive 
mutagenesis analysis revealed that the A-ring of mersacidin could not be extended and 
that the B-ring was particularly amenable to substitutions and insertions (but not deletions) 
(Appleyard et al. 2009). 
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Actagardine and DAB are structurally similar to mersacidin and are proposed to bind lipid 
II in a similar manner (Zimmermann and Jung 1997). Specifically, five out of six residues 
in the C-ring of mersacidin and the B-ring of actagardine and DAB are conserved, forming 
a ‘CTLTXEC’ motif (Figure 1.6 and 1.10). However, the residue that differs (Dha at 
position 16 of mersacidin, compared to Ile at position 10 of actagardine and DAB) is 
essential for mersacidin activity. Site-directed mutagenesis to produce S16I mersacidin 
yielded only small amounts of the product with markedly reduced antimicrobial activity 
(Szekat et al. 2003). The broad activity spectrum of these lantibiotics differs, indicating 
other structural features play a role in bioactivity. 
 
 
Figure 1.10 : Structures of lantibiotics containing a conserved methyl-lanthionine ring 
proposed to bind lipid II (in red).  
The glutamate shown to be essential for mersacidin and haloduracin antimicrobial activity 
is illustrated in blue. The proposed structure of plantaricin C is shown (the stereochemistry 
of the lanthionine between residues 7 and 27 is not known). (Me)Lan rings are labelled A, 
B, C and D. Figure from (Cooper et al. 2010). 
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Other lipid II binding molecules of the mersacidin class include the α-peptide of the two-
component lantibiotics lacticin 3147 and haloduracin produced by L. lactis subsp. lactis 
DPC 3147 and Bacillus halodurans respectively (Figure 1.10). Like actagardine, these 
only possess similarity with the C-ring of mersacidin (the Dha in position 16 of mersacidin 
is His in lacticin 3147 A1 and Val in haloduracin α). Opening the equivalent ring in lacticin 
3147 abolished bioactivity (Field et al. 2007; Cooper et al. 2008). However it may only be 
the sequence conservation within the ring which is essential for lipid II binding; when 
haloduracin was synthesised without the Lan bridge, antibacterial activity was maintained 
(Cooper et al. 2008). There is overall similarity between the C-rings of mersacidin, lacticin 
3147 A1 and plantaricin C, and the B-ring in haloduracin α (Figure 1.10). These rings 
have structural similarity to the A-ring of lacticin 481 (Figure 1.10) and the C-ring of 
lichenicidin α (Begley et al. 2009). However there is reduced sequence identity as the Leu 
and Dha at positions 14 and 16 of mersacidin are Ile and His in lacticin 481, and Val and 
Lys in lichenicidin α. The structural similarity combined with the observed lipid II-
dependent activities of several of these lantibiotics implies that this ring similarity may 
correspond to antimicrobial activity for all members. For example, complete alanine 
scanning mutagenesis of each of the 30 amino acids of LtnA1 (and the 29 amino acids of 
LtnA2) revealed nearly all residues in the C-ring of LtnA1 were essential for bioactivity 
(Cotter et al. 2006). 
In summary the mode of action has only been demonstrated for a small number of 
lantibiotics, but this can be extended to others on the basis of structural similarity. It is 
likely that members of the nisin-like subgroup (subtilin, ericin A and S) and the epidermin-
like subgroup (gallidermin, mutacin 1140 and clausin) bind lipid II through the A and B 
rings. A second mechanism of cell death through pore formation is combined with lipid II 
binding in several nisin-like lantibiotics as well as other types of lantibiotics. In lacticin 
3147, the two components interact synergistically. Lacticin 3147 A1 binds lipid II, however 
this peptide alone has only marginal antibiotic activity. Crucially, lacticin 3147 A2 is able to 
bind the LtnA1–lipid II complex, prompting strong inhibition of cell wall biosynthesis and 
the formation of pores (Wiedemann et al. 2006b). However, pore formation may also 
occur independently as a mechanism of action in other lantibiotics such as plantaricin C, a 
type AII lantibiotic classified in the lacticin 481 subgroup (Figure 1.10). This globular 
lantibiotic has a positively charged, unbridged N-terminus proposed to insert into the 
membrane due to electrostatic interactions with anionic phospholipids (Gonzalez et al. 
1994; Turner et al. 1999). The type B lantibiotics are split into two groups. The mersacidin 
group bind lipid II in a different manner to the type AI lantibiotics. The structural motif 
responsible for binding is also observed in several of the two-component lantibiotics; 
lacticin 3147, lichenicidin and haloduracin. The cinnamycin group possesses a different 
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mode of action entirely. Cinnamycin binds to phosphatidylethanolamine in the membrane 
and thus disrupts membrane morphology and stability (Makino et al. 2003). 
 
1.3.4 Lantipeptide biosynthesis 
The generic locus symbol lan is used to refer to lantibiotic biosynthetic genes until a more 
specific name for each lantibiotic is assigned (e.g. in this work psp is used to refer to 
planosporicin biosynthetic genes) (Patton and van der Donk 2005). Lantibiotics are 
encoded as a prepropeptide by a structural gene (lanA) whose product is post-
translationally modified then exported from the cell. The genes encoding these proteins 
are found clustered together either on the chromosome (e.g. subtilin) or on a plasmid (e.g. 
nisin) (Chatterjee et al. 2005). The prepropeptide consists of the future mature peptide 
sequence (propeptide) at the C-terminus and an N-terminal leader peptide. Numerous 
experiments on different lantibiotic systems suggest three different roles for the leader 
peptide. 
There is much evidence for the leader peptide acting as a scaffold for the binding of 
lantibiotic modification enzymes. The expression of a chimera consisting of the subtilin 
leader fused to an N-terminal nisin - C-terminal subtilin structural region in a strain of B. 
subtilis 168 (encoding all of the cellular machinery for subtilin biosynthesis except for the 
prepropeptide), resulted in production of the corresponding mature lantibiotic (Chakicherla 
and Hansen 1995). Site-directed mutagenesis on different residues of the leader peptides 
of nisin, Pep5 and mutacin II demonstrate weak dependence of enzymatic processing on 
point mutations, indicating the recognition of the leader is through tertiary structural 
elements, not conserved residues (van der Meer et al. 1994; Neis et al. 1997; Chen et al. 
2001). The in vitro reconstitution of lacticin 481 biosynthesis demonstrated that neither the 
length of the leader or any one specific residue is essential for correct modification. 
Instead it is the general properties of each amino acid which matter, for example the 
hydrophobic residue at position 7 is important for the maturation process (Patton et al. 
2008). 
There is also evidence for a role of the leader peptide in signalling for export. As 
described above, the subtilin leader fused to a nisin-subtilin structural region is modified 
and exported from B. subtilis 168 (Chakicherla and Hansen 1995). L. lactis expressing the 
nisT transporter was capable of excreting both unmodified and partially or fully post-
translationally modified forms of prenisin and fusions of the leader peptide with non-
lantibiotic peptides (Kuipers et al. 2004). The lantibiotic transporter is often capable of 
recognising similar lantibiotic leader peptides, however cleavage of the leader peptide to 
release the mature lantibiotic does not always occur. Expression of the subtilin leader 
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peptide DNA sequence fused to the sequence encoding pronisin Z in L. lactis resulted in 
production of the unmodified leader peptide of subtilin linked to a fully matured nisin Z 
structural region (Kuipers et al. 1993b). Leader peptides often contain the motif for 
cleavage by the protease. The purification of the N-terminal protease domain of LctT 
enabled an assessment of the in vitro production of lacticin 481 from variants of the 
prepropeptide (Furgerson Ihnken et al. 2008). Site-directed mutagenesis of the LctA 
leader peptide showed cleavage was slow if Glu8 was mutated and abolished if the GG 
motif was mutated, whereas there was no defect if mutations were made in the propeptide 
or nonconserved residues in the leader peptide (Furgerson Ihnken et al. 2008). However, 
the observation that NisB and NisC have a role in the rate of nisin production could 
undermine the leader peptide role as a recognition motif for export (van Saparoea et al. 
2008). It is suggested that a channeling mechanism of prenisin transfer occurs between 
NisB, NisC and NisT so that once prenisin has found this cluster of enzymes, the leader 
peptide may be less important as transfer between enzymes occurs by diffusion. 
A third role for the leader peptide is in host immunity. In many systems the modified 
lantibiotic shows no activity as long as the leader peptide remains attached. This 
protective role of the leader has been shown for several lantibiotics, including nisin (van 
der Meer et al. 1993; van der Meer et al. 1994), subtilin (Stein and Entian 2002; Corvey et 
al. 2003), lacticin 481 (Xie et al. 2004) and mutatcin II (Chen et al. 2001). 
 
1.3.4.1 Biosynthetic genes 
1.3.4.1.1 LanB 
lanB genes are characteristic of class I lantibiotic clusters. They encode a ~120 kDa 
protein responsible for the dehydration of serine and threonine amino acids to form 2,3-
didehydroalanine (Dha) and (Z)-2,3-didehydrobutyrine (Dhb), respectively (Figure 1.11). 
The first evidence for a role in the formation of these characteristic non-proteogenic amino 
acids came through in vivo work. Targeted mutations in producing strains indicated a role 
for LanB in the dehydration of serine and threonine residues in Pep5 and nisin (Meyer et 
al. 1995; Koponen et al. 2002). Further work demonstrated that LanB is necessary for 
dehydration in a non-producing L. lactis strain. Expression of the nisABTC genes 
efficiently produced fully post-translationally modified prenisin, while expression of just 
nisBT could produce dehydrated prenisin without thioether rings and a dehydrated form of 
a non-lantibiotic peptide (Kuipers et al. 2004). Interestingly, the dehydrations of Ser/Thr 
yielding Dha/Dhb groups in thiopeptides are mediated by enzymes resembling LanB-type 
lantibiotic dehydratases (Li and Kelly 2010). 
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Subsequently, focus has moved to the expression and purification of an active LanB in 
order to study the enzymatic reaction mechanism. Although this has so far proved elusive, 
a substantial amount of information has been accrued along the way. LanB enzymes are 
overall hydrophilic proteins, but contain some hydrophobic domains which imply it may be 
membrane associated. This is supported by the observed co-sedimentation of NisB and 
SpaB with membrane vesicles (Engelke et al. 1992). Yeast-two-hybrid and 
immunoprecipitation studies have suggested that LanBCT enzymes are only active in a 
multimeric lanthionine synthetase complex. For example in nisin biosynthesis, yeast-two-
hybrid revealed an interaction between NisB and NisC as well as an interaction between 
NisC and the NisT, and implied that at least two molecules of NisC and two molecules of 
NisT are part of the complex (Siegers et al. 1996). Likewise a complex of at least two 
each of SpaT, SpaB, and SpaC were demonstrated to be associated with the substrate 
subtilin through yeast-two-hybrid and coimmunoprecipitation experiments (Kiesau et al. 
1997). Yet in vivo data indicates a lack of mutual dependence for activity, as deletions of 
lanC do not prevent the dehydration by LanB, and deletions of lanB do not prevent 
cyclisation by LanC (Meyer et al. 1995; Koponen et al. 2002).  
In the absence of active purified LanB, heterologous expression systems have been 
established to demonstrate the substrate promiscuity of LanB through the expression of 
chimeras and non-lantibiotic peptides. The production of non-naturally occurring peptides 
containing a series of Dhb residues from L. lactis was achieved through expressing both 
nisBT and a plasmid encoding a specific leader peptide fusion construct (Rink et al. 
2007c). Novel hexapeptides fused to the nisin leader and expressed in a L. lactis strain 
 
Figure 1.11 : Dehydration and cyclisation of lantibiotic prepropeptides.  
The dehydration of Ser/Thr to form Dha/Dhb is catalysed by LanB or LanM. The 
intramolecular addition of Cys thiols onto Dha/Dhb to form Lan/MeLan is catalysed by 
LanC or LanM. 
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containing the nisin modifying and export enzymes resulted in the production of correctly 
modified fusion peptides (Rink et al. 2005). A L. lactis strain containing nisBTC was found 
to effectively dehydrate and secrete a wide range of non-lantibiotic peptides, many of 
which also demonstrated ring formation (Kluskens et al. 2005). The non-lantibiotic 
peptides included a number of animal hormones such as vasopressin, angiotensin and 
erythropoietin. Post-translational modifications by NisB and NisC still occur when the nisin 
leader is preceded by a 27 amino acid Sec signal peptide, enabling exploitation of the Sec 
pathway of L. lactis for the secretion of dehydrated variants of therapeutic peptides 
(Kuipers et al. 2006). 
 
1.3.4.1.2 LanC 
lanC genes encode 400-450 amino acid enzymes responsible for cyclisation reactions 
yielding Lan and MeLan bridges. Dha and Dhb are subject to nucleophilic attack by the 
thiol group from a cysteine residue located elsewhere in the peptide chain. This 
intramolecular cyclisation reaction forms characteristic thioether crosslinks. Those formed 
from Dha are Lan bridges, while those formed from Dhb are MeLan bridges (Figure 1.11).  
Section 1.3.4.1.1 referred to studies in which LanBCT enzymes were found only to be 
active in a multimeric lanthionine synthetase complex (Siegers et al. 1996; Kiesau et al. 
1997). Evidence for the role of NisC was initially provided through in vivo work. His-tagged 
nisin precursors expressed in a nisC mutant were dehydrated but did not contain (Me)Lan 
bridges, implying NisC is required for nisin maturation (Koponen et al. 2002). 
Subsequently, purified NisC was able to perform all five cyclisation reactions on a 
dehydrated NisA substrate, confirming the activity of NisC in vitro. (Li et al. 2006). Further 
in vivo work has demonstrated the relaxed substrate specificity of LanC enzymes. NisC is 
able to cyclise a variety of peptides unrelated to nisin, as long as they are fused to the C-
terminus of the NisA leader peptide (Rink et al. 2007a).  
Overall, sequence identity between LanC enzymes is low, only 20-30 %, but there are a 
few strictly conserved histidine and cysteine residues. These were proposed to act as 
ligands to coordinate zinc binding which likely has a role in the activation of Dha and Dhb 
residues (Okeley et al. 2003). This has been verified through the X-ray-structure of NisC 
(Li et al. 2006). Subsequent mutagenesis identified residues essential for catalysis in NisC 
and SpaC (Helfrich et al. 2007; Li and van der Donk 2007). 
In a regioselective reaction, bond formation occurs in one direction. In type A lantibiotics, 
cyclisation occurs in the C-to-N terminal direction to form an endocyclic enolate, whereas 
some substrates of type B lantibiotics undergo cyclisation in the opposite direction to form 
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an exocyclic enolate (Zhou and van der Donk 2002). There is evidence the leader peptide 
controls the regioselectivity of (Me)Lan formation (Section 1.3.4.1.3). In the cyclisation 
reaction, the thiol functional group of the cysteine residue undergoes a 1,4-nucleophilic 
attack on the Michael acceptor system of the Dha/Dhb. It has been observed that the 
cyclisation of short peptide analogues of type A lantibiotic ring systems occurs 
spontaneously to form the naturally occurring Lan or MeLan diastereomer (Zhou and van 
der Donk 2002). However in type B lantibiotics, some cyclisations occur in the N-to-C 
terminal direction and there is evidence to suggest that in the absence of LanC, a mixture 
of stereoisomers is created (Zhou and van der Donk 2002). Likewise there is an indication 
of a similar tendancy towards the natural stereoisomer in nonenzymatic cyclisations of 
precursors. Although a mixture of stereoisomers is created, the major product has the 
stereochemistry of the natural lathionine. However these results are only clear-cut when 
the substrate only has the capacity to form one ring. In more complex substrates 
chemoselectivity is apparent, as cysteine residues will react preferentially with Dha rather 
than Dhb to form Lans over MeLans. (Zhou and van der Donk 2002). Therefore the main 
challenge for LanC enzymes is not the activation of the reaction or the control of 
stereochemistry and regioselectivity of this cyclisation but is instead to overcome the 
chemoselectivity that would otherwise result in Lan formation over MeLan formation. 
 
1.3.4.1.3 LanM 
As an alternative to the individual LanB and LanC genes, type AII lantibiotic gene clusters 
encode a single bifunctional LanM responsible for both the dehydration and cyclisation 
reactions (Figure 1.11). While the N-termini of LanM enzymes share no similarity to LanB 
enzymes, the C-termini share ~20 % identity to LanC enzymes (Okeley et al. 2003). 
Subsequent to the successful in vitro reconstitution of LanC enzymes, three LanM 
enzymes were purified for use in assays. LctM, HalM1 and HalM2, responsible for the 
modification of lacticin 481, haloduracin α and haloduracin β, respectively, all 
demonstrated dehydratase and cyclase activity in vitro (Xie et al. 2004; McClerren et al. 
2006). Studies on LctM and HalM2 suggested that substrate binding via an N-terminal 
leader results in dehydration and cyclisation with a strong preference for N to C 
directionality, providing evidence on the role of the leader peptide in controlling the 
regioseletivity of (Me)Lan formation (Levengood et al. 2007).  
The two functions performed by LanM enzymes are likely achieved through different 
active sites. The detection of completely dehydrated substrates with no or little cyclisation 
supports the hypothesis that all the dehydration reactions are catalysed before ring 
cyclisation begins (Miller et al. 2006). Conserved residues in the cyclase domain on LanM 
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include three zinc ligands and the equivalent of His212 in NisC, the residue proposed to be 
involved in the activation of Dha/Dhb (Li and van der Donk 2007). In accordance with this, 
site-directed mutagenesis of these residues in LctM decreased or abolished cyclisation 
without affecting the dehydration of lacticin 481 (Paul et al. 2007). These results imply 
separate dehydratase and cyclase domains perform the two reactions independently. 
In general, the biosynthetic gene clusters of two component lantibiotics encode an 
individual LanM for each peptide. Exceptions occur when the two substrates are highly 
similar, such as with cytolysin (Gilmore et al. 1994). This would tend to imply substrate 
specificity, but as with LanC enzymes, LanM have remarkable versatility in cyclisation of a 
variety of peptides. Purified LctM was able to process nonlantibiotics and even non-
proteinogenic residues such as homocysteine and β-homocysteine to generate novel 
thioether linkages (Chatterjee et al. 2006). This promiscuity has subsequently been 
exploited in the preparation of analogues of both type AI (e.g. subtilin (Liu and Hansen 
1992)) and type B (e.g. mersacidin (Szekat et al. 2003)) lantibiotics. Whilst most studies 
have focused on model antibiotic-producing bacteria, the smaller genomes of 
cyanobacteria have made use of the promiscuous nature of LanM enzymes. The 
planktonic marine bacterium Prochlorococcus MIT9313 encodes a single LanM enzyme 
able to recognise up to 29 different linear ribosomally synthesised peptides as substrates 
to generate an array of polycyclic, conformationally constrained products with highly 
diverse ring topologies (Li et al. 2010). 
 
1.3.4.1.4 RamC/LanL 
RamC is the cyclase responsible for the formation of Lan bridges in the lantipeptide SapB 
introduced in Section 1.3.2 (Kodani et al. 2004). The structure of this cyclase is unlike that 
of the LanB-like or LanM-like enzymes. The N-terminus of RamC exhibits similarity to 
catalytic domains of Ser/Thr kinases while the C-terminus has some sequence similarity 
to the C-terminal domain of LanM (Hudson and Nodwell 2004). The kinase domain is 
thought to be involved in phosphorylation of the Ser residues to facilitate dehydration, with 
the C-terminal domain catalysing subsequent Lan formation (despite lacking the 
characteristic zinc-binding and catalytic residues of LanC-like domains). 
More recently it has become apparent that RamC is part of a larger group of lantipeptide 
synthetases, sometimes referred to as class III (whereas LanB/C are class I and LanM are 
class II). This class includes enzymes with the generic name LanL, of which VenL was the 
first to be characterised (Goto et al. 2010). Individual expression of each VenL domain 
revealed that Ser and Thr residues are first phosporylated by the kinase domain, followed 
by an elimination catalysed by the lyase 
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(Goto et al. 2010). Subsequent addition of the Cys thiols onto these dehydrated residues 
is performed by the cyclase domain, which contains a LanC-like zinc-binding site and 
active-site residues, yielding (Me)Lan bridges (Goto et al. 2010). Significantly, the 
expression of the VenL N-terminus is the first example of an in vitro reconstituted peptide 
dehydratase, as previously only bifunctional lantipeptide synthetases had been 
reconstituted in vitro. 
 
1.3.4.1.5 Linaridins  
Recently, a new class of post-translationally modified peptides have been identified in 
which modifications previously described in lantibiotics are carried out by unusual 
enzymes or via an alternative modification pathway to those described in lantibiotic 
biosynthesis. These clusters contain cypL homologs and are proposed to be involved in 
the biosynthesis of non-cyclised peptides containing dehydrated amino acids, referred to 
as linaridins (Claesen and Bibb 2010). The type member of the linaridin family is 
cypemycin (described in Section 1.3.2). The cyp cluster does not contain a conventional 
LanB enzyme, instead CypH and CypL are essential for cypemycin biosynthesis. It is 
proposed that CypH and/or CypL are responsible for dehydration of the Thr residues of 
cypemycin to Dhb, however neither CypH nor CypL activity could be reconstituted in vitro 
(Claesen and Bibb 2010). 
 
1.3.4.2 ABC transporters 
ATP-binding cassette (ABC) transporters transduce the free energy of ATP hydrolysis to 
power the translocation of substrates across cell membranes. The ABC superfamily 
consists of transporters with two distinct domains, the transmembrane domain (TMD) and 
the nucleotide-binding domain (NBD). The TMD structure is variable but always contains 
several alpha helices enabling the protein to be embedded in the membrane bilayer 
where it recognises the substrate and undergoes a conformational change resulting in 
transport across the membrane. In contrast the NBD is highly conserved in sequence and 
is located in the cytoplasm where it forms the site for ATP binding. 
The TMD and NBD may be present as two domains of one protein or be encoded on 
separate peptides. The structural architecture of each ABC transporter consists minimally 
of two TMDs and two NBDs, both of which may be present as homodimers or 
heterodimers. Four individual polypeptide chains consisting of two TMD and two NBD 
subunits, may combine to form a full transporter. More commonly, the NBD and TMD 
domains are fused together into a single protein. Many exporters consist of a homodimer 
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of two monomers containing an N-terminal TMD and a C-terminal NBD. In an extension of 
this, all four domains may be fused into a single polypeptide chain arranged as TMD-
NBD-TMD-NBD.  
ABC transporters encoded in lantibiotic gene clusters demonstrate a wide variety of 
architectures. The type of transporter observed in each cluster depends both on the type 
of lantibiotic exported and the phylogeny of the producing organism. Low-GC producers of 
type AI lantibiotics typically encode a single LanT with significant homology to the 
hemolysin B ABC transporter. The E. coli hemolysin exporter HlyB is a single polypeptide 
encoding two TMD and two NBD domains. NisT consists of an N-terminal TMD containing 
six transmembrane helices and a C-terminal NBD, and dimerises to form the functional 
transporter (Qiao and Saris 1996). 
The ABC transporters of type AII lantibiotic clusters from low-GC organisms are similar in 
architecture to type AI clusters but many bear an additional domain at the N-terminus. 
This domain has peptidase activity to cleave the leader peptide as the lantibiotic is 
exported from the cell. This peptidase recognises a double-glycine cleavage site in 
combination with other features of the substrate. This confers the substrate specificity 
which prevents the heterologous production of lacticin 481 through the LcnC transporter 
from an L. lactis strain expressing LctA and LctM genes (Uguen and Uguen 2002). 
In contrast, high-GC producers of type AI and type B lantibiotics encode the NBD and 
TMD domains on two different peptides. For example the cinnamycin, actagardine and 
microbisporicin exporters are CinTH, GarTH and MibTU respectively (Widdick et al. 2003; 
Boakes et al. 2009; Foulston and Bibb 2010). It is presumed that two copies of each 
protein come together to form a tetramer consisting of two homodimers.  
A second ABC transporter is present in many lantibiotic gene clusters to provide a 
mechanism of producer immunity. Many of these proteins are homologous to members of 
the type B ABC transporters of the HisP family. The first to be identified was the NisFEG 
transporter of L. lactis 6F3. Deletion mutants of nisF, nisE and nisG continued to produce 
nisin but were more sensitive to nisin compared to the WT strain (Siegers and Entian 
1995). The functional transporter has the architecture NisF2EG with NisE and NisG 
forming a heterodimer of TMDs and NisF forming a homodimer of two NBDs.  
Several proposals have been suggested to link the mechanism of lantibiotic action to the 
mechanism of the ABC transporter. It has been proposed that LanFEG proteins may 
scavenge lantibiotics that have bound lipid II and/or inserted into the membrane and 
secrete them back out of the cell (Chatterjee et al. 2005). This is supported by the 
observation that lantibiotic concentrations are higher in the supernatant from cells that 
express the LanFEG transporter, indicating a reasonable efficacy of releasing the 
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lantibiotic from the cell surface. Evidence for this comes from heterologous expression of 
nisFEG in a nisin-sensitive strain of B. subtilis which conferred immunity to nisin. This was 
assessed through quantitative in vivo peptide release assays which revealed that NisFEG 
reduced the number of nisin molecules associated with the membrane, presumably 
through transport back into the extracellular space (Stein et al. 2003). Similarly, HPLC 
analysis of the epidermin-producing strain Staphylococcus epidermidis Tu3298 indicated 
that the EpiFEG transporter functions to release epidermin from the cytoplasmic 
membrane (Otto et al. 1998). 
 
1.3.4.3 Other modification enzymes 
1.3.4.3.1 Protease 
As mentioned in Section 1.3.4.2, class II LanT transporters have an additional N-terminal 
peptidase domain and are proposed to cleave the leader peptide to release the mature 
lantibiotic concomitantly with export out of the cytoplasm. The protease domain of LctT 
has been experimentally validated through purification and use in vitro to cleave the LctA 
prepropeptide at the double-glycine site to release mature lacticin 481 (Ihnken et al. 
2008). 
In contrast, class I lantibiotic gene clusters do not use a bifunctional transporter. Instead, 
many encode a separate subtilisin-type serine protease, which may be located 
intracellularly, extracellularly, or anchored to the cell wall surface. NisP, the protease 
responsible for cleavage of the nisin leader, is an example of a protease located on the 
external face of the cell membrane (Schneewind et al. 1995). Evidence for this is provided 
through the observation that supernatant and membrane-free extracts of L. lactis 9800 
were unable to remove the leader from the NisA precursor, whereas whole L. lactis 9800 
cells or cell extracts from E. coli overexpressing NisP demonstrated protease activity (van 
der Meer et al. 1993). Thus NisT exports the post-translationally modified nisin 
prepropeptide, prior to cleavage of the leader peptide. Further work on this system has 
revealed that the arginine at position -1 and the alanine at position -4 in the NisA 
prepropeptide are necessary for cleavage by NisP (van der Meer et al. 1994). The 
presence of (Me)Lan bridges appear to be an additional requirement, as unmodified or 
dehydrated precursor peptides were not recognised by NisP in vivo (Kuipers et al. 2004). 
EpiP is proposed to be an extracellular protein initially translated as a pre-pro-enzyme that 
is subsequently cleaved to reveal the active protease. Like NisP, the arginine at position -
1 of the prepropeptide is essential for cleavage of the leader, but unlike NisP, there 
appears to be no requirement for the presence of (Me)Lan bridges (Geissler et al. 1996). 
The proteases for Pep5, epilancin K7 and lactocin S production (PepP, ElkP and LasP 
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respectively) are all proposed to cleave the leader peptide whilst the prepropeptide is still 
in the cytoplasm. This processing step is linked to the ability of the transporter to export 
the lantibiotic across the membrane (Meyer et al. 1995). 
Although all lantibiotics are ribosomally synthesised with a leader peptide, many 
biosynthetic gene clusters appear not to encode a protease. The best characterised 
example is the subtilin cluster from B. subtilis ATCC 6633. Initial evidence implying the 
role of an extracellular protease came from the observation that culture supernatant from 
a Bacillus strain unable to produce subtilin was able to cleave the leader peptide when 
incubated with subtilin containing (Me)Lan bridges (Stein and Entian 2002). Further 
analysis revealed three of the five extracellular serine proteases encoded by B. subtilis 
were able to cleave the leader peptide to release the mature lantibiotic (Corvey et al. 
2003). The heterologous expression of numerous subtilin-nisin chimeras established that 
the subtilin leader fused to the nisin Z structural region was not cleaved by NisP in L. lactis 
(Kuipers et al. 1993b). The reciprocal experiment used B. subtilis ATCC 6633 to 
heterologously express the subtilin leader peptide fused to the N-terminus of nisin (1-11) 
in turn fused to the C-terminus of subtilin (12-32) to produce a bioactive nisin-subtilin 
chimera with the leader peptide removed (Chakicherla and Hansen 1995). This implied 
that proteolytic processing by LanP enzymes has more substrate specificity than the 
leader peptide cleavage performed by proteases encoded elsewhere in the genome. 
 
1.3.4.3.2 Decarboxylation 
The carboxy-terminus of many lantibiotics is post-translationally modified to introduce a S-
[(Z)-2- aminovinyl]-D-cysteine (AviCys) modification (Figure 1.3). This modification has 
been observed in type AI lantibiotics (e.g. epidermin, gallidermin, microbisporicin, clausin 
and mutacin 1140 in Figure 1.8), type B lantibiotics (e.g. mersacidin in Figure 1.10) and 
other lantipeptides (e.g. cypemycin and grisemycin in Figure 1.6). In the majority of these 
lantibiotics the C-terminal cysteine is decarboxylated to yield an enethiol intermediate 
which subsequently forms an AviCys bridge via cyclisation with a Dha or Dhb in the 
nascent peptide chain. The decarboxylation step is catalysed through a LanD protein, a 
member of the homooligomeric flavin-containing cysteine decarboxylase (HFCD) 
superfamily (Chatterjee et al. 2005). The best characterised LanD is EpiD from the 
epidermin biosynthetic gene cluster in S. epidermidis. The enzymatic activity has been 
reconstituted in vitro with the purified flavoenzyme able to decarboxylate EpiA, and in vivo 
through the coexpression of EpiA with EpiD in E. coli (Kupke et al. 1994; Kupke and Gotz 
1997). Crystal structures have revealed the cofactors required for functionality. These are 
flavin mononucleotide (FMN) in EpiD and flavin adenine dinucleotide (FAD) in MrsD  
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(Blaesse et al. 2000; Blaesse et al. 2003). Available evidence so far suggests that AviCys 
formation is essential for lantibiotic production, the lack of this C-terminal modification may 
well render lantibiotics vulnerable to carboxypeptidase degradation in the external 
environment. Although epidermin can be synthesised without the AviCys modification, 
bioactivity is reduced through either a direct reduction in efficacy or as a consequence of 
reduced stability (Augustin et al. 1992). In contrast, deletion of mibD from M. corallina 
abolished production of all microbisporicin-related peptides (Foulston and Bibb 2010). 
Similarly the generation of mersacidin variants with alterations at residues adjacent to the 
decarboxylated cysteine residues severely reduced production, implying an essential role 
of cysteine decarboxylation in mersacidin biosynthesis (Appleyard et al. 2009). 
As well as LanD enzymes, the HFCD family also encompasses (R)-4’-phospho-N-
pantothenoylcysteine (PPC) decarboxylases (Kupke et al. 2000). CypD bears the most 
significant alignment to PPC decarboxylases instead of LanD enzymes, yet it catalyses 
the decarboxylation of cypemycin. Evidence for this is supplied by the in vivo deletion of 
cypD from S. sp. OH-4156, resulting in the production of non-decarboxylated cypemycin, 
and the in vitro reconstitution of decarboxylase activity with the purified enzyme and the 
CypA prepropeptide (Claesen and Bibb 2010). This suggests that CypD is functionally 
analgous to other LanD enzymes, and that both are derived from a common HFCD 
ancestor to perform the decarboxylation of C-terminal cysteine. Unlike other AviCys 
residues, the sequencing of the cypA prepropeptide revealed that it is formed between 
two cysteine residues; Cys19 and Cys22. The deletion of cypD abolished only the 
decarboxylation of Cys22, and left a Dha residue at position 19. It was proposed that the 
decarboxylation by CypD follows the canonical mechanism, but the dethiolation of Cys19 
to Dha is performed by the same enzymes that catalyse the dehydration of threonine in 
cypemycin, CypH and/or CypL (Claesen and Bibb 2010). Interestingly, linaridins from 
gene clusters only encoding a homologue to the 5′ end of cypH are devoid of cysteines, 
which would be consistent with a role for the C-terminal domain of CypH in the 
dethiolation of cysteine (Claesen and Bibb 2010). 
 
1.3.4.3.3 Hydroxylation 
Hydroxylation most commonly occurs on the beta-carbon of L-Asp (Figure 1.3). Although 
found in a number of mammalian proteins, this modification has so far only been observed 
in the cinnamycin/duramycin group of lantibiotics (Fredenhagen et al. 1990; Kaletta et al. 
1991). The aspartate at position 15 of CinA is hydroxylated to form erythro-3-hydroxy-L-
aspartic acid. The enzyme CinX encoded in the cin cluster is the alpha-
ketoglutarate/iron(II)-dependent hydroxylase responsible for this modification (Okesli et al. 
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2011). A much rarer occurrence in ribosomally synthesised peptides is proline 
hydroxylation. Yet in microbisporicin, both the 3,4-dihydroxyproline and 4-hydroxyproline 
have been identified and it has been proposed that they are introduced through the action 
of the cytochrome p450, MibO (Foulston and Bibb 2010). 
 
1.3.4.3.4 D-Ala 
The ribosome only constructs peptides from L-amino acids, but D-amino acids can be 
subsequently introduced by post-translational modification. Lactobacillus sake L45 
produces Lactocin S, which contains three D-Ala residues, each derived from the post-
translational modification of L-Ser (Skaugen and Nes 1994). The two-component 
lantibiotic lacticin 3147 contains one D-Ala in the A1 peptide (Figure 1.10), and two in the 
A2 peptide (Ryan et al. 1999; Martin et al. 2004). Subsequent work on the lacticin 3147 
gene cluster from L. lactis subsp. lactis DPC 3147 indicated that LtnJ is a dehydrogenase 
capable of dehydrogenating Dha residues which are in turn derived from dehydrated L-Ser 
(Cotter et al. 2005b).  
 
1.3.4.3.5 Other bridges 
1.3.4.3.5.1 Lysinoalanine (LysAla) 
Lysinoalanine bridges are found naturally in body organs and more are generated in food 
proteins through the cooking process (Sternberg et al. 1975). This non-proteogenic amino 
acid is present in cinnamycin and the duramycins (Figure 1.3 and 1.6) (Fredenhagen et al. 
1990; Kaletta et al. 1991). In cinnamycin this bridge is critical in mediating the interaction 
with phosphatidylethanolamine and is formed through a reaction between Lys19 and Ser6, 
using Dha6 as an intermediate. Heterologous expression in E. coli indicated that Cinorf7 is 
critical for the formation of this cross-link (Okesli et al. 2011). 
 
1.3.4.3.5.2 Disulphide 
As disulfide bonds play an important role in the folding and stability of many secreted 
proteins, it is not surprising that they are present in some lantibiotics. This covalent bond 
is formed between the thiol groups of two cysteine residues. It is very unusual for a 
lantibiotic to contain a free cysteine residue, and to date these have only been found in 
the β-peptide of plantaricin W (Holo et al. 2001) and michiganin A (although the structural 
similarity of michiganin A to actagardine implies this cysteine may be involved in MeLan 
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formation with Dhb8) (Holtsmark et al. 2006). Several other lantibiotics have 
prepropeptides which contain more cysteine residues than there are serine and threonine 
residues combined, implying the excess cysteines may be involved in disulphide bridge 
formation. Such is the case with sublancin 168 in which the tertiary structure is stabilised 
through two MeLan and two disulphide bridges (Paik et al. 1998). Other lantibiotics 
containing a disulphide bridge include the α-peptide of plantaricin W (Holo et al. 2001), 
bovicin HJ50 (Xiao et al. 2004), the α-peptide of haloduracin (McClerren et al. 2006) and 
thermophilin 1277 (Kabuki et al. 2009). Although the labyrinthopeptins are not technically 
lantibiotics, as they do not contain a Lan residue, they do contain dehydrated residues 
and labyrinthopeptin A2 also contains a disulphide bond (Meindl et al. 2010). 
 
1.3.4.3.5.3 Labionin 
As well as containing a disulphide bond, the labyrinthopeptins acquire their name due to a 
novel type of bridge structure, (2S,4S,8R)-labionin, a carbacyclic triamino acid residue 
created through the post-translational modification of two serines and a cysteine (Figure 
1.3) (Meindl et al. 2010). The enzyme responsible for this modification was identified as 
LabKC, a kinase-cyclase whose activity has been reconstituted in vitro (Muller et al. 
2010). In contrast to other in vitro synthetases of lantibiotics, LabKC used guanosine 
triphosphate (GTP) instead of ATP for the phospohorylation and dehydration of serine 
residues (Muller et al. 2010).  
The presence of a kinase-cyclase domain classifies this enzyme into the class III 
modification enzymes alongside LanL (Goto et al. 2010) and RamC (Hudson and Nodwell 
2004; Kodani et al. 2004) described in Section 1.3.4.1.4. Class III enzymes contain three 
distinct catalytic domains, an N-terminal phosphoSer/Thr lyase, a middle Ser/Thr kinase 
and a C-terminal LanC-like cyclase. Like RamC, the LanC-like domain of LabKC lacks the 
conserved zinc-binding and catalytic residues seen in LanC and LanM cyclases. It is likely 
this class will be subdivided further to reflect differences in RamC/LanL/LabKC enzymes 
that ultimately result in different nucleotide requirements and different bridge formations. 
 
1.3.4.3.6 Single examples 
For even rarer modifications, so far only one example of their presence in a lantibiotic is 
known. Microbisporicin contains a chlorinated tryptophan, which is proposed to be 
introduced by the enzymes MibHS comprising a tryptophan halogenase and flavin 
reductase respectively (Foulston and Bibb 2010). The C-terminal Lan of actagardine is 
oxidized to form a sulfoxide residue. This reaction is catalysed by the luciferase-like 
  
59 
59 Chapter 1 : Introduction 
monooxygenase GarO, as deletion of this gene from A. garbadinensis resulted in the 
production of deoxy variants of actagardine (Boakes et al. 2009). These chlorination and 
oxidation modifications alter the physico-chemical properties of the molecule and may 
also have an affect on lantibiotic activity. The N-succinylation of subtilin reported during 
late stages of cell growth does result in reduced bioactivity (Chan et al. 1993). Likewise 
the absence of a N,N-dimethylalanine (Me2-Ala) in cypemycin abolishes any antimicrobial 
activity. Identification of the cypemycin gene cluster from Streptomyces sp. OH-4156 
revealed that Me2-Ala is formed by methylation of the N-terminal Ala residue of the 
prepropeptide (Claesen and Bibb 2010). Cypemycin also possesses two L-allo-isoleucine 
residues introduced by side-chain isomerisation of L-Ile (Claesen and Bibb 2010).  
 
1.3.5 Planosporicin 
Planosporicin represents one of the few lantibiotics to be described that is produced by an 
actinomycete. A number of experiments imply the mode of action of planosporicin is 
through inhibition of cell wall biosynthesis. The lantibiotic is active against Staphylococcus 
aureus but inactive to its L-forms due to their lack a functional cell wall (Castiglione et al. 
2007). Inhibition tests of macromolecular syntheses in S. aureus showed that 
peptidoglycan synthesis is severely inhibited at concentrations over 1 µg/ml, whereas 
DNA, RNA and protein synthesis are only marginally affected (Castiglione et al. 2007). 
Treatment of Bacillus megaterium with planosporicin caused the accumulation of UDP-
linked peptidoglycan precursors in the growing bacterial cells, implying planosporicin is a 
cell wall inhibitor acting at a step subsequent to the synthesis of lipid II (Castiglione et al. 
2007). Planosporicin activity against VRE implies it targets lipid II through a moiety other 
than the D-Ala-D-Ala pentapeptide (Castiglione et al. 2007). 
In general, the minimum inhibitory concentrations (MICs) for planosporicin are comparable 
to that of mersacidin and superior to that of actagardine (Table 1.1). In particular 
streptococci, anaerobic clostridia and some Gram-negative bacteria, such as Moraxella 
catarrhalis, are especially sensitive to planosporicin, portraying a wide spectrum of 
antibacterial activity. M. catarrhalis and S. pneumoniae are commonly recognised as the 
most common pathogens of the respiratory tract (Enright and McKenzie 1997). 
Furthermore, planosporicin is active against drug-resistant forms of staphylococci and 
enterococci such as MRSA and VRE.  
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Although nisin displays comparatively higher antimicrobial activity, its low solubility limits 
its use to that of a food preservative (Gowans et al. 1952). In contrast, planosporicin was 
found to be most stable at pH 2 to 6.5 and no degradation was observed when incubated 
at temperatures ranging from 15 to 40 °C (Castiglione et al. 2007). This high stability, 
solubility and activity at physiological pH implies that planosporicin has potential for 
systemic chemotherapy. This is substantiated through in vivo experiments where 
administration of planosporicin to mice infected with S. pyrogenes indicated high efficacy 
 
Table 1.1 : Minimum inhibitory concentrations (in µg/ml) for planosporicin, actagardine, 
mersacidin, nisin and microbisporicin against a range of target pathogens.   
Abbreviations refer to; American Type Culture Collection (ATCC), methicillin-resistant 
(metR), methicillin-resistant S. aureus (MRSA), vancomycin-resistant (VanA), vancomycin-
intermediate-resistant S. aureus (VISA). Reproduced from Castiglione et al. 2008. 
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and low toxicity (Castiglione et al. 2007). Although planosporicin exhibits only modest 
activity against bacterial pathogens, (MIC ranges from 0.25 to >128 µg/ml) the promising 
physico-chemical properties imply that if activity can be enhanced it could represent a 
promising pharmaceutical. 
 
1.4 Main Objectives 
The overall aim of this project was to identify, clone and characterise the planosporicin 
biosynthetic gene cluster through a number of objectives: 
Identification of a planosporicin-producing Planomonospora strain from a culture collection 
and confirmation of the structure of the lantibiotic. 
Identification of the planosporicin biosynthetic gene cluster through genome scanning of 
the planosporicin producer and cloning of the entire gene cluster through the construction 
of a genomic cosmid library. 
Heterologous expression of the gene cluster and delineation of the minimal gene set 
required for planosporicin biosynthesis. 
Generation of deletions within the gene cluster to confirm individual gene functions 
inferred from bioinformatic analysis. 
Determine similarities/differences to other lantibiotic gene clusters in particular with 
respect to the mechanism of regulation of gene expression. 
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Chapter 2 : Materials and Methods 
 
 
2.1 Bacterial plasmids and strains 
Plasmid Description Selection 
markers 
Source/ Reference 
General plasmids   
pIJ790  λ-RED (gam, bet, exo), cat, araC, 
rep101ts  
Chl (Gust et al. 2004) 
pUZ8002  tra, neo, RP4 Kan (Paget et al. 1999) 
pSuperCosI pUC ori cos Carb, Kan Stratagene 
pIJ10702 attP int(ΦC31) oriT pUCori (also 
known as pMJCos1) 
Carb, 
Apra 
(Yanai et al. 2006) 
pIJ773 pBS SK+ containing cassette P1-FRT-
oriT-aac(3)IV- FRT-P2 
Apra (Gust et al. 2004) 
pIJ778 pBS SK+ containing cassette P1-FRT-
oriT-aadA- FRT-P2 
Carb, 
Spec/ 
Strep 
(Gust et al. 2004) 
pIJ780 pBS SK+ containing cassette P1-FRT-
oriT-vph- FRT-P2 
Carb, Vio (Gust et al. 2004) 
pIJ6902 attP int(ΦC31) oriT ter fd to PtipA Carb, Thio (Huang et al. 2005) 
pIJ10700 pBS SK+ containing cassette P1-FRT-
oriT-hyg-FRT- P2 
Hyg (Gust et al. 2004) 
pGEM®-T 
Easy  
TA-cloning vector  Carb Promega 
pSET152  attP int(ΦC31) oriT pUCori  Apra (Bierman et al. 
1992) 
pIJ10706 pSEThyg Hyg S. O'Rourke, John 
Innes Centre 
pSETΩ attP int(ΦC31) oriT pUCori  Spec/ 
Strep 
J. Nodwell, 
McMaster 
University 
pRT801  attP int(ΦBT1) oriT pUCori  Apra (Gregory et al. 
2003) 
Table 2.1 : Plasmids and cosmids used and constructed in this study 
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Plasmid Description Selection 
markers 
Source/ Reference 
pMS82 attP int(ΦBT1) oriT pUCori  Hyg (Gregory et al. 
2003) 
Cosmids for heterologous expression   
pIJ12321 SuperCosI B4-1 Carb, Kan This work 
pIJ12322 SuperCosI F13-1 Carb, Kan This work 
pIJ12323 pIJ10702 B4-1 Carb, 
Apra 
This work 
pIJ12324 pIJ10702 F13-1 Carb, 
Apra 
This work 
pIJ12325 pIJ10702 4B8 Carb, 
Apra 
M. Sosio, 
NAICONS 
pIJ12326 pIJ10702 9A7 Carb, 
Apra 
M. Sosio, 
NAICONS 
pIJ12327 pIJ12323 with genes downstream of 
pspV removed 
Carb, 
Apra 
This work 
pIJ12328 pIJ12329 with genes upstream of 
pspE removed 
Carb, 
Apra 
This work 
pIJ12329 pIJ12329 with genes upstream of orf-
12 removed 
Carb, 
Apra 
This work 
Tools    
pIJ12330 pIJ10706-aac(3)IV Hyg, Apra This work 
pIJ12331 pIJ10706-aadA Hyg, 
Spec/ 
Strep 
This work 
pIJ12332 pIJ10706-vph Hyg, Vio This work 
pIJ12333 pIJ10706-tsr Hyg, Thio This work 
Gene deletion constructs   
pIJ12334 pIJ12321 ∆pspA::(oriT-aac(3)IV) Carb, Kan, 
Hyg 
This work 
pIJ12335 pIJ12322 ∆pspA::(oriT-aac(3)IV) Carb, Kan, 
Apra 
This work 
pIJ12336 pIJ12321 ∆pspA::(oriT-aadA) Carb, Kan, 
Spec/ 
Strep 
This work 
pIJ12337 pIJ12321 ∆pspA::(oriT-hyg) Carb, Kan, 
Hyg 
This work 
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Plasmid Description Selection 
markers 
Source/ Reference 
pIJ12338 pGEM-T Easy containing 
∆pspA::(oriT-hyg) with 4 kb flanking 
sequence 
Carb, Hyg This work 
pIJ12339 pGEM-T Easy containing 
∆pspA::(oriT-hyg) with 2 kb flanking 
sequence 
Carb, Hyg This work 
pIJ12340 pIJ12328 ∆pspA::(oriT-hyg) Carb, Kan, 
Hyg 
This work 
pIJ12521 pIJ12328 ∆pspX::(oriT-hyg) Carb, Kan, 
Hyg 
This work 
pIJ12522 pIJ12328 ∆pspW::(oriT-hyg) Carb, Kan, 
Hyg 
This work 
pIJ12523 pIJ12328 ∆pspYZ::(oriT-hyg) Carb, Kan, 
Hyg 
This work 
pIJ12524 pIJ12321 ∆pspTU::(oriT-hyg) Carb, Kan, 
Hyg 
This work 
pIJ12525 pIJ12327 ∆pspR::(oriT-hyg) Carb, Kan, 
Hyg 
This work 
pIJ12526 pIJ12327 ∆pspEF::(oriT-hyg) Carb, Kan, 
Hyg 
This work 
pIJ12527 pIJ12321 Δorf-19 to orf-12, 
∆pspV::(oriT-hyg) 
Carb, Kan, 
Hyg 
This work 
pIJ12528 pGEM-T Easy containing 
∆pspR::(oriT-hyg) with 2 kb flanking 
sequence 
Carb, Hyg This work 
pIJ12529 pGEM-T Easy containing 
∆pspEF::(oriT-hyg) with 2 kb flanking 
sequence 
Carb, Hyg This work 
pIJ12530 pGEM-T Easy containing 
∆pspV::(oriT-hyg) with 2 kb flanking 
sequence 
Carb, Hyg This work 
pIJ12531 pIJ12321 ∆pspA::(scar) ∆bla::(oriT-
hyg) 
Carb, Kan This work 
Complementation constructs   
pIJ12532 pSET152-PpspA-pspA-XbaI Apra This work 
pIJ12533 pSET152-PpspA-SpeI-XbaI Apra This work 
pIJ12534 pSET152-PpspA-SpeI-pspTU-XbaI Apra This work 
pIJ12535 pSET152-PpspA-SpeI-pspTUV-XbaI Apra This work
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Plasmid Description Selection 
markers 
Source/ Reference 
pIJ12536 pSET152-PpspJ-SpeI-XbaI Apra This work 
pIJ12537 pSET152-PpspJ-SpeI-pspYZ-XbaI Apra This work 
pIJ12538 pSET152-PpspJ-SpeI-pspYZQ-XbaI Apra This work 
pIJ12539 pSET152-PpspX-pspX-XbaI Apra This work 
pIJ12540 pSET152-PpspR-pspR-XbaI Apra This work 
pIJ12138 pIJ10706-PmibA-mibA Hyg (Foulston 2010) 
pIJ12362 pIJ10706-PmibA-mibABCD Hyg (Foulston 2010) 
 
Strain Genotype Antibiotic 
resistance 
Reference 
DH5α recA1 endA1 gyrA96 thi-1 
hsdR17 supE44 relA1 lac 
None (Sambrook and 
Russell 2001) 
ET12567 dam13::Tn9 dcm6  hsdM  hsdR 
recF143  zjj201::Tn10  galK  
galT22 ara14  lacY1  xyl5  leuB6 
thil  tonA31  rpL136  hisG4  
tsx78 mtli glnV44  F- 
Chl, Tet (Macneil et al. 
1992) 
 
BW25113  Δ(araD-araB)567 
ΔlacZ4787(::rrnB-4)  lacIp-
4000(lacIQ) λ-  rpoS369(Am) rph-
1 Δ(rhaD-rhaB)568  hsdR514 
None (Datsenko and 
Wanner 2000) 
 
DH5α/BT340 As DH5α with pCP20 (FLP+, λ 
ci857+, λ PR Repts, ApR, CmR) 
Chl (Cherepanov and 
Wackernagel 
1995; Datsenko 
and Wanner 
2000) 
XL-1 Blue MR recA1, endA1, gyrA96, thi-1, 
hsdR17(rK-, mK+), supE44, 
relA1, lac, [F', proAB, 
lacIqZΔM15::Tn10(tetr)] 
Nal (Sambrook and 
Russell 2001) 
 
  
Table 2.2 : E. coli strains used in this study 
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Table 2.3 : Actinomycetes strains used in this study 
 
Strain Description Source/ 
Reference 
S. lividans TK24 used to construct derivatives:  
M1446 pIJ10702 in ΦC31 attB (Claesen 2010) 
M1286 pIJ12323 in ΦC31 attB (B4-1) This work 
M1287 pIJ12324 in ΦC31 attB (F13-1) This work 
M1290 pIJ12325 in ΦC31 attB 4B8) This work 
M1291 pIJ12326 in ΦC31 attB (9A7) This work 
S. coelicolor M1146 used to construct derivatives:  
M1410 pIJ10702 in ΦC31 attB (Claesen and 
Bibb 2010) 
M1288 pIJ12323 in ΦC31 attB (B4-1) This work 
M1289 pIJ12324 in ΦC31 attB (F13-1) This work 
M1292 pIJ12325 in ΦC31 attB 4B8) This work 
M1293 pIJ12326 in ΦC31 attB (9A7) This work 
Nonomuraea sp. ATCC 39727 used to construct derivatives:  
M1294 pIJ10702 in ΦC31 attB (Foulston and 
Bibb 2010) 
Species Strain Source/ Reference 
Planomonospora alba NRRL 18924 (Mertz 1994)/ NRLL culture 
collection 
Planomonospora sphaerica NRRL 18923 (Mertz 1994)/ NRLL culture 
collection 
Streptomyces coelicolor M1146 (Gomez-Escribano and Bibb 
2011) 
Streptomyces lividans TK24 (Hopwood et al. 1983) 
Microbispora corallina NRRL 30420 (Lee 2003)/ NRRL culture 
collection 
Nonomuraea sp. ATCC 39727 F. Marinelli, University of 
Insubria, Italy 
Micrococcus luteus ATCC 4698 Novacta Biosciences 
Table 2.4 : Actinomycetes strains constructed in this study 
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Strain Description Source/ 
Reference 
M1295 pIJ12323 in ΦC31 attB (B4-1) This work 
M1296 pIJ12324 in ΦC31 attB (F13-1) This work 
M1297 pIJ12325 in ΦC31 attB (4B8) This work 
M1298 pIJ12326 in ΦC31 attB (9A7) This work 
M1299 pIJ12327 in ΦC31 attB  This work 
M1300 pIJ12328 in ΦC31 attB  This work 
M1301 pIJ12329 in ΦC31 attB  This work 
P. alba NRLL18924 used to construct derivatives:  
M1302 ∆pspA::(oriT-hyg) This work 
M1303 ∆pspX::(oriT-hyg) This work 
M1304 ∆pspW::(oriT-hyg) This work 
M1305 ∆pspYZ::(oriT-hyg) This work 
M1306 ∆pspTU::(oriT-hyg) This work 
M1307 ∆pspV::(oriT-hyg) This work 
M1308 ∆pspR::(oriT-hyg) This work 
M1309 ∆pspEF::(oriT-hyg) This work 
 
 
2.2 Oligonucleotides used in this study 
Primer Sequence Description 
General primers  
pSETF 
pSETR 
AAAAGTTCGACAGCGTCTCC 
CTGGCGTAATAGCGAAGAGG 
anneal within 
pSET vectors 
pSET152F 
pSET152R 
TCGCCATTCAGGCTGC 
CTCATTAGGCACCCCAGG 
amplify 
across MCS 
of pGEM-T 
pSET152F2 
pSET152R2 
GTTTTCCCAGTCACGACGTT 
TGTGGAATTGTGAGCGGATA 
amplify 
across MCS 
of pSET152 
Table 2.5 : Primers used in this study 
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Primer Sequence Description 
pRT801F 
pRT801R 
TTTGCAAGCAGCAGATTACG 
CCAAGGTTGAGAAGCTGACC 
anneal within 
pRT801 
pMS82forB 
pMS_Rseq 
seq pr. 
pMS82_rev 
CTACGGGCCGACCGAGGCG 
CTAGTAGTTCCTTCGTCACC 
CTGATGTCATCAGCGGTGG 
anneal within 
pMS82 
pMS82_for seq 
pr. 
TGTACGCCACCGCCTGGTTCTGCGA  
P1 
P2 
ATTCCGGGGATCCGTCGACC 
TGTAGGCTGGAGCTGCTTC 
universal 
priming sites 
Chapter 3: Partial sequencing of 16S rRNA  
T27 
R1492 
AGAGTTTGATCMTGGCTCAG 
TACGGYTACCTTGTTACGACTT 
(Mazza et al. 
2003) 
Chapter 4 : 454 contig test primers and primers for psp probe Anneal 
within: 
1289FlanA 
1289RlanA 
Probe3088F 
Probe3088R 
3088F2 
3088R2 
CGGTGAGTAAATCCTCGTC 
CCGTAGACGTCGAGGAAGC 
CGGCGAGCGGTGCGGAAGTC 
CTCGCCGAGCTGGTGCGCCA 
AACAGGCCGAGCTTGG 
CGCCACGTCCTGAACC 
pspA 
 
pspB 
 
pspB 
   
PMSLanAf 
PMSLanBf 
lanEF_F 
lanEF_R 
CGGTGAGTAAATCCTCGTC 
CCGTAGACGTCGAGGAAGC 
GGACAAGGACTTCTGGTACGC 
GGGTTCATCGTCAGATCTCC 
pspA-pspB 
 
pspE-pspF 
 
End_F 
End_R 
ACATTTCCCCGAAAAGTGC 
TTGTCCGTGGAATGAACAATG 
cosmid end 
sequencing 
ES1F 
ES1R 
GAAGGTCGGCACGTACTCC 
ACTTCGTCGACGGTGAGG 
left border of 
psp cluster 
ES2F 
ES2R 
GTTCTACGTGACGGACTTCG 
TTCCTTGACTTCGGATGACC 
right border 
of psp cluster 
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Primer Sequence Description 
Chapter 6 : Generation of a minimal gene set Application: 
downdisruptF CGGTCCCGGCGCCCGCCGGGCTGAACGGA
CGCGCACCGGACTAGTATTCCGGGGATCCG
TCGACC 
Δorf+7-
orf+14 
::aac(3)IV 
downdisruptR ATCCAGTAGGGCCGCGGTGAGCGTCTCGGC
GCGGCCGCGACTAGTTGTAGGCTGGAGCTG
CTTC 
 
downconfirm GAAAGGCGCCCGAAGCGCTG  
updisruptF TCTACCTGCCCGCCTTCGAACGCGTCGTCA
CGCAGGCCTCTAGAATTCCGGGGATCCGTC
GACC 
 
updisruptR1 CGCCCCGGTCCTCCCGGGTCCCGGCGGGA
GGGCGCCCGGTCTAGATGTAGGCTGGAGCT
GCTTC 
Δorf-19-orf-
12 ::aac(3)IV  
updisruptR2 GCACTGCCATCCGGCCTGCCAGAGGGTGAA
TTCCGCGATTCTAGATGTAGGCTGGAGCTG
CTTC 
Δorf-19-orf-
10 ::aac(3)IV 
upconfirm GCGGCGGCCGTGGTGTTCAC  
Dbv5_F 
Dbv5_R 
GTGACCCTGACCTTGTCACC 
CTCACTGCTGGTCGGTATCA 
anneal within 
dbv5 
Chapter 7 : Assessment of integration sites and resistance 
cassettes 
 
BamHIclone 
XbaIclone 
vphR 
tsrF 
pSET(Nhe)F 
pSET(Nhe)R 
ATATGGATCCGCTATAATGACCCCGAAGCA 
ATATTCTAGAGAATAGGAACTTCGGAATAGG
AAC 
GTCGTCGACTGGGACGAG 
CGCTCTCTGGCAAAGCTC 
GCTCGCTGATGATATGCTGA 
GTACATCACCGACGAGCAAG 
flanking 
resistance 
cassettes 
 
 
flanking 
pSET NheI 
LF025F 
LF025R 
CGCTGACATCCTGGAGAC 
GCACAGCGACCAGCTC 
anneal within 
mibA 
LF026F 
LF026R 
GAGCACGACCAGGGAAAG 
GAACGTGATCGGGCAGTC 
anneal within 
mibD 
Chapter 7 : Constructing biosynthetic mutants Application: 
PspAdisruptF CCGCGAACACCTGTTCGATTATTCGAAGGA
GTAATCATGATTCCGGGGATCCGTCGACC 
ΔpspA::hyg 
  
70 
70 Chapter 2 : Materials and Methods 
Primer Sequence Description 
PspAdisruptR GCGGGCGCCCGGCCCCACGGGCGTGTGCG
GGTGCGGTCATGTAGGCTGGAGCTGCTTC 
 
PspAconfirmF CACACGCCATGTACGTATCC  
PspAconfirmR CGCATCCTGATGTCGTAGC  
HindlanA4F 
SpelanA4R 
ATATAAGCTTGTCATGTCGTGGCCTTCC 
ATATACTAGTGGTGTGGGCGAGGTTAGC 
HindIII-2kb-
ΔpspA::hyg-
2kb-SpeI 
4kb5’confirm CTCCGACCGGCTTTGAC  
4kb3’confirm GACTTCCTGGTCTTCCTGTCC  
HindlanA8F 
SpelanA8R 
ATATAAGCTTGCTTTCCAGAGGTAGGTGTAG
C 
ATATACTAGTCGTTGATCAGGTCGTAGGC 
HindIII-4kb-
ΔpspA::hyg-
4kb-SpeI 
8kb5’confirm GAGATCCGTCCGTGCTGA  
8kb3’confirm GTCTACGACGCCGTGATGT  
-5 disruptF2 GTCGGCGGCGAGCAGGGCGGCGTAGCCGT
CCTCCAGCGAATTCCGGGGATCCGTCGACC 
ΔpspYZ::hyg 
-4disruptR ACCGGCCCCCACCACGGCATCGGGGAGGC
GTGATGACCGTGTAGGCTGGAGCTGCTTC 
 
-5 confirmF AGGACGTTGAGTTCGACAGC  
-4 confirmF ACCGTGTTCCTGGAGATGG  
PspTUdisruptF GGCCGTCGGGGACGGAGACGCCGGCGGCC
TTCGAGATAAATTCCGGGGATCCGTCGACC 
ΔpspTU::hyg 
PspTUdisruptR CAGCAGGGCCAGGACCGCCGCCAGCATCG
CGCCCAGCACTGTAGGCTGGAGCTGCTTC 
 
PspTUconfirmF GCCTACGACCTGATCAACG  
PspTUconfirmR GAAGTAGCGCAGTTCGATCC  
PspTUconfirmR 
10700 
TGCTTCGGGGTCATTATAGC  
PspVdisruptF CCTGGCCCTGCTGCGGATCCGGAGCGGCC
GATGAGCGCCATTCCGGGGATCCGTCGACC 
ΔpspV::hyg 
PspVdisruptR GGGAGCGACCGTGAACCGCATCCGGTGCG
CGTCCGTTCATGTAGGCTGGAGCTGCTTC 
 
PspVconfirmF ATGTTCCCCATGCTGTTCC  
PspVconfirmR ACTTCCAGGACCTGATCACC  
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Primer Sequence Description 
pspV_2kbF 
pspV_2kbR 
ACTTCAACCTCGGCATGG 
ACGTTCACCACGATCAAGC 
2kb-ΔpspV 
::hyg-2kb 
PspEdisruptF GGGCGTGACCACGATCGGCCGAGCAAAGG
AGACACGGTGATTCCGGGGATCCGTCGACC 
ΔpspEF::hyg 
PspFdisruptR CGGGTACGGGCGGCCGTACGCCGTCCTCT
GCGGGGGTCATGTAGGCTGGAGCTGCTT 
 
PspEconfirmE TTCCTTCCTGACTGGAGTGG  
PspFconfirmF GTGCTCAATCTCGCCATACC  
PspEFconfirmR 
10700 
GGGCAGGATAGGTGAAGTAGG  
pspE_2kbF 
pspF_2kbR2 
CGGCCTGATCTATCTGAAGG 
GCAGGAACTGTCCCTCTACC 
2kb-ΔpspEF 
::hyg-2kb 
blaF CCCTGATAAATGCTTCAATAATATTGAAAAAG
GAAGAGTA 
amplify bla-
cassette-bla 
blaR AATCAATCTAAAGTATATATGAGTAAACTTGG
TCTGACAG 
 
Chapter 7 : Complementation of biosynthetic mutants Amplify: 
PpspAF_BamHI 
PspAR_XbaI 
ATGGATCCCACACGCCATGTACGTATCC 
ATTCTAGAAGTGCTTCCTGTGACGATCC 
BamHI-PpspA-
pspA-XbaI 
PpspAR_SpeIBa
mHI 
ATATGGATCCACTAGTGATTACTCCTTCGAA
TAA 
BamHI-PpspA-
SpeI, XbaI 
PpspAF2_BamHI ATATGGATCCGATCTCCTCGGCCACACC  
pspTUF_SpeI 
pspTUR_XbaI 
ATATACTAGTCTGGCATGACCGGGCCGT 
ATATTCTAGAGAGGACGCCTGTCTGCTC 
SpeI-pspTU-
XbaI 
pspTUVR_XbaI ATATTCTAGAGGCCACCTGGAGGAGTTG pspTUV-XbaI 
PpspJF_SpeIBa
mHI 
ATATGGATCCACTAGTGTCGTGGCCTTCCCT
GGT 
BamHI-PpspJ-
SpeI, XbaI 
PpspJR_BamHI ATATGGATCCGGCCATGATCTGCTCGAC  
pspYZF_XbaI 
pspYZR_SpeI 
ATATTCTAGAGATGTTCGTCGGTCATTCGT 
ATATACTAGTGTGATGACCGCGCTGTTG 
SpeI-pspYZ-
XbaI 
pspYZQF_XbaI ATATTCTAGACCGATTCCTTGATCACGTTC pspYZQ-XbaI 
Chapter 8 : Constructing regulatory mutants Application: 
ECFdisruptF CAACCGCGCAGCGGCGATCATGTTGCCCAG
CCGCCTTCGATTCCGGGGATCCGTCGACC 
ΔpspX::hyg 
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Primer Sequence Description 
ECFdisruptR GGATACGTACATGGCGTGTGTCCGGACGAG
GATTTACTCACCGCTGTAGGCTGGAGCTGC
TTC 
 
ECFconfirmF CCAGCAACAGGTCGAAGG  
ECFconfirmR CGTAAATCACGCAATCATGG  
-2disruptF TCGGCGTACGGACCCCGCCGCCGGCCGGG
GCTCGCGTCAATTCCGGGGATCCGTCGACC 
ΔpspW::hyg 
-2disruptR CGCTGCGCGGTTGGAAGGATCGGGACGAC
GATGACGGAATGTAGGCTGGAGCTGCTTC 
 
-2confirmF GTCATGTCGTGGCCTTCC  
-2confirmR GTCGAGGAACTCGCCTACC  
-7disruptF ACCCGCGAGGAGGGGCGTACGGGCGGCCG
GAGGCCTTCAATTCCGGGGATCCGTCGACC 
ΔpspR::hyg 
-7disruptR CGGGGGACCGCATTGCGCCGGCACGCTTC
GCAGGCTGTCTGTAGGCTGGAGCTGCTTC 
 
-7confirmF GGCTGCACAAACACTACGG  
-7confirmR TGATGATCACCGAACTCACG  
pspR_2kbF 
pspR_2kbR 
GTAAGCGTCGTGGTCATCG 
CGCTGTTGTGGATCTTGAGG 
2kb-ΔpspR 
::hyg-2kb 
Chapter 8 : Complementing regulatory mutants Amplify: 
PpspXF_BamHI 
PspXR_XbaI 
ATGGATCCGTCGTCTGGGCAGTGTTCC 
ATTCTAGAACGAGACGCTGGTGATGG 
BamHI-PpspX-
pspX-XbaI 
pspRF_XbaI 
PpspRR_BamHI 
ATATTCTAGAGAAGGTCGGCACGTACTCC 
ATATGGATCCCTCAGCAGGACCATGAAGC 
BamHI-PpspR-
pspR-XbaI 
Chapter 8 : RT-PCR Anneal 
within: 
pspE_RTF 
pspE_RTR 
GTGACGCTCGAGTTCTGG 
ACCTTGGCGACGAAGTAGC 
pspE 
pspF_RTF 
pspF_RTR 
GGCTGCACAAACACTACGG 
CTTCATGAGGGTCGTCTTGC 
pspF 
pspR_RTF 
pspR_RTR 
GCCAGGTCGTCGTACAGC 
CACGTCCATGACCATCTCC 
pspR 
pspQ_RTF 
pspQ_RTR 
CGGAACTTCGGCTACACC 
GGCCGAGACTCACCTTGC 
pspQ 
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Primer Sequence Description 
pspZ_RTF 
pspZ_RTR 
GGGAGTTCCTCGACTACATCG 
GACGGATCTCCCATCAGC 
pspZ 
 
pspY_RTF2 
pspY_RTR 
AGGTACGAGGCCCTGATGG 
GGTGCAGAAGGTGTTGACG 
pspY 
pspJ_RTF 
pspJ_RTR 
CTGGAGCTGCACCTGTCG 
GCCATCTCCAGGAACACG 
pspJ 
pspW_RTF 
pspW_RTR 
ACTGCCGCAGGAGACTGG 
CCAGCAACAGGTCGAAGG 
pspW 
ECF_RTF 
ECF_RTR 
GTCGAGGAACTCGCCTACC 
GTCCCGATCCTTCCAACC 
pspX 
pspA_RTF2 
pspA_RTR2 
CCTGCCGCAGAACACC 
GGGTGCACCACGAGACG 
pspA 
pspT_RTF 
pspT_RTR 
GTCTCGGCCTGGTCTTCC 
GAACAGGTCGAGCATCAGG 
pspT 
pspU_RTF 
pspU_RTR 
GTCGTCTTCAGCGTCATCG 
GTACGTCATGGGGTTGAGG 
pspU 
pspV_RTF 
pspV_RTR 
TCTTCCCCTACCATCTCAACC 
GTTGACCACGGGTTTGTAGG 
pspV 
hrdB_RTF 
hrdB_RTR 
CCAAGGGCTACAAGTTCTCG 
GGCCAGCTTGTTGATGACC 
hrdB 
q16sF 
q16sR 
Orf-10_RTF 
Orf-10_RTR 
TCACGGAGAGTTTGATCCTGGCTC 
GGTCGCCCTCTCAGGCCGG 
GGAGGACTCGCCGTACCC 
ACGTTGTTGTCGCTGATCC 
rrnD 
 
orf-10 
Orf+7_RTF 
Orf+7_RTR 
GCTCCAGTCTGGTGGAGGTC 
TGATCAGGTCCTGGAAGTCG 
orf+7 
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2.3 Culture media and antibiotics 
2.3.1 Antibiotics  
 
Antibiotic Concentration in media (µg/ml) 
Carbenicillin (Carb) 
Kanamycin (Kan) 
Chloramphenicol (Chl) 
Apramycin (Apra) 
 
Hygromycin B (Hyg) 
 
Nalidixic acid (Nal) 
Spectinomycin (Sp) 
Streptomycin (Str) 
Viomycin (Vio) 
Thiostrepton (Thio) 
100 
50 
25 
50 (E. coli and Streptomyces)  
20 (Planomonospora) 
40 (in low salt media e.g. DNA) 
80 (in high salt media e.g. LB) 
25 
50 (E. coli), 200 (Streptomyces sp.) 
50 (E. coli), 10 (Streptomyces sp.) 
30 
50 
 
2.3.2 Agar media 
Unless stated otherwise, the media used for the culturing of S. coelicolor and E. coli were 
prepared as previously described (Kieser et al. 2000; Sambrook and Russell 2001). 
Medium Composition  Instructions for preparation 
L-Agar  
 
Agar 
Difco bacto tryptone 
NaCl 
Glucose 
dH2O 
10 g 
10 g 
5 g 
1 g 
To 1000 ml 
The ingredients, except agar, 
were dissolved, in the distilled 
water and 200 ml aliquots were 
dispensed into 250 ml 
Erlenmeyer flasks containing 
the agar. The flasks were 
closed and autoclaved. 
Table 2.6 : Concentration of antibiotics used in this study 
Table 2.7 : Agar media used in this study 
  
75 
75 Chapter 2 : Materials and Methods 
Medium Composition  Instructions for preparation 
LB-Agar Agar 
Difco bacto tryptone  
Yeast extract  
NaCl 
dH2O 
15 g 
10 g 
 5 g 
10 g 
To 1000 ml 
The ingredients, except agar, 
were dissolved, in the distilled 
water and pH altered to 7.5 
with NaOH 200 ml aliquots 
were dispensed into 250 ml 
Erlenmeyer flasks containing 
the agar. The flasks were 
closed and autoclaved. 
Difco nutrient 
agar (DNA) 
 
Difco nutrient agar 
dH2O 
4.6 g 
200 ml 
Difco Nutrient Agar was placed 
in each 250 ml Erlenmeyer 
flask and distilled water was 
added. The flasks were closed 
and autoclaved. 
Soft Nutrient 
Agar (SNA) 
Difco nutrient broth 
powder 
Difco bacto agar 
dH2O 
8 g 
5 g 
To 1000 ml 
The ingredients, except agar, 
were dissolved, in the distilled 
water and 200 ml aliquots were 
dispensed into 250 ml 
Erlenmeyer flasks containing 
the difco bacto agar. The flasks 
were closed and autoclaved. 
Mannitol 
soya flour 
medium 
(SFM or MS) 
 
Agar   
Mannitol  
Soya flour  
Tap water 
   
20 g 
20 g 
20 g 
To 1000 ml 
The mannitol was dissolved in 
the water and 200 ml aliquots 
poured into 250 ml Erlenmeyer 
flasks each containing agar 
and soya flour. The flasks were 
closed and autoclaved twice 
(115 °C/15 min), with gentle 
shaking between the two runs.
  
Oatbran 
Medium 
(OBM) 
Porridge oats  
Lab M agar     
Tap water   
 
40 g 
20 g 
To 1000 ml 
The ingredients were mixed 
and dispensed into 250 ml 
Erlenmeyer flasks. The flasks 
were closed and autoclaved 
twice (115 °C/15 min), with 
gentle shaking between the 
two runs. 
Trace 
elements for 
ISP4 
FeSO4.7H2O 
MnCl2.4H2O 
ZnSO4.7H2O 
dH2O 
0.1 g  
0.1 g 
0.1 g 
To 100 ml 
The ingredients were 
dissolved, in the distilled water. 
10 ml aliquots were filtered 
through 0.2 µm and dispensed 
into universals. 
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Medium Composition  Instructions for preparation 
ISP4 Difco bacto agar 
Solution 1: 
Soluble starch  
dH2O 
 
Solution 2: 
CaCO3 
K2HPO4 
MgSO4 
NaCl 
(NH4)2SO4 
Trace elements 
dH2O 
20 g 
 
10 g 
500 ml 
 
2 g 
1 g 
1 g 
1 g 
2 g 
1 ml 
500 ml 
The ingredients were combined 
in the distilled water. Solution 1 
and solution 2 were mixed 
together and the pH adjusted 
to pH 7 - 7.4 200 ml aliquots 
were dispensed into 250 ml 
Erlenmeyer flasks. The flasks 
were closed and autoclaved. 
Once molten, yeast extract was 
added to a concentration of 0.1 
% and mixed. 200 ml aliquots 
were dispensed into 250 ml 
Erlenmeyer flasks containing 
the difco bacto agar. The flasks 
were closed and autoclaved. 
AF/MS Lab M agar  
Dextrose 
Yeast extract 
Soy flour 
CaCO3 
NaCl  
dH2O 
10 g 
20 g 
2 g 
8 g 
4 g 
1 g 
To 1000 ml 
The ingredients were combined 
in the distilled water and the pH 
adjusted to pH 7.3. 200 ml 
aliquots were dispensed into 
250 ml Erlenmeyer flasks. The 
flasks were closed and 
autoclaved. 
D/Seed  Lab M agar 
Peptone 
Soluble starch 
Meat extract 
Yeast extract 
Soy flour 
CaCO3 
dH2O 
10 g 
5 g 
20 g 
2 g 
3 g 
2 g 
1 g 
To 1000 ml 
The ingredients were combined 
in the distilled water and the pH 
adjusted to pH 7. 200 ml 
aliquots were dispensed into 
250 ml Erlenmeyer flasks. The 
flasks were closed and 
autoclaved. 
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Medium Composition  Instructions for preparation 
M8 Lab M agar 
Soluble starch 
Meat extract 
Yeast extract 
Glucose 
CaCO3 
Hydrolyzed casein 
dH2O 
10 g 
20 g 
2 g 
2 g 
10 g 
3 g 
4 g 
To 1000 ml 
The ingredients were combined 
in the distilled water and the pH 
adjusted to pH 7. 200 ml 
aliquots were dispensed into 
250 ml Erlenmeyer flasks. The 
flasks were closed and 
autoclaved. 
ATCC 
medium 172 
Agar 
Soluble starch 
Glucose 
Yeast extract 
N-Z amine type A 
CaCO3 
dH2O 
15 g 
20 g 
10 g 
5 g 
5 g 
1 g 
To 1000 ml 
The ingredients were combined 
in the distilled water. 200 ml 
aliquots were dispensed into 
250 ml Erlenmeyer flasks. The 
flasks were closed and 
autoclaved (121 °C/15 min). 
V0.1 
(Marcone et 
al. 2010c) 
 
Agar  
Soluble starch  
Dextrose   
Meat extract   
Yeast extract  
Triptose  
dH2O 
15 g 
2.4 g 
0.1 g 
0.3 g 
0.5 g 
0.5 g 
To 1000 ml 
The ingredients were 
dissolved, in the distilled water 
and the pH adjusted to pH 7.2. 
200 ml aliquots were 
dispensed into 250 ml 
Erlenmeyer flasks. The flasks 
were closed and autoclaved. 
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2.3.3 Liquid media 
Unless stated otherwise, the media used for the culturing of S. coelicolor and E. coli were 
prepared as previously described (Kieser et al. 2000; Sambrook and Russell 2001). 
Medium Composition  Instructions for 
preparation 
L (Lennox)-Broth  
 
Difco bacto tryptone 
Difco yeast extract 
NaCl 
Glucose 
dH2O 
10 g 
5 g 
5 g 
1 g 
To 1000 ml 
The ingredients were 
dissolved, in the 
distilled water and 
aliquots were 
dispensed into 
universals or 250 ml 
flasks and autoclaved. 
LB (Luria-Bertani)-
broth 
Difco bacto tryptone 
Difco yeast extract 
NaCl 
dH2O 
10 g 
5 g 
10 g 
To 1000 ml 
The ingredients were 
dissolved, in the 
distilled water and pH 
adjusted to 7. Aliquots 
were dispensed into 
universals or 250 ml 
flasks and autoclaved. 
SOB 
(minus Mg) 
Tryptone 
Yeast extract 
NaCl 
dH2O 
20 g 
5 g 
0.5 g 
To 950 ml 
After dissolving the 
solutes in water, 10 ml 
250 mM KCl was 
added and the pH was 
adjusted to pH 7 with 5 
N NaOH. The volume 
was then made up to 
1000 ml with deionised 
water and autoclaved. 
SOC   SOC medium is 
identical to SOB 
medium except that 
after autoclaving, 20 ml 
of sterile 1 M solution of 
glucose and 5 ml of 
sterile 2 M MgCl2 were 
added. 
2 X YT medium Difco bacto tryptone 
Difco yeast extract 
NaCl 
dH2O 
16 g 
10 g 
5 g 
To 1000 ml 
The ingredients were 
dissolved, in the 
distilled water and 10 
ml aliquots were 
dispensed into 
universals and 
autoclaved. 
Table 2.8 : Liquid media used in this study 
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Medium Composition  Instructions for 
preparation 
Tryptone soya broth 
(TSB) 
Tryptone soya broth 
powder 
dH2O 
30 g 
 
To 1000 ml 
Tryptone soya broth 
powder was placed in 
each 250 ml 
Erlenmeyer flask and 
distilled water was 
added. The flasks were 
closed and autoclaved. 
Super yeast extract-
malt extract 
(SuperYEME) 
Yeast Extract 
Peptone 
Malt Extract 
Glucose 
Sucrose 
MgCl2 6H2O 
Glycine 
L-Proline 
L-Arginine 
L-Histidine 
Uracil 
L-Cystine 
dH2O 
3 g 
5 g 
3 g 
10 g 
340 g 
1.1 g 
5 g 
0.075 g 
0.075 g 
0.1 g 
0.015 g 
0.075 g 
To 1000 ml 
The ingredients were 
combined in the 
distilled water. 200 ml 
aliquots were 
dispensed into 250 ml 
Erlenmeyer flasks. The 
flasks were closed and 
autoclaved. 
Trace elements for 
ISP4 
FeSO4.7H2O 
MnCl2.4H2O 
ZnSO4.7H2O 
dH2O 
0.1 g  
0.1 g 
0.1 g 
To 100 ml 
The ingredients were 
dissolved, in the 
distilled water. 10 ml 
aliquots were filtered 
through 0.2 µm and 
dispensed into 
universals. 
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Medium Composition  Instructions for 
preparation 
ISP4 Solution 1: 
Soluble starch  
dH2O 
 
Solution 2: 
CaCO3 
K2HPO4 
MgSO4 
NaCl 
(NH4)2SO4 
Trace element 
solution  
dH2O 
 
10 g 
500 ml 
 
2 g 
1 g 
1 g 
1 g 
2 g 
1 ml 
500 ml 
The ingredients were 
combined in the 
distilled water. Solution 
1 and solution 2 were 
mixed together and the 
pH adjusted to pH 7 to 
7.4. 200 ml aliquots 
were dispensed into 
250 ml Erlenmeyer 
flasks. The flasks were 
closed and autoclaved. 
Prior to use, yeast 
extract was added to a 
concentration of 0.1 % 
and mixed. 
AF/MS Dextrose 
Yeast extract 
Soy flour 
CaCO3 
NaCl  
dH2O 
20 g 
2 g 
8 g 
4 g 
1 g 
To 1000 ml 
The ingredients were 
combined in the 
distilled water and the 
pH adjusted to pH 7.3. 
200 ml aliquots were 
dispensed into 250 ml 
Erlenmeyer flasks. The 
flasks were closed and 
autoclaved. 
D/seed Peptone 
Soluble starch 
Meat extract 
Yeast extract 
Soy flour 
CaCO3 
dH2O 
5 g 
20 g 
2 g 
3 g 
2 g 
1 g 
To 1000 ml 
The ingredients were 
combined in the 
distilled water and the 
pH adjusted to pH 7. 
200 ml aliquots were 
dispensed into 250 ml 
Erlenmeyer flasks. The 
flasks were closed and 
autoclaved. 
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Medium Composition  Instructions for 
preparation 
M8 Soluble starch 
Meat extract 
Yeast extract 
Glucose 
CaCO3 
Hydrolyzed casein 
dH2O 
20 g 
2 g 
2 g 
10 g 
3 g 
4 g 
To 1000 ml 
The ingredients were 
combined in the 
distilled water and the 
pH adjusted to pH 7. 
200 ml aliquots were 
dispensed into 250 ml 
Erlenmeyer flasks. The 
flasks were closed and 
autoclaved. 
V 
(Marcone et al. 2010c) 
Soluble starch   
Dextrose   
Meat extract   
Yeast extract  
Triptose  
dH2O 
24 g 
1 g 
3 g 
5 g 
5 g 
To 1000 ml 
The ingredients were 
dissolved in the distilled 
water and the pH 
adjusted to pH 7.2. 200 
ml aliquots were 
dispensed into 250 ml 
Erlenmeyer flasks. The 
flasks were closed and 
autoclaved. 
VSP 
(Marcone et al. 2010c) 
  VSP is identical to V 
except for the addition 
of sucrose to a final 
concentration of 50 g/L 
and of L-proline to 0.5 
g/L after autoclaving. 
Medium 266 (YS) 
(Technikova-Dobrova 
et al. 2004) 
Soluble start 
Yeast extract 
dH2O 
10 g 
2 g 
To 1000 ml 
The ingredients were 
dissolved in the distilled 
water and the pH 
adjusted to pH 7.2. 200 
ml aliquots were 
dispensed into 250 ml 
Erlenmeyer flasks. The 
flasks were closed and 
autoclaved. 
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Medium Composition  Instructions for 
preparation 
Streptosporangium 
Medium (SM) 
(Roes and Meyers 
2008) 
Soluble starch   
Glycerol   
Tryptone 
Bacteriological 
peptone 
Yeast extract  
NaCl 
CaCO3 
Tap Water 
10 g 
10 g  
2.5 g 
5 g 
2 g 
1 g 
3 g 
To 1000 ml 
The ingredients were 
dissolved in the distilled 
water and the pH 
adjusted to pH 7.3. 200 
ml aliquots were 
dispensed into 250 ml 
Erlenmeyer flasks. The 
flasks were closed and 
autoclaved. 
 
2.4 Solutions and buffers 
Solution/buffer Composition and instructions for preparation 
Cosmid isolation solution I Glucose 
Tris-HCl (pH 8) 
EDTA 
50 mM 
25 mM 
10 mM 
Cosmid isolation solution II NaOH 
SDS 
0.2 M 
1 % 
Cosmid isolation solution III Potassium acetate (pH 5.5) 
Acetic acid 
3 M 
Cosmid Library Probing 
Hybridisation Buffer  
SSC 
Denhardt’s solution 
SDS 
Denatured calf thymus DNA 
6x 
1x 
0.5 % 
50 µg/ml 
Cosmid Library Probing 
Wash Buffer  
SSC 
SDS 
0.1x 
1 % 
Table 2.9 : Solutions and buffers used in this study 
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Solution/buffer Composition and instructions for preparation 
DNA loading buffer Bromophenol blue 
Xylene- cyanol blue 
Glycerol 
SDS 
0.125 % (w/v) 
0.125 % (w/v) 
62.5 % (v/v) 
0.625 % (w/v) 
Elution Buffer Tris-Cl 10 mM 
pH 8.5 
SET buffer 
 
 
NaCl 
Tris-HCl (pH 8) 
EDTA (pH 8) 
75 mM 
20 mM 
25 mM 
GET buffer Glucose 
Tris-HCl (pH 8) 
EDTA (pH 8) 
50 mM 
25 mM 
10 mM 
TE buffer Tris-HCl (pH 8) 
EDTA (pH 8) 
10 mM 
1 mM 
20x SSC Sodium citrate 
NaCl 
300 mM 
3 M 
TAE buffer Tris 
Acetic acid 
EDTA 
40 mM 
1.142 % 
1 mM 
TBE buffer Tris base 
Boric acid 
EDTA (pH 8.0) 
89 mM 
89 mM 
2 mM 
 
2.5 General molecular biology methods 
2.5.1 Plasmid isolation 
QIAprep® miniprep kits (Qiagen) were used according to the manufacturer’s instructions. 
Briefly, a 10 ml LB culture of E. coli containing the plasmid of interest was grown overnight 
then centrifuged at 3000 rpm for 10 min. The cell pellet was lysed under alkaline 
conditions to denature high molecular weight chromosomal DNA. The lysate was then 
neutralised and centrifuged in a microcentrifuge at 13000 rpm to remove renatured 
chromosomal DNA, precipitated protein and cell debris. The supernatant was then applied 
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to a silica-gel membrane mounted in a microcentrifuge tube where the plasmid DNA is 
selectively adsorbed. The membrane was washed under high salt and ethanolic buffer 
conditions to remove RNA, protein and metabolites. DNA was eluted from the column in 
elution buffer. Plasmid DNA was routinely stored at -20 °C. 
 
2.5.2 Cosmid isolation 
Cosmid isolation was carried out by alkaline lysis as described by (Sambrook and Russell 
2001). A 9 ml overnight culture of E. coli was centrifuged to pellet the cells which were 
then resuspended by vortexing in 200 µl solution I.  400 µl solution II were added and the 
tubes inverted twelve times. 300 µl of solution III were then added and mixed by inverting 
the tubes six times. The tube was then centrifuged at 13000 rpm in a microcentrifuge for 5 
min at room temperature. The supernatant was mixed with 400 µl phenol/chloroform, 
vortexed for two min and then centrifuged at 13000 rpm in a micro centrifuge for 5 min. 
750 µl of the upper phase were then transferred to a 1.5 ml tube, 750 µl of ice cold 
isopropanol were added and the tube placed on ice for at least 10 min. The precipitated 
DNA was then centrifuged at 13000 rpm in a micro centrifuge for 5 min. The pellet was 
washed with 500 µl 70 % ethanol and centrifuged at 13000 rpm in a microcentrifuge. The 
pellet was dried by leaving the tube open for 10 min at room temperature prior to 
resuspension in 100 µl elution buffer. 
 
2.5.3 Agarose gel electrophoresis 
Typically, a 1 % agarose gel was cast with TBE buffer with 0.5 µg/ml ethidium bromide. 
Size markers were provided by Hyperladder I (Bioline), 1 kb ladder (NEB) or 100 bp 
ladder (NEB) as indicated in figure legends. 10 µl samples in 1x loading dye were loaded 
into the appropriate wells. Agarose gel electrophoresis was performed in 1 % TBE buffer 
at 100 V until completion.  
 
2.5.4 Pulsed-field gel electrophoresis 
Pulsed-field gel electrophoresis (PFGE) was carried out using CHEF DR-III pulse field gel 
apparatus (Bio-Rad) in combination with a cooling module (Bio-Rad) to maintain the buffer 
at a constant temperature. 0.5 % TBE buffer was circulated through the electrophoresis 
tank (at 0.75 L/ min) and pre-cooled to 14 °C. A 1 % TBE gel was cast in the standard 
casting frame supplied (14 x 13 cm). 5-10 µl of MidRange PFG Marker I (NEB) was 
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introduced into one well of the cast gel, then sealed with molten agarose. The gel was 
immersed in the buffer in the electrophoresis tank and the samples loaded into the 
appropriate wells. Electrophoresis was carried out for 18 hours at 14 °C, 6 V/cm with an 
initial switch time of 1 second and a final switch time of 25 seconds. 
 
2.5.5 DNA extraction from an agarose gel 
DNA fragments separated in agarose gels were excised from the gel using a clean scalpel 
and purified using the QIAquick® gel extraction kit (Qiagen). Briefly, the agarose gel slice 
containing the DNA fragment of interest was dissolved in a neutral pH, high salt buffer 
provided with the kit and applied to a silica-gel membrane mounted in a microcentrifuge 
tube. DNA is adsorbed while unwanted primers and impurities were washed away, leaving 
the DNA fragment to be eluted in 30 µl elution buffer. 
 
2.5.6 DNA digestion with restriction enzymes 
Restriction enzyme digestion of cosmids, plasmids or genomic DNA was carried out 
according to the enzyme manufacturer’s instructions. In the case of double digests, an 
appropriate buffer was selected by consulting the manufacturer’s literature (Roche or 
NEB). The reaction volume was usually 15 µl for diagnostic digests and 50-100 µl for 
preparative digests. Unless otherwise instructed, digests were typically carried out for 1.5 
hours at 37 °C. 
 
2.5.7 Ligation 
Ligation of DNA fragments was carried out using T4 DNA ligase and buffer (Invitrogen) 
following manufacturer’s instructions. Typically 50 ng of restriction-digested, gel-purified 
vector were used in a 1:3 molar ratio with the restriction-digested, gel-purified insert 
fragment. For blunt-end ligations, vector ends were typically treated with Calf Intestinal 
Alkaline Phosphatase (NEB) at 37 °C for 30 min. Ligations were typically carried out 
overnight at 4 °C. 3 µl of the ligation reaction were used to transform chemically 
competent E. coli DH5α. 
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2.5.8 Preparation and transformation of electrocompetent E. coli 
The desired E. coli strain was grown overnight at 37 or 30 °C in 10 ml LB broth containing 
the appropriate selection. 50 ml of an appropriate growth medium (typically L broth or 
SOB) were inoculated 1 in 100 with the overnight culture and grown at 37 or 30 °C with 
shaking at 250 rpm to an OD600 of ~0.4. The cells were recovered by centrifugation at 
4000 rpm for 5 min at 4 °C in a Sorvall GS3 rotor. The medium was decanted and the 
pellet resuspended by gentle mixing in 50 ml ice-cold 10 % glycerol. Centrifugation was 
repeated as above and the pellet resuspended in 25 ml ice-cold 10 % glycerol, and the 
process repeated once more with 10 ml ice-cold 10 % glycerol. Finally centrifugation was 
repeated as above and the pellet resuspended in ~1 ml ice-cold 10 % glycerol. 100 µl of 
this cell suspension were typically mixed with ~100 ng of cosmid DNA. Electroporation 
was carried out in a 0.2 cm ice-cold electroporation cuvette using a BioRad GenePulser II 
set to: 200 Ω, 25 µF and 2.5 kV. The time constant was typically 4.5–4.9 ms. 700 µl ice 
cold LB medium was immediately added to the shocked cells. The cells were incubated 
with shaking at 250 rpm for 1 hour at 37 or 30 °C. Typically 200 µl and 600 µl of the 
transformation were spread onto LB agar containing the appropriate selection (or DNA 
agar in the case of hygromycin selection). Plates were incubated overnight at 37 or 30 °C. 
 
2.5.9 Transformation of chemically-competent E. coli 
Chemically-competent E. coli DH5α (Invitrogen) were transformed with DNA according to 
the manufacturer’s instructions. Briefly, a 50 µl aliquot of cells was defrosted on ice for 5 
min. Approximately 100 ng of DNA were added to the cells which were incubated on ice 
for 30 min before a 20-40 second heat shock at 42 °C, then rested on ice for 2 min. 900 µl 
of pre-warmed SOC were added and cells were incubated with shaking at 250 rpm for 1 
hour at 37 °C. Typically 200 and 700 µl of the transformation were spread on LB or DNA 
containing selection. 
 
2.6 General PCR methods and Sanger sequencing 
A BioRad DNA Engine Thermal Cycler was typically used to perform Polymerase chain 
reaction (PCR). PCR tubes were strips of 8 thin-walled 0.2 ml tubes with domed-caps 
(Thermo Scientific). Most primers were designed with an annealing temperature of 55 to 
60 °C, consequently the annealing temperature used for most applications was 56 °C. 
The conditions typically used for different applications are listed below. The use of 4.8 % 
DMSO in PCR reactions facilitates the amplification of templates with a high GC content.  
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2.6.1 General analytical PCR 
 Amount/Concentration Volume (µl) Final Concentration 
Template DNA  1-10 ng 1  
Forward Primer   10 µM 1 0.4 µM 
Reverse Primer  10 µM 1 0.4 µM 
dNTPs 20 mM (5 mM each) 1 400 µM  
(100 µM each) 
Taq Buffer (Roche) 10 x 5 1x 
DMSO  40 % 6 4.8 % 
Taq (Roche) 5 U/µl 0.5 2.5 U 
dH2O  34.5  
Total  50  
 
95 °C 2 min 
95 °C 45 s 
55-60 °C 30 s  x 27 cycles 
72 °C 1-3 min 
72 °C 7 min 
 
2.6.2 High-fidelity amplification for cloning applications 
 Amount/ 
Concentration 
Volume (µl) Final Concentration 
Template DNA  100 ng/µl 1  
Forward Primer   10 µM 5 1 µM 
Reverse Primer  10 µM 5 1 µM 
dNTPs 20 mM (5 mM each) 1 400 µM (50 µM each) 
Expand HiFi Buffer 2 
(Roche) 
10 x 2.5 1 x 
DMSO  40 % 6 4.8 % 
Expand HiFi Taq 
(Roche) 
3.5 U/µl 0.71 2.48 U 
dH2O  28.79  
Total  50  
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94 °C 2 min 
94 °C 45 s 
55-60 °C 45 s  x 27 cycles 
72 °C 1-3 min 
72 °C 7 min 
 
2.6.3 Colony PCR in E. coli 
The PCR reaction mix was as 2.6.1 but with an extra 1 µl dH2O. Colonies of E. coli were 
picked from agar plates using a sterile Gilson pipette tip (Starlabs) and were smeared 
onto the wall of a PCR tube before adding the appropriate PCR mix. The tubes were 
placed in the Thermo cycler using the conditions: 
95 °C 5 min 
95 °C 45 s 
55-60 °C 45 s  x 30 cycles 
72 °C 1-3 min 
72 °C 5 min 
 
2.6.4 Colony PCR in Planomonospora 
Single colonies of P. alba were patched on to plates of D/seed and incubated for three 
days at 30 °C. 50 µl 100 % DMSO were aliquoted into 1.5 ml microcentrifuge tubes for 
Planomonospora mycelium to be scraped into using a sterile toothpick. The tube was 
shaken vigorously for at least one hour and then briefly centrifuged to pellet cell debris. 
2.5 µl of the supernatant were used as the template in the reaction as shown below. 
Control DNA samples were diluted 1 µl into 1.5 µl DMSO and were used in the same way. 
 Amount/Concentration Volume (µl) Final Concentration 
Forward Primer   10 µM 1 0.4 µM 
Reverse Primer  10 µM 1 0.4 µM 
dNTPs 20 mM (5 mM each) 1 400 µM (100 µM each) 
Taq Buffer (Roche) 10 x 5 1 x 
DMSO + template 100 % 2.5 5 % 
Taq (Roche) 5 U/µl 0.5 2.5 U 
dH2O  39  
Total  50  
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95 °C 5 min 
95 °C 45 s 
56-60 °C 45 s  x 30 cycles 
72 °C 1 min 
72 °C 5 min 
 
2.6.5 Purification of PCR products 
The QIAquick™ PCR purification kit (Qiagen) was used according to the manufacturer’s 
instructions to remove unincorporated primers, dNTPs and enzymes from PCR products 
>100 bp. 5 µl of the PCR reaction mixture were used in agarose gel electrophoresis to 
check the correct product was amplified. The remaining PCR mixture was diluted 5 times 
in high salt buffer and applied to a silica-gel membrane mounted in a microcentrifuge tube. 
The DNA fragment was washed then typically eluted in 2 x 25 µl elution buffer heated to 
50 °C. 
 
2.6.7 Sanger sequencing using Big Dye v3.1 
The ABI BigDye® 3.1 dye-terminator reaction mix (Applied Biosystems) was used to label 
purified PCR products or vectors. The manufacturer’s instructions were consulted to find 
what amount of DNA was appropriate as a template, based on its length. Big Dye labeling 
reaction was performed as detailed below and subsequently submitted to The Genome 
Analysis Centre for ABI Sanger Sequencing. The resulting sequence chromatogram files 
were analysed using VectorNTI ContigExpress software. 
 Amount Volume (µl) Final Concentration 
Template   varies varies varies 
Primer  10 µM 3.2 0.32 µM 
ABI BigDye® 3.1 dye-terminator 
reaction mix 
 1  
BigDye® 3.1  Reaction Buffer 5 x 2 1 x 
dH2O  varies  
Total  10  
 
95 °C 10 min 
96 °C 10 s 
50 °C 5 s  x 25 cycles 
60 °C 4 min 
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2.7 Growth conditions 
2.7.1 Growth and storage of E. coli 
E. coli strains were typically grown with the appropriate antibiotic selection either on L 
agar at 30 or 37 °C or in L broth with shaking at 250 rpm. For long-term storage strains 
were grown overnight in L broth and stored in a final concentration of 20 % glycerol at -20 
°C or -80 °C. 
 
2.7.2 Growth and storage of Micrococcus luteus 
M. luteus ATCC 4698 was typically grown either on L agar at 30 or 37 °C or in L broth with 
shaking at 250 rpm. For long-term storage strains were grown overnight in L broth and 
stored in a final concentration of 20 % glycerol at -20 °C or at -80 °C. 
 
2.7.3 Growth and storage of Streptomyces 
Streptomyces was grown and manipulated as described in (Kieser et al. 2000). Growth 
media were as stated in Section 2.3.2 and 2.3.3. For manipulation of Streptomyces and 
growth of confluent lawns for long-term storage, SFM agar medium was used with the 
appropriate antibiotic selection at 30 °C. Spores were collected in approximately 2 ml 20 
% glycerol using a sterile cotton pad through which spores were filtered by collecting with 
a 2 ml syringe and transferring to a 2 ml cryotube. Spore stocks were spun and 1 ml 
supernatant was removed before resuspension and storage at -20 °C. Spore stocks were 
titred by making serial dilutions in water and plating on SFM. The resulting colonies were 
counted from at least three dilutions and averaged. For liquid culture, ~108 Streptomyces 
spores were inoculated into the appropriate media in a 250 ml flask containing a baffle 
and incubated at 240 rpm at 30 °C. 
 
2.7.4 Growth and storage of Planomonospora 
P. alba NRLL18924 and P. sphaerica NRLL18923 were obtained from the NRRL culture 
collection. Growth media were as stated in Section 2.3.2 and 2.3.3. For manipulation of 
Planomonospora and growth of confluent lawns for long-term storage, ISP4 agar medium 
was used with the appropriate antibiotic selection at 30 °C. Spores were resuspended in 
10 ml H2O then filtered through non-absorbant cotton-wool in a glass collection tube as 
described in (Kieser et al. 2000). Spores were spun down and resuspended in 1 ml 20 % 
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glycerol then transferred to a 2 ml cryotube for storage at -20 °C. Spore stocks were titred 
by making serial dilutions in water and plating on ISP4. The resulting colonies were 
counted from at least three dilutions and averaged. For liquid culture, ~107 
Planomonospora spores were inoculated into ISP4 medium in a 25-100 ml flask and 
incubated with shaking at 240 rpm at 30 °C. The use of 3-6 glass beads (2 mm diameter) 
instead of a baffle, prevents foaming and associated anaerobic growth.  
 
2.7.5 Growth and storage of Nonomuraea 
Nonomuraea ATCC 39727 was a gift from Prof Flavia Marinelli (University of Insubria, 
Italy). Nonomuraea ATCC 39727 was grown on V0.1 agar medium at 30 °C. For liquid 
culture, Nonomuraea ATCC 39727 was typically inoculated 1 in 10 into VSP medium in a 
25-100 ml flask containing 3-6 glass beads (2 mm diameter) and incubated with shaking 
at 240 rpm at 30 °C. For long-term storage (master cell bank) culture broth containing 
mycelium was aliquoted into 2 ml cryotubes and stored at -80 °C. 
 
2.7.6 P. alba growth curve 
Cultures to assess the growth rate of P. alba were set up in the following way. 
Approximately 107 P. alba spores or 1 ml of broth containing mycelium were used to 
inoculate 10ml ISP4 in a 25 ml flask containing three glass beads. The culture was grown 
for 24-48 hours at 30 °C with shaking at 240 rpm. 100 µl of the resulting mycelium was 
diluted in 1 ml ISP4 and the optical density at OD450 assessed. Three 100 ml flasks 
containing 25 ml ISP4 and 10 glass beads were inoculated to a starting OD450 of 0.1-0.2. 
The flasks were incubated at 30 °C with shaking at 240 rpm. At appropriate time intervals 
samples were removed.  The growth rate of P. alba was assessed in liquid ISP4 by two 
methods. First, optical density at OD450 (using a 1 in 10 dilution when OD450 > 1) with ISP4 
as a blank. Alternatively a total protein assay was used. 1 ml of culture was sampled at 
the appropriate time intervals. The DC protein assay (Bio-Rad) was used according to the 
manufacturer’s instructions. Bovine serum albumin (BSA) standards of 0.1, 0.2, 0.4, 0.6, 
0.8, 1.0, 1.2 and 1.4 ng/ml were prepared in cuvettes in 0.5 ml volumes. The standard 
curve generated from the standards was used to calculate the protein concentrations in 
the experimental samples. 
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2.8 Microscopy 
2.8.1 Phase-contrast microscopy 
Samples were placed on 76x26 mm glass slides (VWR international) and covered with a 
glass cover slip (18x18 mm; VWR international). Slides were typically observed at 400 
times magnification with a Photomicroscope II in phase-contrast mode (Zeiss). 
 
2.8.2 Cryo-scanning electron microscopy 
High-resolution SEM was carried out by Kim Findlay at the John Innes Centre using a 
Zeiss Supra 55 VP FEG SEM with a Gatan Alto 2500 cryo system at an accelerating 
voltage of 3 kV. 
 
2.9 Next-generation sequencing and analysis 
Genomic DNA isolated from P. alba was sequenced using 454 sequencing technology 
(The Genome Analysis Centre, Norwich Research Park). One quarter of a run of 454 
sequencing yielded 72 Mb of sequence data. Sequence reads were assembled using 
Newbler assembly software. Summary statistics for the data assembly were: 
Total number of contigs : 1017 
Number of contigs at least 500 nt long: 944 
 
Minimum length of all contigs : 110 
Maximum length of all contigs : 141100 
Mean length of all contigs : 7186 
Median length of all contigs : 3186 
 
Minimum length of contigs at least 500 nt long : 506 
Maximum length of contigs at least 500 nt long : 141100 
Mean length of contigs at least 500 nt long : 7718 
Median length of contigs at least 500 nt long : 3592 
 
Minimum GC fraction in all contigs : 0.569 
Maximum GC fraction in all contigs : 0.901 
Mean GC fraction in all contigs : 0.739 
Median GC fraction in all contigs : 0.742 
 
Minimum GC fraction in contigs at least 500 nt long : 0.569 
Maximum GC fraction in contigs at least 500 nt long : 0.833 
Mean GC fraction in contigs at least 500 nt long : 0.739 
Median GC fraction in contigs at least 500 nt long : 0.742 
 
Total number of nucleotides in all contigs : 7308565 
Total number of nucleotides in contigs at least 500 nt long : 7285878 
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The assembled contig sequences were used to construct a database searchable by 
BLAST by Dr Govind Chandra using the format from the BLAST suite of programs version 
2.2.18 (National Center for Biotechnology Information; (Altschul et al. 1990)).  
 
2.10 Isolation of genomic DNA 
2.10.1 P. alba 
2.10.1.1 High-molecular weight genomic DNA 
A seed culture was inoculated with P. alba spores or mycelium and grown for seven days 
at 30 °C 250 rpm. 15 ml ISP4 containing the appropriate selection was inoculated 1 in 10 
with the seed culture. After three days at 30 °C 250 rpm, 10 ml were harvested by 
centrifugation and washed twice with 10 ml 10.3 % sucrose to remove media traces. The 
pellet was resuspended in 5 ml SET buffer and the pH adjusted to pH 8 with 1 N NaOH. 5 
mg of lysozyme (Sigma) and 0.25 mg ribonuclease A (Sigma) was added, mixed by 
inversion, then incubated at 37 °C for 30 min. 3 mg proteinase K (Roche) was added and 
the incubation continued at 37 °C a further 15 min. Next, SDS was added to a final 
concentration of 1 %, along with 2 ml of 5 M NaCl and mixed by inversion. The DNA was 
extracted with 1 ml phenol-chloroform-isoamylalcohol pH 8 using a slow rotary mixer. The 
phenol and aqueous phases were separated by centrifugation at 4000 rpm for 10 min. 
The aqueous phase was removed to a fresh 15 ml tube and the DNA extraction repeated 
with 1 ml chloroform. This was mixed slowly by a rotary mixer, then spun at 4000 rpm for 
10 min. The DNA was precipitated from the aqueous phase with ice-cold isopropanol. 
DNA was spooled from tubes using a sealed glass Pasteur pipette and washed in 70 % 
ethanol. The DNA was air-dried and resuspended in approximately 200 µl elution buffer at 
50 °C. gDNA was stored at 4 °C. 
 
2.10.1.2 Small-scale genomic DNA extraction 
P. alba mycelium was grown for 48-72 hours in liquid culture. 10 ml were harvested by 
centrifugation and washed with 10 ml 10.3 % sucrose to remove media traces. The pellet 
was resuspended in 2.5 ml GET buffer and the pH adjusted to pH 8 with 1 N NaOH. 1.5 
mg of lysozyme and 100 µg RNase A were added, mixed by inversion, then incubated at 
37 °C for 30 min. 3 mg proteinase K were added and the incubation continued at 37 °C a 
further 15 min. Next, SDS was added to a final concentration of 1 %. The DNA was 
extracted with 1 ml phenol-chloroform-isoamylalcohol pH8 with vortexing for 30 seconds 
to mix thoroughly, then centrifugation at 6000 rpm for 15 min at 4 °C. The aqueous phase 
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was removed to a fresh 15 ml tube, and if cloudy, DNA extraction repeated with 1 ml 
chloroform. This was vortexed for 30 seconds, then centrifuged at 6000 rpm for 15 min at 
4 °C. The DNA was precipitated from the aqueous phase with ice-cold isopropanol. DNA 
was spun down at 7000 rpm for 15 min at 4 °C and the pellet washed in 70 % ethanol. 
The DNA was air-dried and resuspended in elution buffer. gDNA was stored at 4°C 
(concentrated samples) and at a concentration of 10 ng/µl at -20 °C. 
 
2.10.2 Nonomuraea 
Nonomuraea mycelium was harvested from 10 ml of culture by centrifugation after 48 
hours growth in liquid culture and washed with 10 ml 10.3 % sucrose to remove media 
traces. The pellet was resuspended in 5 ml SET buffer. The pH of the solution was 
adjusted to pH 8 with 1 N NaOH. 50 mg lysozyme were added and the tube incubated at 
37 °C for 24 hours, adding fresh lysozyme at intervals (approximately 50 mg every 8-12 
hours). After 16 hours incubation, 25 µg RNase A were added and the incubation 
continued at 37 °C. After 20 hours, 3 mg proteinase K were added and the incubation 
continued at 37 °C. After 24 hours incubation, SDS was added to a final concentration of 
1 % and the solution mixed by inversion followed by an overnight incubation at 55 °C. 
Finally, 2 ml 5 M NaCl were added and the DNA was extracted with 4 ml phenol-
chloroform-isoamylalcohol (pH 8) with vortexing to mix thoroughly. After centrifugation at 
4000 rpm for 10 min, the aqueous phase was removed to a fresh 15 ml tube and 4 ml 
chloroform added. Again the tube was vortexed and centrifuged as above. The aqueous 
phase was moved to a fresh tube and the DNA was precipitated with ice-cold isopropanol. 
DNA was spun down at 7000 rpm for 15 min at 4 °C and the pellet washed in 70 % 
ethanol.  The DNA was dried and resuspended in elution buffer. gDNA was stored at 4 °C. 
 
2.10.3 Streptomyces 
10 ml of 50:50 TSB:superYEME liquid medium in a baffled Universal was inoculated with  
~108 Streptomyces spores. The culture was incubated at 30 °C for 24-36 hours. The  
mycelium was harvested and resuspended in 2.5 ml of SET buffer then 1.5 mg lysozyme 
and 0.25 mg RNase A were added. The mycelium was incubated at 37 °C for 30 min. 0.6 
mg of proteinase K (20 mg/ml) was added and incubation continued for a further 15 min. 
SDS was added to a final concentration of 1 % and mixed by inversion before incubating 
at 55 °C for 15 min. The DNA was extracted with 1 ml phenol-chloroform-isoamylalcohol 
pH 8 with vortexing to mix thoroughly and centrifugation at 6000 rpm for 15 min at 4 °C. 
The aqueous phase was removed to a fresh tube and the DNA was precipitated by adding 
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1/10 volume 0.3 M sodium acetate (pH 6) and 1 volume ice-cold isopropanol. DNA was 
pelleted by centrifugation for 15 min at 7000 rpm and washed in 70 % ethanol. The DNA 
was air-dried and resuspended in 100 µl elution buffer at 50 °C. gDNA was subsequently 
stored at 4 °C. 
 
2.11 Cosmid Library Preparation 
2.11.1 Preparation of insert gDNA 
High molecular weight P. alba gDNA was partially digested with Sau3AI (Roche). 50 µg 
gDNA were digested with 0.025 units of Sau3AI for 30 seconds in a volume of 250 µl. The 
reaction was immediately quenched with EDTA. The digested DNA was extracted by 
adding 500 µl phenol-chloroform-isoamylalcohol pH 8 and gently mixing on a rotary mixer. 
The phenol and aqueous phases were separated by centrifugation at 13000 rpm for 4 min 
at 4 °C. The aqueous phase was moved to a fresh tube using a wide-bore tip. The DNA 
extraction repeated with 500 µl chloroform. The tube contents were mixed slowly by a 
rotary mixer, then spun at 13000 rpm for 4 min at 4 °C. Sodium acetate was added to the 
supernatant to a final concentration of 0.3 M. The DNA was precipitated with 500 µl ice-
cold isopropanol. DNA was pelleted at 13000 rpm for 4 min at 4 °C. The pellet was 
washed in 70% ethanol by gentle inversion. The DNA was air-dried and resuspended in 
25 µl elution buffer heated to 50 °C. The partially digested gDNA was dephosphorylated 
with calf intestinal alkaline phosphatase (CamBio) in 50 µl total reaction at 37 °C for 1 
hour. The reaction was immediately quenched with EDTA then the partially digested 
dephosphorylated DNA was extracted with phenol-chloroform-isoamylalcohol pH 8 the 
chloroform and precipitated with isopropanol as described above. The DNA was air-dried 
and resuspended in 25 µl elution buffer heated to 50 °C. The partially digested and 
dephosphorylated DNA was checked on PFGE. The partial Sau3AI digestion reduced the 
gDNA from 100–200 kb to 30-50 kb in size for ligation into the SuperCosI vector.  
 
2.11.2 Preparation of pSuperCos1 vector and ligation with insert DNA 
10 µg SuperCosI vector (Stratagene) were linearised with 9 U/µg XbaI (Roche) in a total 
volume of 100 µl at 37 °C for 1 hour. Complete digestion was indicated by a linear 
SuperCosI band at 7.9 kb when 1 µl of the digestion was checked on a 1 % TBE agarose 
gel. The vector DNA was purified from the remaining reaction with the Qiagen PCR 
purification kit. The DNA was eluted twice in 25 µl elution buffer warmed to 50 °C. The 
purified XbaI digested DNA was treated with 30 U calf intestinal alkaline phosphatase 
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(Cambio), in 100 µl total reaction for 1 hour at 37 °C. The DNA was purified with the 
Qiagen PCR purification kit and eluted twice in 25 µl elution buffer warmed to 50 °C. The 
DNA was digested with 10 U/µg BamHI (NEB) in 100 µl total volume at 37 °C for 1 hour. 
The DNA was purified with the Qiagen PCR purification kit and eluted with twice in 25 µl 
elution buffer warmed to 50 °C. The generation of fragments of the expected sizes of 1.3 
kb and 6.6 kb was checked by running 2 µl of the treated DNA and alongside the 7.9 kb 
XbaI linearised DNA on a 1 % TBE agarose gel by electrophoresis. Ligation was carried 
out as follows with the reaction incubated at 4 °C overnight 
 Sample Negative Control 
Insert DNA Sau3AI digested 2.5 µg 2.5 µg 
pSuperCosI BamHI digested 1 µg 1 µg 
10 x T4 ligase buffer (Promega) 2 µl 2 µl 
T4 DNA ligase 3U/µl (Promega) 1 µl - 
H2O to 20 µl to 20 µl 
 
2.11.3 Phage packaging 
4 µl of each ligation reaction were packaged into λ-phage using the GigaPack III Gold 
Packaging Extract (Stratagene) according to the manufacturer’s instructions. Briefly, 
packaging extracts were removed from -80 °C storage to dry ice. Extracts were rapidly 
thawed and 4 µl of each ligation reaction immediately added. The extract was gently 
mixed and incubated at room temperature for 2 hours. 500 µl SM buffer were added, then 
20 µl chloroform were also added. Packaged phage were stored at 4 °C and used within 1 
month. 
 
2.11.4 Phage titration 
Escherichia coli XL-I Blue MR (Stratagene) was streaked from a glycerol stock at -20 °C 
on to LB agar and was grown at 37 °C overnight. A single colony from this plate was used 
to inoculate 10 ml LB broth and grown overnight at 37 °C. 1 ml of this culture was used to 
inoculate 50 ml LB broth containing 10 mM MgSO4 and 0.2 % maltose. This culture was 
grown at 37 °C for 3 hours. Cells were recovered by centrifugation and diluted to an OD600 
of 0.5 in 10 mM MgSO4. Packaged phage were diluted in SM buffer to a totally volume of 
25 µl. Transfection of E. coli cells with 1 µl of 1/5, 1/10, 1/50 and 1/100 dilutions of phage 
was carried out by mixing 25 µl cells with 25 µl each dilution and incubating cells at room 
temperature for 30 min. 200 µl LB broth were added to each tube and incubated at 37 °C 
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for 1 hour with gentle shaking every 15 min. The entire transfection reaction was plated 
out on LB agar containing 100 µg/ml carbenicillin and incubated overnight at 37 °C. The 
resulting colonies were counted to give the phage titre per µl of phage extract used. The 
resulting clones were picked into 5 ml LB broth and grown at 37 ºC overnight. The 
packaged extract was estimated to contain 20 colony forming units per µl of undiluted 
extract.  
 
2.11.5 Phage transfection of E. coli to construct cosmid library 
This was carried out as a scaled-up version of the phage titration. It was calculated that in 
order to obtain the 3072 colonies needed to make the library, 225 µl of the packaged 
extract were transfected to construct the final cosmid library. 500 µl E. coli XL-I Blue MR 
cells at OD600 of 0.5 in 10 mM MgSO4 were added to 225 µl of the pooled packaged 
phage extracts made up to 500 µl with SM buffer. 5 ml LB broth were added and 
incubated at 37 °C for 1 hour with gentle mixing every 15 min. 500 µl of the transfection 
mix were plated out on each of 6 Genetix plates (240 x 240 x 20 mm) containing 250 ml 
LB agar with 100 µg/ml carbenicillin to give an estimated plating density of 750 colonies 
per plate. Plates were incubated inverted overnight at 37 °C. 
 
2.11.6 Library picking and transfer to membrane 
3072 colonies were picked using Q-Bot (Genetix) into 8 x 384 well archive plates 
containing freezing broth (LB and glycerol) and 100 µg/ml carbenicillin. Two copies of the 
archive plates were replicated and all copies of the library were stored at -80 °C. The 
entire library was spotted two-fold onto nylon membrane in a double off-set pattern. The 
clones on the membrane were grown on LB agar overnight and baked on to the 
membrane at 80 °C. The membrane was stored at -20 °C. 
 
2.11.7 Probe preparation and library hybridisation 
Three probes were amplified from P. alba gDNA by PCR using three pairs of primers. 
1289FlanA and 1289RlanA primers amplify 230 bp of pspA. 3088F and 3088R amplify 
547 bp of pspB. PMSLanAf and PMSLanBf amplify 1701 bp spanning pspA and 5’ pspB. 
The PCR products were separated by electrophoresis on a 1 % TBE agarose gel, purified 
by PCR purification and ligated into pGEM-T vector (Promega) by TA cloning according to 
the manufacturer’s instructions. 2 µl of the ligation were used to transform DH5α cells and 
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plated onto LB containing 100 µg/ml carbenicillin, 0.5 mM IPTG and 80 µg/ml X-Gal. One 
white colony of each insert cloned in pGEM-T was grown in liquid LB broth containing 100 
µg/ml carbenicillin. The vector was mini-prepped from the cell pellet using a Qiagen kit. A 
restriction digest with EcoRI revealed the correct sized insert was present in each vector. 
The insert was amplified out of the vector and purified by gel-extraction with a Qiagen kit 
and the concentration measured using Nanodrop (Thermo Scientific). Each amplified 
probe was sequenced and found not to contain any mutations. 25 ng of the purified DNA 
fragment were diluted to a final volume of 50 µl in TE. The DNA was denatured at 95-100 
°C for 5 min and snap cooled on ice for 5 min before centrifuging briefly. The DNA was 
added to a tube containing Rediprime II random prime labelling reaction mix (Amersham), 
to which was then added 5 µl 32P-αdCTP and mixed by pipetting. The tube was incubated 
at 37 °C for 30 min and the reaction stopped by adding 5 µl 0.2 M EDTA. The tube was 
heated to 100 °C for 5 min then snap cooled on ice for 5 min before centrifuging briefly. 
Three copies of the membrane containing the cosmid library clones were prepared by 
soaking for 1 hour at 42 °C in a pre-hybridisation solution of: 5 x SSC, 0.5 % SDS, 1 mM 
EDTA (pH 8). The solution was replaced with fresh pre-hybridisation solution and soaked 
for a further 2 hours. The bacterial debris were scraped off using a damp paper towel and 
the membranes were rinsed twice in 2 x SSC. 
The membranes were each placed into a large hybridisation tube containing 50 ml of 
hybridisation buffer warmed to 60 °C and were pre-hybridised for 5 hours at 65 °C in a 
Techne rotisserie oven. The pre-hybridisation solution was replaced with 10 ml of fresh 
hybridisation buffer. To each of the three tubes, 30 µl of one labelled probe were added. 
The filter was hybridised at 60 °C in a Techne rotisserie oven for a total of 20.5 hours. The 
hybridisation solution was removed and the filter washed five times in 30 ml of pre-
warmed wash buffer at 60 °C until the counts per minute were reduced to ~20. The filter 
was wrapped in clingfilm and exposed to a phosphor plate overnight. The plate was 
visualised using a phosphorimager (Fuji). Alignment of the membrane with the grid pattern 
of the 386 well plates along with the double off-set pattern of the spots allowed the 
location of the positive clones to be identified. Positive clones were selected from the 
library and grown on LB agar containing 100 µg/ml carbenicillin. 
 
2.12 Cosmid sequencing and sequence analysis 
Cosmid end-sequencing was carried out as decribed in 2.6.7 using the primers End_F 
and End_R to obtain approximately 800 base pairs of sequence each end. Cosmids B4-1 
and F13-1 did not appear to contain lantibiotic biosynthetic genes on the ends of the 
cosmid so were sequenced using Sanger sequencing by the Cambridge University DNA 
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Sequencing Service. The complete cosmid sequences were annotated using Artemis 
(Sanger Centre, Cambridge). Open-reading frames were called on the basis of the GC 
content across triplets. Start sites, ATG or GTG, were further adjusted by locating the 
presence of ribosome-binding sites (RBSs) approximately 6-10 nucleotides upstream of 
the start site and based around the sequence GGAGG. A BLAST search of the National 
Center for Biotechnology Information (NCBI) database using a protein query was used to 
annotate these putative open-reading frames based on homology. 
 
2.13 PCR targeting of cosmids 
REDIRECT© technology; ‘PCR targeting system in Streptomyces coelicolor A3(2)’ by 
Bertolt Gust, Tobias Kieser and Keith Chater (2002) was used as a basis to carry out PCR 
targeting. This technology is based on the PCR targeting system described by Datsenko 
and Wanner and was further developed by Bertolt Gust (Datsenko and Wanner 2000; 
Gust et al. 2003). The protocol was further adapted for use with Planomonospora through 
some minor modifications. 
 
2.13.1 Construction of integrative cosmids 
The B4-1 cosmid (pIJ12321) was targeted to introduce an integrase (intΦC31), phage 
attachment site (attP), origin of transfer (oriT) and apramycin resistance cassette 
(aac(3)IV), creating pIJ12323. Cosmid F13-1 (pIJ12322) was similarly targeted to create 
pIJ12324. This was achieved through the replacement of neo on the SuperCosI backbone 
with the 5247 bp oriT-attP-int-aac(3)IV cassette. 
E. coli BW25113/pIJ790 containing the SuperCosI cosmid to be targeted was grown in 10 
ml L broth containing 50 µg/ml carbenicillin, 50 µg/ml kanamycin and 25 µg/ml 
chloramphenicol overnight at 30 °C with shaking at 250 rpm. 10 ml SOB (without Mg) 
containing carbenicillin, kanamycin, chloramphenicol and 100 µl 1 M L-arabinose were 
inoculated 1 in 100 with this overnight culture and was incubated with shaking at 30 °C for 
~4 hours until OD600 ∼0.6. Electrocompetent cells were generated from the induced culture 
as described in 2.5.8. 50 µl of the cell suspension were mixed with ∼100 ng gel purified 
5247 bp SspI fragment derived from pIJ10702 (pMJCOS1). Electroporation was carried 
out as 2.5.8. Typically 500 µl aliquots of the transformation mix were plated onto two 
plates of L agar containing 50 µg/ml apramycin and 100 µg/ml carbenicillin and were 
incubated overnight at 37 °C.  
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After incubation overnight, colonies were scraped from one transformation plate in 1 ml 
H2O. The cells were pelleted by centrifugation and the cosmid DNA purified using the 
standard cosmid preparation protocol described in 2.5.2. 1 µl of the resulting cosmid DNA 
was used to transform 50 µl chemically competent E. coli DH5α, as described in 2.5.9. 
Typically 200 µl and 800 µl of the transformation were plated on to L agar containing 50 
ug/ml apramycin and 100 µg/ml carbenicillin and were incubated overnight at 37 °C.  
Resulting transformants were picked into 10 ml L broth with the same antibiotic selection 
and were grown overnight at 37 °C. Cosmid DNA was prepared from these overnight 
cultures following the standard cosmid preparation protocol described in Section 2.5.2. 
Cosmid DNA which had been successfully targeted with the pIJ10702 SspI fragment was 
confirmed by NotI restriction digest which yields a diagnostic band-shift from 6807 bp to 
8682 bp. Restriction digest with BamHI was used to confirm the identity of the cosmid. 
 
2.13.2 Construction of mutant cosmids by gene replacement 
The mutation of a specific cosmid by gene replacement was carried out in E. coli 
BW25113/pIJ790 containing the cosmid to be targeted essentially as described in 2.13.1. 
The gene replacement cassette was amplified by high-fidelity PCR using the vector 
pIJ10700 containing the hyg-oriT cassette as a template. The primers were designed to 
anneal to the universal primer binding sites of 19 and 20 bp which flank the cassette, and 
have 39 bp extensions homologous to the sequence flanking the region of cosmid to be 
replaced (primer sequences are listed in Table 2.5). PCR was carried out as follows: 
 Amount/ Concentration Volume (µl) Final Concentration 
Template DNA  100 ng/µl 0.5  
Forward Primer   100 µM 0.5 1 µM 
Reverse Primer  100 µM 0.5 1 µM 
dNTPs 40 mM (10 mM each) 1 800 µM (200 µM each) 
Expand HiFi 
Buffer 2 (Roche) 
10x 5 1x 
DMSO  100 % 2.5 5 % 
Expand HiFi Taq 
(Roche) 
2.5 U/µl 1 2.5 U 
dH2O  39  
Total  50  
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94 °C 2 min 
94 °C 45 s 
50 °C 45 s 
72 °C 90 s 
94 °C 45 s 
55 °C 45 s 
72 °C 90 s 
72 °C 5 min 
 
The PCR reaction was treated with 1 µl DpnI (NEB; 20 U/µl) for 1 hour at 37 °C to remove 
template DNA. The PCR-amplified template was purified using the Qiagen PCR 
purification kit and was eluted in 25 µl elution buffer heated to 55 °C. 1 µl of the purified 
cassette was separated on a 1 % TBE agarose gel by electrophoresis to check the size 
and quality of the cassette DNA. 1 µl (approximately 100 ng) of the purified cassette DNA 
was used to transform E. coli BW25113/pIJ790 containing the cosmid, and prepared as 
described in 2.13.1. Transformants were selected on DNA agar containing 40 µg/ml 
hygromycin. Transformed cosmids were transferred to E. coli DH5α as described in 2.13.1 
and the correct targeting of the cosmid confirmed by PCR, using primers flanking the 
cassette insertion (listed in Table 2.5). The resulting confirmation PCR products were 
purified using a PCR purification kit, and the correct replacement of the gene in question 
was confirmed by sequencing as described in 2.6.7. To confirm that no other 
rearrangements had occurred in the targeted cosmids, targeted and WT cosmids were 
subjected to restriction digest analysis. Usually a couple of digests were performed 
individually with either; NotI, BamHI, NcoI or PstI, and fragments compared by separating 
on a 1 % TBE agarose gel by electrophoresis. The restriction digest patterns were 
compared to those from in silico digests of the respective WT and mutant cosmids (using 
NEB Cutter). 
 
2.13.3 Construction of minimal gene set 
Minimal gene sets were created by gene replacement of DNA regions outside of the 
biosynthetic gene cluster. The vector pIJ773 containing apramycinR-oriT cassette was the 
template used to amplify the extended resistance cassette. The primers were designed to 
contain an additional restriction site for an enzyme which does not cut elsewhere on the 
cosmid. This site is located between the universal primer binding site and the 39 bp 
extension which has homology to the cosmid. To remove the genes upstream of the 
cluster, SpeI sites were introduced, while XbaI sites were introduced to remove the genes 
downstream of the cluster. Gene replacement was carried out in E. coli BW25113/pIJ790 
containing cosmid B4-1 essentially as described in 2.12.2. The region of cosmid upstream 
and downstream of the biosynthetic gene cluster were targeted in turn. The targeting was 
S 
HN 
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checked by PCR using primers annealing outside the resistance cassette, and by a 
diagnostic restriction digest. A preparative digest was performed on the targeted cosmid, 
using the enzyme which recognises the site engineered into the primers. The cosmid was 
gel extracted and religated to remove the resistance cassette. This was checked by PCR 
and restriction digest. The minimalised cosmid was targeted to replace neo on the 
SuperCosI backbone with the oriT-attP-int-aac(3)IV cassettef as described in 2.13.1.  
 
2.13.4 FLP-mediated recombination to generate scar mutants 
E. coli DH5α/BT340 was grown in 10 ml L broth containing 25 µg/ml chloramphenicol 
overnight at 30 °C with shaking at 250 rpm. 10 ml L broth containing chloramphenicol 
were inoculated 1 in 100 with this overnight culture and was incubated with shaking at 30 
°C for 3-4 hours until OD600 ∼0.6. Electrocompetent cells were generated from the induced 
culture as described in 2.5.8. 50 µl of the cell suspension were mixed with ∼100 ng 
cosmid containing the FRT-flanked cassette to be removed. Electroporation was carried 
out as in 2.5.8. Typically 200 µl and 800 µl aliquots of the transformation mix were plated 
onto DNA agar containing 25 µg/ml chloramphenicol and 80 µg/ml hygromycin and were 
incubated for 2 days at 30 °C. Approximately eight single colonies were picked and 
streaked on to L agar without antibiotics and incubated at 42 °C overnight to promote 
FLP-recombination. Single colonies from these plates were picked and streaked first onto 
DNA agar containing hygromycin and then onto L agar containing carbenicillin and 
kanamycin. The plates were incubated at 37 °C overnight and compared to identify clones 
sensitive to the selection for the cassette used for mutagenesis (hyg) but resistant to the 
selection for the cosmid backbone (carb and kan). Four to eight such clones were 
selected and the removal of the cassette confirmed by PCR using flanking primers and 
the PCR products checked by Sanger sequencing. 
The scar cosmid has had the oriT removed along with the resistance marker. One option 
to introduce the scar cosmid into P. alba is to use protoplast transformation. Alternatively 
the scar cosmid can be targeted once more to re-introduce the oriT in order to facilitate 
the mobilisation of the construct by conjugal transfer. The bla gene on the SuperCosI 
backbone was targeted for replacement with bla-oriT-resistance marker-bla. The scarred 
construct with oriT and additional resistance marker introduced into the backbone in place 
of bla was conjugated into P. alba. Kanamycin-resistant P. alba colonies containing the 
entire scar cosmid integrated by a single crossover were isolated. These were restreaked 
onto to kanamycin-free ISP4, followed by screening for concomitant loss of kanamycin 
resistance, indicating a double crossover event has occurred to leave the 81 bp scar 
sequence in the P. alba chromosome in place of the gene of interest. 
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2.14 Conjugation methods 
2.14.1 Streptomyces 
E. coli ET12567/pUZ8002 harbouring the plasmid or cosmid to be transferred was grown 
overnight in 10 ml L broth containing the plasmid selection as well as 50 µg/ml kanamycin 
and 25 µg/ml chloramphenicol at 37 °C with shaking at 250 rpm. 100 µl of this overnight 
culture were inoculated into 10 ml L broth containing the same selection and was grown at 
37 °C with shaking at 250 rpm until the culture reached an OD600 of 0.4. The cells were 
pelleted at 3000 rpm for 10 min, then washed twice with 10 ml of L broth to remove 
antibiotics. The pellet was then resuspended in 1 ml of L broth. For each conjugation 10 µl 
(approximately 108) Streptomyces spores were added to 500 µl 2x YT broth. Spores were 
heat shocked at 50 °C for 10 min and allowed to cool. Then 0.5 ml of the E. coli cell 
suspension was added to the spores. The mix was serially diluted and the 10-1, 10-2 and 
10-3 dilutions were plated out onto SFM media containing 10 mM MgCl2. The plates were 
incubated at 30 °C for 16-20 hours. Each plate was overlaid with 1 ml water containing 0.5 
mg nalidixic acid (20 µl of 25 mg/ml stock to give a final concentration of 20 µg/ml in 25 ml 
agar plate) to kill E. coli donor cells and the selection for the plasmid as appropriate, as 
detailed in (Kieser et al. 2000). The incubation was continued at 30 °C. Single 
exconjugants were picked after 3-5 days growth and were streaked on to SFM containing 
25 µg/ml nalidixic acid and the plasmid selection (typically 50 µg/ml apramycin).  
 
2.14.2 P. alba 
E. coli ET12567 pUZ8002 harbouring the plasmid or cosmid to be transferred, were 
prepared for conjugation as described in 2.14.1. For each conjugation, 10 µl 
(approximately 106) Planomonospora spores were added to 500 µl ISP4 broth. Spores 
were heat shocked at 50 °C for 10 min to synchronise germination and allowed to cool. In 
some cases, spores were incubated at 37 °C 250 rpm for 2.5 hours after heat shock then 
vortexed to disperse germ tubes which may have clumped together. Then 0.5 ml of the E. 
coli cell suspension was added to the germinated spores and inverted to mix. 200 µl 
aliquots were plated onto ISP4 media containing 10 mM MgCl2. The plates were 
incubated at 30 °C for 18-20 hours. Each plate was overlaid with 1 ml water containing 0.5 
mg nalidixic acid and the appropriate selection for the plasmid. Typically this selection was 
1.25 mg hygromycin (25 µl of 50 mg/ml stock to give a final concentration of 50 µg/ml in 
25 ml agar plate) or 0.5 mg apramycin (10 µl of 50 mg/ml stock to give a final 
concentration of 20 µg/ml in a 25 ml agar plate). One plate from each conjugation was 
overlaid with 1 ml water containing 0.5 mg nalidixic acid only as a control. Incubation was 
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continued at 30 °C. Single exconjugants were picked after 10 days for small integrative 
constructs, or 2-4 weeks for homologous recombination with cosmids.  
 
2.14.3 Nonomuraea 
Nonomuraea mycelium was harvested from 24-48 hour old cultures by centrifugation at 
4000 rpm for 10 min and was washed twice in ice cold 20 % glycerol. The mycelial pellet 
was resuspended in approximately half the original volume ice-cold 20 % glycerol. 
Mycelial samples were used immediately or were stored at -80 °C and defrosted on ice 
prior to conjugation. E. coli ET12567 pUZ8002 harbouring the plasmid or cosmid to be 
transferred, were prepared for conjugation as described in 2.14.1. 0.5 ml of mycelium was 
mixed with 0.5 ml of E. coli for each conjugation. 200 µl aliquots were plated onto V0.1 
media containing 10 mM MgCl2. The plates were incubated at 30 °C for 18-20 hours. Each 
plate was overlaid with 1 ml water containing 0.5 mg nalidixic acid and the appropriate 
selection for the plasmid (typically 1.25 mg apramycin). One plate from each conjugation 
was overlaid with 1 ml water containing 0.5 mg nalidixic acid only as a control. Incubation 
was continued at 30 °C. Single exconjugants were picked after 14 days for small 
integrative constructs, or 3-5 weeks for homologous recombination with cosmids. 
 
2.15 Generation of mutants by homologous recombination in P. alba 
The region of cosmid B4-1 or a truncated derivative encoding the gene to be deleted was 
replaced with the hyg-oriT cassette amplified by high-fidelity PCR from pIJ10700 as 
described in 2.12.2. The successful mutation of the cosmid to Δorf::hyg-oriT was 
confirmed by PCR using the appropriate verification primer pair (listed in Table 2.5) along 
with restriction digest to confirm the integrity of the rest of the cosmid. The mutant cosmid 
was transferred to E. coli ET12567 pUZ8002 and the resulting strain used to transfer the 
cosmid to P. alba spores by conjugation as described in 2.14.2. Exconjugants were 
typically streaked for single colonies successively three times on selected on ISP4 
containing 25 µg/ml nalidixic acid and 40 µg/ml hygromycin. These were sub-cultured in 
ISP4 containing 40 µg/ml hygromycin for 7 days at 30 °C to promote double-crossover 
recombination events. Mycelium from this culture was streaked to obtain single colonies 
on ISP4 containing 40 µg/ml hygromycin. Single colonies were assayed for growth on 
ISP4 containing 50 µg/ml kanamycin. Sensitivity to kanamycin indicated a double-
crossover recombination event so these colonies were sub-cultured in ISP4 containing 40 
µg/ml hygromycin for 7 days at 30 °C, from which mycelium was stored as a master cell 
bank at -80 °C. A further sub-culture in ISP4 containing 40 µg/ml hygromycin was grown 
  
105 
105 Chapter 2 : Materials and Methods 
at 30 °C for 2-3 days for preparation of genomic DNA, as described in Section 2.10.1. 
This genomic DNA was analysed by PCR using the appropriate verification primer pair. 
The absence of the WT gene was also confirmed using gene internal primers (listed in 
Table 2.5). 
 
2.16 Complementation of mutant phenotypes 
Complementation of mutant phenotypes was carried out via the introduction of the deleted 
open-reading frame in trans with expression from the native promoter of the open-reading 
frame in question. The vector was pSET152, which contains the apramycin resistance 
marker and integrates at the ΦC31 integration site in P. alba. 
To complement the deletion of pspA, the region between pspX and pspA (PpspA) and the 
open-reading frame of pspA were amplified by high-fidelity PCR using primers 
PpspAF_BamHI and PspAR_XbaI. The resulting fragment was cloned into BamHI and 
XbaI double digested pSET152 to create pIJ12532. 
To complement the deletion of pspX, the region between pspA and pspX (PpspX) and the 
open-reading frame of pspX were amplified by high-fidelity PCR using primers 
PpspXF_BamHI and PspXR_XbaI. The resulting fragment was cloned into BamHI and 
XbaI double digested pSET152 to create pIJ12539. 
To complement the deletion of pspR, the region between pspQ and pspR (PpspR) and the 
open-reading frame of pspR were amplified by high-fidelity PCR using primers 
PpspRF_XbaI and PspRR_BamHI. The resulting fragment was cloned into BamHI and 
XbaI double digested pSET152 to create pIJ12540. 
To complement the other deletion mutants two further vectors were generated based on 
pSET152 containing either the intergenic region between pspX and pspA (PpspA; 
pIJ12533), or between pspW and pspJ (PpspJ; pIJ12536). These regions were amplified by 
high-fidelity PCR using primers PpspAF2_BamHI and PpspAR_SpeIBamHI, and 
PpspJF_SpeIBamHI and PpspJR_BamHI respectively. These primers were designed to 
allow introduction of the fragment into pSET152 using BamHI, as well as introducing a 
unique SpeI site. The resulting fragment was first cloned into the commercial vector 
pGEM-T. Four white colonies were prepped for plasmid DNA and the insert amplified in 
high-fidelity PCR using pSET152F and pSET152R primers. The PCR product was 
sequenced and plasmids lacking spontaneous mutations were liberated from pGEM-T in a 
BamHI digest. The isolated fragment was ligated into BamHI digested, dephosphorylated 
pSET152. Colony PCR using one primer within the insert (1289FlanA or -3confirmR) and 
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one primer in the vector (pSET152F2) identified clones in which the insert was ligated in 
the correct orientation so that the introduced SpeI site is next to the XbaI site present in 
pSET152. This created pIJ12533 (pSET152-PpspA-SpeI-XbaI) and pIJ12536 (pSET152-
PpspJ-SpeI-XbaI). The appropriate psp gene and its cognate putative RBS (GGAGG lying 
9-12 bp upstream from the start codon) were amplified from pIJ12321 by high-fidelity PCR 
using the appropriate primer pair (listed in Table 2.5). Primers were designed to allow the 
ORF to be cloned into the SpeI site introduced with the promoter and the XbaI site already 
present in pIJ12533 and pIJ12536 such that they lay downstream of the respective 
promoter region. 
All constructs were confirmed by Sanger sequencing. The resulting constructs, along with 
the empty vector controls (promoter only), were mobilised into the respective mutant strain 
via conjugation from E. coli ET12567 pUZ8002 as described in Section 2.14.2.  
 
2.17 Bioassay methods 
2.17.1 Solid bioassay 
The indicator organism was M. luteus ATCC 4698. 50 µl of a glycerol stock were streaked 
onto L agar plates and incubated for 2 days at 30 °C. A single colony was used to 
inoculate L broth which was grown overnight at 30 °C with shaking at 250 rpm. This 
culture was diluted 1 in 25 into 50 ml L broth and grown at 30 °C with shaking until an OD 
of 0.4-0.6 was reached. This culture was diluted 1 in 10 into molten soft nutrient agar at 50 
°C and approximately 10 ml used to overlay each 25 ml plate containing the growing 
producer organism. The plates were incubated at 30 °C overnight, or until defined halos 
were visible. 
 
2.17.2 Liquid bioassay 
The indicator organism was M. luteus ATCC 4698. An overnight culture was grown and 
subcultured as described in 2.13.1. This culture was diluted 1 in 10 into molten L agar at 
50 °C and approximately 50 ml poured into 100 mm square petri dishes. 40 µl samples of 
spent culture supernatant were applied as 2x 20 µl to sterile antibiotic assay discs and 
allowed to dry. These were then placed onto plates containing the target organism and 
the plates incubated at 30 °C overnight, or until halos are clearly defined. 
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2.18 Mass Spectrometry  
2.18.1 Matrix-Assisted Laser-Desorption Ionisation Time of Flight (MALDI-ToF) 
2.18.1.1 Low mass range: 700 - 4000 Da 
Culture supernatants were diluted 1 in 5 with 5 % formic acid (ARISTAR®, VWR). The 
diluted sample (~0.8 µl) was spotted onto a PAC plate (Prespotted AnchorChipTM MALDI 
target plate, Bruker Daltonics) and the spots were washed briefly with 8 µl 10 mM 
ammonium phosphate/ 0.1 % TFA according to the manufacturer. After drying, the 
samples were analysed by MALDI-TOF on a Bruker Ultraflex TOF/TOF. The instrument 
was calibrated using the prespotted standards (~200 laser shots). Samples were analysed 
using a laser power of approximately 25 % and spectra were summed from ~20 x 20 laser 
shots. The accuracy of MALDI-ToF MS was 20-50 ppm. Analysis of mass spectrometry 
data and figure preparation was carried out using FlexAnalysis software (Bruker 
Daltonics). 
 
2.18.1.2 High mass range: 4000 - 12000 Da 
Culture supernatants were diluted 1 in 5 with 5% formic acid (ARISTAR®, VWR).  Matrix 
(sinapic acid, Fluka/Sigma-Aldrich) dissolved in 90 % acetonitrile/10 % of 0.1 % 
trifluoroacetic acid (Rathburn Chemicals Ltd) at 2 mg/ml was spotted onto an 
AnchorChipTM MALDI steel target plate (Bruker Daltonics). Samples (diluted culture 
supernatants) were then spotted onto the dried matrix spots and incubated for 3-5 min. 
The spots were washed shortly with 10 mM ammonium phosphate, 0.1 % TFA according 
to the manufacturer. Ubiquitin and insulin (Sigma-Aldrich) were spotted with sinapic acid 
as matrix in a similar way and used as standards for mass calibration. The samples were 
analysed by MALDI-TOF on a Bruker Ultraflex TOF/TOF using a method optimised for the 
mass range up to 12 kDa in linear mode. The data was processed in FlexAnalysis (Bruker 
Daltonics). 
 
2.18.2 Electrospray ionisation (ESI) 
For sequence analysis, culture supernatants were applied to a Qtof II® mass 
spectrometer (Micromass) using Picotip® emitters (Newobjective). The instrument was 
setup in positive ion mode and calibrated in the range of m/z 100-2200 using MS/MS 
fragments of Glu-Fibrinopeptide B (Sigma) as standards. Planosporicin was analysed both 
by full scan MS analysis for mass determination and by MS/MS fragmentation for 
  
108 
108 Chapter 2 : Materials and Methods 
sequence analysis. Fragmentation was carried out at a collision energy setting of 45 V. A 
large number of spectra was collected and processed using the Masslynx® 4.1 software 
(Waters). For de novo sequencing the PepSeq option in Masslynx was used, and 
peaklists were generated using the Transform option. 
 
2.19 Extraction Methods for planosporicin 
2.19.1 Methanol extraction from P. alba mycelium 
A 100 ml flask filled with 20 ml of AF/MS media was inoculated 1 in 10 with a P. alba seed 
culture and grown under normal culture conditions. After 4-10 days, mycelium from the 
entire culture collected by centrifugation at 4000 rpm for 15 min. A sample of supernatant 
was collected for analysis and the rest discarded. The cell pellet was extracted with 20 ml 
of MeOH and vortexed three times for 1 min. A 1 ml sample was taken and sonicated 
three times at 30 seconds in a Branston 2510 sonicator. The remaining ~19 ml of 
vortexed mycelium was centrifuged at 4000 rpm for 15 min and 1 ml of the supernatant 
was dried down in a miVac Duo concentrator (GeneVac). Likewise the vortexed and 
sonicated mycelium was centrifuged at 13000 rpm for 5 min and the supernatant dried 
down to ~100 µl. Extracts were stored at -20 °C. 
 
2.19.2 Concentration of planosporicin with Diaion HP20 bead matrix 
Concentration of planosporicin was carried out using a method based on (Castiglione et 
al. 2007). Supernatant was harvested from a culture of Planomonospora and filtered 
through 0.2 µm (Millipore). The supernatant was acidified to ~pH 3 with concentrated 
sulphuric acid. Diaion HP20 polystyrene resin (Mitsubishi Chemical Co.) was prepared by 
washing in 100 % methanol for 15 min followed by water for 15 min.  The resin was added 
to the supernatant at 2.6 % v/v. Tubes containing supernatant and resin were incubated 
for two hours at 4 °C on a vertical rotating mixer. The resin was then recovered by 
centrifugation at 4000 rpm for 5 min. The bulk of the ‘spent’ supernatant was carefully 
removed with a pipette and stored for later analysis. The resin was washed once in 5 ml 
methanol/water 1:1 (v/v) for 1 min and the wash fraction stored for later analysis. The 
resin was eluted in 1 ml methanol/water-saturated butanol/water 9:1:1 (v/v/v) for 5 min at 
room temperature on a vertical rotating mixer. The eluant was stored for later analysis. 
The elution was repeated several times to give a series of fractions. 40 µl samples were 
tested for bioactivity by applying to antibiotic assay discs. Eluant samples could also be 
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concentrated by drying under vacuum and samples resuspended in 5 % formic acid for 
MALDI-ToF mass spectrometry. 
 
2.19.3 Analytical High-Pressure Liquid Chromatography (HPLC) 
HPLC was carried out on a HP Agilent 1100 machine using a C18 column with 
dimensions 4.6 mm x 250 mm (Waters). The column was equilibrated overnight to 65 % 
phase A (90 % ammonium formate (2 % v/v) and 10 % HPLC-grade acetonitrile) and 35 
% phase B (30 % ammonium formate (2 % v/v) and 70 % HPLC-grade acetonitrile). A 40 
µl injection of supernatant was loaded onto the column and eluted at a 1 ml/min flow rate 
with a linear gradient from 35 % to 90 % phase B in phase A for 30 min. UV spectroscopy 
data were collected at 268 nm. An autocollector was set to collect fractions when the UV 
268 nm absorbance exceeded a gradient of 0.05 U/second and a threshold of 0.5 units. 
HPLC fractions were collected from 100 µl injections in a maximum volume of 800 µl per 
vial.  
 
2.20 RNA methods 
2.20.1 Isolation of RNA from P. alba 
P. alba spores (108) were inoculated into 10 ml liquid ISP4 media in 25 ml conical flasks 
containing three glass beads and the appropriate antibiotic selection. These seed cultures 
were grown for one week at 30 °C with shaking at 250 rpm to allow dispersed mycelial 
growth. Mycelial density was estimated through measuring optical density at 450 nm. 
Precultures were used to inoculate 30 ml liquid AF/MS media in 250 ml conical flasks 
containing twelve glass beads to a starting OD450 of 0.1-0.2. 
Two methods were successfully used to extract RNA from P. alba mycelia at a variety of 
timepoints. In the first method, 3-4 ml culture were harvested, mixed with double the 
volume of RNAprotect solution (Qiagen), vortexed for 5 seconds and left for 5 min at room 
temperature.  Mycelium was collected by centrifugation at 4000 rpm for 10 min; after the 
supernatant was discarded, the mycelial pellets were stored at -80 °C for up to 2 weeks 
before the extraction of RNA. 
To extract RNA, mycelial pellets were gently resuspended in 200 µl TE buffer containing 
15 mg/ml lysozyme and incubated at room temperature for 1 hour. 250 µl of resuspended 
mycelium were transferred to 2 ml screw-capped tubes to which 300 mg 0.1 mm diameter 
silica beads (Biospec Products Inc.) and 700 µl of RLT buffer without β-mercaptoethanol 
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(Qiagen) were added. Mycelium was lysed in a FastPrep machine (Thermo Scientific) for 
30 seconds at a speed of 6.5. The cell debris was collected by centrifugation at 13000 
rpm for 1 min at 4 °C. The resulting supernatant was cleared by two successive phenol 
chloroform-isoamylalcohol pH 8 extractions followed by a third extraction using only 
chloroform. In each case the cell lysate was added to a 2 ml tube containing 700 µl of the 
solvent, vortexed for 1 min and centrifuged at 13000 rpm for 10 min at 4 °C. The aqueous 
phase (~600 µl) was removed to an RNase-free 2 ml tube and 440 µl of 100 % ethanol 
added.  The solution was mixed well then applied to an RNeasy mini column (Qiagen). 
The RNA was purified following the manufacturer’s instructions and performing an on-
column DNaseI digestion (Qiagen). RNA was eluted from the column twice with 30 µl of 
RNase-free distilled water. RNA was stored at -80 °C. 
An alternative method of extracting RNA from P. alba involved harvesting 3-4 ml culture at 
the appropriate timepoint in 2 x 2 ml round-bottom tubes. Mycelium was collected by 
centrifugation at 13000 rpm for 1-2 min. ~1 ml of supernatant was decanted into a fresh 
tube for later analysis. The remaining supernatant was discarded and the mycelial pellet 
flash-frozen in liquid nitrogen. These pellets were moved to -80 °C for storage until the 
extraction of RNA. 
To extract RNA, mycelial pellets were collected on dry ice. An RNAase-free pestle and 
mortar was cooled on dry ice with liquid nitrogen. Each mycelial pellet was ground using 
the pestle and mortar in a small volume of liquid nitrogen. The resulting powder was 
scraped into a 15 ml tube using RNAase-free plasticard. 1.5 ml TRI reagent (Sigma) was 
added to each tube and allowed to stand for 5-10 min at room temperature. Next 300 µl 
chloroform were added, vortexed for 15 seconds then left at room temperature for 2 min. 
The tubes were centrifuged for 15 min at 6000 rpm at 4 °C. The aqueous phase (~600 µl) 
was removed to an RNase-free 2 ml tube and made up to 900 µl with RLT buffer without 
β-mercaptoethanol (Qiagen). To this, 500 µl of 90 % ethanol were added. The solution 
was mixed well then applied to an RNeasy mini column (Qiagen). As described above, the 
RNA was purified following the manufacturer’s instructions during which an on-column 
DNaseI digestion (Qiagen) was also performed. RNA was eluted from the column twice 
with 30 µl of RNase-free distilled water. RNA was stored at -80 °C. The yield of RNA 
depended on the timepoint sampled, but an average of 92 µg RNA per 3-4 ml of culture 
sampled was obtained. 
 
2.20.2 DNaseI treatment of RNA 
In addition to the on-column DNaseI digest, RNA was subject to a second DNaseI digest 
to ensure RNA samples were free from contamination with genomic DNA prior to RT-
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PCR. 2.5 µg purified RNA were digested with 1.25 U RNase-free DNaseI (Invitrogen) in a 
volume of 25 µl at room temperature for 15 min. The reaction was inactivated through the 
addition of 2.5 mM EDTA and heated at 65 °C for 10 min. 8 µl of this reaction contained 
0.73 µg RNA which was used as the template in the synthesis of cDNA (Section 2.20.4). 
 
2.20.3 Confirming RNA quality 
2.20.3.1 Checking for DNA contamination 
A control PCR experiment was performed to confirm the absence of DNA contamination in 
RNA samples. General analytical PCR was carried out as described in Section 2.6.1 but 
with 150-300 ng RNA as a template and a total of 30 cycles. Primers hrdB_RTF and 
hrdB_RTR were used to amplify the constitutively expressed hrdB gene. 10 ng of P. alba 
gDNA was used as a positive control. 
 
2.20.3.2 Checking RNA concentration 
The concentration of RNA was quantified using Nanodrop (Thermo scientific). Each 
sample was diluted 1 µl in 4 µl H2O for a more accurate reading. The 260/280 ratio was 
between 1.9 and 2.3, and the 260/230 ratio was greater than 1.8 and in most cases also 
greater than the 260/280 reading, as expected for pure RNA. 
 
2.20.3.3 Checking RNA quality 
A gel tank, tray and comb was soaked in 0.1 M NaOH overnight, then treated with 
RNAzap and rinsed in 2 x autoclaved water. 1 % agarose was made up in 1x TBE buffer 
and autoclaved before adding 0.5 µg/ml ethidium bromide. Approximately 1 µg RNA was 
separated on a 1 % TBE agarose gel by electrophoresis. This revealed both the 23S and 
16S bands, and often the 5S band and larger mRNA aggregates. 
 
2.20.4 cDNA synthesis 
1µg RNA was converted to cDNA using Superscript III 1st strand synthesis Supermix 
(Invitrogen) following manufacturer’s instructions. In addition a no enzyme blank was run 
for each RNA template, using standard taq PCR buffer. Reactions were carried out as 
follows: 
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Component Volume (µl) 
2x Reaction Mix (Invitrogen) 10 
Superscript III 1st strand RT enzyme mix (Invitrogen) 2 
Template RNA (0.73 µg) 8 
RNase-free dH2O  to 20 µl 
 
25 °C  10 min 
42 °C  120 min 
50 °C  30 min   
55 °C  30 min 
85 °C  5 min 
 
The reactions were chilled briefly on ice then 1 µl RNase H (Invitrogen) was added and 
incubated at 37 °C for 20 min. cDNA from each reverse transcriptase reaction was diluted 
1 in 10 in H2O and was determined by Nanodrop (Thermo Scientific) to contain 
approximately 80-110 ng cDNA. cDNA was either used immediately in Section 2.20.5 and 
2.20.6 or stored at -80 °C until use. 
 
2.20.5 Reverse transcriptase (RT)-PCR 
Freshly diluted 1 in 10 cDNA was used as a template in standard PCR with Taq 
polymerase (Section 2.6.1) in a 25 µl total reaction volume. RT-PCR primers listed in 
Table 2.5 were specially designed using strict rules. The length was 18-20 bp, GC content 
between 40-60 %, melting temperature between 55-60 °C (and a maximum different of 4 
°C between primers in a pair). In addition 3’ end T, hairpins and primer dimers were 
avoided. Furthermore the amplicon had a length of 80-150 bp, the GC content between 
40-60 % and secondary structure avoided. For all PCR reactions an annealing 
temperature of 56 °C and 30 cycles of amplification were used. The PCR products were 
checked by adding 5 µl of 10x Orange G to each reaction and analysing 10 µl on a 2 % 
TBE agarose gel by electrophoresis. The positive control for each cDNA template used 
primers hrdB_RTF and hrdB_RTR annealing to a gene with 90 % nucleotide identity to S. 
coelicolor hrdB. The negative control used a 1/10 dilution of the RT reaction on RNA 
template without the RT enzyme. 
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2.20.6 Quantitative (q) RT-PCR 
Freshly diluted 1 in 100 cDNA was used as a template in qPCR using SYBR GreenER 
qPCR SuperMix Universal (Invitrogen). Reactions were carried out as follows: 
Component Volume (µl) 
SYBR GreenER qPCR SuperMix Universal (Invitrogen) 12 
DMSO (40 %) 3 
Forward primer (10 µM) 0.5 
Reverse primer (10 µM) 0.5 
ROX 0.2 
1:100 cDNA 2.5 
RNase-free dH2O  to 25 µl 
 
Primers used were those previously designed for RT-PCR and used in Section 2.20.5. In 
parallel to reactions using cDNA, each primer pair was also used in reactions on different 
dilutions of P. alba genomic DNA in the same 96-well plate to generate a standard curve 
for each gene analysed. Assuming the P. alba genome is 7.5 Mb (based on the statistics 
from 454 next generation sequencing), four genome dilutions were made with; 1.5 x10+6, 
1.5 x10+5, 1.5 x10+4 and 1.5 x10+3 genomes. To set up each reaction, 2.5 µl of the 
appropriate sample were pipetted into the bottem of each well of a white qPCR plate 
(ABI). Then 22.5 µl of the appropriate master mix were pipetted into each well, taking care 
not to touch the tip against the well. In every qPCR run, all reactions were run in triplicate. 
At least 2 sets of 3 blank wells (no template) were included in each run. Negative controls 
used a 1/100 dilution of the RT reaction on RNA template without the RT enzyme as a 
template with primers hrdB_RTF and hrdBRTR. Once set up, the plate was sealed with an 
adhesive lid then covered in foil and kept at 4 °C  for a maximum of 1 hour before being 
run in a Chromo4 machine (BioRad, CA, USA). The PCR program consisted of: 
50 °C  2 min 
95 °C  10 min 
95 °C  15 s  
56-58 °C  60 s  x 40 cycles 
95 °C  1 s  
melting curve analysis 
plate read 
 
qPCR results were analysed using Opticon 2 Monitor software (MJ Research, Waltham, 
MA, USA). The quality of the data was assessed in two ways. For each well of the 
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reaction, a meltcurve was run. If the primers have amplified just one product then there 
should be one clean peak in the rate of change of fluorescence. Multiple peaks imply 
multiple products, from non-specific binding of the primers or the formation of primer 
dimers. For each well, a quantitation graph is available. These are used to check at which 
cycle number the amplification takes off from. For the standard curve, triplicates amplify at 
the same time, with the more concentrated gDNA samples taking off earlier. This is further 
clarified through adding 5 µl of 10x Orange G to each reaction and analysing 20 µl on a 2 
% TBE agarose gel by electrophoresis. One band of the expected size should be visible.  
The threshold cycle (Ct) value denotes how many PCR cycles are required for the sample 
fluorescence to reach the threshold level (i.e. the more target DNA present in a sample, 
the lower the Ct value). The Ct values were averaged from each triplicate (standard curve, 
samples and negative control) to obtain a mean. A standard curve for each primer pair 
was drawn by plotting Ct values against the number of genomes. A regression line was 
drawn and the R2 value calculated. The primer efficiency was calculated using the 
equation: E = (10^(-1/slope)-1)x100. The standard curve was used to calculate the copy 
number of cDNA in sample. This number was normalised against the copy number of 
hrdB in each sample to take account of likely different concentrations of cDNA in each 
sample.  
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Chapter 3 : Structure of planosporicin 
 
 
3.1 Introduction 
The genus Planomonospora is a member of the Streptosporangiaceae family, with the 
type genus Streptosporangium (Goodfellow et al. 1990). This family was formed from a 
number of genera on the basis of 16S rRNA sequence similarity. In total, five validly 
described Planomonospora strains have been isolated from soil samples collected from 
five continents; Africa, Europe, Asia, North America and South America. These include P. 
alba from the Sudan and P. sphaerica from India (Mertz 1994), both of which were studied 
in this Chapter. Prior to this work, no antimicrobial compounds were reported to be 
produced by any of these five Planomonospora strains. 
In 2004 a patent submitted by Vicuron Pharmaceuticals Inc. described another 
Planomonospora strain, Planomonospora. sp. DSM 14920 (Losi et al. 2004). Over two 
years later, a paper described how extracts from this strain were found to contain a cell-
wall active antibiotic that was not a β-lactam (Castiglione et al. 2007). Liquid 
chromatography coupled to mass spectrometry (LC-MS) identified a novel lantibiotic, 
referred to as NAI-97, which was patented as antibiotic ID 97518 in 2004 and 
subsequently named planosporicin three years later (Castiglione et al. 2007). 
Planosporicin shows a wide spectrum of in vitro antimicrobial activity against a range of 
Gram-positive pathogens that includes those resistant to methicillin and vancomycin (as 
discussed in Chapter 1). Given the increasing prevalence of multi-drug resistant 
pathogens, planosporicin and its derivatives may be of commercial interest.  
This Chapter describes how a second Planomonospora strain was found to produce 
planosporicin. Conditions were optimised for its growth, sporulation and planosporicin 
production, which enabled studies to validate the structure of the lantibiotic. 
 
3.2 Analysis of P. alba and P. sphaerica 
3.2.1 Growth characteristics of P. alba and P. sphaerica on agar media 
Prior to the commencement of this project, the only Planomonospora strain proven to 
produce planosporicin was Planomonospora sp. DSM 14920 (Castiglione et al. 2007). 
This strain is not publicly available, so two other Planomonospora strains were accessed 
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from culture collections to assess their ability to produce planosporicin (as described in 
Section 2.1 of Chapter 2).  
P. alba and P.  sphaerica were grown on a range of typical actinomycete agar media. 
Growth was most prolific on agar plates of ISP4, OBM, AF/MS and D/seed media (Figure 
3.1). Growth of P. alba on ISP4 and OBM agar media resulted in production of a thin, 
white/cream aerial mycelium that entirely covered the yellow vegetative mycelium. 
However, growth morphology was substantially different on AF/MS and D/seed agar 
media. A thick, convoluted cream/yellow vegetative mycelium that lacked production of 
any aerial mycelium was observed. In contrast, growth of P. sphaerica on ISP4 and OBM 
agar media resulted in production of a pinkish/orange vegetative mycelium, almost entirely 
covered by a white/cream aerial mycelium bearing sporangia. Like P. alba, the 
morphology of P. sphaerica mycelium changed on AF/MS and D/seed agar media. P. 
sphaerica pinkish/orange vegetative mycelium was thick and convoluted on both agar 
media with scant white/cream aerial hyphae only visible on D/seed agar. Growth of both 
Planomonospora strains was slow on all of the agar media tested, with 5 to 10 days of 
incubation required to produce utilisable colonies. 
 
3.2.2 Growth characteristics of P. alba in liquid media 
Preliminary analysis of bioactive compounds produced by P. alba and P. sphaerica in 
Section 3.3.1 (see later) led to P. alba being the focus of this work. Thus the growth 
characteristics of P. alba were also observed in liquid medium. A steel spring was 
originally used to try to promote dispersed growth of the culture, however the mycelium 
grew in large potentially physiologically heterogeneous pellets (Figure 3.2 A-D). This could 
have been due to foaming prompted by increased agitation of the media by the steel 
spring, resulting in the deposition of mycelium onto the sides of the flask and aggregation 
into pellets. However the addition of 0.05 % Antifoam 289 (Sigma) appeared to have little 
effect on pellet formation (Figure 3.2 B). The addition of 5 % sucrose or 0.5 % proline to 
culture media had been shown previously to improve mycelial dispersion in two related 
Streptosporangiaceae; Nonomuraea and Microbispora (Foulston and Bibb 2010; Marcone 
et al. 2010b). However these additional ingredients did not significantly improve the 
dispersion of P. alba mycelium (Figure 3.2 C). The greatest increase in mycelial dispersal 
was observed when the steel spring was exchanged for glass beads to agitate the media 
(Figure 3.2 E-H). The addition of 0.05 % Antifoam 289, 5 % sucrose and 0.5 % proline 
had negligible further effects on dispersion of mycelium (Figure 3.2 F-H). 
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Figure 3.1 : Morphology of P. alba and P. sphaerica grown on agar media.  
Spores were streaked on different media (as labelled) and incubated for 7 days at 30 ˚C. 
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The relatively dispersed growth of P. alba in liquid culture in the presence of glass beads 
allowed for an accurate assessment of growth rate. Growth was quantified through either 
a total protein assay or, more generally, by measuring the optical density of the culture at 
450 nm. These methods gave essentially the same results (Figure 3.3). The growth curve 
of P. alba differed depending on the starting density of the cultures. In a typical growth 
curve, rapid growth commenced within 20 hours of inoculation and continued for a further 
80 hours. Light microscopy revealed that the mycelial morphology changed over time from 
small, elongated clumps of mycelium, to dense mycelial masses with no fragmentation 
apparent. 
 
Figure 3.2 : Morphology of P. alba in liquid ISP4 media.  
40 ml cultures were grown under different conditions for 3 days at 30 °C with shaking at 
250 rpm. To promote dispersed growth, flasks A to D contain a stainless steel spring, 
flasks E to H contain glass beads. Flasks B and F contain 0.05 % Antifoam 289 (Sigma). 
Flasks C and G contain 5 % sucrose and 0.5 % proline. Flasks D and H contain 0.05 % 
Antifoam 289, 5 % sucrose and 0.5 % proline. All flasks were inoculated 1 in 10 from a 24 
hour culture grown in 50 ml ISP4 with a stainless steel spring to promote dispersed growth.  
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3.2.3 Scanning electron microscopy of P. alba 
P. alba was grown on ISP4 agar medium to prompt sporulation. Colony structure and 
sporulation was observed by scanning electron microscopy (SEM). Magnification X 3,500 
revealed bunches of clavate monospores (Figure 3.4 A). However these micrographs 
differ somewhat from those published when the species was first classified 16 years ago 
(Mertz 1994). In the Mertz paper, P. alba was grown for 14 days on ATCC medium 172 
and a magnification of X 5,000 revealed spores in two parallel lines along the 
sporangiophore (Figure 3.4 B). This arrangement is illustrated and annotated in Figure 3.4 
C (Miyadoh 1997). Yet in this work, P. alba did not sporulate well on ATCC medium 172, 
and most sporulation was observed on ISP4 medium. Even on ISP4 medium, some 
sporangia appear empty, with no evidence of spore release through opercula. This may 
imply that not all spores develop properly on this medium, or could simply be an artefact 
created during SEM. 
 
Figure 3.3 : Growth curve of P. alba measured by OD450 and total protein assay.  
A 48 hour preculture was used to inoculate 50 ml AF/MS cultures in triplicate to an OD450 
~0.2. Flasks were cultured for 8 days at 30 °C with shaking at 250 rpm. At each time point, 
optical density at 450 nm was measured (blue diamonds) and 1 ml culture was used in a 
total protein assay (red squares). Standard deviation is displayed in error bars. 
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Figure 3.4 : Morphology of P. alba spores.  
A; Scanning electron micrograph of P. alba grown on ISP4 media for 7 days at 30 °C, 
showing sporangia attached to sporangiophores. Magnification is X 3,500. Scale bar is 2 
µm. B; Scanning electron micrograph of P. alba grown on ATCC medium 172 for 14 days 
at 30 °C, showing parallel rows of sporangia with attached sporangiophores. Magnification 
is X 5,000. Scale bar is 1.25 µm. From Mertz et al. 1994. C; Schematic of a 
sporangiophore bearing clavate monospores, adapted from Miyadoh, 1997. 
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3.2.4 16S rRNA 
The 16S rRNA of P. alba was partially sequenced using the F27 and R1492 PCR primers 
(Mazza et al. 2003). The sequence is identical to that of P. alba JCN 9373 deposited in 
the National Center for Biotechnology Information (NCBI) protein database as 
NR_024778.1. M. Sosio kindly provided the 16S rRNA sequence of P. sp. DSM 14920, 
the NAI-97 producer strain. Multiple sequence alignment through CLUSTALW2 (Chenna 
et al. 2003) revealed that out of 1441 bp of aligned sequence, there is just one point 
mutation at base 1403 which is ‘T’ in P. alba and ‘C’ in P. sp. DSM 14920. A more 
comprehensive analysis included 16S rRNA partial sequence from P. sphaerica JCM 
9374 (NR_024779.1), P. parontospora subsp. antibiotica JCM 3094 (NR_024730.1) and 
P. venezuelensis JCM 3167 (NR_024732.1). A phylogenetic tree based on partial 16S 
rRNA sequences is depicted in Figure 3.5. This reveals that P. alba and P. sp. DSM 
14920 are very closely related within the Planomonospora genus, it seems they may 
represent two different strains of the same species. 
 
3.3 Planosporicin production 
3.3.1 Detection by bioassay 
Attempts to detect planosporicin production were initially carried out using a bioassay on 
agar plates with Micrococcus luteus as an indicator organism, as detailed in Chapter 2. 
Production of an antibiotic compound was observed by both P. alba and P. sphaerica on 
several media. Although P. alba often produced a bioactive compound on ISP4 and 
D/seed media, a halo of inhibition was most consistently observed on AF/MS medium 
(Figure 3.6). In order to characterise the nature of this bioactive compound, cultures of 
both strains were grown in AF/MS liquid medium and the supernatants assayed for 
 
Figure 3.5 : Phylogram based on alignment of partial 16S rRNA sequences from five 
Planomonospora strains.  
16S rRNA sequences were retrieved from the NCBI databank: NR_024778.1 (P. alba JCN 
9373), NR_024779.1 (P. sphaerica JCM 9374), NR_024730.1 (P. parontospora subsp. 
antibiotica JCM 3094) and NR_024732.1 (P. venezuelensis JCM 3167).  The alignment 
was performed using ClustalW2 (Chenna et al. 2003). 
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bioactivity against M. luteus. Only the supernatant obtained from P. alba retained its 
activity after passage through a 0.2 µM filter, indicating the production of a small bioactive 
molecule. 
Supernatants obtained from different stages of a P. alba growth curve were also assayed 
for antibiotic production. Entry into stationary phase occurred after approximately 100 
hours of incubation. At this point, but not before, the P. alba culture supernatant contained 
a compound that inhibited the growth of M. luteus (Figure 3.7). Thus the remainder of this 
Chapter is focused on the identification of the bioactive molecule produced by P. alba. 
 
Figure 3.6 : P. alba solid bioassay.  
P.alba was grown as a patch on plates of different media for 5 days before an overlay with 
the M. luteus indicator organism. Production of a bioactive compound by P. alba resulted 
in a halo of inhibition of M. luteus growth. 
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3.3.2 Matrix-Assisted Laser Desorption/Ionisation Time-of-Flight analysis 
To identify the bioactive compound, filtered culture supernatants were subjected to Matrix-
Assisted Laser Desorption/Ionisation Time-of-Flight (MALDI-ToF) analysis. In MALDI, the 
sample is co-crystallised with a matrix compound that protects it from direct laser 
excitation, but allows vaporisation into the mass analyser. This soft-ionisation technique 
minimises sample damage, resulting in little fragmentation. The time-of-flight (ToF) mass 
analyser separates the ions according to their mass-to-charge ratio (m/z). Samples are 
acidified prior to application to the matrix, thus the masses labelled in spectra represent 
the protonated ion,  [M + H]+ or other adducts. The high resolution of the method 
separates the isotopes of the molecules, giving a multiplet of peaks making up the fine 
structure of each main peak. For all five elements that occur in peptides, the lightest 
isotope is also by far the commonest. The monoisotopic mass of a peptide is the mass it 
 
Figure 3.7 : Growth curve of P. alba in liquid medium.  
A 7 day old preculture was used to inoculate 30 ml AF/MS cultures in duplicate to an OD450 
~0.1; these were incubated for 10 days at 30 °C with shaking at 250 rpm. OD450 was 
measured at regular intervals with standard deviation displayed in error bars. 40 µl of 
culture supernatant from each time point was applied to assay discs, which were laid onto 
a plate of M. luteus. Plates were incubated at 30 °C for 36 hours before being 
photographed. 
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would have if all constituent atoms were of the commonest isotope, thus this is the lowest 
mass in the multiplet. 
The original reported mass for planosporicin was 2194 Da, calculated from the mass of 
the doubly charged ion [M + 2H]2+ observed in electrospray ionisation mass spectrometry 
(ESI-MS) (Castiglione et al. 2007). However this was calculated from the second isotope, 
with a mass-to-charge ratio (m/z) of 1097.5. If instead the monoisoptopic mass is used, 
with a m/z of 1096.9, the expected mass for planosporicin becomes 2191.8 Da (i.e. 
((1096.9-1)x 2)). Likewise, theoretical calculations based on the presumed composition of 
the mature peptide predict a mass of 2191.7790 Da.  
MALDI-ToF was carried out by Dr Gerhard Saalbach and Dr Mike Naldrett (JIC 
Proteomics Facility) in the range of 700-4000 Da. Culture supernatants of P. alba that 
possessed bioactivity revealed a compound with a monoisotopic mass of 2191.7 Da ([M + 
H]+ = 2192.7; Figure 3.8), corroborating the theoretical calculations and the ESI-MS data 
published previously for planosporicin produced by P. sp. DSM 14920.  It thus seemed 
likely that P. alba did indeed produce the same lantibiotic. 
In the full scan spectrum range, multiple peaks were observed. These were attributed in 
part to sodium and potassium adducts of the compound, which are 23 and 39 Da larger, 
respectively, than the expected mass of the compound (Figure 3.8 and Table 3.1). 
Additional peaks likely represent oxidation of the sulphur atom in each of the five (Me)Lan 
bridges, creating compounds with incremental mass increases of 16 Da (Wilson-Stanford 
et al. 2009). In addition, oxidation of methionine and tryptophan may also occur during 
sample preparation for MALDI (Zhang et al. 2007). Planosporicin has one tryptophan at 
position six, so a total of six oxidations are possible. The most commonly observed peaks 
had a mass of 2192 Da, 2208 Da, 2214 Da and 2230 Da (Figure 3.8). These correspond 
to the protonated adduct, the oxidation of one (Me)Lan bridge, the sodium adduct and the 
potassium adduct, respectively. A similar profile was observed previously in the MALDI-
ToF spectrum of the lantibiotic microbisporicin (Foulston and Bibb 2010). 
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3.3.3 Purification of bioactive compounds 
To confirm that the bioactive compound had exactly the same mass as planosporicin, a 
very pure and concentrated sample is needed. Several extraction methods were 
investigated. Vicuron Pharmaceuticals Inc. reported that planosporicin could be recovered 
Planosporicin adduct Predicted mass (Da) 
[M + H]+ 2192.779 
[M + H]+ + O 2208.779 
[M + Na]+ 2214.779 
[M + H]+ + 2O 2224.779 
[M + Na]+ + O 2230.779 
[M + K]+ 2230.779 
[M + H]+ + 3O 2240.779 
[M + Na]+ + 2O 2246.779 
[M + K]+ + O 2246.779 
[M + H]+ + 4O 2256.779 
[M + Na]+ + 3O 2262.779 
[M + K]+ + 2O 2262.779 
[M + H]+ + 5O 2272.779 
[M + Na]+ + 4O 2278.779 
[M + K]+ + 3O 2278.779 
[M + H]+ + 6O 2288.779 
[M + Na]+ + 5O 2294.779 
[M + K]+ + 4O 2294.779 
[M + Na]+ + 6O 2310.779 
[M + K]+ + 5O 2310.779 
[M + K]+ + 6O 2326.779 
 
Table 3.1 : The predicted masses of planosporicin adducts. 
The expected m/z peaks for the protonated [M + H]+, sodium [M + Na]+ and potassium [M 
+ K]+ adducts of each compound are shown. The expected m/z peaks resulting from the 
oxidation of each lanthionine bridge are also shown as + nO. m/z peaks frequently 
observed in spectra of P. alba supernatants are shaded in blue. 
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from the culture supernatant through extraction with water-immiscible organic solvents, 
particularly alkanols of at least four carbon atoms (Losi et al. 2004). However, extraction 
with butan-1-ol resulted in only a slight increase in the concentration of the bioactive 
peptide as measured by bioassay (data not shown). The use of Sep-Pak Vac (Waters) 
cartridges significantly increased the concentration of all compounds in the supernatant. 
Although a much larger halo of inhibition was observed, a lot of media components were 
also present, obscuring the MALDI-ToF spectra (data not shown). Diaion HP20 
hydrophobic polystyrene resin was found to bind the bioactive compounds which were 
eluted with methanol:butanol:water (9:1:1) (Chapter 2). Bioassays of the supernatant 
before and after extraction revealed that the bioactive compound was concentrated in the 
resin eluent, affording a larger halo of inhibition (Figure 3.9 A and B). These eluted 
fractions were concentrated by drying, resuspended in 5 % formic acid and subjected to 
ESI-MS. The bioactive compound was subjected to full scan MS analysis for mass 
determination. MALDI-ToF was carried out by Dr Gerhard Saalbach and Dr Mike Naldrett 
(JIC Proteomics Facility). Eighty scans were collected and processed to obtain the exact 
monoisotopic mass of the double charged ion; [M + 2H]2+ is 1096.9027 Da (Figure 3.9 C). 
This mass was used to accurately calculate the mass of the bioactive molecule present in 
the supernatant of P. alba; (1096.9027-1)x2 = 2191.8054 Da. This mass corresponded 
extremely well to the predicted mass of planosporicin of 2191.7790 Da, and suggested 
very strongly that P. alba did indeed make planosporicin. 
 
3.4 Structural analysis of planosporicin 
3.4.1 Genome scanning 
The presence of (Me)Lan bridges prevents structural characterisation of planosporicin 
through Edman degradation. Thus a combination of ESI-MS, tandem mass spectrometry 
(MS/MS) and NMR was used to accumulate data to propose the structure of the 24 amino 
acid peptide (Figure 3.10 A) (Castiglione et al. 2007). The MS/MS data were published as 
a table of the m/z of the six major fragments. These fragments were annotated as defined 
parts of the mature peptide and used to justify the arrangement of Me(Lan) bridges in the 
proposed structure (Castiglione et al. 2007). However several fragments were proposed to 
result from cleavage at both ends of the peptide (e.g. a fragment corresponding to 
residues 6-23), which is unlikely in MS/MS (G. Saalbach, personal communication). 
Furthermore, the NOE connectivity matrix did not link the Pro-Gly motif to the rest of the 
molecule, suggesting that a revision of the published primary structure might also be 
necessary. 
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High molecular weight P. alba genomic DNA was analysed through a 454-based genome 
scan (described further in Chapter 4). The published planosporicin tertiary structure 
published was used to predict a likely primary structure (Castiglione et al. 2007). The Dha 
and Dhb residues were predicted to be derived from serine and threonine residues, 
respectively. For each (Me)Lan bridge, it was initially assumed that the cysteine residue 
was always C-terminal to the serine or threonine residue, as found in many lantibiotics 
(Chatterjee et al. 2005). Thus the more N-terminal residue was assumed to be serine or 
threonine and the C-terminal residue was assumed to be cysteine. On this basis, the 
primary amino acid sequence of planosporicin was predicted (Figure 3.10 B). This protein 
sequence was used to search the 454 database using TBLASTN, one of the Basic Local 
Alignment Search Tool (BLAST) search programs that takes a given amino acid sequence 
and searches six-frame translations of a nucleotide sequence database for similar 
sequences (Altschul et al. 1990). A search of the P. alba 454 contig database using the 
predicted planosporicin propeptide sequence identified a contig encoding a 56-residue 
peptide (Figure 3.10 C). Closer inspection revealed that this peptide was likely to consist 
of a 32-residue leader peptide, followed by a 24-residue propeptide. The leader peptide 
contained no cysteine residues. The presence of a ‘FQLD’ motif between positions -17 
and -14 indicated that this putative lantibiotic is likely to belong to ‘Class I’. FNLD-type 
motifs are characteristic of type AI lantibiotics, which also show particular conservation at 
positions -1, -2 and -4 of the leader peptide which are commonly arginine/glutamine, 
proline and alanine/isoleucine, respectively (Chatterjee et al. 2005). Planosporicin 
possesses the conserved proline at position -2, which implies that cleavage of the leader 
peptide will be through a separate LanP protease rather than a chimeric LanT transporter. 
The propeptide sequence identified through genome scanning differed significantly from 
the predicted sequence. Firstly, the Pro-Gly motif located at the C-terminus of the 
published structure was revealed to be located in the middle of the peptide as Pro9 and 
Gly10 (Figure 3.10 B and C). Secondly, it appeared that the five (Me)Lan bridges did not 
have uniform directionality. As yet, all thioether crosslinks of type A lantibiotics are 
incorporated by LanC enzymes solely in the N-to-C terminal direction, i.e. with the 
cysteine residue located C-terminal to the serine or threonine residue (Chatterjee et al. 
2005). However, the second Lan bridge of this peptide appeared to be derived from a 
cysteine residue that was located N-terminal to the serine residue. This reversed 
directionality is seen in some type B lantibiotics. For example, cinnamycin contains two 
MeLans in which the cysteine is positioned N-terminally to the threonine (Kaletta et al. 
1991).  
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The identification of the FQLD motif indicative of type A lantibiotics was at odds with the 
reverse orientation of one Lan bridge. Thus further structural analysis was undertaken to 
determine the conformation of the (Me)Lan bridges within the molecule. 
 
 
3.4.2 Tandem mass spectrometry (MS/MS) 
MS/MS involves multiple rounds of mass spectrometry, with fragmentation occurring 
between each round. This requires a pure and concentrated sample. The concentration of 
planosporicin in filtered P. alba supernatant was too low for direct analysis. Therefore, 
filtered P. alba culture supernatant was concentrated using a hydrophobic polystyrene 
resin (detailed in Section 3.3.3). Several batch elutions were combined, dried down, 
resuspended in 5% formic acid and subjected to MALDI-ToF mass spectrometry. This 
extraction method was found to concentrate and partially purify planosporicin-associated 
masses from the P. alba supernatant. 
During MS/MS, fragmentation is induced through collision-induced dissociation with an 
inert gas, resulting in bond breakage. The products are referred to as a-, b- or c-ions 
 
Figure 3.10 : Structure of planosporicin.  
Residues are; unmodified (white), dehydrated (purple), dehydrated and cyclised (blue). A; 
The original structure proposed in 2007 by Castiglione et al. B; The predicted primary 
amino acid sequence based on the structure in A. C; The 56 residue peptide identified 
from P. alba by genome scanning. The 32 residue leader peptide (black) is followed by a 
24 residue propeptide. Underlined is the Pro-Gly motif. 
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(representing different points of cleavage with respect to the peptide bond in the peptide 
chain) when the charge is retained by the amino-terminal fragment and x-, y- or z-ions 
(again representing different cleavage positions) when it is retained by the carboxy-
terminal fragment (Figure 3.11 A). Most commonly, breakage occurs through the lowest 
energy pathway, and consequently cleavage of the amide bond is favoured energetically 
(Steen and Mann 2004). Thus the fragments most commonly observed are b-ions when 
charge is retained on the N-terminus and y-ions when charge is retained on the C-
terminus of the peptide. Other fragment ions are possible due to the further loss of 
ammonia or water (Steen and Mann 2004). 
MS/MS was carried out by Dr Gerhard Saalbach and Dr Mike Naldrett (JIC Proteomics 
Facility). The 2191.8054 Da peptide was isolated, a round of fragmentation was carried 
out and a product ion scan assembled (Figure 3.11 B). The fragments obtained through 
MS/MS of a lantibiotic are often difficult to interpret due to the presence of the (Me)Lan 
bridges. As indicated above, peptides most frequently break once through the amide bond 
under low energy collision, but other cleavages can be induced when a higher energy 
collision is used. Thus in these experiments 45 V was used compared to the usual 30 V. 
This larger fragmentation force resulted in the cleavage of many different bonds, including 
the (Me)Lan bridges.  
Through tabulating all the possible b-type and y-type ions that could be generated, 
identification of a majority of the high intensity peaks was possible (Table 3.2). Notably 
there were no y-ions corresponding to the loss of residues 1 to 3, and there were no 
fragments for the additional loss of C-terminal residues. Thus, unlike the data published in 
2007 by Castiglione et al., double breaks leading to losses at both termini were not 
detected. Three of the main MS/MS peaks correspond to fragments containing intact rings 
(Figure 3.12). The peak at m/z 1470.11 is only consistent with a structure in which Ala3 is 
bridged to a residue N-terminal to Abu8. Likewise the peaks at m/z 1029.05 and 1130.07 
could only be formed if Ala13 was bridged to a residue located C-terminal to its position. 
This indicated that the originally published tertiary structure of planosporicin was incorrect 
and that in fact Lan bridges connect Ala3-Ala7 and Ala13-Ala20, and not Ala3-Ala13 and Ala7-
Ala18 as initially proposed.  
Subsequently, Maffioli et al. (2009) repeated the NMR experiments of  Castiglione et al. 
(2007) and performed additional MS/MS analysis on planosporicin produced by P. sp. 
DSM 14920. This new MS/MS data correlates well with that obtained in these studies for 
planosporicin produced by P. alba (Table 3.2). The results of this analysis confirmed 
beyond reasonable doubt that the peptide produced by P. alba was indeed planosporicin. 
The lantibiotic from both Planomonospora strains fragmented in precisely the same way, 
thus the same conclusions on the bridging pattern were reached independently.  
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m/z fragment m/z (Maffioli et al. 2009) 
1828.09 5-24(SH) 1829.9 
1387.08 9-24(SH) 1387.6 
2076.15 1-23[-Ala(OH)SH] 2076.9 
1470.11 8-24 1470.7 
1029.05 13-24  
1130.07 12-24 1130.7 
2079.08 2-24  
1996.13 3-24  
 
Table 3.2 : The major fragments from MS/MS of the 2191.8054 Da peptide planosporicin.  
The fragments of planosporicin produced by P. alba are listed as [M + H]+ ions in the left 
hand column in descending order of intensity. In bold are fragments corresponding to the 
breakage of a peptide bond between lanthionine bridges (depicted in Figure 3.12). The 
right hand column lists the published masses as a result of MS/MS on planosporicin 
produced by P. sp. DSM 14920. 
 
Figure 3.12 : Revised structure of planosporicin based on peptide fragments from MS/MS.  
The quoted masses correspond to [M + H]+ y-ions extending from the point of cleavage (the 
dashed lines) to the C-terminus of the peptide. 
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3.5 Similarity to other lantibiotics 
3.5.1 Nisin 
The confirmation of the structure of planosporicin produced by P. sp. DSM 14920 (Maffioli 
et al. 2009) and P. alba (this work) enables a comparison to other lantibiotics. Nisin is the 
most extensively studied of all lantibiotics. The two common forms of nisin are nisin A and 
Z, which differ by a single amino acid at position 27, which is histidine in nisin A and 
asparagine in nisin Z (de Vos et al. 1993). More recently, two further variants, nisin Q and 
nisin F were also isolated from strains of L. lactis (Zendo et al. 2003; de Kwaadsteniet et 
al. 2008). Nisin Q differs at four positions (Val15, Leu21, Asn27, and Val30) from nisin A 
(Ala15, Met21, His27, and Ile30). Nisin F is most similar to nisin Z, differing at position 30, 
which is valine in nisin F, compared to isoleucine in nisin Z. Another two natural variants 
of nisin are produced by Streptococcus uberis; nisin U and nisin U2 (Wirawan et al. 2006). 
In total, the six nisin variants differ in up to 10 out of 34 amino acids present in nisin A. 
The structures of nisin A and Z were determined in 1971 and 1991, respectively (Gross 
and Morell 1971; Mulders et al. 1991). This was later confirmed by genetic analysis of the 
prepropeptide, nisA (Buchman et al. 1988). 
The first identified form of nisin, nisin A, is used for comparison in this work. ClustalW2 
was used to align the planosporicin prepropeptide sequence with nisin (NisA) to reveal 
regions of conserved sequence (Chenna et al. 2003). There are conserved regions in 
both the leader peptide and the propeptide (Figure 3.13). As noted in Section 3.4.1, the 
planosporicin leader peptide contains an FQLD motif similar to the FNLD motif first 
identified in nisin. The leader peptide is also similar to that of nisin in the region involved in 
cleavage to release the mature lantibiotic. The proline at position -2 and the alanine at 
position -4 are conserved in planosporicin. However the arginine at position -1 is not 
conserved in planosporicin, yet in nisin, mutation of this residue led to reduced processing 
of the peptide by the NisP leader peptidase (van der Meer et al. 1994). The most striking 
similarity is between the propeptides. The N-terminal 11 residues of planosporicin are 
identical to those of nisin except for valine at position 4 and tryptophan at position 6, 
which are isoleucine and leucine in nisin, respectively (Figure 3.13). This similarity in 
primary structure is reflected at the tertiary level. Nisin consists of N-terminal and C-
terminal domains connected by methionine at position 21, acting as a flexible hinge region 
(Figure 3.14). This structure has subsequently been observed in several other lantibiotics, 
including subtilin produced by Bacillus subtilis (Figure 3.14). The N-terminal domain of 
these lantibiotics consists of two (Me)Lan rings termed the A and B rings. The revised 
structure of planosporicin has (Me)Lan rings in the same configuration at the N-terminus 
(Figure 3.14).  
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Figure 3.13 : An alignment of the planosporicin prepropeptide (PspA) with eight others. 
Namely nisin (NisA), epidermin (EpiA), microbisporicin (MibA), subtilin (SpaA), gallidermin 
(GdmA), actoracin (ActA), clausin (ClsA) and megateracin (MegA). Alignment constructed 
using ClustalW2 (Chenna et al. 2003). The partially conserved FNLD motif is in red. A 
putative conserved cleavage site is in green. The N-terminal 11 amino acids of the mature 
lantibiotic are in blue. The arrow indicates the putative cleavage site of the prepropeptide. 
The amino acid positions referred to in the text are numbered starting from this cleavage 
site. 
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Figure 3.14 : A comparison of lantibiotics with structural similarity to planosporicin. 
Residues are; unmodified (white), dehydrated (purple), dehydrated and cyclised residues 
(blue), other modifications (green). Abbreviations refer to; amino butyric acid (Abu), 
dehydroalanine (Dha), lanthionine (Ala-S-Ala), dehydrobutyrine (Dhb) and methyl 
lanthionine (Abu-S-Ala). N-terminal A and B rings are labelled. 
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3.5.2 Microbisporicin 
The species Microbispora corallina is currently represented by four strains; DSM 44681 
and DSM 44682 (Nakajima et al. 1999), NRRL 30420 (Lee 2003) and ATCC PTA-5024 
(Lazzarini et al. 2005). Two of these strains have been reported to make lantibiotic 
compounds. M. corallina NRRL 30420 was reported to make the compounds MF-BA-
1768α1 and MF-BA-1768β1 (Lee 2003). M. corallina ATCC PTA-5024  was reported to 
produce a lantibiotic patented as antibiotic 107891 (Lazzarini et al. 2005). Three years 
later it was revealed that this compound was discovered during the same screen that led 
to the discovery of planosporicin (Castiglione et al. 2008). In this paper, microbisporicin 
was described as two factors; microbisporicin A1 and A2. The compounds produced by 
M. corallina NRRL 30420 and ATCC PTA-5024 were initially thought to be two different 
lantibiotics. However it is now known that the bioactive compound produced by both 
strains is the lantibiotic microbisporicin. In 2010 the mib gene cluster was identified from 
M. corallina sp. NRRL 30420 (Foulston and Bibb 2010). This revealed microbisporicin is a 
single prepropeptide produced by a single biosynthetic gene cluster and that the 
composition of the microbisporicin complex varies with the culture conditions used. 
The primary structures of planosporicin and microbisporicin are highly similar (Figure 
3.13). As would be expected, the highest similarity is between the propeptide, as selection 
is maintained at the level of peptide structure, while the leader peptide has more freedom 
for diversification. Thus while the prepropeptides share 57 % identity end-to-end, the 
propeptides share 75 % end-to-end identity. In total, there are only six residues which 
differ between the two 24 amino acid peptides. In the N-terminal domain, differences 
occur at positions 1, 4 and 6, which change from isoleucine, valine and tryptophan in 
planosporicin to valine, tryptophan and leucine in microbisporicin. In the C-terminal 
domain, differences occur at positions 14, 19 and 22 changing glutamate, glycine and 
histidine in planosporicin to proline, asparagine and phenylalanine in microbisporicin. 
Despite this similarity, the originally published structure of planosporicin and 
microbisporicin differed markedly. In contrast, the revised structure of planosporicin 
revealed similar ring topology to microbisporicin (Figure 3.14). Both lantibiotics have one 
MeLan bridge linking Abu8-Ala11. Both share the three Lan bridges linking Ala3-Ala7, Ala13-
Ala20 and Ala18-Ala23. However whereas planosporicin possesses a forth Lan bridge 
linking Ala21-Ala24, microbisporicin has an AviCys residue (Figure 3.14). Furthermore, both 
lantibiotics have dehydrated residues at positions two and five. However in microbisporicin 
the tryptophan at position 6 is chlorinated and the proline at position 14 is dihydroxylated. 
These unusual post-translational modifications are not observed in planosporicin as these 
are two of the six residues which are not conserved between the two lantibiotics. 
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Degradation of peptides commonly occurs through specific proteases which attack either 
the amino or carboxy termini. Most lantibiotics (such as planosporicin, microbisporicin and 
nisin in Figure 3.14) have a dehydrated residue (Dha/Dhb) as the second amino acid of 
the mature peptide to prevent degradation by amino proteases (van der Donk, personal 
communication). Likewise, the carboxy terminus is also protected through specific 
modifications. Planosporicin has a Lan bridge formed from Cys24 following nucleophilic 
attack on the dehydrated Ser21. This protects the lantibiotic from degradation by 
carboxypeptidases, although the carboxy terminus is still exposed. This C- terminal 
(Me)Lan is also seen in other lantibiotics, including salivaricin A (Ross et al. 1993) and 
mutacin II (Chen et al. 1998). In contrast, the AviCys modification in microbisporicin 
removes the carboxy terminus and introduces an alkene group, conferring additional 
rigidity that may confer additional protection from proteases.  
 
3.5.3 Actoracin 
The NCBI protein database was searched using BLASTP and the planosporicin 
propeptide (i.e. without the leader peptide) as a protein query (Altschul et al. 1990). This 
revealed that planosporicin shares 75 % identity end-to-end with a putative propeptide 
from Actinomyces sp. oral taxon 848 str. F0332. Importantly, eight out of eleven N-
terminal residues are conserved including those that from the A and B rings of 
planosporicin. The structure of this putative lantibiotic was predicted on the basis of the 
known structure of microbisporicin and named ‘actoracin’ (Figure 3.15) (Foulston 2010). 
Actoracin was predicted to have the same bridging pattern as planosporicin combined 
with the AviCys of microbisporicin. This propeptide corresponds to the 24 C-terminal 
amino acids of an 86 residue peptide encoded by gene ID ZP_06162152, which 
presumably encodes the complete prepropeptide. This prepropeptide was named ActA, 
and alignments with other prepropeptides reveals the presence of an ‘FNLD’ type motif in 
the leader peptide, characteristic of type AI lantibiotics (Figure 3.13).  
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Figure 3.15 : A comparison of lantibiotics with structural similarity to planosporicin. 
Residues are; unmodified (white), dehydrated (purple), dehydrated and cyclised residues 
(blue). Abbreviations refer to; amino butyric acid (Abu), dehydroalanine (Dha), lanthionine 
(Ala-S-Ala), dehydrobutyrine (Dhb) and methyl lanthionine (Abu-S-Ala). N-terminal A and B 
rings are labelled. 
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3.5.4 Clausin  
Another putative peptide with a significant alignment to the planosporicin propeptide was 
identified in the genome sequence of Bacillus megaterium QM B1551. This 22 amino acid 
putative propeptide exhibited 63 % end-to-end identity with planosporicin. Although two 
residues shorter, there is a marked similarity at the N-terminus, where 10/11 residues are 
conserved (Figure 3.15). The only change is at position 6, which is leucine, as in 
microbisporicin and nisin. The structure of this putative lantibiotic, termed here 
megateracin, was modelled on the structure of epidermin, which is also a 22 amino acid 
lantibiotic with an N-terminus similar to planosporicin (Figure 3.15). In the NCBI database, 
this entry is annotated as a ‘putative antibiotic protein’ with locus tag BMQ_pBM70151, 
but in this work the prepropeptide is referred to as MegA.  
A related organism, Bacillus clausii, has been marketed as Enterogermina® by Sanofi-
Aventis as a probiotic to combat gastrointestinal disorders. The peptide responsible for its 
biological activity was recently identified, characterised and named clausin (Bressollier et 
al. 2007; Bouhss et al. 2009). Thus a different species of Bacillus produces a lantibiotic 
structurally similar to megateracin from B. megaterium (Figure 3.15). Clausin was recently 
reported to interact with lipid intermediates of the cell wall biosynthesis pathway by 
binding to the pyrophosphate moiety of lipid I and lipid II (Bouhss et al. 2009). In the B. 
clausii genome sequence, the lanA gene encoding the prepropeptide of clausin had not 
been identified by the genome annotation software. However, the primary structure of 
clausin from B. clausii can be deduced from its published tertiary structure (Bressollier et 
al. 2007; Bouhss et al. 2009). Previous analysis of the B. clausii KSM-K16 genome in the 
region 369440-3707200 in Artemis (Rutherford et al. 2000), identified a putative 
prepropeptide from 3706154-3706766 which was named ClsA and was predicted to 
produce a mature lantibiotic with the same sequence as clausin (Foulston 2010).  
Thus it appears that two species of Bacillus produce two structurally similar lantibiotics. 
The tertiary structure of clausin corresponds to the lanA previously identified from the B. 
clausii genome (Foulston 2010). While clausin is not yet entered in the NCBI database, a 
BLASTP search identified a similar lantibiotic from B. megaterium. The two lantibiotics 
produced by the Bacillus sp. described in this Section differ at four out of 22 positions; 1, 
6, 13 and 17. Figure 3.13 depicts the alignment of the MegA and ClsA prepropeptides 
with those of other lantibiotics. The presence of a ‘FNLD’ type motif suggests that these 
lantibiotics are of type AI. The strongest similarity in primary sequence is to the lantibiotic 
epidermin, produced by Staphylococcus epidermidis and its structural analogue 
gallidermin, produced by Staphylococcus gallinarum. This is reflected in the ring topology 
with three (Me)Lan bridges and an AviCys at the C-terminus (Figure 3.15). At the N-
terminus, nine out of eleven amino acids match those of planosporicin, corresponding to 
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the A and B rings, whereas C-terminal similarity is reduced, sharing only one out of the 
three Lan bridges observed in planosporicin (Figure 3.15). 
 
3.5.5 Kineosporiacin 
Another planosporicin-like lantibiotic is produced by Kineosporia sp., an actinomycete of 
the Kineosporiaceae family. A patent was filed for this compound in which it is reported 
that Edman sequencing was blocked after the first residue, probably due to the presence 
of (Me)Lan bridges in the molecule (Shimizu and Masaki 2004). Thus the lantibiotic was 
chemically modified to introduce modifications that made the peptide accessible to Edman 
sequencing (Meyer et al. 1994). However this method did not discriminate between 
cysteine, serine and threonine residues incorporated into (Me)Lan bridges or between 
dehydrated serine and threonine residues, and therefore only the partial amino acid 
sequence of the mature compound was reported (Shimizu and Masaki 2004). Since no 
genome sequence for any Kineosporia sp. was available, it was not possible to identify 
the biosynthetic gene cluster. Instead, the structure of the putative lantibiotic was 
predicted by modelling the partial amino acid sequence on the structure of microbisporicin 
and was named kineosporiacin (Figure 3.15) (Foulston 2010). The N-terminus of this 
molecule is likely to form the A and B-rings found in planosporicin. Of the confirmed 
residues, only position 6 (a leucine) differs from planosporicin (a tryptophan). 
 
3.6 Discussion 
P. alba is an actinomycete that forms a branched, non-fragmenting substrate mycelium 
and aerial hyphae that bear clavate spore vesicles each containing a single spore (Mertz 
1994). This Chapter confirmed that P. alba produces the pentacyclic lantibiotic 
planosporicin in which 50 % of the 24 amino acids are subject to post-translational 
modification. A recent in silico analysis compared all known lantibiotic structures (Rink et 
al. 2005). Although no strict sequence motifs were defined that govern the modification, 
statistical analysis demonstrates that dehydratable serines and threonines are more often 
flanked by hydrophobic than by hydrophilic amino acids. It was also indicated that serine 
residues escape dehydration more often than threonines. However in planosporicin, the 
only unmodified Ser/Thr residue is  a threonine at position 12. 
Lantibiotics are commonly classified on the basis of their structure and the type of 
enzymes that introduce post-translational modifications. Type AI lantibiotics are those 
which are elongated and use individual modification enzymes, whilst type BII are globular 
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and use a bifunctional enzyme to create (Me)Lan bridges. The revision of the 
planosporicin structure from that published by (Castiglione et al. 2007) to that of (Maffioli 
et al. 2009) involved both a shift of two amino acids and a reorganisation of two Lan 
bridges (Figure 3.14). This has implications for the classification of planosporicin. The 
original classification as a type B lantibiotic reflected the presence of two thioether 
crosslinks between Ala3–Ala11 and Ala7–Ala18 constraining the lantibiotic into a compact 
shape. The structural revision gives planosporicin an elongated shape, characteristic of 
type A lantibiotics. The change in bridging pattern resulted in an N-terminus consisting of 
rings Ala3–Ala7 and Abu8–Ala11 that resemble the A and B rings of nisin (Figure 3.14). 
Thus the overall elongated structure of planosporicin and its N-terminal similarity to nisin 
suggests that it is a type A lantibiotic.  
The N-terminus of nisin is dominated by the presence of the A and B Me(Lan) rings 
(Figure 3.14). NMR studies have revealed these two rings wrap around the 
pyrophosphate group of lipid II (Hsu et al. 2004). The backbone of the nisin peptide chain 
forms five hydrogen bonds to the pyrophosphate. Thus there is no involvement of the 
specific side-chains of each amino acid component. The high degree of N-terminal 
homology of planosporicin to nisin implies a similar mode of action. Homology modelling 
revealed the A and B rings can accommodate a variety of side-chain compositions apart 
from at the conserved positions 3 and 7-11 (Hsu et al. 2004). Planosporicin possesses the 
conserved Ser3 and LCTPGC motif at positions 6-11, indicating that it too can form a 
pyrophosphate cage around lipid II.  
Analysis of other similar known and putative lantibiotics (actoracin, megateracin, clausin 
and kineosporiacin) with significant alignments to planosporicin indicated that these 
molecules may form a separate subclass of type AI lantibiotics. The type member of this 
group is microbisporicin produced by M. corallina (Castiglione et al. 2008; Foulston and 
Bibb 2010). Microbisporicin is distinguished from planosporicin by several additional post-
translational modifications and a greater potency against Gram-positive bacterial 
pathogens. Microbisporicin is now in late pre-clinical trials with Sentinella Pharmaceuticals 
Inc. The increased activity of microbisporicin compared to planosporicin could be due to 
the presence of a chlorinated tryptophan, dihydroxyproline and AviCys group. It is 
possible that these additional modifications increase the affinity of microbisporicin to lipid 
II, increasing its efficacy as an antimicrobial compound. In particular, the difference in the 
C-termini of the two lantibiotics has an effect on the charge of the molecules. The free 
carboxy terminus of planosporicin confers an additional negative charge whereas the 
carboxy terminus of microbisporicin is used in the AviCys modification. This difference 
may be responsible for the difference in potency observed between the two molecules. 
Both lantibiotics are thought to target lipid II in the cell wall, so it can be envisaged that the 
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additional negative charge on planosporicin has the effect of repelling the peptide away 
from the negative cell membrane. In contrast, microbisporicin lacks this negative charge, 
enabling a greater affinity with the cell membrane, facilitating the binding of lipid II and 
conferring increased potency. 
The confirmation of the structure of planosporicin presented in this Chapter gives scope 
for further work on the structure-activity relationships of this promising subclass of 
lantibiotics. This information adds to the wealth of knowledge about lantibiotics which can 
be used to define rules for the rational design of modified peptides (Rink et al. 2005). A 
comparison of the biosynthetic gene clusters for planosporicin and microbisporicin will 
likely reveal similarities and differences in their synthesis. Thus the identification of the 
planosporicin biosynthetic gene cluster is the focus of Chapter 4 and bioinformatic 
analysis of the constituent genes follows in Chapter 5. 
 
3.7 Summary 
P. alba sporulated best on ISP4 agar medium. SEM pictures revealed a cluster of clavate 
monospores on each sporangiophore. 
P. alba produced planosporicin most consistently on AF/MS agar medium, resulting in a 
halo of growth inhibition of the assay organism M. luteus.  
MALDI-ToF and ESI mass spectrometry analyses of culture supernatants of P. alba grown 
in AF/MS liquid medium revealed peaks corresponding in mass to planosporicin. 
A hydrophobic polystyrene resin was used to concentrate and partially purify planosporicin 
from culture supernatant. 
454 genome scanning revealed the correct primary structure of planosporicin. 
MS/MS analysis predicted the subsequently revised and correct tertiary structure of 
planosporicin. 
Planosporicin is a type A lantibiotic with close N-terminal similarity to nisin and 
microbisporicin.  
Planosporicin is likely to bind the pyrophosphate moiety of lipid II through the A and B-
rings at its N-terminus. 
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Chapter 4 : Identification of the 
planosporicin biosynthetic gene cluster  
 
 
4.1 Introduction 
The original aim of this project was to identify the gene cluster responsible for the 
biosynthesis of planosporicin. Planosporicin had previously been identified as a 
secondary metabolite of P. sp. DSM 14920 (Losi et al. 2004). Its in vitro activity against a 
range of Gram-positive human pathogens, activity at physiological pH and low toxicity in 
murinae implied a potential clinical role as a novel antimicrobial (Castiglione et al. 2007).  
During the ‘golden age’ of antibiotics from the 1940s to the 1990s, the main method of 
discovery was through the detection of bioactive compounds in extracts from natural 
sources (Zerikly and Challis 2009). The discovery of planosporicin described in Chapter 3 
is one example of antibiotic discovery using this approach. Nowadays, genome scanning 
can also be used to identify cryptic gene clusters in combination with genetic engineering 
techniques to define their products. This additional strategy takes advantage of new 
technologies to find novel metabolites. A recent example of a lantibiotic identified through 
genome mining is lichenicidin. The two-peptide lantibiotic was isolated from Bacillus 
licheniformis ATCC 14580 after identifying a gene with homology to lanM (Begley et al. 
2009). The success of such techniques has led to the development to further tools for 
genome mining. BAGEL2 identifies putative bacteriocins using additional features such as 
the genomic context of biosynthetic genes in addition to their homology to characterised 
genes (de Jong et al. 2010). 
Once the gene cluster has been identified, the next step is cloning and characterisation. 
As genetic engineering techniques began to complement screening of cell extracts, a 
number of new methods emerged during the 1980s. The generation of non-producing 
mutants allows characterisation of the biosynthetic pathway. In these mutants, fragments 
of the WT genome can be screened for their ability to complement this mutation and thus 
identify biosynthetic genes. This method was used in Streptomyces griseus to identify 
mutants blocked in the pathway of streptomycin biosynthesis (Hara and Beppu 1982). 
Alternatively, the resistance genes of a biosynthetic gene cluster could be cloned directly 
into a heterologous expression host and screened for resistance to the bioactive 
compound. This method was used to identify the tylosin-resistance genes tlrA and trlB 
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from Streptomyces fradiae on a restriction fragment which conferred resistance to tylosin 
on Streptomyces lividans (Cox et al. 1986). Often these resistance genes can 
subsequently be used as a probe to locate nearby biosynthetic genes.  
Many variations on a theme have developed since these early examples, each with their 
own advantages and disadvantages. Thus the method used is rationalised on a case-by-
case basis depending on the information known about the system and the technology 
available. In 2003, the first lantibiotic gene cluster was cloned from a high GC organism; 
the cinnamycin biosynthetic gene cluster was cloned from S. cinnamoneus (Widdick et al. 
2003). A radiolabelled probe was generated using sequence data for the part of the 
cinnamycin gene cluster from Streptoverticillium griseoverticillatum. Southern analyses 
identified a fragment of the gene cluster in S. cinnamoneus which was used as the 
template to design primers to clone overlapping DNA fragments that were subsequently 
cloned together. These fragments were sequenced and shown to correspond to the 17 kb 
cinnamycin biosynthetic gene cluster.  
However this primer walking technique is time-consuming. A popular alternative is the 
generation of a stable large insert library from a complex genome. Several different 
cloning vectors have been used, but perhaps most popular are cosmids, fosmids, 
bacterial artificial chromomosomes (BACs) and P1-derived artificial chromosomes 
(PACs). The choice of system often depends on the size of the biosynthetic gene cluster, 
which varies dramatically depending on the complexity of the biosynthetic pathway. The 
enzymatic requirements of secondary metabolites varies depending on their mechanism 
of synthesis. Non-ribosomal peptides and polyketides are synthesised by non-ribosomal 
peptide synthetases (NRPSs) and polyketide synthases (PKSs), respectively. Non-
ribosomal peptides are biosynthesised through the sequential condensation of amino acid 
monomers, whereas polyketides are synthesised from the repetitive addition of two 
carbon ketide units derived from thioesters of short carboxylic acids such as acetate. 
NRPSs and PKSs are large, multi-enzymatic, multi-domain megasynthetases. 
Consequently the biosynthetic gene cluster can be over 100 kb in size. The 80.7 kb gene 
cluster for simocyclinone D8 was cloned from Streptomyces antibioticus Tü60 40 on six 
overlapping cosmids (Trefzer et al. 2002). Simocyclinone D8 consists of four different 
moieties, one of which is a polyketide. Consequently the gene cluster is highly complex 
with 49 protein coding sequences including a type II PKS. The large size of this cluster 
prevents cloning into a single cosmid. In contrast, the entire daptomycin NRPS was 
identified in a 128 kb region of the S. roseosporus genome cloned in a BAC through 
heterologous expression in S. lividans (Miao et al. 2005). Ribosomal peptides such as 
lantibiotics follow the canonical route of mRNA translation by ribosomes. Thus few 
lantibiotic clusters are larger than 20 kb. Consequently it is reasonable to predict that the 
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entire planosporicin gene cluster can be cloned within the ~40 kb insert DNA of a typical 
cosmid, as will be attempted in this Chapter. 
Once a library is obtained, there are several screening methods. Oxazolomycin A is a 
peptide-polyketide hybrid compound. The oxazolomycin biosynthetic gene cluster was 
identified from Streptomyces albus JA3453 by screening a cosmid library with a 
degenerate probe (Zhao et al. 2006). The 79.5 kb cluster covered four overlapping 
cosmids, consisting of 20 open reading frames (ORFs) that encode both NRPSs and 
PKSs. However, screening libraries with degenerate probes is not the most reliable 
method, since non-specific hybridisation can yield false positives (Claesen and Bibb 
2010). The simocylinone cluster was identified through hybridisation with three different 
probes; two were fragments from the landomycin and urdamycin biosynthetic gene 
clusters and one was an amplified product of a likely simocylinone biosynthetic gene from 
S. antibioticus (Trefzer et al. 2002). 
Recently, the method of screening such libraries has been adapted to avoid the pitfalls of 
a degenerate probe. This is particularly useful when identifying an unknown gene cluster 
from an organism whose codon usage is also not well known. The microbisporicin gene 
cluster was identified from M. corallina through probing a cosmid library with a specific 
probe (Foulston and Bibb 2010). Information to amplify this probe was obtained from 
genome scanning data generated through next generation sequencing. Likewise, the 
cypemycin gene cluster was identified from Streptomyces sp. OH-4156 through similar 
methods. Solexa-based genome scanning revealed a contig containing the structural 
peptide that was used as a probe for cosmids containing the entire cypemycin gene 
cluster (Claesen and Bibb 2010). This Chapter describes the construction of a P. alba 
cosmid library which was probed for the planosporicin gene cluster using sequence 
information obtained through genome scanning. 
 
4.2 454 sequencing 
454 genome scanning of P. alba was initially carried out by the University of Liverpool. 
Although the data was of fairly poor quality, regions commonly found in many lantibiotic 
gene clusters were identified. The published planosporicin structure provided a basis for 
predicting the propeptide sequence, as described in Chapter 3. A search of the P. alba 
454 contig database using a protein query (TBLASTN) revealed that the LanA 
prepropeptide was encoded fairly centrally within the 1729 bp contig01289. Analysis in 
Frameplot 2.3.2 predicted the likely protein-coding region of this high-GC content DNA 
(Bibb et al. 1984). Similar TBLASTN searches using SpaB (the dehydratase enzyme of 
the subtilin gene cluster) as a query revealed that the 5’ end of lanB was also present on 
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contig01289, while the middle of lanB covers the entirety of the 559 bp contig03088. PCR 
was able to link contig01289 to contig03088, filling the 112 bp gap between the two 
contigs. These two contigs were used to design probes for the psp cluster as described in 
Section 4.4 (Figure 4.1). 
 
 
Thus preliminary scanning identified small sections of the planosporicin gene cluster and 
PCR linked these sections together to form a larger, contiguous sequence. TBLASTN 
searches were also carried out for other common lan genes. However some are too 
similar to housekeeping genes to prove useful. For example lanT bears close homology to 
many ATP-binding cassette (ABC) transport systems that are difficult to assign to specific 
functions. However the ABC transporters conferring immunity typically contain an ‘E-loop’, 
instead of the well-conserved Q-loop in the nucleotide-binding domain which distinguishes 
them from others (Okuda et al. 2010). A TBLASTN search with MibE and MibF revealed 
that the 2552 bp contig00809 likely contained lantibiotic immunity genes. A gene similar to 
MibE was located centrally within this contig, and like MibE was predicted to contain six 
membrane spanning domains. The 5’ terminus of a gene similar to MibF was also located 
on this contig. These may form the self-resistance mechanism to protect P. alba from its 
own lantibiotic. The observed similarity of planosporicin to microbisporicin discussed in 
Chapter 3 inspired TBLASTN searches for unusual enzymes found in the microbisporicin 
cluster, such as MibD, the enzyme catalysing S-[(Z)-2-aminovinyl]-D-cysteine formation 
and MibH, the FAD-dependent tryptophan halogenase. However, no hits were found in 
either case.  
 
Figure 4.1 : A schematic depicting three genes proposed to be part of the planosporicin 
biosynthetic gene cluster annotated using the generic designation ‘lan’.  
The sequence is covered by two contigs generated from 454 genome scanning data linked 
by PCR. Three probes; lanA, lanAB and lanB were amplified on the basis of this data. 
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Subsequently, 454 next generation sequencing was repeated on the Norwich Research 
Park at The Genome Analysis Centre. P. alba genomic DNA was fragmented into 400-600 
bp fragments, quantified, amplified by emulsion PCR and sequenced on a quarter of a 
plate. This generated 72 Mb of data which was assembled into 1017 contigs. These 
contigs contain 7.3 Mb of data, so the reads gave approximately 10-fold coverage of the 
genome. The Newbler assembler predicted a genome size of 9.1 Mb, but as 99 % of 
reads were assembled into contigs, it seems likely that the P. alba genome is 
approximately 7.5 Mb. A full statistical analysis of this assembly is given in Chapter 2. In 
brief, there were 944 contigs at least 500 bp long, the largest of which was 140 kb. Half of 
the entire assembly was contained in contigs or scaffolds equal to or larger than 17 kb. 
The mean GC content of the assembled data was 73.9 mol%GC (Figure 4.2). All contigs 
were stored in a database from which TBLASTN searches identified regions common in 
most lantibiotic clusters. In total, three large contigs: 00232 (~8 kb), 00214 (~8.5 kb) and 
00436 (~4 kb) appeared to cover the entire psp cluster with just small gaps of <100 bp 
between the contigs. 
 
4.3 Cosmid library preparation 
A cosmid library was constructed as described in Chapter 2. A cosmid is essentially a 
plasmid that contains cos sites from lambda phage. Cosmids frequently also contain a 
bacterial origin of replication, an antibiotic resistance gene and a cloning site. Thus they 
can replicate as plasmids in bacteria, and transfected cells can be identified through their 
ability to survive on the appropriate antibiotic selection. The presence of cos sites enables 
packaging of the linear cosmid into phage heads. This packaging step selects for large 
inserts, providing a clear advantage over BAC and PAC vectors. Once packaged the 
cosmid can be stably introduced into cells by transduction. Consequently, cosmids are 
able to contain 30 to 50 kb of DNA, while most plasmid cloning vectors are generally able 
to carry only up to 20 kb. 
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4.3.1 Genomic DNA 
The cosmid library used P. alba genomic DNA (gDNA) as insert DNA. A critical stage is 
the isolation of high molecular weight gDNA at a high concentration as described in 
Chapter 2.11. The extracted P. alba gDNA was subjected to pulsed field gel 
electrophoresis and the size was estimated to range from 100-300 kb (Figure 4.3). A 
partial restriction digest reduced the P. alba gDNA to 30-50 kb, an optimal size for phage 
packaging (Figure 4.3). Subsequent dephosphorylation of the digested fragments reduced 
the risk of cloning two non-contiguous segments of genomic DNA into the same cosmid 
vector.  
 
Figure 4.2 : Histogram of the GC content for the assembled contigs from 454 sequencing 
of P. alba genomic DNA. 
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4.3.2 Cosmid library construction 
The construction of the cosmid library was a multi-step cloning process and is described 
in Chapter 2 and depicted as a schematic in Figure 4.4. The first step involved digesting 
the vector DNA to generate two vector arms. This was accomplished by digestion with two 
different enzymes. First the cosmid vector SuperCosI (Stratagene) was linearised by 
digestion with the single cutter XbaI and the linear vector was dephosphorylated. Then the 
vector was digested with a second enzyme, BamHI, which is isocaudomeric to the Sau3AI 
used for the partial digestion of gDNA as described in 4.3.1. The identical overhangs 
generated by BamHI and Sau3AI allowed the insertion of the digested gDNA into the 
vector. The ligation product was packaged in vitro into phage heads using packaging 
extracts derived from E. coli lysogens. The packaged cosmids were titred, then scaled-up 
to transfect the appropriate E. coli host to generate a library of several thousand colonies. 
 
Figure 4.3 : High molecular weight P. alba gDNA analysed by PFGE.  
gDNA was subjected to partial digestion with Sau3AI. Increasing incubation time resulted 
in smaller fragments of gDNA. A negative control of gDNA with no Sau3AI treatment 
(undigested) was also run. Size estimation is given by MidRange I PFG Marker (NEB) with 
band size in kb indicated next to the gel (bold figures represent major bands). 
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Of these, 3072 colonies were robotically arrayed into eight 384 well plates to create the 
cosmid library. If the P. alba genome is approximately 7.5 Mb in size, and the average 
cosmid insert is 40 kb then a library of 3072 clones gives over 16-fold coverage of the 
genome. Thus we can expect to find approximately 16 library clones containing at least 
part of the planosporicin biosynthetic gene cluster. 
 
4.4 Clone identification 
4.4.1 Probe preparation 
Genome scanning data described in Section 4.2 was used to generate probes to hybridise 
to the cosmid library. Contig01289 and contig03088 were linked by PCR, creating a 2.4 kb 
fragment containing the planosporicin lanA and the 5’ terminus of its lanB. The sequence 
of this fragment was used to design three pairs of primers to amplify probes spanning 230 
bp of lanA, 547 bp of lanB and 1701 bp of lanAB (Figure 4.1). Each probe was initially 
amplified from P. alba gDNA using the Expand High Fidelity PCR System (Roche). This 
kit contains Taq DNA Polymerase and a polymerase with proofreading activity. Taq adds 
a single adenine nucleotide to the 3′ end of amplified DNA fragments, creating an A-tail.  
This A-tail was used to ligate the amplified fragment into the commercial vector pGEM-T 
(Promega). pGEM-T is a linear construct due to digestion with EcoRV and has 3´ terminal 
thymidine overhangs added at both termini. The EcoRV digestion cleaved lacZα, 
encoding the α fragment of the LacZ protein which is required to complement in vivo a 
defective C-terminal segment of β-galactosidase (LacZ). The 3´ terminal thymidines 
provided a compatible overhang for the PCR products. The products of the ligation 
reaction were introduced into E. coli DH5α by transformation and plated onto LB media 
containing 100 µg/ml carbenicillin, 0.5 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) 
and 80 µg/ml X-gal (galactose linked to a substituted indole). IPTG functions as the 
inducer of the Lac operon. If the pGEM-T vector recircularises, a functional LacZα 
fragment is formed that combines with the Ω subunit of the LacZ protein encoded in the E. 
coli chromosome to form a functional β-galactosidase enzyme. The colourless X-gal 
would then be metabolised by the β-galactosidase to form 5-bromo-4-chloro-indoxyl which 
is spontaneously oxidized to 5,5'-dibromo-4,4'-dichloro-indigo, an insoluble blue pigment, 
yielding a blue colony. In contrast, white colonies would indicate the presence of an insert 
ligated within the pGEM-T vector, preventing expression of a functional β- galactosidase 
enzyme. Several white colonies from each ligation were sequenced to confirm the lack of 
mutations potentially introduced by PCR. Each probe was amplified with the Expand High 
Fidelity PCR System, using a sequenced plasmid as template.  
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4.4.2 Hybridisation to cosmid library 
The 3072 clones of the cosmid library were transferred from eight different 384 well plates 
to a nylon membrane. Each cosmid was spotted twice in a characteristic duplex pattern to 
enable identification of which plate each hybridising clone came from. The three PCR 
products from Section 4.4.1 were randomly labelled with 32P-αdCTP to enable detection 
through photostimulated luminescence (PSL). Each labelled probe was hybridised 
individually with a separate copy of the cosmid library that was then exposed to a 
phosphor imaging plate. The radioactive signal was stored in the phosphor plate then later 
read by a phosphorimager. PSL releases the stored energy through stimulation with 
visible light, to produce a luminescent signal read by the phosphorimager, revealing a 
highly sensitive image of the original pattern of radiation.  
Eight clones gave a distinctive double spot pattern with all three probes (Figure 4.5). A 
further five clones only hybridised well to a couple of the probes, implying they only 
contained part of the gene cluster. Thus probing the library with three probes located 
within just 1830 bp of the P. alba genome revealed 13 clones putatively containing at least 
part of the planosporicin biosynthetic gene cluster. 
 
4.5 Clones picked from the library 
4.5.1 PCR on P. alba 
The eight positive clones identified in 4.4.2 were picked from the library and grown to 
amplify the cosmid DNA for isolation as described in Chapter 2. The presence of the 
planosporicin biosynthetic genes was confirmed by PCR using primers to amplify lanA 
(1289FlanA and 1289RlanA) and lanB (3088F2 and 3088R2). Additionally, the primers 
FlanEF and RlanEF were designed to anneal within contig00809 to amplify the putative 
immunity gene lanE. The 221 bp fragment was successfully amplified from all eight 
cosmids, indicating that it most likely corresponds to an ABC transporter in the 
planosporicin biosynthetic gene cluster. Long-range PCR was also attempted. A primer 
annealing to the cosmid backbone was used in combination with a primer annealing to a 
lantibiotic gene. Combinations of end_F and end_R with primers for lanA or lanE all failed 
to amplify a product. Likewise attempts to link lanA with lanE by long-range PCR also 
failed. It is likely these genes are located too distantly from each other to allow the 
amplification of a PCR product.  
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Figure 4.5 : Hybridisation of the P. alba cosmid library with three different probes. 
Cosmids taken forward for further investigation are ringed and labelled. A; Probe for 1701 
bp spanning lanA and lanB. B; Probe for 230 bp of lanA. C; Probe for 547 bp of lanB. 
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4.5.2 End-sequencing of P. alba cosmids 
Primers annealing to the cosmid vector backbone were used to sequence into the insert 
DNA of all eight cosmids that might have contained the entire planosporicin biosynthetic 
gene cluster. Primers end_F and end_R from table 2.6 were used to obtain ~800 bp of 
sequence data from each cosmid. This end-sequence data was used in a BLASTN search 
of the P. alba 454 database to identify contigs corresponding to the ends of each cosmid. 
Analysis of these contigs in Frameplot enabled the identification of likely ORFs from which 
the translated protein was used in a BLASTP search of the NCBI protein database to 
determine if lantibiotic genes are located close to the ends of the cosmid inserts. The 
absence of likely lantibiotic biosynthetic genes would imply that the entire planosporicin 
gene cluster is centrally located within the cosmid insert. End-sequence data from 
cosmids G15-1, J7-5 and K6-8 had significant alignment to either a permease or ATP-
binding component of an ABC-type transporter. Based on studies with microbisporicin, it 
seemed likely that the planosporicin biosynthetic gene cluster would contain at least two 
ABC-type transporters; one to export the lantibiotic after synthesis and one that functioned 
as an immunity mechanism. For this reason these cosmid clones may not have contained 
the entire gene cluster. In contrast, the sequence at one end of cosmid B4-1 had 
homology to a Streptosporangium roseum dihydrofolate reductase, while the other end 
had homology to an Actinosynnema mirum methyl-accepting chemotaxis protein. Neither 
of these proteins have an obvious role in lantibiotic biosynthesis so this cosmid was a 
strong candidate for containing the entire gene cluster. 
 
4.5.3 Restriction digest on P. alba cosmids 
Further information as to the insert DNA contained in each cosmid was gleaned from 
restriction digests with different enzymes. All eight cosmids identified in Section 4.4.2 
displayed some common fragments when digested with BamHI or PstI (Figure 4.6). 
Cosmids F13-1 and F6-6 appeared almost identical according to the size of the restriction 
fragments generated. Cosmids B4-1, G22-5 and E18-8 also had strikingly similar band 
patterns. Thus cosmids B4-1 and F13-1 were chosen for sequencing. These cosmids 
contained all planosporicin biosynthetic genes identified so far (Section 4.5.1), but none 
were present at the ends of the cosmid (Section 4.5.2). Despite these similarities, they 
gave different restriction digest patterns. The total size of each cosmid was estimated by 
addition of all the digest fragments. Both cosmids were approximately 40 kb in size, giving 
an estimated insert size of 32 kb, likely large enough to contain the entire biosynthetic 
gene cluster. For the rest of this thesis, cosmid B4-1 is referred to as pIJ12321 and 
cosmid F13-1 is referred to as pIJ12322. 
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4.6 Cosmid sequencing and annotation 
4.6.1 Sequencing 
P. alba cosmids B4-1 (pIJ12321) and F13-1 (pIJ12322) were sequenced using Sanger 
sequencing at the DNA sequencing facility at the University of Cambridge. The insert DNA 
in pIJ12321 was 37760 bp, while pIJ12322 contained 37916 bp. Although very similar in 
size, the segment of cloned P. alba gDNA differed slightly between the two cosmids. 
pIJ12321 has the 1830 bp of sequence used to identify the clone located centrally within 
the insert DNA, whereas in pIJ12322 this sequence is located towards the right hand 
border of the insert DNA with the vector backbone. ClustalW2 was used to align the insert 
gDNA from pIJ12321 and pIJ12322 (Chenna et al. 2003). This identified one discrepancy, 
an additional cytosine residue in the pIJ12322 sequence. This potential frameshift 
mutation would have destroyed a stop codon present in the pIJ12321 sequence. 
Correspondence with the Cambridge Sequencing facility confirmed that this additional 
cytosine was an error during the assembly of the pIJ12322 sequence in Consed (Gordon 
et al. 1998). 
  
 
Figure 4.6 : Restriction digest patterns of different P. alba cosmids.  
A; Digest with BamHI. B; Digest with NcoI. Size estimation is given by Hyperladder I 
(Bioline) with band size in kb indicated next to the gel.   
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4.6.2 Annotation 
The full insert DNA of pIJ12321 was annotated using Artemis software (Rutherford et al. 
2000). Instrumental to the correct assignment of ORFs was analysis of the GC content. 
The high-GC content of actinomycete genomes skews the usage of codons. The triplet 
code allows most freedom at the third codon position. Consequently the first, second and 
third nucleotide positions of codons show distinct differences in GC content, changing 
from intermediate to low to high GC content (Bibb et al. 1984). The GC-frameplot tool 
within the Artemis program tracks the GC content at each position within a moving window 
of a stipulated number of codons. Analysis of the GC content at each position reveals 
both where ORFs may be situated and their directionality (Figure 4.7). The start site of 
each ORF was adjusted to an ATG or GTG with a potential ribosome-binding site (RBS) 
nearby. The sequence GGAGG was used as the ideal RBS, located approximately 5 to 15 
bp upstream of the start codon (Kieser et al. 2000). Thus the final annotation uses the 
start codon with a putative RBS upstream which creates the largest ORF. 
The protein sequences from putative ORFs were compared to the NCBI protein database 
using the BLASTP search program (Altschul et al. 1990). Proteins with a high percentage 
similarity to those encoded by the planosporicin gene cluster were used to assign a 
putative function to each ORF.  
It is interesting to note that a number of genes appear translationally coupled due to 
overlapping start and stop codons. This is common in gene clusters as a method of co-
ordinating regulation. Translational coupling is common where the stoichiometric ratio of 
protein expression is essential for optimal functionality. Elsewhere in the cluster, there are 
larger gaps between ORFs. This gives scope for regulation of transcription through RNA 
secondary structure. Hairpin loops in mRNA may act as transcription terminators. These 
alter the stoichiometry of protein expression; coding regions before the stem loop are 
transcribed at a higher rate compared to those after the stem loop. This may be crucial 
when an enzyme and its substrate are expressed from the same operon. One enzyme 
can process many substrates so the stoichiometric ratio needs to be altered accordingly to 
optimise efficiency. 
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4.7 P. sp. DSM 14920 cosmids 
4.7.1 PCR on P. sp. DSM 14920 cosmids 
The NAICONS consortium constructed a second Planomonospora cosmid library with 
gDNA from P. sp. DSM 14920. In this strain, planosporicin is referred to as NAI-97. 
NAICONS identified four partially overlapping cosmids that appeared to contain 
planosporicin biosynthetic genes. In this work, PCR using cosmids 4B8 and 9A7 as 
templates amplified all three lan genes; lanA, lanB and lanE, while cosmid 4H8 appeared 
to lack lanE and cosmid 7C2 to lack lanB (Figure 4.8). 
 
 
The sequence and annotation of pIJ12321, described in detail in Chapter 5, depicts the 
organisation of the psp cluster in P. alba. Genome scanning of P. sp. DSM 14920 
identified the planosporicin prepropeptide and analysis of a few kilobases upstream and 
downstream revealed a gene organisation very similar to that of P. alba (M. Sosio, 
personal communication). To investigate if sequences flanking the biosynthetic gene 
cluster in each strain show synteny, primers were designed to amplify across the 
predicted left and right borders of the psp cluster. These primers amplified a fragment of 
the same size whether P. alba or P. sp. DSM 14920 DNA was used as a template (Figure 
4.9). Thus gene order appears to be conserved between the psp clusters from P. alba and 
P. sp. DSM 14920. 
 
Figure 4.8 : PCR analysis to determine which P. DSM 14920 cosmids were likely to 
contain the entire planosporicin gene cluster.  
Cosmids 9A7, 4H8, 4B8 and 9A7 were used as templates to amplify lanA (1289FlanA and 
1289RlanA; 230 bp), lanB (3088F2 and 3088R2; 303 bp) and lanE (FlanEF and RlanEF; 
221 bp) from the psp gene cluster. PCR products were run on a 1 % agarose gel by 
electrophoresis. The ladder is Hyperladder I (Bioline) with band sizes annotated in bp. 
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4.7.2 Restriction digest on P. sp. DSM 14920 cosmids 
Interestingly, restriction digests comparing P. alba cosmids with those from P. sp. DSM 
14920 appeared quite different. Figure 4.10 depicts the band pattern created by a BamHI 
or NcoI digest. Several restriction fragments are common across all eight P. alba cosmids. 
The majority of these are absent from the digest pattern of the P. sp. DSM 14920 
cosmids. This implies that although the amino acid sequences of the encoded proteins is 
conserved, there is considerable variation at the nucleotide level in the planosporicin 
biosynthetic gene clusters from the two Planomonospora species. 
 
 
Figure 4.9 : PCR analysis to check the similarity of P. DSM 14920 cosmid 4B8 to P. alba 
cosmid B4-1, both encoding the planosporicin gene cluster.  
Cosmid DNA was used as a template to amplify regions across the borders of the 
planosporicin gene cluster. LongAmp polymerase (NEB) was used to amplify two regions. 
ES1F and ES1R amplify 1073 bp across the left hand border. ES2F and ES2R amplify 
1883 bp across the right hand border. PCR products were run on a 1 % agarose gel by 
electrophoresis. The ladder is Hyperladder I (Bioline) with band sizes annotated in kb.  
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Figure 4.10 : Restriction digest patterns of eight P. alba cosmids and four P. sp. DSM 
14920 cosmids with two different enzmyes.  
A; Digest with BamHI. B; Digest with NcoI.  Restriction fragments were run on a 1 % 
agarose gel by electrophoresis. Size estimation is given by Hyperladder I (Bioline) with 
band size in kb indicated next to the gel. 
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4.7.3 End-sequencing of P. sp. DSM 14920 cosmids 
The P. sp. DSM 14920 cosmid library was made with a derivative of the SuperCosI vector 
used for the P. alba cosmid library. Consequently the same primers; end_F and end_R 
were used to sequence into the ends of the insert DNA. Cosmid 7C2 yielded end-
sequence data, which a BLASTN search of the P. alba 454 database yielded contig01289 
as a top hit. The presence of lanA and lanB at the end of this insert implied that part of the 
lantibiotic biosynthetic gene cluster would be missing from the cosmid. Cosmids 4B8 and 
9A7 gave end-sequences which a BLASTP search of the NCBI protein database revealed 
similarity to Streptosporangium roseum genes for primary metabolism, implying the entire 
cluster may be present within these cosmids. For the rest of this work, cosmid 4B8 is 
referred to as pIJ12325 and cosmid F13-1 is referred to as pIJ12326. 
 
4.8 Discussion 
This Chapter describes how genome scanning through 454 sequencing created contigs 
that enabled BLAST-type searches for genes similar to those commonly found in 
lantibiotic gene clusters. This information allowed the amplification of probes which were 
hybridised against a P. alba cosmid library. From the selection of positive hits, a 
combination of PCR, restriction digests and end-sequencing were used to deduce which 
cosmids likely contained the entire cluster which were then sent for sequencing.  The next 
Chapter continues along this theme with the bioinformatic characterisation of the cluster 
and a full discussion of the likely functions of individual genes. 
Further work has fully justified the methodology chosen to identify the planosporicin gene 
cluster. An activity based screen could have been performed by integrating the P. alba 
cosmid library into a heterologous host. However, choice of host would have been difficult, 
as there would have been no guarantee that the cluster would have been expressed at a 
level that allowed planosporicin detection. Likewise, use of heterologous expression to 
identify which cosmids out of those which give a positive hit after hybridisation with a 
radioactive probe would likely have proven a futile exercise, as Chapter 6 details how 
attempts made to heterologously express the gene cluster proved slow and cumbersome. 
Chapter 3 described how the predicted planosporicin propeptide sequence based on the 
2007 structure of planosporicin had a number of errors (Castiglione et al. 2007). 454 
sequence data revealed the C terminal Pro and Gly residues were actually located at 
positions 9 and 10 respectively. This was further confirmed in this Chapter through the 
amplification and sequencing of the lanA prepropeptide from P. alba as a probe to identify 
positive clones from the cosmid library. A retrospective investigation into the methods 
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used to identify the planosporicin biosynthetic gene cluster enables the conclusion that 
this genome scanning approach was appropriate. The differences in the precursor peptide 
compared to the published structure (Chapter 3) and lack of heterologous expression in 
Streptomyces (Chapter 6) would most likely have confounded other methods. 
 
4.9 Summary 
454 genome scanning revealed the lanA gene for planosporicin within the P. alba genome 
A cosmid library was generated from P. alba gDNA 
Three probes for the planosporicin gene cluster were amplified using 454 sequence data. 
Eight out of 3072 clones hybridised to all three probes 
Cosmids B4-1 (pIJ12321) and F13-1 (pIJ12322) were sequenced 
pIJ12321 contained the entire 15.3 kb cluster centrally located within 37 kb of P. alba 
gDNA 
Two cosmids from P. sp. DSM 14920 appear likely to contain the planosporicin gene 
cluster 
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Chapter 5 : The planosporicin 
biosynthetic gene cluster 
 
 
5.1 Introduction  
In Chapter 4, two cosmids were sequenced which revealed that pIJ12321 contains a 
37.76 kb insert with the planosporicin structural gene, pspA, located centrally on the 
cloned insert. pIJ12322 is similar in size but the structural gene is located towards the 
right hand border of the insert so that the C-terminus of pspV is missing. Thus for the 
purpose of this work, it is the annotation of pIJ12321 which is described. 
This Chapter details the bioinformatic analysis of the planosporicin biosynthetic gene 
cluster. This analysis will identify proteins from other organisms that are highly similar in 
sequence. These proteins are likely to exhibit conservation in which changes at a specific 
position of an amino acid sequence preserve the physico-chemical properties of the 
original residue. As function is conserved on the protein level, it is protein, not nucleotide, 
sequences that will be analysed. It is sometimes assumed that if two proteins have highly 
similar sequences then they are homologous, however sequence similarity does not 
always arise through common ancestry. Convergent evolution may result in two 
sequences being similar if they have both been selected to bind a particular substrate. 
Instead, these are functionally analogous sequences that have evolved separately. In this 
work the similarity between protein sequences will be quantified through ‘percent identity’, 
the extent to which two amino acid sequences are invariant.  
In this Chapter, each of the proteins encoded within the proposed planosporicin 
biosynthetic gene cluster were used as a query in a search against all sequences in the 
current NCBI database to assign putative functions on the basis of sequence identity. In 
general, one type of database search, BLASTP, was used (Altschul et al. 1990). However 
in some cases a Position-Specific Iterative BLAST (PSI-BLAST) was used to find distant 
relatives of a protein (Altschul et al. 1997). This method first generates a list of closely 
related proteins from which the significant features are summarised and used as a query 
against the protein database to identify further proteins with a significant alignment. The 
process is iterated until no further proteins are found. Another bioinformatic tool was used 
for multiple sequence alignments, namely ClustalW2 (Chenna et al. 2003). Further 
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genomic analysis was performed using the Artemis Comparison Tool (Sanger Institute, 
Hinxton, UK). 
 
5.2 Features of the minimal gene set 
The annotation and bioinformatic analysis of pIJ12321 enabled a prediction of the likely 
minimal set of genes required for planosporicin biosynthesis, depicted in Figure 5.1. This 
annotation began in Chapter 3 with the identification of pspA encoding the planosporicin 
prepropeptide. A cluster of 14 genes surrounding pspA is likely to be responsible for 
planosporicin biosynthesis and they are discussed in Sections 5.3, 5.4 and 5.5. The 
cluster runs from 14970bp (pspE) to 30259bp (pspV) of the insert DNA of pIJ12321, 
representing a ~15.3 kb cluster. The GC content of the P. alba insert DNA cloned into 
pIJ12321 is 73.58 mol%, while the GC content of the cluster from pspE to pspV is slightly 
higher at 74.26 mol%. Interestingly, the rare codon ‘TTA’ occurs in the coding region of 
pspX, suggesting that production of planosporicin may be controlled by the bldA tRNA 
and therefore developmentally regulated (Leskiw et al. 1991). A detailed bioinformatics 
analysis of these genes along with others that may form part of the minimal gene set 
follows in the subsequent Sections and is summarised in Table 5.1. 
 
 
 
Figure 5.1 : The putative planosporicin gene cluster with each gene shown to scale. 
Translationally coupled genes are separated vertically. 
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5.3 Biosynthetic enzymes 
5.3.1 PspB 
The 1067 residue PspB protein bears most resemblance to the lantibiotic dehydratases 
(which are commonly ~1000 residues). It contains three conserved domains, two of which 
correspond to the N and C termini of lantibiotic dehydratases (pfam04737 and 
pfam04738) and a third which commonly also occurs in longer LanB proteins 
(TIGR03891). The protein with most similarity to PspB was MibB, the microbisporicin 
dehydratase from M. corallina (Table 5.1). The top non-mib result was a putative 
lantibiotic dehydratase from Desmospora sp. 8437 (Table 5.1). This genus is in the family 
Thermoactinomycetaceae, Gram-positive endospore-forming bacteria in the Firmicutes 
phylum. This strain was isolated from human blood and subject to whole genome shotgun 
sequencing as part of the Human Microbiome Project. Nucleotide region 42690-45878 of 
the database entry contains the PspB-like protein. Downstream lies a putative LanC as 
well as several ABC transporters; however no putative prepropeptide had been 
annotated.  
The next four proteins with significant alignments to PspB are from different species of 
Bacillus. Namely Bacillus clausii KSM-K16 (28 % over 1098 residues), Bacillus 
megaterium QM B1551 (29 % over 1082 residues), Bacillus cereus AH 1273 (28 % over 
1033 residues) and Bacillus mycoides DSM 2048 (29 % over 1033 residues). The gene 
that encodes the PspB-like protein in B. megaterium (pBM70150) lies downstream of a 
gene encoding a protein which resembles PspA (pBM70151) identified in Chapter 3 and 
named megateracin. Likewise the gene encoding the PspB-like protein in B. mycoides 
(bmyco0001_53840) lies downstream of a putative lanA gene (bmyco0001_53830). Both 
of these putative 22 amino acid lantibiotics show a good alignment to clausin (B. clausii), 
gallidermin (S. gallinarum) and epidermin (S. epidermidis), as well as to the 24 amino acid 
lantibiotic planosporicin (P. alba). The context of these four Bacillus clusters is discussed 
further in Section 5.6.3. 
Other proteins with good alignments to PspB include lantibiotic dehydratases from several 
streptomycetes, including Streptomyces violaceusniger Tu 4113 (34 % over 1099 
residues) and Streptomyces noursei ATCC 11455 (35 % over 1125 residues). Other 
actinomycetes, such as Actinomyces sp. oral taxon 848 str. F0332, contain a protein with 
similarity to PspB; 32 % identity over 1074 residues. Interestingly, the PspB-like protein in 
Actinomyces sp. lies downstream of a protein identified due to its similarity to PspA and 
named actoracin (described in Chapter 3). 
PspB has lower levels of similarity to LanB proteins from characterised biosynthetic gene 
clusters. There is just 23 % identity to SpaB and EpiB, the dehydratase enzymes involved 
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in subtilin and epidermin biosynthesis, respectively. PspB has just 22 % identity to MutB 
and NisB, the enzymes responsible for dehydrations in mutacin III and nisin, respectively. 
All four of these LanB proteins correspond to type AI lantibiotic gene clusters. The low 
level of similarity is to be expected, as members of the LanB family commonly share only 
~25 % sequence identity (Chatterjee et al. 2005). On the basis of similarity to so many 
LanB enzymes, PspB is proposed to catalyse the formation of Dha and Dhb residues in 
planosporicin through the dehydration of specific serine and threonine residues, 
respectively. 
Over the years, much in vivo work has been carried out to characterise the substrate 
specificity of LanB enzymes. The use of lantibiotic expression systems to produce 
lantibiotic analogues demonstrate the susbstrate promiscuity of these enzymes. For 
example the modification of non-lanthionine peptides by NisB and NisT when 
heterologously expressed as a chimera with the nisin leader peptide indicates the 
substrate promiscuity of LanB enzymes (Rink et al. 2007c). Likewise, the LanM enzymes 
responsible for the dehydration and cyclisation of type AI and type II lantibiotics 
demonstrate similar promiscuity which has been exploited in evolution. The planktonic 
marine cyanobacteria Prochlorococcus MIT9313 was found to encode a single LanM 
enzyme responsible for the dehydration and cyclisation of up to 29 different 
prepropeptides (Li et al. 2010). However this promiscuity must be tempered with a certain 
level of selectivity. Planosporicin contains an unmodified threonine residue at position 12 
which is conserved in microbisporicin and actoracin (described in Chapter 3) whereas the 
threonine at position 2 is dehydrated to form dehydrobutyrine in all three lantibiotics. 
 
5.3.2 PspC 
pspC encodes a 467 amino acid protein which contains the conserved domain pfam05147 
(LanC-like proteins) and shows strong similarity to lantibiotic cyclases. The two proteins 
with the most significant alignment to PspC were both proteins from actinomycetes. These 
are MibC, the lantibiotic cyclase responsible for the formation of (Me)Lan bridges in 
microbisporicin from M. corallina, and a conserved hypothetical protein from Actinomyces 
sp. oral taxon 848 str. F0332 (Table 5.1). The ‘hypothetical’ protein from Actinomyces sp. 
occurs downstream of the actoracin prepropeptide and likely LanB and is almost certainly 
the LanC enzyme in this biosynthetic gene cluster. The next five hits correspond to 
various members of the Firmicutes phylum. These include Desmospora sp. 8437 (33 % 
over 432 residues), Paenibacillus alvei (31 % over 448 residues), Paenibacillus polymyxa 
E681 (32 % over 462 residues), B. cereus AH 1273 (31 % over 434 residues) and B. 
mycoides DSM 2048 (31 % over 434 residues). In addition, both B. clausii KSM-K16 and 
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B. megaterium QM B1551 contain proteins with high similarity to PspC; 31 % (over 462 
residues) and 30 % (over 447 residues), respectively. This supports the prediction that the 
planosporicin-like lantibiotics clausin and megateracin are produced by these strains (as 
described in Chapter 3) and is discussed further in Section 5.6.3. LanC enzymes from 
characterised lantibiotic biosynthetic gene clusters with similarity to PspC include SpaC 
(29 % over 454 residues), NisC (26 % over 401 residues), EpiC (25 % over 399 residues) 
and MutC (21 % over 430 residues).  
NisC has been demonstrated to be necessary in vivo for the introduction of (Me)lan 
bridges into nisin (Koponen et al. 2002). This was further substantiated in vitro where 
purified NisC was demonstrated to introduce all five thioether crosslinks into nisin (Li et al. 
2006). Subsequently NisC was subjected to site-directed mutagenesis of conserved 
residues (His212, Arg280, Asp141, and Tyr285) as well as of the ligands to the zinc ion in the 
active site (Cys284, Cys330, and His331). His212 and Asp141 as well as all three zinc ligands 
were found to be essential for cyclisation activity (Li and van der Donk 2007).  
LanC enzymes are zinc metalloproteins, in which the bound metal is proposed to activate 
the thiol moiety of the cysteine residue for nucleophilic addition onto the dehydrated 
serine or threonine (Li et al. 2006). PspC contains the conserved histidine and cysteine 
residues which are proposed to coordinate a zinc ion involved in the catalysis of (Me)Lan 
bridge formation in planosporicin (Figure 5.2). 
 
5.3.3 PspTU 
ATP-Binding Cassette (ABC) transporters use the hydrolysis of ATP without protein 
phosphorylation to energise the transport of substrates across cell membranes. ABC 
transporters contain two conserved regions; a highly conserved nucleotide-binding 
domain (NBD) and a less conserved transmembrane domain (TMD). The NBDs bind and 
hydrolyse ATP to supply the active energy for transport. Substrate specificity is 
determined by two TMDs that also provide the translocation pathway across the bilayer.  
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Figure 5.2 : Sequence alignment of PspC with five highly similar LanC proteins.  
Namely MibC (microbisporicin), SpaC (subtilin), EpiC (epidermin), MutC (mutacin III) and 
NisC (nisin)). Alignment constructed using ClustalW2 (Chenna et al. 2003)) Active site 
residues that are absolutely conserved among the LanC proteins are in red (Helfrich et al. 
2007). Residues corresponding to Cys284, Cys330, and His331 in NisC coordinate the zinc ion 
and are underlined (Li et al. 2006). 
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The 322 residue PspT protein contains the conserved domain cl09099, signifying it is a 
member of the P-loop NTPase Superfamily. PspT contains the Walker A motif 
(GxxxxGK[S/T], where x is any residue), and the Walker B motif (hhhh[D/E], where h is a 
hydrophobic residue) (Figure 5.3 A). The Walker A motif forms a phosphate-binding loop 
which binds the beta-gamma phosphate moiety of ATP while the Walker B motif binds the 
Mg2+ cation. In addition, three other conserved motifs are present in PspT. The H-
loop/switch region contains a highly conserved histidine residue that is also important in 
the interaction of the ABC domain with ATP (Figure 5.3 A). The ABC transporter signature 
is a motif (also known as the LSGGQ motif) that is specific to the ABC transporter family 
(Figure 5.3 A). The Q-loop/lid, located between Walker A and the signature, consists of a 
glutamine residue residing in a flexible loop (Figure 5.3 A). This is thought to connect the 
NBD to the TMD to couple ATP hydrolysis to the conformational changes of the TMD 
during substrate translocation. Together the Walker A, Walker B, Q-loop and H-loop 
regions form the nucleotide-binding site (Schneider and Hunke 1998). 
 
 
The protein with the most significant alignment to PspT is the MibT ABC transporter ATP-
binding domain from M. corallina (Table 5.1). This protein is proposed to have a role in the 
export of the lantibiotic microbisporicin after biosynthesis (Foulston and Bibb 2010). 
 
Figure 5.3 : Features of the ABC transporter PspTU.  
A; Putative conserved domains detected in PspT (using BLASTP (Altschul et al. 2001)). B; 
Predicted transmembrane helices in PspU (using TMHMM (Krogh et al. 2001)). 
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Another lantibiotic export protein with high similarity to PspT is CinT (44 % across 282 
residues). The CinT protein from S. cinnamoneus is likely to export the lantibiotic 
cinnamycin out of the mycelium (Widdick et al. 2003). A number of other proteins with 
high similarity to PspT are annotated as the ATPase subunit of a daunorubicin resistance 
ABC transporter, DrrA. Daunorubicin was initially isolated from Streptomyces peucetius 
and is a chemotherapeutic of the anthracycline family (Stutzman-Engwall and Hutchinson 
1989). These PspT-like proteins were identified from three different phyla, which included 
a couple of Actinobacteria; S. violaceusniger Tu 4113 (42 % across 293 residues) and 
Thermobispora bispora DSM 43833 (43 % across 303 residues). In addition there was a 
thermophillic anaerobe able to produce hydrogen as a waste product from carbon 
monoxide and water, the Firmicute Carboxydothermus hydrogenoformans Z-2901 (38 % 
across 301 residues), and a couple of members from the Chloroflexi phylum; a 
thermophillic, green non-sulfur bacterium Thermomicrobium roseum DSM 5159 (40 % 
across 299 residues), and a mesophilic, anaerobic bacterium Dehalogenimonas 
lykanthroporepellens BL-DC-9 (39 % across 298 resides). The only protein with a different 
annotated function amongst the eight proteins with most significant similarity to PspT was 
a protein from Streptomyces sviceus ATCC 29083 (40 % identity across 298 residues). 
This protein was annotated as the nodulation ABC transporter NodI, which in nitrogen-
fixing root nodule bacteria works with NodJ to export a variety of modified carbohydrate 
molecules as signals to plant hosts to establish root nodules. 
The TMD consists of alpha helices embedded in the membrane bilayer. Most TMDs 
consist of a total of 12 α-helices with six α-helices per monomer to form a 
transmembrane-spanning permease component which functions to recognise substrates 
and undergo conformational changes to enable transport across the membrane (Young 
and Holland 1999). Using the TMHMM Server v. 2.0, the 265 amino acid protein PspU 
was predicted to contain six transmembrane (TM) helices (Figure 5.3 B) (Krogh et al. 
2001). The best alignment of PspU was to MibU, the ABC-type multidrug transport system 
permease component from M. corallina (Table 5.1). Other hits included ABC transporter 
proteins from a number of actinomycetes; T. bispora DSM 43833, Thermomonospora 
curvata DSM 43183 (in the same suborder, Streptosporangineae, as Planomonospora), 
Acidimicrobium ferrooxidans DSM 10331 and Sphaerobacter thermophilus DSM 20745 
(although in 2004 Sphaerobacter was reclassified to the class Thermomicrobia in the 
phylum Chloroflexi (Hugenholtz and Stackebrandt 2004)). In addition, three of the top 
eight hits are annotated as the membrane protein of the daunorubicin resistance ABC 
transporter, DrrB.  Notably the CinH protein from S. cinnamoneus also had a significant 
alignment to PspU (34 % over 235 residues). 
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On the basis of the observed similarity to ABC transporters involved in the export of 
secondary metabolites, PspTU is proposed to function as the exporter responsible for the 
efflux of planosporicin out of P. alba mycelium after biosynthesis. Like CinTH and MibTU, 
PspTU is proposed to function as a tetramer of two dimers. As with both CinH and MibU, 
no putative peptidase domain was identified in PspU. This supports the idea that two 
classes of lantibiotic exporters exist, as discussed in Chapter 1. The division lies not with 
the classification of the lantibiotic, but rather is a reflection of the phylum of the producing 
organsims. All known lantibiotic gene clusters characterised so far from the actinomycete 
phylum contain exporters in which the NBD and TMD domains are located on separate 
proteins, whereas lantibiotic clusters from low-GC producers use a single protein 
containing both the NBD and TMD domains. Thus PspTU is another example from a high-
GC organism that encodes the two domains on separate proteins. 
 
5.3.4 PspYZ 
As with PspT, the 301 amino acid protein PspZ contains the conserved domain cl09099 
corresponding to the Walker A, Walker B, Q-loop and H-loop regions which form the 
nucleotide-binding site (Figure 5.4 A).  
Although no putative conserved domains were detected in PspY, it had a high percentage 
identity with a number of TMD proteins. The TMHMM Server v. 2.0 predicted that the 264 
amino acid protein PspY contained six TM helices (Figure 5.4 B) (Krogh et al. 2001). A 
BLASTP search revealed just 16 proteins with a significant alignment which ranged from 
40 % across 245 residues for Tbis_3436 from T. bispora DSM 43833 to 37 % across 140 
residues for Elen_1457 from Eggerthella lenta DSM 2243. When compared with the 
search results using PspZ as query, all 16 hits for PspY also have a neighbouring gene 
that has a significant alignment with PspZ.  A majority of these PspYZ-like proteins are 
encoded by the order Actinomycetales in the Actinobacteria phyla; Tbis_3436 and 3435 
from T. bispora DSM 43833, MibYZ from M. corallina, Sros_1169 and 1168 from 
Streptosporangium roseum DSM 43021, Franean1_3994 and 3995 from Frankia sp. 
EAN1pec, and ZP_06162160 and 06162161 from Actinomyces sp. oral taxon 848 str. 
F0332. Other orders included the Bifidobacteriales with Bbr_1071 and 1072 from 
Bifidobacterium breve UCC2003, and Blon_1404 and 1405 from Bifidobacterium longum 
subsp. infantis ATCC 15697, and the order Coriobacteriales with Elen_1457 and 1458 
from E. lenta DSM 2243 and two genes from Eggerthella sp. 1_3_56FAA. Together these 
account for 10 of the PspY-like proteins. Five of the remaining matches correspond to the 
Chloroflexi Ktedonobacter racemifer, an aerobic and mesophilic bacterium. The final 
PspY-like protein is from an uncultured bacterium division (OP8) from an environmental 
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sample. For eleven of these PspYZ-like proteins, enough genome sequence was 
available to investigate the gene context of these ABC transporters. This is summarised in 
Figure 5.5 and discussed further in Section 5.6.2. 
 
 
This analysis does not enable a conclusion as to the function of PspYZ. The presence of 
similar proteins in gene clusters that also encode putative prepropeptide nearby (M. 
corallina and Actinomyces sp.) implies that PspYZ does play a role in planosporicin 
biosynthesis. The level of similarity between the NBD and TMD domains of PspTU and 
PspYZ differs significantly. While both PspT and PspU bear most similarity to MibTU (63 
% and 61 %, respectively, with all other hits ~40 %), PspZ (NBD) has 59 % identity to 
MibZ while PspY (TMD) has only 39 % (and all other hits have a similar % identity). This 
could reflect a difference in the substrate recognised. While PspU and MibU are proposed 
to recognise similar lantibiotics for export, it could be that PspY and MibY are recognising 
very different substrates. On this basis it can be concluded that all the PspY-like proteins 
shown in Figure 5.5 are transporting different, as yet unknown, substrates. 
 
Figure 5.4 : Features of the ABC transporter PspYZ.  
A; Putative conserved domains detected in PspZ (using BLASTP (Altschul et al. 2001)). 
Areas in blue were omitted from the domain search due to compositional bias. B; 
Predicted transmembrane helices in PspY (using TMHMM (Krogh et al. 2001)). 
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Figure 5.5 : A schematic showing the syntenous arrangement of the proteins bearing 
significant similarity to those encoded by pspX, pspW, pspJ, pspY and pspZ.  
Genes are coloured and labelled according to the respective genes from the psp cluster, 
with the locus tag given below. 
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5.3.5 PspEF 
As seen in both PspT and PspZ, the 249 residue PspF sequence contains the 
characteristic regions which form the nucleotide-binding site of ATP-binding proteins 
(Figure 5.6 A).  Like PspU and PspY, the 268 residue PspE had a high percentage identity 
with a number of ABC transporter permease proteins. The TMHMM Server v. 2.0 
predicted that PspE contained six TM helices (Figure 5.6 B) (Krogh et al. 2001). Thus, like 
PspTU and PspYZ, PspE and PspF are thought to function coordinately as an ABC 
transporter in which PspE is the membrane embedded permease unit and PspF is the 
ATP-binding cassette. 
 
 
In lantibiotic producers, immunity is commonly provided (in part) through an ABC 
transporter with the generic name LanFEG (as described in Chapter 1). The LanF protein 
forms a homodimer of ATP-binding proteins that associate with the LanEG heterodimer 
embedded in the membrane. There is some sequence similarity between PspEF and 
proteins conferring self-protection on other producers of type AI lantibiotics, the highest of 
 
Figure 5.6 : Features of the ABC transporter PspEF.  
A; Putative conserved domains detected in PspF (using BLASTP (Altschul et al. 2001)). 
Areas in blue were omitted from the domain search due to compositional bias. B; Predicted 
transmembrane helices in PspE (using TMHMM (Krogh et al. 2001)). 
  
179 
179 Chapter 5 : The planosporicin biosynthetic gene cluster 
which is 25 % identity over 240 amino acids to SpaE in the subtilin gene cluster of B. 
subtilis. 
Nisin is the best-studied lantibiotic and the immunity mechanism is well understood. The 
nisin biosynthetic gene cluster encodes two immunity mechanisms which both contribute 
to producer immunity. NisFEG exports nisin that has already entered the cytoplasmic 
membrane to reduce the number of cell-attached nisin molecules (Siegers and Entian 
1995). In parallel, the lipoprotein NisI is orientated to the outside of the cytoplasmic 
membrane where it sequesters nisin at the surface of the membrane, thus preventing it 
from binding lipid II and forming pores (Kuipers et al. 1993a). In addition approximately 
half of the NisI produced escapes the lipid modification and is instead secreted into the 
medium where it is likely to play a role in nisin immunity (Koponen et al. 2004). 
In contrast, several lantibiotic immunity systems have been described which lack a 
lipoprotein LanI entirely. Instead the LanFEG ABC transporter alone confers self-
protection on the producing strain. For example S. epidermidis, the producer of epidermin, 
uses the ABC transporter EpiFEG to confer immunity (Peschel and Gotz 1996). Likewise 
MrsFEG is the only requirement for self-resistance to mersacidin (Guder et al. 2002). 
However the lantibiotic producer to which PspEF has highest similarity is MibEF from M. 
corallina (Table 5.1). MibEF is an ABC transporter proposed to confer self-protection to 
microbisporicin (Foulston and Bibb 2010). In this cluster, the LanE functions without a 
LanG to presumably form a homodimeric permease. This is also thought to be the case in 
the lacticin 3147 and the bovicin HJ50 gene clusters in which no lanG genes have been 
identified (Draper et al. 2009; Liu et al. 2009). In accordance with this, the six TM helices 
of PspE are proposed to form a dimeric protease unit with another PspE to traverse the 
membrane 12 times in total.  
Sequence alignments reveal that in contrast to the Q loop, LanF proteins contain the E 
loop, where instead of a glutamine residue, a glutamic acid residue is present (Figure 5.7). 
The E loop in the NukF protein was found to play a significant role in resistance to nukacin 
ISK-1 in Staphylococcus warneri ISK-1. The amino acid replacements E85Q and E85A in 
the E loop were found to impair the level of immunity and transport activity whilst 
maintaining ATPase activity at WT levels (Okuda et al. 2010). The reciprocal experiment 
in the daunorubicin transporter of Streptomyces peuciticus, DrrA, revealed that the amino 
acid replacement Q88E reduced transport activity (Rao and Kaur 2008). Thus it would 
appear that LanF and DrrA form two separate groups of ABC transporters. Indeed in the 
alignment in Figure 5.6, PspF is more similar to NukF and other LanF proteins, all of 
which display a conserved E-loop (in purple), while PspT and PspZ are more similar to 
DrrA, LanT and LanZ proteins with a conserved Q-loop (in orange). 
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Figure 5.7 : Sequence alignment of the three ATP-binding proteins in the planosporicin 
cluster (PspF, PspZ, PspT) with ten highly similar ATP-binding proteins.  
Four are from high-GC lantibiotic clusters; MibF, MibZ, MibT (microbisporicin) and CinT 
(cinnamycin). Five are from low-GC lantibiotic clusters SpaF (subtilin), EpiF (epidermin), 
NisF (nisin), NukF (nukacin ISK-1) and MutF (mutacin III). The last is DrrA, the 
daunorubicin export ATP-binding protein from Streptomyces peuciticus. The alignment 
was constructed using ClustalW2 and is truncated at the C-terminus (Chenna et al. 2003)). 
Common motifs are highlighted, namely the Walker A and Walker B motifs (red), E/Q loop 
(purple/orange), Signature motif (blue), and H loop (green) (Okuda et al., 2010). 
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On the basis of the observed similarity of PspEF to ABC transporters involved in lantibiotic 
immunity, PspEF is proposed to function as the mechanism of immunity by diminishing 
the concentration of planosporicin molecules near the lipid II target by actively transporting 
them away from the membrane. 
 
5.4 Regulatory proteins 
5.4.1 PspX 
Sigma factors are key regulators of bacterial transcription, able to recruit the RNA 
polymerase core enzyme to relevant promoter sequences. Over twenty years ago, a new 
sigma factor was purified from E. coli RNA polymerase and named σE or σ24 (Erickson 
and Gross 1989). The subsequent discovery of homologues in other bacteria including the 
σE of S. coelicolor revealed that these sigma factors form a distinctive subfamily within the 
σ70 family (Lonetto et al. 1994). These sigma factors were found to be involved in the 
response to cell envelope or oxidative stress as well as the regulation of iron uptake, 
development and virulence, so were named the extracytoplasmic function (ECF) sigma 
factors (Missiakas and Raina 1998). Members of the σ70 family have four regions that are 
generally conserved, of which ECF sigma factors share similarity across three. Region 1 
ensures that the sigma factor will only bind the promoter when it is complexed with core 
RNA polymerase, but is only found in some ECF sigma factors (Lonetto et al. 1994). pspX 
encodes a 185 amino acid protein containing the conserved domain pfam04542, part of 
the cl08419 superfamily. Pfam04542 corresponds to the most conserved region of the σ70 
class, region 2. This contains the primary core RNA polymerase binding determinant 
(region 2.1), which interacts with the clamp domain of beta prime, the largest polymerase 
subunit (Malhotra et al. 1996). Region 2.3 includes four aromatic residues involved in 
promoter melting, while region 2.4 contains the -10 sequence recognition determinants 
(Lonetto et al. 1994). Region 3 is not present in ECF sigma factors, with the consequence 
that these proteins are often shorter than others in the σ70 family (Lonetto et al. 1994). 
Region 4 contains a helix-turn-helix DNA binding motif that recognises the -35 element of 
promoters (Campbell et al. 2002). In accordance with this, all sequences with a significant 
alignment to PspX are annotated as RNA polymerase sigma factors of either the σ70 
family or more specifically the σ24/σE extracytoplasmic function (ECF) subfamily. 
The two protein sequences bearing most similarity to PspX are ECF sigma factors MibX 
from M. corallina (58 % identity end-to-end) and Tbis_3432 from T. bispora DSM 43833 
(56 % identity end-to-end) (Table 5.1). Five further proteins from actinomycetes make up 
the top seven sequences with most similarity to PspX. These are ECF sigma factors 
Franean1_3991 from Frankia sp. EAN1pec (52 % over 163 residues), Sros_1172 from S. 
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roseum DSM 43021 (49 % over 168 residues), ZP_06162157.1 from Actinomyces sp. oral 
taxon 848 str. F0332 (43 % over 176 residues), Blon_1401 from B. longum subsp. infantis 
ATCC 15697 (42 % over 170 residues) and Bbr_1068 from B. breve UCC2003 (40 % over 
170 residues). Slightly less conserved was Elen_1454 from E. lenta DSM 2243 (42 % 
over 161 residues) and CAI_78578 from an uncultured candidate division OP8 bacterium 
(34 % over 183 residues). All nine of these PspX-like proteins are encoded in gene 
clusters containing minimally lanXWJYZ (Figure 5.5). 
A couple of years ago, Hidden-Markov Model analysis grouped 1735 ECF proteins into 43 
major phylogenetically distinct groups on the basis of sequence similarity (Staron et al. 
2009). The associated web tool, ECFfinder, was used to classify PspX into one of the 
groups. The best match had a score of 184.1 to group ECF01, a group of RpoE-like ECF 
sigma factors from nine different phyla. In contrast, it had previously been noted that 
group ECF33 contained three sigma factors with sequence similarity to MibX (Foulston 
2010). These three proteins also shared a significant percentage identity with PspX. 
These were BBta_3011 from Bradyrhizobium sp. BTAi1 (37 % over 184 residues), 
M115118 from Mesorhizobium loti MAFF303099 (38 % over 174 residues) and 
Rpal_2022 from Rhodopseudomonas palustris TIE-1 (35 % across 175 residues). 
 
5.4.2 PspW 
Very few sequences in the current NCBI database produce a significant alignment with 
the 314 residue protein PspW. The two most similar sequences are the hypothetical 
protein Tbis_3433 from T. bispora DSM 43833 (43 % over 201 residues) and putative 
anti-sigma factor MibW from M. corallina (38 % over 201 residues) (Table 5.1). Of the total 
of nine hits, four more are of particular interest. These are the hypothetical proteins 
Sros_1171 from S. roseum DSM 43021 (31 % over 210 residues), Krac_2613 and 
Krac_2809 from Ktedonobacter racemifer DSM 44963 (30 % over 142 residues and 21 % 
over 156 residues, respectively) and CAI78580 from uncultured candidate division OP8 
bacterium (26 % over 170 residues). In all six cases the PspW-like protein is encoded 
downstream of a gene previously identified to encode a PspX-like protein (Figure 5.5). 
Subsequently, these PspW-like proteins were also used as a query in a BLASTP search 
against the NCBI database to reveal more PspW-like proteins. Sros_1171 from S. roseum 
DSM 43021, ZP_06162158 from Actinomyces sp. oral taxon 848 and Franean1_3992 
from Frankia sp. EAN1pec were shown to have significant similarity to MibW. Proteins 
sharing a high percentage identity to ZP_06162159 from Actinomyces sp. oral taxon 848 
include E. lenta DSM 2243 Elen_1456, B. breve UCC2003 Bbr_1070 and B. longum 
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subsp. infantis ATCC 15697 Blon_1403. These results have been incorporated into the 
schematic in Figure 5.5. 
The location of pspW within the psp cluster gives a clue as to its possible function. pspW 
appears translationally coupled to the ECF sigma factor pspX. It has been noted that both 
groups linked to PspX, ECF01 and ECF33, contain characteristic membrane-anchored 
anti-σ factors (Staron et al. 2009). In accordance with this, TMHMM v.2 was used to 
predict the number of TM helices in each of these proteins (Krogh et al. 2001). PspW, 
Sros_1171, Krac_2613 and CAI78580.1 were predicted to have five TM helices, whereas 
Tbis_3433, MibW, Krac_2809, ZP_06162158 and Franean1_3992 were all predicted to 
have six (Figure 5.8). All nine proteins had at least 60 amino acids at the N-terminus that 
did not form part of a helix. The C-terminus of all nine proteins is cytoplasmic (22 residues 
in PspW) and could serve to bind the cognate sigma factor encoded by the neighbouring 
gene, sequestering it away from the RNA polymerase sigma factor. The proteins with six 
TM helices also have a cytoplasmic N-terminus, whereas those with only five TM helices 
have an extracellular N-terminus. However this interpretation relies on all TM helices 
being predicted successfully. The six TM helices of MibW are predicted to occur within the 
region from 74-244 residues, which coincides with the region showing significant similarity 
to PspW, implying PspW may instead form six TM helices. A comparison of 17 programs 
that can identify transmembrane regions concluded that TMHMM v2.0 was the most 
effective (Moller et al. 2001). However many other programs are available. The preferred 
model from TMpred predicted six TM helices in PspW with a cytoplasmic N-terminus 
(Hofmann and Stoffel 1993). Five helices were the same as predicted by TMHMM, but an 
additional helix was also predicted between residues 106 to 133 with the consequence 
that the N-terminus becomes cytoplasmic. Therefore it is more likely that the longer 
cytoplasmic N-termini serve to sequester the cognate sigma factor, but in any case it is 
likely that the sigma factor binding domain will be positioned at the same location in all 
PspW-like anti-sigma factors. 
An alignment of all nine amino acid sequences did not indicate any conserved motifs that 
could be involved in interacting with the ECF sigma factors. The anti-sigma factor domain 
(ASD) was initially identified in the N-terminus of Rhodobacter sphaerorides ChrR and E. 
coli RseA (Campbell et al. 2007). The ASD consensus represents a structural fold 
conserved in an estimated 33 % of anti-sigma factors. The ASD is involved in contacting 
the cognate ECF sigma factor in an interaction which is mediated in response to specific 
environmental signals by a C-terminal domain (Campbell et al. 2007). However no such 
motif was identified in PspW-like proteins.  
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Figure 5.8 : A schematic showing the transmembrane helices predicted to occur in PspW 
and eight PspW-like proteins.  
Namely Tbis_3433, MibW, Sros_1171, Krac_2613, Krac_2809, CAI78580.1, 
ZP_06162158 and Franean1_3992. Predictions were made using the full length protein 
sequences submitted to TMHMM (Krogh et al. 2001). Transmembrane helices are 
illustrated in red, cytoplasmic loops in blue and external loops in pink. 
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Although the membrane topology of PspW is not fully defined, it is likely that PspW does 
function to regulate the activity of PspX. The membrane location of PspW means that on 
binding PspX, it could sequester the sigma factor away from its promoter binding sites 
thus preventing transcription initiation. In accordance with characterised systems, an 
extracellular signal (such as cell wall stress) would then be detected either directly by the 
anti-sigma factor or be mediated through an additional protein, allowing the release of the 
sigma factor and expression of the relevant regulon. In group ECF01, which PspX bears 
most similarity to, the best characterised example is σW from B. subtilis (Staron et al. 
2009). σW is regulated by the anti-sigma factor RsiW which is in turn regulated through 
proteolytic degradation (Schobel et al. 2004; Zellmeier et al. 2006). Indeed proteolytic 
degradation is a common mechanism for the release of the sigma factor upon receipt of 
the appropriate signal (Heinrich and Wiegert 2009). Alternatively, a conformational change 
can regulate the binding of the anti-sigma factor to its cognate sigma factor, such as with 
S. coelicolor σR. Here regulation occurs through a conformational change in the anti-
sigma factor, the zinc metalloprotein RsrA, due to a thiol-disulphide redox switch (Paget et 
al. 2001). In addition, PspX activity could be regulated at the level of transcription or by 
the protoeolytic processing of a pro-σ-factor. Examples of both of these mechanisms have 
been characterised in S. coelicolor. Transcription of sigE is regulated by the CseB/CseC 
two-component system (Hutchings et al. 2006). σBldN is synthesised as an inactive pro-σ 
factor which is subject to proteolytic processing to release active BldN (Bibb et al. 2000). 
 
5.4.3 PspR 
The 260 amino acid PspR contains the conserved domain pfam cd06170 (part of the 
superfamily cl10457) between residues 190 to 250. This corresponds to a helix-turn-helix 
motif responsible for DNA binding. Proteins belonging to this group include the LuxR-like 
transcriptional regulators. Within this family, there are both transcriptional activators and 
repressors. In Vibrio fisheri, N-acyl derivatives of homoserine lactone act as signalling 
molecules which bind to the N-terminal domain of LuxR, resulting in dimerisation and 
activation of gene expression through quorum-sensing (Stevens et al. 1994). In contrast, 
in Sinorhizobium meliloti it is phophorylation of the N-terminal domain of FixJ which leads 
to multimerisation and the subsequent transcriptional activation of nitrogen fixation genes 
(Da Re et al. 1999). In PspR, there is an N-terminal domain which may be modified to 
modulate the DNA binding property of the C-terminal LuxR-like DNA binding domain. 
PspR bears most similarity to MibR, the putative DNA-binding protein from M. corallina 
(33 % identity over 205 residues) (Table 5.1). Other proteins with similarity to PspR come 
from a range of organisms. The two-component response regulator YP_075969 from 
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Symbiobacterium thermophilum IAM 14863 shares 38 % identity over 82 residues. S. 
thermophilum depends on microbial commensalism so is currently uncultivable under 
laboratory conditions. The 3.57 Mb genome has been sequenced, revealing a GC content 
of 68.7 %, yet the genome bears most similarity to those in the Firmicutes phylum (Ueda 
et al. 2004). Aside from these two proteins, a majority of other alignments show similarity 
only within the putative helix-turn-helix domain of the protein. Thus PspR is a putative 
transcriptional regulator of the psp gene cluster. 
 
5.5 Unknown proteins 
5.5.1 PspJ 
The PspJ protein has a significant alignment with just six proteins in the current NCBI 
database, all of which are annotated as hypothetical proteins. Four are from high-GC 
actinomycetes, namely Tbis_3437 from T. bispora DSM 43833, MibJ from M. corallina, 
Franean1_3993 from Frankia sp. EAN1pec and Sros_1170 from S. roseum DSM 43021. 
Two further hits are krac_2614 and krac_2810 from K. racemifer DSM 44963 in the 
Chloroflexi phylum. As only five PspJ-like proteins were identified, a Position-Specific 
Iterated BLAST (PSI-BLAST) was used as a variation on BLASTP in which the significant 
alignments are combined into a multiple alignment from which a position-specific score 
matrix is constructed and used to search the database for additional significant 
alignments. This whole process is then iterated as necessary to find other members of the 
same protein family (Altschul et al. 1990). Within three iterations, a hypothetical protein 
CAI78582.1 from uncultured candidate division OP8 bacterium (22 % over 125 residues) 
and a hypothetical protein Blon_1403 B. longum subsp. infantis ATCC 15697 (24 % over 
194 residues) were also identified as part of the PspJ family. In addition, candidate PspJ 
proteins from other clusters subject to BLASTP searches against the NCBI database 
revealed similarity to other putative PspJ proteins. These were identified in Actinomyces 
sp. oral taxon 848 str. F0332, B. breve UCC2003, E. lenta DSM 2243 and Eggerthella sp. 
1_3_56FAA. Figure 5.5 depicts the arrangement of these pspJ-like genes in species in 
which enough genome sequence is available to investigate the flanking regions. In nearly 
all cases the lanJ is adjacent to lanY in a cluster similar to pspXWJYZ. A schematic for the 
cluster in Eggerthella sp. is not shown. At the time of writing the cluster is spread over two 
contigs. Contig1.16 contains lanJYZ on the right hand border while Contig1.17 contains 
lanX on the left hand border so it is likely that a lanW occurs in between the two contigs. 
Although BLASTP did not reveal any conserved domains, the server TMHMM predicted 
that PspJ contains four TM helices (Krogh et al. 2001). The same prediction was made for 
MibJ, which is proposed to reside as a membrane protein (Foulston and Bibb 2010). Other 
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PspJ-like proteins have varying numbers of predicted TM helices; Franean1_3993 and 
Sros_1170 are both predicted to form five TM helices, but Tbis_3437, Bbr_1070, 
ZP_06162159, Blon_1403 and Elen_1456 are all predicted to form six TM helices (Figure 
5.9 A). While the number of helices varies, all proteins are predicted to contain a loop of 
approximately 20 residues in the second quarter of the protein. For PspJ this loop is 
predicted to be extracellular, however for all other PspJ-like proteins it is predicted to be 
cytoplasmic. An alignment of all nine proteins does not reveal a distinct motif, however L. 
Foulston observed the loop included a number of conserved charged and polar residues 
(aspartate, glutamate, glutamine, threonine and arginine) indicating that they could form a 
catalytic site or be involved in protein-protein interaction (Figure 5.9 B) (Foulston 2010). 
However, TMpred identified six possible TM helices in PspJ (Hofmann and Stoffel 1993). 
Five were identical to those predicted by TMHMM but there was an additional helix 
between residues 46 to 65. If PspJ is a six TM helix protein, then it will have a cytoplasmic 
loop between residues 65 to 87 like the other PspJ-like proteins. 
The striking syntenous conservation of lanX, lanW, lanY, lanZ and lanJ in a wide range of 
actinomycete genomes, primarily from the orders Actinomycetales, Bifidobacteriales and 
Coriobacteriales, implies that these proteins function together in a common role. LanX is 
known to function as a sigma factor with LanW as its cognate anti-sigma factor (as 
described in Section 5.4). It is plausible that LanJ also functions in the mechanism of ECF 
factor regulation. 
 
5.5.2 PspQ 
pspQ encodes a 213 residue protein with highest percent identity to Tbis_3434 of T. 
bispora DSM 43833 (56 % over 129 residues) and MibQ of M. corallina (62 % over 103 
residues) (Table 5.1). Other sequences producing significant alignments included 
Bbr_1073 of B. breve UCC2003 (35 % over 119 residues), Blon_1406 of B. longum 
subsp. infantis ATCC 15697 (40 % over 75 residues) and ZP_06162162.1 Actinomyces 
sp. oral taxon 848 str. F0332 38/110 (35 % over 110 residues). Thus in Figure 5.5 half of 
the clusters encode a PspQ-like protein in addition to pspXWJYZ. Out of the many 
proteins identified in BLASTP to have a significant alignment with PspQ, several were 
annotated as lipoproteins. 
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Figure 5.9 : Features of PspJ-like proteins.  
A; Predicted transmembrane helices in PspJ-like proteins (using TMHMM (Krogh et al. 
2001)). Proteins were predicted to contain either 4 (top; PspJ and MibJ), 5 (middle 
Franean1_3993 and Sros_1170) or 6 (bottom; Tbis_3437 and ZP_06162159) TM helices. 
B; Sequence alignment (constructed using ClustalW2 (Chenna et al. 2003)) of the N-
termini of PspJ-like proteins. The loop between residues 60-100 contains a conserved 
glutamate and arginine (in red). 
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Alignment of PspQ with the five PspQ-like proteins revealed a conserved lipobox motif in 
the putative signal peptide (Figure 5.10). Lipoproteins are modified at the N-terminus with 
an N-acyl diacyl glyceryl group (derived from phospholipids), which serves to anchor 
these proteins at the membrane-aqueous interface (Sutcliffe and Harrington 2002; 
Hutchings et al. 2009). Lipoproteins contain a lipobox motif which consists of an invariant 
cysteine residue in the +1 position) that is lipid-modified. The residues in positions -3, -2 
and -1 fall into a consensus sequence of L/V/I, A/S/T/V/I, G/A/S. In addition, the N-
terminal residues commonly contain positively charged residues while the region between 
the N-terminus and the lipobox consists of hydrophobic and uncharged residues. These 
features were used to identify likely lipoproteins using the DOLOP protein database 
(Madan Babu and Sankaran 2002). Figure 5.11 depicts how PspQ was identified as a 
putative lipoprotein by having 3 positively charged residues within the first 14 residues of 
the signal sequence, a hydrophobic stretch of 14 residues, followed by the the lipobox 
LTAC. Tbis_3434 was identified by having 4 positively charged residues within the first 10 
residues of the signal sequence, a hydrophobic stretch of 13 residues, followed by the 
lipobox VSGC. MibQ was identified by having 2 positively charged residues within the first 
8 residues of the signal sequence, a hydrophobic stretch of 12 residues, followed by the 
lipobox LAGC. Bbr_1073, Blon_1406 and ZP_06162162.1* did not meet the criteria for a 
lipoprotein. 
The SignalP 3.0 server was used to predict the likelihood that PspQ-like proteins have a 
signal peptide sequence (Emanuelsson et al. 2007). PspQ, Tbis_3434 and MibQ were all 
predicted to contain signal peptides with a probability ranging from 0.998-1.000, while 
Bbr_1073, Blon_1406 and ZP_06162162.1 were predicted to be non-secreted proteins 
(signal peptide probability <0.08 for all three proteins). The alignment in Figure 5.10 
implies that ZP_06162162 may be annotated incorrectly, as the N-terminus appears 
truncated with the start codon only two bases before the lipobox motif. L. Foulston 
reannotated this ORF to include an additional 36 amino acids at the N-terminus and 
named the resulting protein sequence ZP_06162162* (Foulston 2010). However the 
SignalP server still predicted ZP_06162162* to be a non-secreted protein, with a signal 
peptide probability of just 0.201. 
The LipoP 1.0 server was used to determine if the signal peptides detected above were 
likely to be lipoprotein signal peptides (Juncker et al. 2003). The server uses a Hidden 
Markov Model to report a score for the query sequence that corresponds to lipoprotein 
probability. For MibQ, the best prediction (with a score of 17.6393) is a lipoprotein with a 
cleavage site between amino acid 23 and 24 (LLLAG|CTGGG) as shown in Figure 5.10. 
For Tbis_3434 the best prediction (with a score of 10.4199) predicts cleavage between 
amino acids 30 and 31. But another prediction with a score just 0.65449 lower predicts a 
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signal peptide with cleavage between amino acids 26 and 27 (LLVSG|CAGAG). Although 
a lipoprotein signal peptide was predicted between amino acids 31 and 32 
(LLLTA|CGGSG) in PspQ, the prediction had a score of just 2.87306. In contrast, 
Bbr_1073, Blon_1406 and ZP_06162162* were not predicted to be lipoproteins according 
to the algorithm used in LipoP. 
 
 
So although a multiple sequence alignment revealed a putative lipobox in the N-terminus 
of all six proteins (Figure 5.10), a more thorough investigation into other features 
commonly found in lipoproteins revealed that only PspQ, Tbis_3434 and MibQ are likely to 
be true lipoproteins (Figure 5.11). The C-terminus of PspQ contained the conserved 
domain pfam10709, which is a member of the superfamily cl11305 (Finn et al. 2008). 
Although this family is conserved in bacteria, its function is not known. Thus the role of the 
probable lipoprotein PspQ in planosporicin biosynthesis is unknown. However there is a 
precedent for the presence of a lipoprotein in lantibiotic gene clusters. The nisin and 
 
Figure 5.10 : An alignment of PspQ with five PspQ-like proteins.  
Namely Tbis_3434 (Thermobispora bispora DSM 43833), MibQ (M. corallina), Bbr_1073 
(Bifidobacterium breve UCC2003), Blon_1406 (Bifidobacterium longum subsp. infantis 
ATCC 15697) and ZP_06162162.1 (Actinomyces sp. oral taxon 848 str. F0332). Alignment 
constructed using ClustalW (Chenna et al. 2003) with the conserved lipobox motif L-3-
[A/S/T]-2-[G/A]-1-C+1 illustrated in red (Sutcliffe and Harrington 2002). The cleavage site  
predicted in Tbis_3434, MibQ and PspQ by LipoP is indicated (Juncker et al. 2003). 
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subtilin gene clusters encode the lipoproteins NisI and SpaI, respectively (Figure 5.11). 
These proteins are anchored to the membrane through covalent N-terminal lipidation at 
the conserved cysteine of the lipobox motif after removal of the signal peptide. Once in 
place, they act as a mechanism of immunity by sequestering the respective lantibiotic to 
prevent interaction with lipid II (Qiao et al. 1995; Stein et al. 2003). The striking similarity 
between PspQ and MibQ may reflect the distinctive similarity in the structure of the target 
lantibiotics planosporicin and microbisporicin. In contrast the noted lack of strong 
sequence similarity among other LanI proteins is thought to reflect the different lantibiotic 
structures that each LanI protein must recognise (Kuipers et al. 1993a). It has been 
postulated that MibQ could function as a self-resistance mechanism for M. corallina, 
working independently to MibEF to intercept microbisporicin, preventing interaction with its 
cellular target (Foulston and Bibb 2010). Prominent examples of the function of other 
lipoproteins includes that of CseA, a lipoprotein which negatively regulates the ECF sigma 
factor σE in S. coelicolor (Hutchings et al. 2006). The location of pspQ near pspXW in the 
planosporicin gene cluster and a similar arrangement in the respective gene clusters in M. 
corallina and T. bispora implies that LanQ may instead play a role in the activation of the 
ECF sigma factor LanX. 
 
 
5.5.3 PspV 
PspV is a 438 amino acid protein which bears closest resemblance to two hypothetical 
proteins from the Actinomycetales; MibV from M. corallina and Ndas_4690 from 
Nocardiopsis dassonvillei subsp. dassonvillei DSM 43111 (Table 5.1). In both of these 
 
Figure 5.11 : The tripartite nature of the signal sequence of lipoproteins.  
Three PspQ-like proteins predicted to be lipoproteins (PspQ, Tbis_3434 and MibQ) and 
two characterised lipoproteins from lantibiotic clusters are shown. The individual parts in 
the signal sequence are separated into the positively-charged N-terminus, hydrophobic 
region and lipobox. Charged amino acids in the N-terminus are in red. In all three 
examples 12-14 residues separate the lipobox and the charged residues. The lipobox is in 
blue with the consensus sequence L/V/I, A/S/T/V/I, G/A/S. 
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organisms, the lanV appears to be located within a lantibiotic gene cluster (figure 5.12). 
MibV is encoded within the operon mibABCDTUV containing genes essential for 
microbisporicin biosynthesis, however the function of MibV is unknown (Foulston and Bibb 
2010). Ndas_4690 is encoded in an operon of eight genes that correspond to an as-yet 
uncharacterised lantibiotic gene cluster (Figure 5.12). This operon contains a putative 
prepropeptide Ndas_4696, which contains the motif ‘INLD’, a variation on the FNLD motif 
found in the leader peptides of type AI lantibiotics. However the putative propeptide does 
not have a significant alignment with any characterised lantibiotics, indicating a novel 
structure. Downstream of the prepropeptide gene are genes encoding two typical type AI 
modification enzymes; a lantibiotic dehydratase (Ndas_4694) and a lantibiotic cyclase 
(Ndas_4693), followed by genes encoding an ABC transporter (Ndas_4692), a LuxR-type 
regulator (Ndas_4688) and several other possible lantibiotic modification enzymes (Figure 
5.12). Unlike other ABC transporters from characterised lantibiotic clusters from high-GC 
organisms, Ndas_4692 is a single protein encoding two permease and two ATPase 
domains in an alternating pattern. Both permease domains are predicted to contain six TM 
helices in the TMHMM server v2.0. Three other proteins are annotated as an O-
methyltransferase (Ndas_4691), a cytochrome P450 (Ndas_4689) and a luciferase-like 
monooxygenase (Ndas_4695). There is a precedent for each of these enzymes in 
lantibiotic clusters. In the cyp cluster, cypM encodes an S-adenosyl methionine (SAM)-
dependent methyltransferase presumed to be required for the methylation of the N-
terminal alanine of cypemycin (Claesen and Bibb 2010). Cytochrome p450 enzymes 
typically function as mono-oxygenases, but in the mib cluster, MibO is proposed to be 
responsible for the dihydroxylation of proline (Foulston and Bibb 2010). The 
monooxygenase, GarO, from the act gene cluster of A. garbadinensis is proposed to 
oxidize the sulphur of the C terminal MeLan bridge, forming the sulfoxide residue of 
actagardine (Boakes et al. 2009). 
  
193 
193 Chapter 5 : The planosporicin biosynthetic gene cluster 
 
Along with MibV and Ndas_4690, proteins from three strains of Bacillus amyloliquefaciens 
make up the top five proteins with the most significant alignment to PspV. Further PspV-
like proteins were predominantly from the Streptomyces genus. Namely S. venezuelae, 
Streptomyces ambofaciens, Streptomyces viridochromogenes, Streptomyces roseosporus 
and S. griseus.  These are all annotated as hypothetical proteins with no conserved 
domains, however several are encoded in clusters that include a small hypothetical 
peptide. One of these clusters also contains a typical lantibiotic modification enzyme. S. 
venezuelae contains two proteins with similarity to PspV; SMD01132/Sven_0540 (34 % 
over 196 residues) and SMDO01134/Sven_ 0538 (27 % over 187 residues). These occur 
in an operon along with SMDO01129/Sven_ 0536, a putative 39 residue peptide (Figure 
5.12). The adjacent operon encodes a putative 66 residue peptide (SMDO01139/Sven_ 
0545), along with a putative LanM bifunctional dehydratase/cyclase (SMDO01140/Sven_ 
0546), indicating this to be a type AII or B lantibiotic cluster. This LanM had previously 
 
Figure 5.12 : A schematic showing the context of genes encoding proteins with significant 
similarity to PspV in the genomes listed.  
Genes are coloured and labelled according to the respective genes from the psp cluster, 
with the locus tag given below. Genes labelled according to nomenclature from other 
clusters are D; flavin-dependent decarboxylase, P; serine protease and M; 
dehyratase/cyclase. Genes labelled with numbers are 1; monooxygenase, 2; O-
methyltransferase, 3; cytochrome P450, 4; glycosyltransferase, 5; ‘radical SAM’ protein, 6; 
‘major facilitator’ protein. 
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been identified as a cryptic lantipeptide cluster through bioinformatic analysis of the S. 
venezuelae genome, sequenced by Diversa Corp. (Claesen 2010). Analysis of the LanM 
(SMD01140/Sven_ 0546) revealed the Zinc-binding site residues were conserved, but the 
catalytic His residues were missing. The adjacent LanA (SMD01139/ Sven_ 0545) 
contains a serine and several threonines that may be dehydrated by the LanM. Noteably, 
the LanA contains only one cysteine which is located at the C-terminus so may form an 
AviCys (although there is no LanD homologue) as observed in linaridins, removing the 
need for an active LanM cyclase domain. The function of this LanM has previously been 
investigated through deletion analysis in S. venezuelae and heterologous expression in S. 
lividans. The deleted strain showed no difference in antibacterial activity against M. luteus 
compared to WT S. venezuelae (likely producing chloramphenicol or jadomycin) (Claesen 
2010). Chemical induction with GlcNAc prompted a zone of inhibition from S. lividans 
heterologously expressing cosmid 1-B5 from the S. venezulae cosmid library (insert 
contains the LanM cluster and the PspV-like proteins), however this phenotype was not 
reproducible (Claesen 2010). S. venezuelae microarray data revealed that neither of 
these operons are induced during development or under stress simulated through sub-
inhibitory levels of daptomycin treatment (data not shown). 
The association of PspV-like proteins MibV, Ndas_4690 and Sven_0538/0540 with 
lantibiotic gene clusters suggests they may have a novel role in lantibiotic biosynthesis. 
The fact that both type AI and type AII/ B clusters contain putative lanV genes implies they 
play a generic role perhaps as a scaffold or chaperone to aid the binding of modification 
or processing enzymes to the prepropeptide. 
 
5.5.4 ORF-10 and ORF-11 
The ORF located at position -10 from the prepropeptide pspA encodes a 102 amino acid 
protein. This protein has very little significant similarity to proteins in the current NCBI 
database. Interestingly, two of the only proteins to bear resemblance to the protein 
encoded by orf-10 are annotated as protease Do from Ochrobactrum intermedium LMG 
3301 and Ochrobactrum anthropi ATCC 49188 (32 % and 33 % over 79 residues, 
respectively) (Table 5.1). orf-10 is in a likely operon of two genes. The ORF located at 
position -11 from the prepropeptide pspA encodes a 78 amino acid protein with no 
conserved domains and bears similarity only to hypothetical proteins. 
Protease Do, or DegP, is a periplasmic serine protease required for E. coli survival at high 
temperatures. However, all LanP enzymes demonstrated to cleave the leader peptide to 
release the mature lantibiotic so far share homology with the serine protease subtilisin. 
LanP proteases are encoded by several low-GC lantibiotic gene clusters (e.g. NisP for 
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nisin; EpiP for epidermin) as described in Chapter 1, but so far no actinomycete lantibiotic 
gene cluster is known to contain a separate lanP. It is proposed that a protease encoded 
elsewhere in the genome fulfils the role of removing the leader peptide. This has been 
demonstrated for subtilin, which uses an extracellular serine protease to cleave the leader 
peptide, releasing the mature lantibiotic. In contrast, type AII LanT enzymes contain an 
extra N-terminal peptidase domain suggesting a role in processing of the leader peptide 
concomitant with export. Section 5.4 suggested that the release of the ECF sigma factor 
PspX from the cognate anti-sigma factor PspW could be mediated through proteolysis. If 
so, it is possible that the putative protease ORF-10 together with ORF-11 may encode 
proteins which fulfill these roles. 
 
5.6 Synteny 
Section 5.3, 5.4 and 5.5 identified proteins from the NCBI database that had significant 
similarity to proteins encoded by the planosporicin biosynthetic gene cluster. Many of 
these proteins occurred in similar gene clusters. Most notably, there was remarkable 
similarity to the microbisporicin gene cluster from M. corallina. However the lantibiotic 
biosynthetic enzymes LanB and LanC found in B. clausii KSM-K16 and Actinomyces oral 
taxon 848 also bore a resemblance to those of the psp cluster. This implies that 
planosporicin may be one of several microbisporicin-like lantibiotics forming a distinct 
subfamily in the type AI group. The peptide sequences producing significant alignments to 
the planosporicin prepropeptide, PspA, were discussed in detail in Chapter 3. In brief, 
most similarity was seen with the microbisporicin prepropeptide (MibA) from M. corallina 
(67 % over 46 residues) and the conserved domain protein, actoracin (ZP_06162152.1), 
from Actinomyces sp. oral taxon 848 str. F0332 (55 % over 42 residues) (Table 5.1). The 
third annotated protein with significant similarity was the putative antibiotic protein 
megateracin (BMQ_pBM70151) from B. megaterium QM B1551 (45 % over 47 residues). 
A search of the literature revealed planosporicin-like peptides in B. clausii (clausin) and 
Kineosporia sp. (kineosporiacin). To investigate this further, the context of the genes 
encoding these planosporicin-like prepropeptides was examined in order to determine the 
extent of similarity between the gene clusters. 
 
5.6.1 mib cluster 
Chapter 3 described the similarity between the lantibiotics planosporicin and 
microbisporicin. The annotation of the planosporicin biosynthetic gene cluster revealed it 
bears a striking resemblance to the microbisporicin cluster. Nearly every gene of the psp 
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cluster has a counterpart in the mib cluster (Table 5.1). The similarity extends from a 
sharing a high percentage identity through to a striking level of synteny. This is best 
demonstrated through use of the Artemis Comparison Tool (Figure 5.13). The 
lanABCTUV operon is almost identical in both clusters, with the addition of mibD between 
mibC and mibT. Adjacent to lanA, both clusters contain divergently transcribed lanXW. 
Both clusters also contain the operons lanJYZQ and lanR. However the mib cluster also 
contains a mibO gene between mibZ and mibQ. Additionally there is a reorientation of 
these two operons between the clusters. The immunity genes lanEF have the biggest 
change in location, being downstream of pspR and upstream of mibV. The 20 genes of 
the mib cluster include five not observed in the psp cluster, namely mibD, mibO, mibH, 
mibS and mibN. These genes encode enzymes catalysing post translational modifications 
to the microbipsoricin prepropeptide which are not observed in planosporicin. MibD 
catalyses the incorporation of the AviCys residue at the C-terminus, MibO is a candidate 
for the catalysis of the dihydroxylation of proline and MibHSN are proposed to catalyse the 
chlorination of tryptophan (Foulston and Bibb 2010).  
 
5.6.2 Actinomyces sp. cluster 
Chapter 3 described an as-yet uncharacterised putative lantibiotic from an Actinomyces 
sp. that was named actoracin (Foulston 2010). The genome of Actinomyces oral taxon 
848 strain F0332 was isolated from the human mouth and sequenced as part of the 
human microbiome project. L. Foulston identified the gene cluster corresponding to 
actoracin biosynthesis in nucleotide region 154000-170000 of the genome sequence 
(Figure 5.14) (Foulston 2010). As expected for a lantibiotic cluster, the prepropeptide was 
encoded adjacent to the biosynthetic genes lanB, lanC and lanD (described in Section 
5.3). Additional similarity to the psp and mib clusters was evident through a neighbouring 
cluster containing conserved lanXWJYZ (described in Sections 5.3, 5.4 and 5.5). 
Unusually for a lantibiotic cluster, there is just one ABC transporter, LanYZ. This could 
function to both export the lantibiotic and confer immunity on the producing strain. 
Alternatively this function could be provided through genes encoded elsewhere in the 
genome. If this is not the case, then it may be that the gene cluster encodes a lantipeptide 
without anti-microbial function that may instead act as a signalling molecule. 
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Figure 5.13 : A comparison of the psp and mib clusters using the Artemis Comparison 
Tool (ACT; Sanger).  
The alignment used the insert DNA sequence from pIJ12321 (P. alba) and pIJ12125 (M. 
corallina) with minimum cut-off 40 and maximum cut-off 210 and is cropped to show only 
the biosynthetic gene clusters. The insert DNA sequence from pIJ12125 was kindly 
provided by L. Foulston. 
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5.6.3 Bacillus sp. clusters 
Chapter 3 also identified planosporicin-like prepropeptides in several species of Bacillus. 
B. megaterium QM B1551 encodes a prepropeptide likely to be expressed as a lantibiotic 
termed megateracin. Interestingly, two lanA genes encoding the same 46 amino acid 
peptide (BMQ_pBM70152 and BMQ_pBM70151) are indicated in the current annotation 
of B. megaterium QM B1551 (Figure 5.14). Immediately downstream is a lantibiotic 
dehydratase, an ABC transporter, lantibiotic cyclase and a flavoprotein. The ABC 
transporter BMQ_pBM70149 contains both an ATPase and a permease domain, typical of 
a low-GC Gram-positive LanT. Further downstream are two further ATP-binding 
components of ABC transporters and three hypothetic proteins which TMHMM reveals are 
likely to be the permease component, none of which have significant similarity to the ABC 
transporters of the psp and mib clusters. Other features typical of a low-GC gene cluster 
include a two-component system comprising a DNA-binding response regulator 
(BMQ_pBM70141) and a sensory histidine kinase (BMQ_pBM70140). 
B. clausii has been described as the producing strain of the lantibiotic clausin (Bouhss et 
al. 2009). Although this prepropeptide has not been annotated, the lantibiotic modification 
enzymes downstream have been. The lanBCD operon (ABC_3559-3557) is typical of a 
lantibiotic gene cluster. The LanBC enzymes have a high percentage identity with PspBC 
(as described in Section 5.3). Likewise, all three enzymes are similar to MibBCD (Foulston 
2010). However further downstream this similarity ends. Regulation is likely mediated 
through a two-component histidine kinase-response regulator pair. Thus the B. clausii 
cluster resembles a typical low-GC type AI cluster.  
This theme is continued through two more Bacillus clusters identified due to sharing a 
significant alignment with the enzymes PspB and PspC. Gene clusters found in B. 
mycoides and B. cereus are similar to the psp and mib gene clusters only with respect to 
the lantibiotic modification enzymes (Figure 5.14). The method of export, immunity and 
regulation all appear very similar to low-GC Gram-positive type AI clusters. 
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Figure 5.14 : A schematic showing the arrangement of clusters encoding proteins 
identified to have significant similarity to PspABC in the genomes listed.  
Genes are coloured and labelled according to the respective genes from the psp cluster, 
with the locus tag given below. Genes labelled according to nomenclature from other 
clusters are O; cytochrome P450, D; flavin-dependent decarboxylase, P; serine protease 
and K; sensor histidine kinase. 
  
200 
200 Chapter 5 : The planosporicin biosynthetic gene cluster 
5.7 Discussion 
Chapter 3 characterised planosporicin as a type A lantibiotic due to its elongated 
structure. Chapter 4 identified the gene cluster responsible for planosporicin biosynthesis 
and this Chapter completes the annotation and bioinformatic analysis of this cluster. The 
psp cluster contains the modification enzymes pspB and pspC downstream of pspA, and 
so can now be characterised as a member of class I lantibiotics due to the use of two 
individual enzymes to incorporate (Me)Lan bridges instead of one bifunctional lanM. The 
cluster contains three ABC transporters; pspTU, pspYZ and pspEF. All consist of one 
permease component (predicted to contain six TM helices) and are likely to form a 
homodimer in the membrane. The ATPase domains are predicted to form a homodimer 
that interacts with the cytoplasmic interface of the permease dimer. PspF is distinctive in 
containing an E-loop instead of the canonical H-loop seen in PspT and PspZ. The E-loop 
implies that PspEF forms the immunity transporter conferring self-protection on P. alba 
from its own lantibiotic. The location of pspTU downstream of pspC implies this 
transporter functions to export the modified lantibiotic out of the cell. The presence of a 
third ABC transporter, PspYZ, is unusual in lantibiotic clusters and a function is not yet 
known. There are a couple of putative regulatory mechanisms encoded by the cluster. 
pspX encodes a sigma factor and is translationally coupled to its proposed cognate anti-
sigma factor gene pspW. Additionally there is a transcriptional regulator encoded by pspR, 
which may function as an activator or repressor of psp transcription. Unusually for an 
actinomycete lantibiotic cluster, there is a candidate protease encoded by orf-10 which 
may be responsible for cleavage of the leader peptide to release the mature lantibiotic. 
orf-11 appears to be located in the same operon, but its function is unknown. Three 
further genes within the psp cluster also have as-yet unknown functions. PspV aligns only 
to hypothetical proteins, PspJ is likely to be a membrane protein and PspQ is a putative 
lipoprotein. 
This Chapter detailed the annotation of the planosporicin biosynthetic gene cluster on the 
basis of percent identity to known lantibiotic biosynthetic genes. Overall, the planosporicin 
gene cluster is most similar to the cluster for microbisporicin, both of which originate from 
genera in the same family, Streptosporangiaceae. However the six genes, pspXWJYZQ, 
also bear a resemblance to several smaller clusters in the order Actinomycetales; 
Thermobispora, Streptosporangium, Frankia and Actinomyces. Two other orders also 
contain clusters that encode proteins with a significant alignment; Bifidobacteriales 
(Bifidobacterium) and Coriobacteriales (Eggerthella). Likewise, when looking at clusters 
containing a protein with a high level of similarity to PspV, two more clusters from the 
Actinomycetales were observed, one from the genus Nocardiopsis and another from 
Streptomyces. 
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Percent identity is a factual measurement, whereas homology is a hypothesis supported 
by evidence. The fact that all of these proteins sharing a high percentage of identity occur 
within the same phylum provides some evidence to suggest that they may be 
homologous. However it cannot be proven that the sequence similarity is due to common 
ancestry. It is perhaps more likely that these proteins resulted from horizontal gene 
transfer between two organisms, so should be termed xenologues. The function of 
xenologues tends to be similar although this can depend on how substantial the change in 
context was for the transferred gene.  
The synteny observed between the planosporicin and microbisporicin gene clusters 
implies they may be related through horizontal gene transfer. The propagation of this 
lantibiotic biosynthetic gene cluster is possible due to the selective advantage conferred 
on the new host. Natural selection drives chemical innovation, as subsequent to transfer, 
diversification is common, resulting in a multiplication of the members of that natural 
product family (Fischbach et al. 2008). The differences observed between the psp and 
mib clusters must have occurred reasonably quickly and produced intermediates that 
justified keeping the cluster. The changes observed in the psp and mib clusters occurred 
within individual genes through mutation so that the amino acid percent identity ranges 
from 31 % to 67 % (Table 5.1). More drastic changes to the number of genes resulted in 
those encoding enzymes catalysing additional modifications of microbisporicin such as the 
amino-vinyl cysteine, chlorination of tryptophan and dihydroxylation of proline being 
subsequently deleted by the psp cluster or acquired by the mib cluster. 
When investigating proteins with a significant alignment to the planosporicin 
prepropeptide, the species identified are more diverse. Some are Actinobacteria 
(Microbispora and Actinomyces) while others are Firmicutes (Bacillus). Similarity through 
vertical descent is unlikely, while horizontal transfer is possible. However convergent 
evolution could instead select for a structure which has a particularly effective mode of 
action (Fischbach 2009). 
Although function based on percent identity gives a good indication of likely roles in 
planosporicin biosynthesis, further confirmation is needed through genetic manipulation of 
the cluster. Chapter 6 uses heterologous expression of the psp cluster to define the 
minimal gene set within pIJ12321 for planosporicin biosynthesis. Chapters 7 and 8 
describe numerous genetic knockouts in P. alba with the aim of elucidating the function of 
individual psp genes. 
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5.8 Summary 
PspA is the prepropeptide of planosporicin. 
PspB is a putative lantibiotic dehydratase proposed to dehydrate serine residues to form 
Dha and threonine residues to form Dhb. 
PspC is a putative lantibiotic cyclase proposed to activate the thiol moiety of cysteine 
residues to perform a nucleophilic attack on Dha/Dhb residues in the nascent peptide 
chain to form (Me)Lan bridges. 
PspT (ATPase) and PspU (permease) together form an ABC transporter proposed to be 
responsible for secretion of planosporicin. 
PspY (permease) and PspZ (ATPase) together form an ABC transporter of unknown 
function. 
PspE (permease) and PspF (ATPase) together form an ABC transporter proposed to 
confer immunity to planosporicin on the producer, P. alba. 
PspX is likely to be an ECF σ-factor involved in the regulation of planosporicin expression. 
PspW is translationally coupled to PspX and likely acts as its cognate anti-σ factor. 
PspR is a LuxR-like protein due to a helix-turn-helix domain at the C-terminus so is 
proposed to be involved in regulation of the psp cluster. 
PspJ is a hypothetical protein predicted to contain several transmembrane helices. 
PspQ has a predicted signal peptide sequence containing a lipobox motif LTAC 
corresponding to the conserved motif of lipoproteins. 
PspV is a hypothetical protein with similarity to proteins in clusters containing either 
lanB/C or lanM biosynthetic enzymes. 
pspXWJYZQ encode proteins with most homology to the products of gene clusters with 
the same synteny. Some of these gene clusters also encode lantibiotic biosynthetic 
genes. 
The psp gene cluster bears a striking resemblance to the mib gene cluster of M. corallina 
encoding the related lantibiotic, microbisporicin. 
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Chapter 6 : Heterologous production of 
planosporicin 
 
 
6.1 Introduction  
Chapter 5 provided a detailed bioinformatic analysis of the putative planosporicin 
biosynthetic gene cluster. The next step in the analysis of planosporicin biosynthesis was 
the expression of the psp gene cluster in a heterologous host. The reasons for this were 
two-fold. On a theoretical level, heterologous production would provide demonstrable 
proof that the cloned fragment contained all of the genes required for planosporicin 
production. On a practical level, expression of the psp cluster in a genetically tractable 
host would provide a platform for later deletion analysis. Often the development of efficient 
protocols for the genetic manipulation of a relatively uncharacterised natural producer is 
time consuming and may give unsatisfactory results. Thus the in vivo manipulation of the 
biosynthetic gene cluster in a heterologous host could provide an alternative route to 
determine the function of the constituent genes. 
At the time this work was undertaken, there was no published method for the genetic 
manipulation of the genus Planomonospora. Indeed only three genera of the 
Streptosporangiaceae had been shown to be genetically manipulable, namely 
Nonomuraea (Stinchi et al. 2003), Planobispora (Beltrametti et al. 2006) and Microbispora 
(Foulston and Bibb 2010). 
In contrast the genus Streptomyces is well studied and several species are widely used 
laboratory strains that are easy to manipulate genetically. Furthermore, there are several 
examples of the successful expression of secondary metabolite biosynthetic gene clusters 
from non-streptomycete actinomycetes heterologously in Streptomyces. For example, the 
capreomycin NRPS gene cluster from Saccharohrix mutabilis subsp. capreolus was 
integrated into the chromosome of S. lividans yielding of 50 mg/ml capreomycin without 
modifying the regulation of the cluster (Felnagle et al. 2007). 
Moreover, there were four examples of the expression of high-GC lantibiotic pathways in 
heterologous hosts at the time when this work was attempted. Three moved a gene 
cluster between different Streptomyces species. Transfer of the cinnamycin cluster from 
S. cinnamoneus cinnamoneus DSM 40005 to S. lividans resulted in heterologous 
production of cinnamycin (Widdick et al. 2003). Transfer of the cypemycin lantipeptide 
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gene cluster from Streptomyces sp. OH-4156 to S. venezuelae and S. coelicolor M1146 
resulted in heterologous production of cypemycin (Claesen and Bibb 2010). And transfer 
of the grisemycin lantipeptide gene cluster from Streptomyces griseus to S. coelicolor 
M1146 resulted in heterologous production of grisemycin (Claesen and Bibb 2011). 
There was also one example where a high-GC lantibiotic gene cluster had been 
expressed in a different genus. The actagardine gene cluster was transferred from 
Actinoplanes garbadinensis into S. lividans 1326, resulting in heterologous production of 
actagardine (Boakes et al. 2009). The same approach was used to produce actagardine 
in S. lividans TK24 and S. coelicolor M1146 (Bell 2010). Under the current classification 
system, the genus Actinoplanes is in the family Micromonosporaceae while the genus 
Streptomyces in the Streptomycetaceae (Goodfellow et al. 1990). Thus this latter work set 
a precedent for the successful transfer of a high-GC lantibiotic gene cluster between 
families. This Chapter describes the mobilisation of the planosporicin biosynthetic gene 
cluster into various heterologous hosts and the attempts made to detect production of the 
mature, exported lantibiotic. 
 
6.2 Expression of the planosporicin gene cluster in Streptomyces species 
6.2.1 Mobilisation of cosmids 
pIJ12321 (cosmid B4-1), identified in Chapter 4 and annotated in Chapter 5, appeared to 
contain the entire psp gene cluster. In contrast, pIJ12322 (cosmid F13-1) appeared to lack 
the 3’ 233 bp of the 1317 bp pspV coding sequence at the right hand border of the 
proposed cluster. To assess whether pspV was required for planosporicin production, 
each cosmid was integrated at the phage attachment site (attB) of a heterologous host. 
The stable integration of a construct into the chromosome of the host posed several 
advantages, not least that it obviated the need for continued antibiotic selection, which is 
of obvious benefit when assaying for the production of an antimicrobial compound. 
pIJ10702 (also known as pMJCOS1) is a derivative of the SuperCosI vector used to 
construct the P. alba cosmid library in Chapter 4. In pIJ10702, the kanamycin resistance 
gene (aph) of SuperCosI has been replaced by an oriT-attP-int-aac(3)IV cassette (Yanai 
et al. 2006). This cassette was isolated by digesting pIJ10702 with SspI and recovering 
the 5.2 kb fragment from an agarose gel. The SuperCos backbone of both pIJ12321 and 
pIJ12322 was then PCR-targeted with the SspI fragment from pIJ10702. Double-
crossover recombination replaced the aph gene of the SuperCos backbone with the oriT-
attP-int-aac(3)IV cassette through sequence homology in the regions flanking both the 
resident resistance gene and the incoming cassette. The aac(3)IV gene conferred 
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resistance to apramycin, which allowed selection of the replacement event in E. coli, and 
which could also be used subsequently to select for transfer of the cosmid to 
actinomycete hosts. The oriT is an E. coli origin of transfer that would subsequently allow 
the cosmid to be conjugated into an actinomycete host (Kieser et al. 2000). The 
attachment site (attP) and integrase gene (int) of phage ΦC31 would permit stable 
integration of the cosmids into the chromosome of the heterologous host (Bierman et al. 
1992). The recombination event to generate the targeted pIJ12321 and pIJ12322 
derivatives was carried out in E. coli BW25113 harboring pIJ790 as described in Chapter 
2. Transformation of bacteria with linear DNA is normally prohibited due to the bacterial 
intracellular exonucleases that degrade linear DNA. However, pIJ790 encodes three 
genes (gam, bet and exo) that confer the bacteriophage λ Red recombination functions. 
Exo is an 5′ to 3′ double-strand (ds)DNA-dependent exonuclease. It degrades linear 
dsDNA to leave long, 3’ single strand (ss)DNA overhangs (Court et al. 2002). Bet is a 
ssDNA binding protein that protects the overhangs from single-strand nuclease attack and 
promotes annealing between complementary ssDNA targets (Karakousis et al. 1998). 
Gam functions in parallel to inhibit the host nucleases, RecBCD and SbcCD. Thus linear 
dsDNA introduced into the cell is protected form degradation, promoting a greatly 
enhanced rate of recombination (Gust et al. 2003). The constructs were subsequently 
moved into E. coli DH5α to verify the absence of gross rearrangements within the P. alba 
insert DNA via restriction analysis. Targeting of pIJ12321 created pIJ12323 (Figure 6.1), 
while targeting of pIJ12322 yielded pIJ12324. 
Many Streptomyces species, such as S. coelicolor, carry a methyl-specific restriction 
system as a mechanism for the destruction of heterologous DNA. Thus the successful 
introduction of constructs requires prior passaging through the non-methylating E. coli 
ET12567 containing the non-transmissible RP4 derivative pUZ8002 (Gust et al. 2003). 
This enables RP4 tra-mediated mobilisation of the cosmid in trans into Streptomyces by 
intergeneric conjugation. S. lividans does not contain a methyl-sensing restriction system, 
so alternative, more robust E. coli strains harboring pUZ8002 can be used instead as the 
donor strain. However, for simplicity, pIJ12323 and pIJ12324, as well as a pIJ10702 
vector-only control, were introduced into E. coli ET12567/pUZ8002, which was then used 
to conjugate the constructs into both S. lividans TK24 and S. coelicolor M1146. 
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S. lividans has been used successfully as a heterologous host for expression of lantibiotic 
biosynthetic gene clusters from S. cinnamoneus cinnamoneus and A. garbadiensis 
(Widdick et al. 2003; Boakes et al. 2009). S. coelicolor M1146 is a derivative of S. 
coelicolor M145 with four endogenous secondary metabolic gene clusters (those 
responsible for actinorhodin, prodiginine, CPK and CDA biosynthesis) deleted (Gomez-
Escribano and Bibb 2011). With these potentially competitive sinks for carbon and 
nitrogen removed, and with no endogenous antibiotic activity remaining, S. coelicolor 
M1146 is a more effective host for the heterologous expression of secondary metabolic 
gene clusters. This strain has been used to heterologously produce cypemycin from S. sp. 
OH-4156 and the novel lantipeptide grisemycin from S. griseus (Claesen and Bibb 2010; 
Claesen and Bibb 2011). Further derivatives based on S. coelicolor M1146 were 
subsequently constructed through the introduction of point mutations into rpoB and rpsL to 
pleiotropically increase the level of secondary metabolite production (Gomez-Escribano 
and Bibb 2011). S. coelicolor M1154 contains the additional mutations rpoB[C1298T] and 
rpsL[A262G]; however, this strain was not available at the time of this work. 
Exconjugants were selected using apramycin resistance conferred by the aac(3)IV gene 
introduced into the backbone of SuperCosI by PCR-targeting (see above). Four 
exconjugants from each mating were streaked three times on selective medium for clone 
 
Figure 6.1 : Construct pIJ12323; pIJ12321 (cosmid B4-1) with the backbone targeted with 
the oriT-attP-int-aac(3)IV cassette  from pIJ10702.  
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purification. Genomic DNA was prepared from one exconjugant from each mating. S. 
lividans TK24 clones containing the empty vector pIJ10702, pIJ12323 and pIJ12324 were 
assigned strain numbers M1446, M1286 and M1287, respectively (Table 6.1). Likewise, 
S. coelicolor M1146 containing pIJ10702, pIJ12323 and pIJ12324 were assigned strain 
numbers M1410, M1288 and M1289, respectively (Table 6.1). PCR analysis using primers 
annealing within the psp gene cluster confirmed the successful introduction of pIJ12323 
and pIJ12324 into S. lividans TK24 (creating M1286 and M1287) and S. coelicolor M1146 
(creating M1288 and M1289) (Figure 6.2).  
 
 
6.2.2 Bioassays and MALDI-ToF analysis 
pIJ10706, pIJ12323 and pIJ12324 integrated into S. lividans TK24 and S. coelicolor 
M1146 were assessed for the production of antibiotic activity. Four exconjugants from 
each conjugation were grown as 1 x 1 cm patches on a range of agar media. After 5 days 
incubation, each plate was overlaid with the target organism, M. luteus, as described in 
Chapter 2. However no halo of inhibition was observed (data not shown). The agar media 
used included those that gave apparently high levels of planosporicin production by P. 
alba; ISP4, AF/MS, D/Seed and M8. 
 
Plasmid Description S. lividans TK24 
S. coelicolor 
M1146 
Nonomuraea  
ATCC 39727 
pIJ10702 pMJCosI M1446 M1410 M1294 
pIJ12323 pIJ10702 B4-1 M1286 M1288 M1295 
pIJ12324 pIJ10702 F13-1 M1287 M1289 M1296 
pIJ12325 pIJ10702 4B8 M1290 M1292 M1297 
pIJ12326 pIJ10702 9A7 M1291 M1293 M1298 
pIJ12327 pIJ10702 B4-1 Δorf+7-orf+14 NA NA M1299 
pIJ12328 pIJ10702 B4-1 Δorf+7-orf+14 and Δorf-12-orf-19 NA NA M1300 
pIJ12329 pIJ10702 B4-1 Δorf+7-orf+14 and Δorf-10-orf-19 NA NA M1301 
 
Table 6.1 : Strains made in this Chapter through integration of various plasmids into the 
ΦC31 phage attachment site. 
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Two exconjugants from each conjugation were cultured in liquid media. After 4, 6 and 8 
days of growth, culture supernatants were assayed for bioactivity against M. luteus. No 
halo of inhibition was observed when the strains were cultured in ISP4, AF/MS or D/seed 
liquid media (data not shown). The use of R5 medium prompted the production of 
actinorhodin by the S. lividans strains, affording a small halo of inhibition. However when 
sent for MALDI-ToF analysis, the largest peaks were in the 1500-1600 Da range and were 
also observed in the vector only control. No peaks with masses corresponding to 
planosporicin were produced by Streptomyces strains harbouring the psp gene cluster 
(data not shown). 
The lack of compounds of the expected mass of planosporicin upon MALDI-ToF analysis 
implied that Streptomyces species are not capable of expressing the psp gene cluster. 
There are many potential explanations for this lack of expression, providing a multitude of 
avenues to pursue, however time restrictions prevented further investigation (discussed in 
Section 6.6). Instead the remainder of this Chapter focused on finding a host where the 
cluster was expressed. 
  
 
Figure 6.2 : PCR confirmation of the integration of Planomonospora cosmids pIJ12323, 
pIJ12324, pIJ12325 and pIJ12326 in S. coelicolor M1146 and S. lividans TK24.  
Genomic DNAs extracted from S. coelicolor M1410, M1288, M1289, M1292 and M1293 
and from S. lividans M1446, M1286, M1287, M1290 and M1291 were used as templates to 
amplify pspA (1289FlanA and 1289RlanA; 230 bp) and pspB (3088F and 3088R; 303 bp) 
from the psp gene cluster. pIJ12321 cosmid DNA was used as a positive control. PCR 
products were run on a 1 % agarose gel by electrophoresis. The ladder is Hyperladder I 
(Bioline) with band sizes annotated in bp.  
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6.3 Expression of the planosporicin gene cluster in Nonomuraea 
6.3.1 Mobilisation of cosmids 
Subsequently, an alternative heterologous host was sought. The Streptomyces genus is 
only distantly related to Planomonospora, whereas Nonomuraea is located with 
Planomonospora in the family Streptosporangiaceae. Although not as genetically tractable 
as Streptomyces, several tools are now available for the genetic manipulation of 
Nonomuraea species. Nonomuraea ATCC 39727 produces A40926, the precursor of the 
glycopeptide dalbavancin. The dbv gene cluster, responsible for A40926 biosynthesis, 
was isolated and characterised from Nonomuraea ATCC 39727 (Sosio et al. 2003). The 
first instance of genetic manipulation of Nonomuraea sp. ATCC 39727 was the generation 
of a deletion mutation in the dbv gene cluster (Sosio et al. 2003; Stinchi et al. 2003). More 
recently, methods for introducing larger constructs into Nonomuraea through conjugation 
with E. coli were reported. This enabled the specific deletion of genes within the A40926 
gene cluster (Marcone et al. 2010a). Most recently, the mib gene cluster was integrated 
into the Nonomuraea chromosome, resulting in the heterologous production of 
microbisporicin (Foulston and Bibb 2010). Thus Nonomuraea appeared to be a good 
candidate for the heterologous expression of the psp gene cluster.  
pIJ10702, pIJ12323 and pIJ12324 (described in Section 6.2.1) were integrated into the 
chromosome of Nonomuraea sp. ATCC 39727 through selection for resistance to 
apramycin (although there is no experimental evidence that this integration was site-
specific). The protocol was based on that used for conjugation into Streptomyces. 
However, as Nonomuraea does not sporulate under lab conditions, cosmids were 
transferred directly into freshly harvested mycelium as described previously (Foulston and 
Bibb 2010; Marcone et al. 2010c). Putative exconjugants were streaked at least three 
times on V0.1 agar medium with nalidixic acid and apramycin selection. Although common 
practise when conjugating into spores, this is especially important when conjugating into 
mycelial fragments. It is possible that within a mycelial compartment that contains multiple 
genomes, the presence of the integrated resistance gene in just one chromosome may 
provide sufficient resistance to enable the survival of non-targeted genomes, resulting in a 
mixed population. Thus successive rounds of growth on selective agar medium are 
necessary to remove non-targeted nucleoids, leaving a genetically homogenous strain.  
The efficiency of conjugating cosmids into Nonomuraea was very low. In total, two 
exconjugants with integrated pIJ12323 and just one exconjugant with integrated pIJ12324 
were identified. These were grown under selection in liquid culture from which genomic 
DNA was purified to be used as a template in PCR analysis. Fragments corresponding to 
pspA and pspE were amplified from all three exconjugants to confirm the presence of the 
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planosporicin biosynthetic gene cluster (Figure 6.3). In addition, amplification of dbv5 from 
the A40926 gene cluster confirmed the host as Nonomuraea (Figure 6.3). Nonomuraea 
with integrated pIJ10702 was assigned strain M1294, while Nonomuraea with integrated 
pIJ12323 was assigned strain M1295, and Nonomuraea with integrated pIJ12324 was 
assigned strain M1296 (Table 6.1). 
 
6.3.2 Bioassay and MALDI-ToF analysis 
6.3.2.1 Nonomuraea M1295  
Nonomuraea M1294 (harbouring the vector only control pIJ10702) and Nonomuraea 
M1295 (harbouring pIJ12323) were assessed for the production of a compound with 
antibiotic activity. Nonomuraea is not an ideal host for the production of heterologous 
antibacterial compounds since it produces the glycopeptide antibiotic A40926. Thus 
bioassays of Nonomuraea exconjugants grown on agar medium would likely be futile 
since even the vector only control would produce a halo of inhibition, although it is 
conceivable that a larger zone of inhibition could be indicative of expression of a 
heterologous gene cluster.  
 
Figure 6.3 : PCR confirmation of the integration of Planomonospora cosmids pIJ12323 
and pIJ12324 in Nonomuraea ATCC 39727.  
Genomic DNAs extracted from Nonomuraea M1295 and M1296 were used as templates to 
amplify pspA (1289FlanA and 1289RlanA; 230 bp) and pspE (FlanEF and RlanEF; 221 bp) 
from the psp gene cluster and dbv5 from the A40926 gene cluster (Dbv5F and Dbv5R; 375 
bp). Genomic DNA from Nonomuraea M1294, which contains the empty pIJ10702 vector, 
was used as a negative control. pIJ12321 cosmid DNA was used as a positive control. 
PCR products were run on a 1 % agarose gel by electrophoresis. The ladder is 
Hyperladder I (Bioline) with band sizes annotated in bp. 
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Consequently the strains were cultured in liquid medium, and culture supernatants 
assayed for bioactivity against M. luteus and sent for MALDI-ToF analysis to confirm 
planosporicin production. It was anticipated that VSP medium, which proved effective for 
growth of Nonomuraea, would also support planosporicin production. Moreover, 
expression of the mib gene cluster of Microbispora corallina in the same strain of 
Nonomuraea had been achieved in this medium (Foulston and Bibb 2010). However, 
initial results were disappointing. While the majority of culture supernatants produced 
halos of inhibition of M. luteus potentially attributable to A40926, MALDI-ToF analysis 
failed to reveal peaks with masses corresponding to planosporicin (data not shown).  
Subsequently, additional media were assessed for their ability to support planosporicin 
production in Nonomuraea. It was assumed that as a member of the 
Streptosporangiaceae, Nonomuraea would grow best in media optimised for genera 
within this family. Six such media were tested; ISP4, AF/MS, D/Seed, M8, medium 266 
(YS) and Streptosporangium medium (SM). A compound with anti-microbial activity 
(presumably A40926) was observed in supernatants of cultures of Nonomuraea M1294 
(vector only control) grown in AF/MS, D/seed, YS and SM media, producing a small, often 
diffuse halo of growth inhibition of M. luteus (Figure 6.4). A significantly larger halo with a 
more defined boundary was observed with culture supernatants from Nonomuraea M1295 
(containing the psp gene cluster) grown in ISP4 and SM media (Figure 6.4). The lack of 
antimicrobial production by Nonomuraea M1294 in ISP4 media gave a clean background 
for the assessment of planosporicin production (Figure 6.4). However, repeat cultures in 
ISP4 medium often failed to reveal any antibiotic production. Due to these reproducibility 
issues, the best medium for studying the production of planosporicin in Nonomuraea was 
deemed to be SM.  
Both exconjugants of Nonomuraea with integrated pIJ12323 secreted peptides into the 
culture supernatant with masses corresponding to planosporicin. Figure 6.5 demonstrates 
the sharp zone of inhibition observed in Nonomuraea M1295 compared to Nonomuraea 
M1294. MALDI-ToF analysis confirmed that this sharp zone was due to planosporicin 
production (Figure 6.6). This proved beyond reasonable doubt that the cloned DNA insert 
of pIJ12323 (derived from pIJ12321) contained the entire planosporicin biosynthetic gene 
cluster.  
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Figure 6.4 : Heterologous expression of the planosporicin gene cluster integrated into the 
Nonomuraea ATCC 39727 chromosome.  
Nonomuraea M1294 and M1295 were grown in 6 different media; AF/MS, D/seed, ISP4, 
M8, medium 266 (YS) and streptosporangium medium (SM). A positive control of P. alba 
in AF/MS was grown in parallel. Supernatant samples were taken after 6 days of growth 
and tested for antibiotic activity. 40 µl supernatant was applied to antibiotic assay discs 
which were laid onto a lawn of M. luteus. The plate was incubated for 36 hours at 30 °C 
before zones of inhibition were photographed. 
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6.3.2.2 Nonomuraea M1296 
Section 6.3.2.1 demonstrated that the heterologous production of planosporicin by 
Nonomuraea M1295 was most consistent when cultured in SM. This media was originally 
developed to culture novel Nonomuraea species and subsequently used to prompt 
secondary metabolite production from the Streptosporangium genus (Pfefferle et al. 2000; 
Roes and Meyers 2008).  
 
 
Figure 6.5 : Heterologous expression of the planosporicin gene cluster integrated into the 
Nonomuraea ATCC 39727 chromosome.  
A; Nonomuraea M1294, M1295 and M1296 were cultured in SM medium. B; Supernatant 
samples were taken at 4, 5 and 6 days of growth. 40 µl of each culture supernatant were 
applied to antibiotic assay discs which were laid onto a lawn of M. luteus. The plate was 
incubated for 36 hours at 30 °C before zones of inhibition were photographed. 
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Nonomuraea M1296 (lacking part of pspV), Nonomuraea M1294 (vector only control), and 
the positive control strain Nonomuraea M1295 were cultured in parallel in SM media. After 
4, 5 and 6 days, samples of culture supernatant were assessed for the production of 
antibiotic activity. Nonomuraea M1296 supernatants gave a very diffuse halo of M. luteus 
inhibition (Figure 6.5). This bioassay phenotype closely resembles the vector only control. 
MALDI-ToF analysis failed to reveal peptides corresponding to the mass of planosporicin 
(Figure 6.6). A40926 has a molecular mass [M+H]+ of 1731 Da (Sosio et al. 2003). 
However a peak with this mass was not detected, indeed no significant peptide masses in 
the range 700-4000 Da were routinely observed in M1294 supernatants. Thus the diffuse 
halo observed in bioassays with M1294 was likely due to a non-peptide antimicrobial 
produced by Nonomuraea ATCC 39727 in SM media. The lack of a full-length pspV in 
M1296 appears to prevent planosporicin production. MALDI-ToF analysis of supernatant 
samples in a broad spectrum scan did not reveal the presence of early intermediates such 
as the 5484.616 Da theoretical mass of planosporicin with the leader sequence still 
attached. This implies that pspV has an essential role in biosynthesis, at least in a 
heterologous host. However, despite many conjugation attempts, only one exconjugant of 
Nonomuraea M1296 was obtained, so the lack of planosporicin production may be due to 
a problem with this particular isolate. 
 
6.4 Construction of a minimal gene set for planosporicin production 
6.4.1 Creation of constructs 
The likely boundaries of the planosporicin biosynthetic gene cluster within pIJ12321 could 
be inferred from the putative functions of the constituent genes (as discussed in Chapter 
5). Furthermore, the marked synteny of the planosporicin and microbisporicin biosynthetic 
gene cluster provided further clues. To confirm the boundaries of the planosporicin 
biosynthetic gene cluster, potentially nonessential DNA regions were removed from the 
cosmid inserts in an attempt to define the minimal set of genes required for planosporicin 
production. 
The boundary downstream of the cluster was relatively easy to predict based on the 
putative function of proteins assigned from their similarity to other proteins in the NCBI 
database. It is likely that pspV denotes the downstream boundary. Further downstream, 
ORFs are predicted to have a putative role in benzoate metabolism, and thus not to be 
part of the psp cluster. In contrast, the likely upstream boundary was more difficult to 
predict. pspEF are almost certainly part of the cluster due to the high percentage identity 
of their products to the immunity ABC transporters of other lantibiotic clusters. 
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Immediately upstream of pspEF there are two possibly co-transcribed genes, one of which 
may encode a protease function (as described in Chapter 5). Lantibiotic gene clusters 
often encode a protease to cleave the leader peptide, releasing the mature lantibiotic, but 
so far, no lantibiotic gene cluster from an actinomycete has been found to encode such a 
function. Further upstream there is a putative terpenoid biosynthetic cluster. Therefore two 
potential minimal gene sets were made, both with pspV delineating the right-hand border 
and with either pspE or the putative protease gene delineating the left-hand border. 
Sometimes a restriction fragment can be isolated that contains a minimal gene set. For 
example a 12.9 kb SacI fragment from Streptomyces chartreusis conferred tunicamycin 
production on S. coelicolor M1146, delineating the boundaries of the tun gene cluster 
(Wyszynski et al. 2010). Due to the lack of convenient restriction sites to excise the 
putative minimal set of psp genes, an alternative strategy was sought. A similar problem 
was faced when generating the minimal gene set for cypemycin (Claesen and Bibb 2010). 
In this work the flanking regions were targeted as above but the resistance cassette was 
removed through the action of FLP recombinase, leaving unique restriction sites XbaI and 
SspI either side of the cypemycin minimal gene set. These sites were utilised to excise a 
12.2 kb XbaI-SspI fragment that was then ligated into pSET152 and the resulting 
construct conjugated into S. coelicolor M1146. However this method can be problematic, 
as the removal of the resistance cassette by FLP recombinase leaves an 81 bp ‘scar’ 
sequence that is a functional FRT site. This represents a potential target for homologous 
recombination during subsequent targeting with constructs containing FRT sites.  
A variation on this method was first used in this work as described in Chapter 2 and 
outlined in Figure 6.7. Primers with either an XbaI or SpeI recognition site between the 
resistance marker and the 39 bp flanking sequence used for recombination in E. coli were 
used to amplify a resistance cassette. PCR targeting replaced the DNA regions outside of 
the proposed minimal gene set with a resistance cassette flanked by unique restriction 
sites. Subsequently, the resistance cassette was digested out and the minimal gene set 
ligated back together. pIJ12321 was first PCR-targeted to remove genes downstream of 
the cluster, to the right of pspV. This cosmid was targeted a second time using two 
alternative constructs to remove genes upstream of the cluster. All three of these reduced 
gene sets were PCR-targeted to replace the kanamycin resistance gene (aph) in 
SuperCosI with the oriT-attP-int-aac(3)IV cassette (as detailed in Section 6.2.1). Removal 
of all genes downstream of pspV and subsequent introduction of the oriT-attP-int-aac(3)IV 
cassette into the vector backbone created pIJ12327 (Figure 6.8). Removal of all genes 
downstream of pspV and upstream of the putative protease created pIJ12328 (Figure 
6.8). Removal of two further genes upstream of pspE (including the putative lanP) created 
pIJ12329 (Figure 6.8). 
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These three constructs were conjugated into Nonomuraea using the method described in 
Section 6.3.1. Nonomuraea exconjugants were obtained containing pIJ12327, pIJ12328 
or pIJ12329, with each construct integrated into the ΦC31 phage attachment site. 
Genomic DNA was purified from four exconjugants with integrated pIJ12327, five 
exconjugants with pIJ12328 and three exconjugants with pIJ12329. PCR analysis using 
primers annealing within pspA and pspE confirmed the presence of the psp gene cluster 
(Figure 6.9). 
 
 
Figure 6.7 : Strategy for the construction of a minimal psp gene set.  
Schematic displays cosmid insert only (backbone not shown) with orfs as annotated in 
Chapter 4. The DNA insert of pIJ12321 was PCR-targeted to replace all ORFs 
downstream of pspV with a resistance cassette (in red) and unique XbaI restriction sites 
(dashed lines). The resistance gene was removed by XbaI digestion and the resulting 
construct subjected to a second targeting event upstream of pspE or orf-10 with a 
resistance cassette (in red) and unique SpeI restriction sites (dashed lines). The resistance 
gene was subsequently removed through SpeI digestion. In total, three reduced psp 
cosmids were created. 
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Figure 6.8 : Schematic illustrating the reduced psp gene clusters.  
The insert DNA of cosmid pIJ12321 was PCR-targeted to create three reduced versions. 
The SupercosI backbone of each of these constructs was PCR-targeted to introduce an 
integrase (intΦC31), phage attachment site (attP) and origin of transfer (oriT), creating 
pIJ12327, pIJ12328 and pIJ12329. The diagram is not drawn to scale. 
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6.4.2 Bioassay and MALDI-ToF analysis 
To define the right-hand boundary, four exconjugants of Nonomuraea with integrated 
pIJ12327 were tested for the heterologous expression of planosporicin. All four 
exconjugants produced a compound with antibiotic activity that MALDI-ToF revealed to be 
due to planosporicin (data not shown). To define the left-hand boundary, three 
exconjugants of Nonomuraea with integrated pIJ12328 and five exconjugants of 
Nonomuraea with integrated pIJ12329 were grown in SM and samples of supernatant 
were assayed for antibiotic production (Figure 6.10). It is interesting to note that the halo 
size varies between different exconjugants carrying the same integrated construct. This 
 
Figure 6.9 : PCR confirmation of the integration of Planomonospora cosmids pIJ12327, 
pIJ12328 and pIJ12329 in Nonomuraea ATCC 39727.  
Genomic DNAs extracted from Nonomuraea M1299 (integrated pIJ12327), M1300 
(integrated pIJ12328) and M1301 (integrated pIJ12329) were used as templates to amplify 
pspA (1289FlanA and 1289RlanA; 230 bp) and pspE (FlanEF and RlanEF; 221 bp) from 
the psp gene cluster. Genomic DNA from Nonomuraea M1294, which contains the empty 
pIJ10702 vector, was used as a negative control. pIJ12321 cosmid DNA was used as a 
positive control. PCR products were run on a 2 % agarose gel by electrophoresis. The 
ladder is Hyperladder I (Bioline) with band sizes annotated in bp. 
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might reflect the presence of both WT and integrant genomes in the mycelium of the 
Nonomuraea exconjugants. Nonomuraea pIJ12328_5 and Nonomuraea pIJ12329 
exconjugants 1, 3 and 5 gave larger halos of inhibition than the Nonomuraea pIJ10702 
empty vector control (M1294). Of the three Nonomuraea pIJ12328 exconjugants, only 
pIJ12328_5 gave peaks corresponding to planosporicin upon MALDI-ToF analysis, 
whereas all five Nonomuraea pIJ12329 exconjugants produced the lantibiotic (data not 
shown). Nonomuraea pIJ12327_1 was assigned strain M1299, Nonomuraea pIJ12328_5 
was assigned strain M1300 and Nonomuraea pIJ12329_3 was assigned strain M1301 
(Table 6.1). These three strains were used in subsequent assays. 
 
 
Figure 6.10 : Heterologous production of planosporicin from reduced gene sets integrated 
into the Nonomuraea ATCC 39727 chromosome.  
Nonomuraea M1300 clones 1, 4 and 5 and M1301 clones 1 to 5 were cultured in SM 
medium for 6 days. A positive control of Nonomuraea M1295 and a negative control of 
Nonomuraea M1294 were cultured in parallel. Samples of culture supernatants were 
tested for antibiotic activity. 40 µl of supernatant were applied to antibiotic assay discs 
which were laid onto a lawn of M. luteus. The plate was incubated for 36 hours at 30 °C 
before zones of inhibition were photographed. 
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Thus the heterologous expression of pIJ12327, pIJ12328 and pIJ12329 in Nonomuraea 
resulted in planosporicin production. Bioassays with M. luteus revealed antibiotic 
production, while MALDI-ToF analysis confirmed that the compound was planosporicin 
(Figure 6.11 and 6.12). Consequently, the gene encoding a putative protease is not 
required for cleavage of the planosporicin leader peptide in Nonomuraea. The halo 
produced through bioassay with Nonomuraea M1299, M1300 and M1301 was 
comparable in size to that produced by Nonomuraea M1295. Thus the 15 genes from 
pspE to pspV are sufficient for planosporicin production in Nonomuraea, and are 
predicted to constitute a minimal gene set. 
 
 
Figure 6.11 : Heterologous expression of the planosporicin gene cluster integrated into the 
Nonomuraea ATCC 39727 chromosome.  
Nonomuraea M1294, M1295_1, M1299_1, M1300_5 and M1301_3 were cultured in SM 
medium. Supernatant samples were taken after 8 days of growth and tested for antibiotic 
activity. 40 µl of supernatant to were applied to antibiotic assay discs that were laid upon a 
lawn of M. luteus. The plate was incubated for 36 hours at 30°C before zones of inhibition 
were photographed. 
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Figure 6.12 : Heterologous production of planosporicin from reduced gene clusters 
derived from pIJ12321 integrated into the Nonomuraea ATCC 39727 chromosome.  
Nonomuraea M1294, M1295_1, M1299_4, M1300_5 and M1301_3 were cultured in SM 
medium. Supernatant samples were taken after 8 days of growth and analysed by MALDI-
ToF mass spectrometry. Intensity is given on the y-axis in arbitrary units (au) and the 
mass/charge ratio (m/z) on the x-axis. The monoisotopic mass of each m/z peak is 
labelled. 
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6.5 Heterologous expression of P. sp. DSM 14920 cosmids 
6.5.1 Creation of constructs 
As described in Section 4.7 of Chapter 4, the NAICONS consortium constructed a cosmid 
library from P. sp. DSM 14920 genomic DNA which had also been reported to produce 
planosporicin. Four partially overlapping cosmids each containing all or part of the 
planosporicin biosynthetic gene cluster and flanking regions were received from 
NAICONS. Chapter 4 confirmed that pIJ12325 and pIJ12326 contained a number of 
planosporicin biosynthetic genes. 
The vector used by NAICONS to create the cosmid library was a SuperCos1 derivative 
carrying the oriT-attP-int-aac(3)IV cassette. Thus the cosmids were introduced into the 
donor strain E. coli ET12567/pUZ8002 by transformation and mobilised into three different 
hosts; S. lividans TK24, S. coelicolor M1146 and Nonomuraea ATCC 39727 according to 
the method described in Section 6.2.1 and 6.3.1.  
Integration of pIJ12325 and pIJ12326 into S. lividans TK24 created strains M1290 and 
M1291, respectively, while their integration into S. coelicolor M1146 created strains 
M1292 and M1293, respectively (Table 6.1). PCR analyses using gDNAs isolated from 
these strains as templates revealed that the cosmids had integrated into the host’s 
genome (Figure 6.2). Integration of pIJ12325 and pIJ12326 into the ΦC31 phage 
attachment site of Nonomuraea created strains M1297 and M1298 (Table 6.1). One 
exconjugant from each mating was obtained and the amplification of dbv5 from the 
A40926 cluster confirmed these strains as Nonomuraea derivatives. Both pspA and pspE 
were successfully amplified from M1297 and M1298, confirming of the presence of the 
planosporicin biosynthetic gene cluster (Figure 6.13).  
 
6.5.2 Bioassay and MALDI-ToF analysis 
The lack of a complete sequence for the insert DNA of the two cosmids meant it was not 
certain that the entire biosynthetic gene cluster was present on either construct. 
Planosporicin production was not detected from S. lividans M1290 or M1291, nor from S. 
coelicolor M1292 or M1293 when cultured in liquid AF/MS and R5 media. No antibiotic 
compounds were detected by bioassay and no compounds corresponding to 
planosporicin were detected in MALDI-ToF (data not shown).  
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Prior success with the heterologous expression of the psp gene cluster from P. alba in 
Nonomuraea made this host the main candidate for expression of the cluster from P. sp. 
DSM 14920. Both Nonomuraea M1297 and M1298 produced planosporicin. Bioassay with 
M. luteus revealed antibiotic activity, and MALDI-ToF analysis identified a compound with 
a mass of 2192 Da, the mass of planosporicin (Figure 6.14 and 6.15).  
Culture supernatants from Nonomuraea M1297 and M1298 carrying the planosporicin 
gene cluster from P. sp. DSM 14920 gave the same spectrum of peaks in MALDI-ToF as 
Nonomuraea M1295 carrying the psp cluster from P. alba (Figure 6.15), confirming that 
both Planomonospora strains do indeed produce planosporicin. 
 
 
Figure 6.13 : PCR confirmation of the integration of Planomonospora cosmids pIJ12325 
and pIJ12326 in Nonomuraea ATCC 39727.  
Genomic DNAs extracted from Nonomuraea M1297 and M1298 were used as templates to 
amplify pspA (1289FlanA and 1289RlanA; 230 bp) and pspE (FlanEF and RlanEF; 221 bp) 
from the psp gene cluster and dbv5 from the A40926 gene cluster of Nonomuraea (Dbv5F 
and Dbv5R; 375 bp). Genomic DNA from Nonomuraea M1294, which contains the empty 
pIJ10702 vector, was used as a negative control. pIJ12321 cosmid DNA was used as a 
positive control. PCR products were run on a 1 % agarose gel by electrophoresis. The 
ladder is Hyperladder I (Bioline) with band sizes annotated in bp.  
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Figure 6.14 : Heterologous expression of the planosporicin gene cluster integrated into the 
Nonomuraea ATCC 39727 chromosome.  
Nonomuraea M1294, M1295, M1296, M1297 and M1298 were cultured in SM medium. 
Supernatant samples were taken after 8 days of growth and tested for antibiotic activity. 40 
µl of supernatant were applied to antibiotic assay discs that were laid upon a lawn of M. 
luteus. The plate was incubated for 36 hours at 30 °C before zones of inhibition were 
photographed. 
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Figure 6.15 : Heterologous production of planosporicin from P. sp. DSM 14920 cosmids 
integrated into the Nonomuraea ATCC 39727 chromosome.  
Nonomuraea M1294, M1295, M1297 and M1298 were cultured in SM medium. 
Supernatant samples were taken after 8 days of growth and investigated by MALDI-ToF 
mass spectrometry. Intensity is given on the y-axis in arbitrary units (au) and the 
mass/charge ratio (m/z) on the x-axis. The monoisotopic mass of each m/z peak is 
labelled. 
  
227 
227 Chapter 6 : Heterologous production of planosporicin 
6.6 Discussion 
Attempts to express the psp gene cluster of P. alba in two heterologous Streptomyces 
species were not successful. Similar failures in heterologous production from gene 
clusters moved between genera have been observed for both low-GC and high-GC 
lantibiotic clusters. For example, it is not possible to heterologously produce the lantibiotic 
nisin in B. subtilis 168 after transfer of the nisin biosynthetic gene cluster from L. lactis 
ATCC 11454 (Yuksel and Hansen 2007). Likewise, no microbisporicin was detected when 
the complete mib gene cluster was mobilised into several Streptomyces species (Foulston 
and Bibb 2010). A number of strategies were previously utilised in an attempt to prompt 
microbisporicin production by S. lividans TK24. Growth conditions were altered and 
external inducers such as ATP and GlcNAc were added, as well as attempts at auto-
induction through the addition of microbisporicin (Foulston 2010). The constitutive 
promoter ermE*p was introduced to drive expression of mibX, mibA and mibE in the event 
that the heterologous host did not transcribe the cluster at a high level (Foulston 2010). 
mibW, encoding an anti-sigma factor, was deleted in an attempt to relieve possible 
repression of transcription (although this resulted in an apparent suppressor mutation in 
mibX that is likely to abolish sigma factor function) (Foulston and Bibb 2011). A shotgun 
library of M. corallina DNA was introduced into an S. lividans derivative containing the mib 
gene cluster in an attempt to provide a potentially missing Microbispora regulatory gene 
(Foulston 2010).  Yet all of these attempts failed to promote microbisporicin production in 
the heterologous streptomycete host. Although transcription of genes of the mib cluster 
was detected in S. lividans, a Western blot carried out to detect production of the 
lantibiotic was inconclusive and no peaks corresponding to microbisporicin were observed 
in MALDI-ToF (Foulston 2010). The similarity between the planosporicin and 
microbisporicin gene clusters, particularly with regards the likely mechanism of regulation, 
implies that inferences made about the failure of heterologous expression of the mib 
cluster are likely true for the psp cluster too. Thus a full investigation into the reasons for 
this failure was not pursued here. 
It is likely that physiological differences due to the taxonomic distance between 
Streptomyces, a member of the Streptomycetaceae, and P. alba, a Streptosporangeacea, 
may prevent heterologous production of planosporicin. This is consistent with the 
expression of the psp gene cluster in Nonomuraea, a fellow member of the 
Streptosporangeacea family. 
However, Nonomuraea is not an optimal host for gene inactivation studies of heterologous 
gene clusters: it produces at least one other molecule with antibiotic activity, and the 
transfer of cosmids by conjugation from E. coli is inefficient. Furthermore, when used to 
investigate the microbisporicin gene cluster, Nonomuraea exconjugants harboring deleted 
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versions of the mib cluster produced both false-positive and false-negative results 
compared to the phenotype of M. corallina deletion mutants (Foulston 2010). In this work, 
the expression of planosporicin appeared to vary between different exconjugants 
containing the same integrated construct. Of the three Nonomuraea exconjugants with 
integrated pIJ12328, only one produced planosporicin. It is possible that despite streaking 
all three exconjugants several times on selection, the WT genotype was not completely 
removed from two exconjugants. It is possible the WT genotype in the mixed genome 
became the predominant form during growth without selection to provide samples for 
bioassay and MALDI-ToF analysis. In contrast, the five exconjugants of Nonomuraea with 
integrated pIJ12329 all produced planosporicin but exhibited different levels of production. 
A mixed population of WT and integrant genomes could account for this. However the 
copy number of the psp gene cluster could also differ between exconjugants due to 
tandem integration of cosmids. Although analysis of production in this work was not 
quantitative, heterologous production of novobiocin in S. coelicolor revealed that 
derivatives with tandem integrations gave higher production levels than those with a 
single-copy of the gene cluster (Eustaquio et al. 2005).  
This work provides some evidence for increased conjugation efficiency with smaller 
vectors. Only two exconjugants of Nonomuraea with integrated pIJ12323 and one 
exconjugant of Nonomuraea with integrated pIJ12324, pIJ12325 or pIJ12326 were 
identified despite many conjugations with E. coli harbouring cosmids of ~46.5 kb. In 
contrast, the smaller vectors pIJ12327, pIJ12328 and pIJ12329, which varied from 25 to 
40 kb, gave many more exconjugants for analysis. The number of Streptomyces 
exconjugants obtained with vectors that integrate site-specifically into the chromosome 
had previously been found to vary with the size of the construct used. S. coelicolor yielded 
more exconjugants with a 7.8 kb plasmid compared to one which is 11.5 kb, however S. 
lividans showed the opposite trend, yielding more exconjugants with the larger plasmid 
(Flett et al. 1997). It was suggested that an additional restriction site in the larger plasmid 
was recognised by a S. coelicolor endonuclease, reducing the efficiency of conjugal 
transfer of the larger plasmid. This Chapter suggests that above a certain threshold size, 
likely ~40 kb, the efficiency of mating decreases dramatically. Thus the single most 
effective method to increase the number of Nonomuraea exconjugants obtained is to 
reduce the size of the construct. 
Chapter 4 described the identification of the planosporicin biosynthetic gene cluster while 
Chapter 5 gave a full analysis of the constituent genes. This Chapter confirms that this 
cluster is sufficient for production of planosporicin in a heterologous host. Transfer of a 
cosmid containing the entire psp gene cluster to Nonomuraea conferred the ability to 
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produce planosporicin. Shortening the cosmids’ inserts to create reduced gene sets 
served to identify the minimal set of genes required for planosporicin production. 
 
6.7 Summary 
pIJ12321 (cosmid B4-1) and pIJ12322 (cosmid F13-1) carrying insert DNA from P. alba 
were PCR-targeted to enable conjugation and stable integration at the ΦC31 site of 
actinomycete recipients, creating pIJ12323 and pIJ12324, respectively. Both cosmids 
were mobilised into S. lividans TK24, S. coelicolor M1146 and Nonomuraea ATCC 39727. 
Both Streptomyces species failed to produce planosporicin heterologously under any 
conditions tested, whereas Nonomuraea M1295 (harboring pIJ12323) produced 
planosporicin in an active, exported form as detected by bioassay and MALDI-ToF 
analysis. 
Genes flanking the psp cluster were removed from pIJ12321, creating three reduced gene 
sets pIJ12327, pIJ12328 and pIJ12329. 
Nonomuraea strains M1299, M1300 and M1301 (harboring pIJ12327, pIJ12328 and 
pIJ12329, respectively) all produced planosporicin. Thus the two genes adjacent to pspE 
that were removed from pIJ12329 are not necessary for heterologous production in 
Nonomuraea. 
pIJ12325 and pIJ12326 carrying DNA from P. sp. DSM 14920 were mobilised into 
Nonomuraea ATCC 39727. Bioassay and MALDI-ToF analysis confirmed the production 
of planosporicin by the resulting exconjugants. 
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Chapter 7 : Mutational analysis of 
planosporicin biosynthesis 
 
 
7.1 Introduction  
The functional analysis of biosynthetic pathways is generally investigated through a 
combination of heterologous host gene expression and native host gene inactivation. 
Chapter 6 described the difficulties encountered when striving for planosporicin production 
in a heterologous host. Although Nonomuraea did produce planosporicin, there are 
several reasons for not pursuing a full analysis of the cluster through individual knockout 
mutations in this host. Not only does Nonomuraea produce its own antibiotic, A40926, it is 
slow growing and does not sporulate. Consequently, conjugations must be performed with 
mycelium, which often leads to differences in copy number between clones. Furthermore, 
if part of the predicted biosynthetic gene cluster is not essential for production in the 
heterologous host, this may be due to host-encoded genes complementing particular 
functions. For example, the analysis of the cinnamycin gene cluster in the heterologous 
host S. lividans, revealed several genes that were not essential for biosynthesis in the 
heterologous host. This prompted subsequent analysis in the natural producer to check if 
the same phenotype was observed (S. O’Rourke, unpublished).  
On balance, although P. alba is slow growing, taking up to a week for workable colonies 
on agar media or sufficient mycelial biomass in liquid culture, it does sporulate. 
Furthermore, the development of tools for the direct genetic manipulation of P. alba 
presents an opportunity for knowledge-based improvement of planosporicin production in 
this strain.  
Prior to this work, the genetic manipulation of the Planomonospora genus had not been 
demonstrated. Fundamental to the generation of deletion mutants in P. alba was the 
development of methods to mobilise vectors into P. alba via conjugation with E. coli and 
the use of resistance markers to select for homologous recombination events. The 
complementation of these mutants requires the use of a phage integration site in which to 
integrate the complementation construct. This Chapter first investigates the genetic 
tractability of P. alba and defines the genetic tools available for P. alba genetic 
modification. The remainder of the Chapter focuses on the creation of a number of 
deletion mutations in planosporicin biosynthetic genes. 
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7.2 Methods and tools developed for use with P. alba 
The PCR-targeting technique was originally developed and optimised for use with 
Streptomyces, so modifications were needed to develop a robust conjugation method for 
Planomonospora. It is widely recognised that conjugation is much more efficient than 
transformation of protoplasts and can be applied to many actinomycetes (Matsushima and 
Baltz 1996). Although protoplasts from a couple of Streptosporangiaceae (M. corallina 
and Nonomuraea ATCC 39727) have been made, regenerated and transformed, 
conjugation into mycelia was subsequently found to be a more efficient method (Foulston 
and Bibb 2010; Marcone et al. 2010b; Marcone et al. 2010c). As protoplast transformation 
has not previously been attempted in Planomonospora, conjugation of plasmid constructs 
from E. coli into P. alba was the method of choice for the generation of mutant strains. It is 
not known if P. alba possesses a methyl-specific restriction system. In case it does, 
constructs were routinely passaged through methylation-deficient E. coli 
ET12567/pUZ8002 prior to conjugation into P. alba (Macneil et al. 1992). 
 
7.2.1 Conjugation methods 
The genetic manipulation of P. alba requires at least two markers that can be selected 
both in E. coli and P. alba. To this end, the antibiotics routinely used as selectable 
markers in Streptomyces genetics were tested to see if P. alba is naturally resistant. 
Individual ISP4 agar plates were made, each containing an antibiotic at the concentration 
commonly used for selection in other actinomycetes (Kieser et al. 2000). P. alba was 
unable to grow on 50 µg/ml apramycin, 40 µg/ml hygromycin, 200 µg/ml spectinomycin 
with 10 µg/ml streptomycin, 30 µg/ml viomycin, 50 µg/ml thiostrepton or 50 µg/ml 
kanamycin. These antibiotics were therefore deemed to be suitable for selection of DNA 
introduced into P. alba. Furthermore, P. alba, like other actinomycetes, grew in the 
presence of 50 µg/ml nalidixic acid, so this antibiotic can be used to selectively kill E. coli 
after the conjugation event.  
The following text summarises the results obtained in preliminary experiments aimed at 
developing a workable conjugation protocol for P. alba.  The conjugative vectors used 
were generally pIJ10706 and pMS82 with selection for hygromycin resistance.  
A number of factors were optimised for the conjugation of P. alba. Although preparation of 
the donor E. coli strain was not altered, the preparation method of the recipient was 
investigated. Constructs were successfully conjugated both into spores and freshly grown 
P. alba mycelium. P. alba mycelium was collected at mid to late exponential phase (after 
48 hours of growth) and washed in glycerol before mating. This method yielded similar 
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numbers of exconjugants to conjugation with P. alba spores thawed from storage at -20 
°C in 20 % glycerol. A marginal increase in the number of exconjugants was observed if 
the spores were subjected to heat shock (to synchronise germination) prior to conjugation. 
The number of exconjugants was sometimes observed to increase if the spores were 
incubated at 37 °C 250 rpm for 2.5 hours after heat shock to encourage the growth of 
germ tubes. Light microscopy images confirmed the emergence of germ tubes after heat 
shock. These germ tubes became longer, often with branching and tended to clump 
together after further incubation. Freshly emerged germ tubes contain few mycelial 
compartments, so the conjugation event is more likely to produce exconjugants which are 
homogenous clones. Thus the use of heat shocked spores was favoured for the majority 
of matings. 
The appropriate medium for the preparation of P. alba spores and growth of exconjugants 
was next investigated. The recipient conjugated equally well when mycelium was 
prepared in ISP4, D/seed, M8 or AF/MS liquid media, but not in the 2xYT broth 
recommended for Streptomyces. The addition of 10 mM MgCl2 to the agar medium used 
to plate out conjugations was known to promote conjugation between Streptomyces and 
E. coli (Kieser et al. 2000). Conjugation mixtures were thus plated out on a range of media 
all containing 10 mM MgCl2. The agar media tested were those giving the best growth of 
P. alba (ISP4, M8, D/seed and M8 agar), as well as a range of media used for other 
actinomycetes (SFM, OBM, MV, R2 and R5 agar). P. alba vegetative mycelium was able 
to grow on all media, although aerial mycelium and sporulation was only observed on 
ISP4, OBM and MV agar. Exconjugants were routinely observed on ISP4 and often on M8 
and D/seed agar. Thus for the majority of conjugations, matings were plated onto ISP4 
agar containing 10 mM MgCl2.  
The ratio of the donor E. coli to recipient spores was also investigated. In Streptomyces 
conjugations, commonly 108 donor cells and 108 recipient spores are used. This mating is 
so efficient, serial dilutions are plated to obtain individual exconjugants, or alternatively the 
number of spores used is reduced. It had been shown previously that the number of 
exconjugant colonies increased in proportion to the number of spores used (up to a 
maximum of 108), while a reduction in the initial number of donor cells by a factor of 10 did 
not affect the exconjugant frequency markedly (Flett et al. 1997). In P. alba conjugations, 
no significant difference in conjugation efficiency was observed when the ratio of donor E. 
coli to recipient spores was altered. The incubation time for each mating was also varied. 
After plating on ISP4 agar containing 10 mM MgCl2, the conjugation mixture of E. coli and 
P. alba was incubated for 18 to 22 hours at 30 °C. Plates were then overlaid with 1 ml 
water containing 0.5 mg nalidixic acid to kill the E. coli donor and the relevant antibiotic to 
select for exconjugants. With longer incubation times, the haze of E. coli growth became 
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more visible, but the number of exconjugants and their time to emerge did not vary 
significantly. Thus conjugation plates were routinely overlaid after 20 hours growth at 30 
°C. Single colonies of P. alba were routinely visible after approximately two weeks growth, 
although a longer incubation time was often required for sporulation of these colonies 
(Figure 7.1). Plates overlaid only with nalidixic acid revealed lawns of P. alba (Figure 7.1), 
indicating that viable P. alba is present in the conjugation mixture. The final, optimised 
protocol with revised spore preparation and media usage is detailed in Chapter 2. 
 
7.2.2 Integration sites 
The Streptomyces temperate phages ΦC31 and ΦBT1 each possess an attP-int locus 
that facilitates integration into conserved attB sites present in recipient genomes. In S. 
coelicolor, the ΦC31 attB lies within SCO3798, while the ΦBT1 attB lies within SCO4848 
(Gregory et al. 2003). Although both phage integrate intragenically, the genes appear 
non-essential for S. coelicolor growth in the laboratory (Baltz 1998). The ΦC31 and ΦBT1 
attP-int loci have been incorporated into numerous vectors that are used in a broad range 
of actinomycetes. 
The aim in these studies was to use one or both of these integration sites to introduce a 
WT copy of a gene to complement various P. alba mutants. However initial 454 data 
coverage (carried out by the University of Liverpool) was not extensive enough to reveal 
the presence of these attB sites in the P. alba genome. Instead two constructs were 
conjugated into P. alba to test for their ability to integrate into the host chromosome. 
pMS82 uses the ΦBT1 attB site, while pIJ10706 integrates into the ΦC31 attB site, and 
both vectors contain the hygromycin resistance cassette (Table 7.1). Hygromycin-resistant 
exconjugants were obtained from both matings. Colony PCR (Figure 7.2) of 12 putative 
pMS82 exconjugants picked directly from a conjugation plate using primers annealing 
within pMS82 confirmed the presence of the vector. Subsequent extraction of genomic 
DNA (gDNA) from P. alba exconjugants containing either pMS82 or pIJ10706 followed by 
PCR with primers internal to the vector, confirmed their presence in each exconjugant 
(Figure 7.3). 
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Figure 7.1 : Conjugation with E. coli ET12567 pUZ8002 harbouring pMS82.  
P. alba spores were used directly in conjugation or subject to 50 °C heat shock for 10 
minutes, cooled and mixed with E. coli. All conjugations were plated on ISP4 agar 
containing 10 mM MgCl2. After 20 hours at 30 °C, plates were overlaid with 1 ml H20 
containing antibiotics to give a final concentration of either 20 µg/ml nalidixic acid alone 
(left hand side) or 20 µg/ml nalidixic acid and 40 µg/ml hygromycin (right hand side). After 
a further 7 days incubation at 30 °C, growth of P. alba vegetative mycelium was visible on 
the plates containing just nalidixic acid. After a further 10 days, a lawn of sporulating P. 
alba was visible on the same plates.  After a further 5 days, individual colonies had grown 
through the hygromycin selection and sporulated (indicated with arrows). Negative control 
plates were photographed after a total of 17 days at 30 °C. Hygromycin selective plates 
were photographed after a total of 22 days at 30 °C. 
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Construct Integration site Resistance gene Size (Kb) Exconjugants 
pSET152 ΦC31 aac(3)IV 5.7 no 
pIJ10706 ΦC31 hyg 5.9 yes 
pSETΩ ΦC31 aadA 7.0 no 
pMS82 ΦBT1 hyg 6.1 yes 
pRT801 ΦBT1 aac(3)IV 5.1 no 
pIJ10702 ΦC31 aac(3)IV 9.8 no 
pIJ12330 ΦC31 hyg, aac(3)IV 7.0 yes* 
pIJ12331 ΦC31 hyg, aadA 7.0 yes* 
pIJ12332 ΦC31 hyg, vph 7.1 yes* 
pIJ12333 ΦC31 hyg, tsr 7.0 yes* 
 
Table 7.1 : A list of the site-specific integrative vectors conjugated into P. alba.  
The resistance genes correspond to apramycin resistance (aac(3)IV), 
spectinomycin/streptomycin resistance (aadA), hygromycin resistance (hyg), viomycin 
resistance (vph) and thiostrepton resistance (tsr). *Exconjugants were only obtained if 
selected with hygromycin. 
 
Figure 7.2 : Colony PCR analysis to confirm the integration of pMS82 into the genome of 
P. alba.  
Vegetative mycelium from 12 putative P. alba exconjugants was suspended in DMSO and 
used as a template to amplify an 1817 bp fragment of pMS82 (with primers pMS82forB 
and pMS_Rseq). pMS82 plasmid DNA was used as a positive control and WT P. alba 
gDNA as a negative control. PCR products were run on a 1 % agarose gel by 
electrophoresis. The ladder is Hyperladder I (Bioline) with band sizes annotated in bp.  
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Subsequently, 454 next generation sequencing was repeated at The Genome Analysis 
Centre (as described in Chapter 4) to provide greater genome coverage. The ΦBT1 attB 
site of S. coelicolor is a 73 bp sequence in which the crossover site occurs between bases 
35-43. The P. alba 454 contig database was searched using this 73 bp sequence as a 
query. However no significant hits were found. Subsequently the nucleotide sequence of 
SCO4848, the gene containing the ΦBT1 attB site of S. coelicolor, was used as a 
BLASTN input, but again no P. alba contigs were identified. In parallel, 43 bp of the ΦC31 
attB site of S. coelicolor was used as a BLASTN input to search the 454 contig database. 
This analysis identified a 22 bp region within contig00142 which has 95 % identity across 
22 bp of the S. coelicolor ΦC31 attB site (Figure 7.4). Located centrally within the aligned 
region is a TT pair surrounded by GC nucleotides which are also conserved in the ΦC31 
attB site of other Streptomyces sp. (Combes et al. 2002). 
 
 
Figure 7.3 : PCR analysis to confirm the integration of pIJ10706 into the  P. alba genome. 
Genomic DNA extracted from 4 exconjugants was used as a template to amplify a 323 bp 
fragment of pIJ10706 (primers pSETF and pSETR). pIJ10706 DNA was used as a positive 
control and WT P. alba gDNA as a negative control. In parallel, genomic DNA extracted 
from P. alba in which colony PCR had indicated that pMS82 had successfully integrated 
into the host genome was used as a template to amplify a fragment within pMS82 
(pMS82forB and pMS_Rseq; 529 bp). pMS82 plasmid DNA was used as a positive control 
and WT P. alba gDNA as a negative control. PCR products were run on a 1 % agarose gel 
by electrophoresis. The ladder is Hyperladder I (Bioline) with band sizes annotated in bp.  
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Interestingly, when the nucleotide sequence of SCO3798, the gene containing the ΦC31 
attB site of S. coelicolor, was used as a BLASTN input no P. alba contigs were identified. 
It would appear that the attB site has a significantly different context in P. alba compared 
to S. coelicolor. The presence of only a small conserved region makes database 
searching difficult. Thus while the more recent 454 data revealed the presence of a likely 
ΦC31 attB site, it was unable to locate a contig containing a ΦBT1 attB. Although the 
putative ΦC31 attB site identified through genome scanning of the P. alba genome has 
not been verified experimentally as the site used for integration, the successful integration 
of both vectors suggests the existence of chromosomal attachments sites for each in the 
P. alba genome. Herein the successful conjugation of integrative plasmids is assumed to 
occur through site-specific integration of the constructs into the P. alba chromosome. 
 
7.2.3 Resistance cassettes 
To adapt the procedure of λ RED mediated recombination from Streptomyces to 
Planomonospora, cassettes for gene disruptions that can be selected in E. coli were 
assessed for their ability to be selected in Planomonospora. It was important to be able to 
select for at least two different resistance genes; one to select for the targeted 
replacement of the gene with the cassette by homologous recombination and one to 
select for the integration of the complementation construct. This work tested a number of 
constructs containing different resistance markers (Table 7.1). 
Section 7.2.2 revealed that conjugations were successful with pIJ10706 and pMS82 
vectors, with integration achieved by selecting for resistance to hygromycin (although 
there is no experimental evidence that this integration was site-specific). To investigate 
which other resistance cassettes could be used, P. alba was conjugated with E. coli 
harbouring one of three further vectors; pRT801, pSET152 and pIJ10702. All vectors 
contained the apramycin resistance cassette but while pRT801 integrates into the ΦBT1 
attB site, pSET152 and pIJ10702 integrate into the ΦC31 attB site (Table 7.1). No 
apramycin-resistant exconjugants were obtained from either mating. In addition a fourth 
 
Figure 7.4 : An alignment of a section of the S. coelicolor ΦC31 insertion site with a region 
of contig00142 from the P. alba 454 contig database.  
The TT pair conserved in the ΦC31 attB site of other Streptomyces sp. is in bold. 
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vector, pSETΩ, which integrates into the ΦC31 site was mobilised from E. coli into P. alba 
(Table 7.1). pSETΩ contains the aadA gene for spectinomycin/streptomycin (spec/strep) 
resistance; however no exconjugants were obtained after this mating. 
To further investigate this, four more constructs based on pIJ10706 were made, each 
containing an additional resistance gene. Vectors pIJ12330, pIJ12331, pIJ12332 and 
pIJ12333 contain the additional genes aac(3)IV, aadA, vph and tsr, conferring resistance 
to apramycin, spec/strep, viomycin and thiostrepton, respectively (Table 7.1 and Figure 
7.5), and their construction is described below. 
Primers BamHIclone and XbaIclone were designed to anneal either side of the selectable 
markers present in pIJ773 (aac(3)IV), pIJ778 (aadA) and pIJ780 (vph). The primers were 
designed to include the promoter region of each resistance gene but exclude the oriT site, 
as this is already present in pIJ10706. The LongAmp Taq DNA polymerase (NEB) was 
used to amplify aac(3)IV, aadA and vph and introduce BamHI and XbaI. restriction sites 5’ 
and 3’, respectively, of each resistance gene. LongAmp consists of a blend of Taq and 
Deep VentR™ DNA Polymerases. Deep Vent polymerase exhibits 3´ to 5´ exonuclease 
activity to increase the fidelity of Taq polymerase which adds a single nucleotide base 
extension (usually adenine) to the 3′ end of amplified DNA fragments. The A-tail of the 
PCR products was used to ligate the amplified fragment into the commercial vector 
pGEM-T for blue-white screening (as described in Chapter 4). Four white colonies from 
each ligation were subjected to colony PCR with the pSET152F and pSET152R primers to 
successfully amplify across the lacZα gene and confirm that each fragment had indeed 
been inserted into the vector (data not shown). Plasmid DNA was prepared from one 
clone of pGEM-T aac(3)IV, pGEM-T aadA and pGEM-T vph. The insert was liberated from 
the vector backbone using a double digest with BamHI and XbaI and isolated from an 
agarose gel. pIJ10706 was similarly digested with BamHI and XbaI, gel extracted and 
used in a ligation with the three different inserts. pSET152F and pSET152R primers 
amplified a 295 bp fragment from pIJ10706, whereas the integration of 1045 bp aac(3)IV, 
1082 bp aadA and 1150 bp vph would increase the fragment size amplified accordingly. 
Successful ligation of aac(3)IV, aadA and vph into pIJ10706 to create pIJ12330, pIJ12331 
and pIJ12332, respectively (Figure 7.5), was subsequently confirmed by PCR (data not 
shown). For further confirmation, plasmid DNA was purified from two clones of each 
construct. A diagnostic digest with XbaI and BamHI excised the insert from pIJ10706, 
revealing two bands of the expected sizes on an agarose gel. High-fidelity PCR with 
pSET152F and pSET152R amplified a fragment which was sequenced to confirm that the 
correct fragment had been ligated into each construct. Each plasmid was introduced into 
E. coli ET12567/pUZ8002 by transformation. Two clones from each transformation were 
confirmed by PCR and one of each was chosen for conjugation into P. alba. 
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Figure 7.5 : Schematic of four new constructs based on pIJ10706.  
pIJ12330, pIJ12331 and pIJ12332 have the aac(3)IV, aadA and vph resistance genes, 
respectively, cloned in the BamHI-XbaI sites of pIJ10706. PCR with pSET152F and R 
primers amplified 302 bp from pIJ10706, 1357 bp of aac(3)IV from pIJ12330, 1400 bp of 
aadA from pIJ12331 and 1472 bp of vph from pIJ12332 (data not shown). pIJ12333 has 
the tsr resistance gene cloned in the NheI site of pIJ10706. Thus PCR with pSET(NhE)F 
and R primers amplified 220 bp from pIJ10706 and 1251 bp of tsr from pIJ12333 (data not 
shown). 
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In contrast, different methodology was used to create pIJ12333; instead of amplifying the 
tsr resistance cassette, it was excised as a 1037 bp NheI fragment from pIJ6902 and the 
isolated fragment ligated directly into the single NheI site of similarly digested pIJ10706.  
Primers pSET(Nhe)F and pSET(Nhe)R were designed to amplify across the NheI site in 
pIJ10706. PCR on pIJ10706 revealed the expected 220 bp band, while the successful 
ligation of tsr into the NheI site of the vector resulted in the amplification of a 1257 bp 
fragment (Figure 7.5). Three colonies were checked by PCR across the NheI site. In 
addition, plasmid DNA was purified and high-fidelity PCR amplified a fragment that was 
sequenced. All three colonies had tsr integrated into the NheI site. One clone was 
designated pIJ12333 and introduced into E. coli ET12567/pUZ8002 by transformation to 
be used as the donor for conjugation into P. alba. 
The four constructs pIJ12330, pIJ12331, pIJ12332 and pIJ12333 were integrated into the 
P. alba genome using hygromycin to select for exconjugants. P. alba exconjugants 
containing the integrated plasmid were subsequently tested for resistance to other 
antibiotics.  
P. alba exconjugants containing pIJ12330 and pIJ12331 were relatively easy to isolate. 
Four exconjugants from each of the two conjugations were streaked three times on ISP4 
agar whilst maintaining selection with hygromycin. Two exconjugants from each 
conjugation were subject to gDNA extraction. PCR with primers pSET152F and 
pSET152R confirmed the presence of aac(3)IV and aadA integrated into the P. alba 
genome. Spores from each exconjugant were tested for resistance to hygromycin, 
apramycin and spec/strep. P. alba harbouring pIJ12330 conferred hygromycin and 
apramycin resistance, while P. alba harbouring pIJ12331 conferred resistance to 
hygromycin and spec/strep (Figure 7.6). Although direct selection for apramycin or 
spec/strep resistance in conjugations with pSET152 and pSETΩ was unsuccessful, P. 
alba is evidently able to express these resistance genes, enabling selection to be 
maintained through use of these antibiotics. However the spec/strep selection appears 
unreliable. Colonies of WT P. alba and of P. alba containing pIJ10706 grew through the 
spec/strep selection after 22 days incubation whereas no such colonies were observed 
after further incubation of the same strains grown on ISP4 agar containing apramycin. 
Furthermore the aac(3)IV cassette of pIJ12330 appears to confer some cross-resistance 
to spec/strep (Figure 7.6). In contrast, there is no reported cross-resistance conferred by 
aac(3)IV on spectinomycin or streptomycin in S. lividans or S. coelicolor (Kieser et al. 
2000). The enzyme encoded by aac(3)IV catalyses the acetyl CoA-dependent acetylation 
of an amino group of apramycin, thus inactivating the antibiotic. As spectinomycin and 
streptomycin are also aminoglycosides, AAC(3)IV may conceivably modify one or both of 
these antibiotics confer some resistance in P. alba. Thus, of these two possible additional 
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resistance genes, apramycin was favoured as a selectable marker for use in subsequent 
experiments with Planomonospora. 
 
Figure 7.6 : Growth of P. alba strains with antibiotic selection.  
Spores from exconjugants of P. alba with integrated pIJ12330 or pIJ12331 were streaked 
onto ISP4 agar containing hygromycin, apramycin or spectinomycin/streptomycin. WT P. 
alba and P. alba with pIJ10706 integrated into the chromosome were used as controls. 
Plates were incubated for 6 days at 30 °C then photographed (left hand side) and after a 
further 16 days at 30 °C photographed again (right hand side). Note that development is 
slower in the presence of spec/strep selection but P. alba with integrated pIJ12331 did 
eventually sporulate. 
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Conjugations to mobilise pIJ2330 and pIJ2331 into P. alba were less efficient. Only one 
exconjugant was obtained with pIJ2332 and only two with pIJ12333. All three 
exconjugants were subjected to gDNA extraction to provide a template for PCR. vph and 
tsr genes integrated into the P. alba genome were successfully amplified from the 
appropriate exconjugants (data not shown). Spores from each exconjugant were tested 
for resistance to hygromycin, viomycin and thiostrepton. P. alba harbouring pIJ12332 
conferred hygromycin and viomycin resistance, while P. alba harbouring pIJ12333 
conferred resistance to hygromycin and thiostrepton (Figure 7.7). 
 
Figure 7.7 : Growth of P. alba strains with antibiotic selection.  
Spores from exconjugants of P. alba with integrated pIJ12332 or pIJ12333 were streaked 
onto ISP4 agar containing either; no selection, hygromycin, viomycin or thiostrepton. WT 
P. alba and P. alba with integrated pIJ10706 were used as controls. Plates were incubated 
for 7 days at 30 °C then photographed.  
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Subsequently all four conjugations were repeated but with direct selection for apramycin, 
spec/strep, viomycin or thiostrepton in the overlay. Control conjugations were also carried 
out in parallel selecting for hygromycin resistance.  Although exconjugants were obtained 
when selecting for hygromycin, none were obtained when selecting for the alternative 
resistance marker. The reason why direct selection with these antibiotics is not successful 
remains unclear. It could be that the expression of the resistance genes was not high 
enough to enable growth through primary selection, but is sufficient for maintenance.  
These experiments indicated that the hygromycin resistance cassette worked most 
effectively in P. alba. This cassette was therefore used to make targeted deletions in the 
planosporicin biosynthetic gene cluster located in the P. alba genome. A second 
resistance cassette is also needed to select for integration of a plasmid harbouring a WT 
copy of a psp gene in order to complement the mutation in trans. Apramycin resistance is 
widely used in Streptomyces genetics, and many tools are available containing this 
marker, making it the obvious choice. pSET152 and pIJ10706 differ only in the coding 
sequences of the resistance genes they carry (apramycin and hygromycin, respectively). 
Both plasmids not only share the same integration site, but also the same promoter region 
for the selective marker (it had been shown previously that the apramycin gene promoter 
gave greater resistance to hygromycin than the native promoter when used to transcribe 
hyg, which is why it was used in the construction of pIJ10706 (S. O’Rourke, personal 
communication)). On the basis that aac(3)IV is indeed expressed in P. alba but not at a 
high enough level to enable primary selection, attempts were made to select with lower 
concentrations of apramycin. The minimum inhibitory concentration (MIC) of apramycin in 
ISP4 agar was first investigated. P. alba was sensitive to an overlay containing 0.25 mg 
apramycin in 1 ml water (giving a final concentration of 10 µg/ml in a 25 ml ISP4 plate), 
which is five times lower than the recommended amount of apramycin in Streptomyces 
conjugations. While no exconjugants were obtained when conjugations of pSET152 into 
P. alba were overlaid with 1 ml of water containing 1.25 mg of apramycin (50 µg/ml final 
concentration), several sporulating P. alba colonies grew through an overlay with reduced 
amounts of apramycin. Ten colonies were obtained from the 1 ml overlay with 0.3 mg 
apramycin (12 µg/ml final concentration), four colonies from 0.4 mg apramycin (16 µg/ml 
final concentration), and three colonies from 0.5 mg apramycin (20 µg/ml final 
concentration). These putative exconjugants were streaked out three times on ISP4 agar 
containing 25 µg/ml nalidixic acid and 50 µg/ml apramycin.  gDNA was isolated from four 
of these exconjugants (representing each reduced level of selection) and used in the PCR 
with primers pSET152F and pSET152R; in each case a 323 bp fragment of pSET152 was 
amplified. Thus reducing the quantity of apramycin used in the overlay to a level only 
marginally above the MIC allowed the growth of apramycin resistant exconjugants. 
Repeated conjugations with pSET152 revealed that occasionally patches of the 
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conjugation mixture would grow through 1 ml overlays containing 0.3 or 0.4 mg 
apramycin. Thus the integration of complementation constructs based on pSET152 was 
subsequently selected with 1 ml overlays containing 0.5 mg apramycin. 
 
7.3 Targeted deletions within the planosporicin gene cluster of P. alba 
Recombination-based genetic engineering (recombineering) enables the replacement of a 
section of a bacterial chromosome with a selectable marker. The canonical procedure 
developed for Streptomyces at the John Innes Centre by Bertold Gust enabled the 
creation of precise gene replacements in vivo (Gust et al. 2003). This efficient method 
circumvents time consuming digestion and ligation-mediated techniques in vitro. The 
procedure can be split into three steps. Firstly, primers are designed which have 19 or 20 
nt 3’ ends that anneal to a disruption cassette and 39 nt 5’ extensions corresponding to 
the sequence flanking the gene to be replaced. These primers amplify the disruption 
cassette containing an oriT and a resistance gene which is selectable both in E. coli and 
the target organism, in this case Planomonospora. Secondly, the amplified fragment is 
used to transform E. coli BW/pIJ790 harboring a cosmid carrying the gene to be disrupted. 
As described in Chapter 6, pIJ790 expresses λ RED genes which prevent the degradation 
of small, linear DNA fragments. As a result, the target gene is replaced with the PCR-
amplified DNA. Thirdly, the cosmid containing the disrupted gene is conjugated into the 
target strain (here Planomonospora) via the methylation-deficient E. coli donor strain 
ET12567/pUZ8002. The non-transmissible pUZ8002 acts in trans in E. coli to mobilise the 
oriT present in the resistance cassette (described in Chapter 6). A double crossover event 
replaces the target gene with the resistance cassette, creating a targeted deletion mutant. 
However this strategy depends on a reasonably high frequency of recombination in the 
targeted organism. Prior to this work, this had not been demonstrated for P. alba. 
Chapter 5 gave a detailed bioinformatic analysis of the 15 genes constituting the 
planosporicin biosynthetic gene cluster. These genes were shown to be sufficient for 
heterologous production of planosporicin in Nonomuraea ATCC 39727 in Chapter 6. The 
demonstration that genes within the cluster are necessary for planosporicin production in 
the native producer would provide further proof that this gene cluster does indeed encode 
the biosynthetic machinery for planosporicin production, and would more definitively 
define the minimal gene set. For this purpose, the gene encoding the planosporicin 
precursor peptide, pspA, was replaced with a resistance cassette using the 
recombineering method described above. In contrast, pspB and pspC were not targeted 
for replacement. There is much experimental evidence showing that LanB is required for 
dehydration of serine and threonine and LanC for correct (Me)Lan bridge formation. For 
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example, the deletion of pepB and pepC from Staphylococcus epidermidis 5 led to 
accumulation of Pep5 prepeptide in the cells without excretion of processed peptide. A 
pepC-deletion clone did not excrete correctly matured Pep5 but it did produce fragments 
from which serine and threonine were absent but unmodified cysteine residues were 
present, implying Dha and Dhb had been formed (Meyer et al. 1995). Likewise the 
expression of his-tagged nisin precursors in nisB and nisC mutant L. lactis strains 
revealed that nisin precursors from the strain lacking NisB activity were totally unmodified, 
whereas nisin precursors from the strain lacking NisC activity, but having NisB activity, 
contained dehydrated residues but were devoid of (Me)Lan bridges (Koponen et al. 2002). 
Further evidence for these functions comes from the heterologous expression of 
combinations of modification enzymes and prepropeptide chimeras in non-producing 
strains as well as in vitro enzymology discussed in Chapter 1. Thus, due to time 
limitations, this Chapter will focus on targeting only psp genes whose biosynthetic function 
was less certain. These include the three ABC transporters; pspTU, pspYZ and pspEF, 
and one gene with unknown function, pspV. 
 
7.3.1 pspA 
7.3.1.1 PCR analysis 
To confirm the function of the proposed biosynthetic gene cluster in the native host, the 
proposed pspA structural gene was targeted using recombineering as described in 
Section 7.3. In this first attempt to make a targeted deletion in the P. alba genome, three 
different resistance cassettes were used. All three resistance cassettes are based on the 
structure: P1-FRT-oriT-resistance gene-FRT-P2, in which P1 and P2 are universal priming 
sites (identical in all disruption cassettes) and FRT is the FLP-recombinase recognition 
target. The cassette from pIJ773 contains the resistance gene aac(3)IV, pIJ778 contains 
aadA and pIJ10700 contains hyg. Disruption primers PspAdisruptF and PspAdisruptR 
were designed containing sequences which matched all three disruption cassettes. 
PspAdisruptF consists of 39 bp from the sense strand of pspA ending in the ATG start 
codon followed by 20 bp matching the left end of the disruption cassette. PspAdisruptR 
consists of 39 bp from the anti-sense strand ending in the TGA stop codon followed by 19 
bp matching the right end of the disruption cassette. The pIJ773 cassette was used to 
replace pspA in pIJ12321 and pIJ12322 to create pIJ12334 and pIJ12335, respectively. 
The pIJ778 and pIJ10700 cassettes were used to replace pspA in pIJ12321, creating 
pIJ12336 and pIJ12337, respectively. These constructs were conjugated into P. alba and 
exconjugants were selected with the appropriate antibiotic. 
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Despite many conjugation attempts with pIJ12334 and pIJ12335, no apramycin-resistant 
P. alba colonies emerged through the overlay on conjugation plates. Somewhat 
surprisingly, several spectinomycin and streptomycin resistant P. alba colonies did 
emerge after conjugation with pIJ12336 and grew well when streaked on ISP4 agar 
containing nalidixic acid and spec/strep. However, PCR on gDNA extracted from two 
exconjugants revealed the presence of the WT pspA gene, with no band corresponding to 
ΔpspA::778. It is likely these colonies acquired spontaneous mutations conferring 
resistance to 200 µg/ml spectinomycin and 10 µg/ml streptomycin. 
Likewise, no hygromycin-resistant P. alba exconjugants were obtained after conjugation 
with pIJ12337. Yet Section 7.2.3 had indicated that the hygromycin resistance cassette 
would be the most effective for making P. alba deletion mutants. Hygromycin resistant 
exconjugants containing the hygromycin resistance gene integrated into the chromosome 
were readily isolated from conjugation plates, demonstrating that small, integrative vectors 
can be conjugated into P. alba. When making deletion mutants using recombineering, 
constructs containing large regions of homologous DNA (e.g. cosmid clones) are often 
used.  While enhancing the probability of recombination, such constructs are likely to 
conjugate less efficiently than smaller plasmids, potentially precluding the isolation of the 
desired exconjugants. To address this concern and to potentially improve the efficiency of 
conjugation, the size of the homologous recombination vector was reduced. pIJ12337 
contains 22299 bp of sequence homologous to the region upstream of pspA and 15295 
bp of sequence homologous to the region downstream of pspA. In many actinomycetes, 
just 2 kb of homologous sequence is sufficient for detectable homologous recombination. 
Therefore primers were designed to amplify ΔpspA::hyg with either ~2 kb homologous 
sequence either side (creating a ~5.5 kb fragment) or ~4 kb homologous sequence 
(creating a ~9.5 kb fragment). LongAmp polymerase was used to amplify the fragments 
which were cloned into the commercial vector pGEM-T, creating pIJ12338 and pIJ12339, 
respectively (Figure 7.8). In parallel, pspA was also targeted in pIJ12328, leaving ~8 kb 
homologous sequence upstream and downstream of pspA, creating pIJ12340. All three of 
these constructs were successfully conjugated into P. alba. Four exconjugants from each 
conjugation were streaked three times on ISP4 agar containing nalidixic acid and 
hygromycin. They were then grown in liquid culture and gDNA prepared from the resulting 
mycelium. These gDNA preparations were assessed by PCR using the primers 
1289FlanA, which anneals to the left of pspA, and 1289RlanA, which anneals within pspA. 
Thus if the WT gene had been successfully deleted, no band would be observed. In 
parallel, another PCR was carried out using primers pspAconfirmF and pspAconfirmR that 
flank pspA in the WT P. alba genome. If the WT gene had been replaced by the 
hygromycin cassette, the amplified fragment would shift from 848 bp to 2059 bp. This shift 
in band size was observed in nine out of twelve clones, with the three remaining clones 
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showing both amplified bands, suggesting that only a single-crossover recombination 
event had occurred (Figure 7.9). Of the four exconjugants from the conjugation with 
pIJ12338, two had a double-crossover recombination event, entirely removing the WT 
pspA gene from the genome. Of the four exconjugants from the conjugation with 
pIJ12339, three were double-crossovers. Of the four exconjugants from the conjugation 
with pIJ12340, all were confirmed as true ΔpspA::hyg mutants. This perhaps reflects the 
greater likelihood of homologous recombination occurring when a larger section of 
homologous DNA is present. 
 
Figure 7.8 : Schematic of reduced constructs used to make a targeted deletion of pspA. 
pIJ12338 and pIJ12339 consist of the pGEM-T vector backbone ligated to the pIJ10700 
cassette flanked by regions homologous to sequences either side of pspA. pIJ12338 has 2 
kb of flanking homology, while pIJ12339 has 4 kb. 
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7.3.1.2 Bioassay and MALDI-ToF analysis 
One exconjugant corresponding to a double crossover event with each construct was 
tested for planosporicin production by bioassay and MALDI-ToF. All three exconjugants 
produced no antibiotic compounds when assayed against M. luteus. Likewise, no peptides 
with a mass corresponding to planosporicin were detected in MALDI-ToF (Figure 7.10). 
Thus the replacement of pspA with P1-FRT-oriT-hyg-FRT-P2 abolished production of 
planosporicin.  
 
Figure 7.9 : PCR confirmation of the deletion of pspA from the P. alba chromosome.  
This targeting was achieved through conjugation with pIJ12338, pIJ12339 or pIJ12340.  
Genomic DNAs extracted from four P. alba exconjugants from each conjugation were used 
as templates to amplify pspA using two sets of primers. A; 1289FlanA and 1289RlanA 
anneal within pspA to amplify 230 bp if the WT gene is present. B; PspAconfirmF and 
PspAconfirmR anneal either side of the disrupted region to amplify 2720 bp ΔpspA::hyg or 
848 bp WT pspA. Genomic DNA from WT P. alba was used as a control. PCR products 
were run on a 1 % agarose gel by electrophoresis. The ladder is Hyperladder I (Bioline) 
with band sizes annotated in bp. 
  
249 
249 Chapter 7 : Mutational analysis of planosporicin biosynthesis 
 
Figure 7.10 : Abolition of planosporicin production due to the targeted deletion of pspA in 
P. alba.  
The deletion was made through conjugation with three different constructs; pIJ12338, 
pIJ12339 and pIJ12340. The three P. alba ΔpspA::hyg mutants and a WT P. alba control 
were cultured in AF/MS medium. Supernatant samples were taken after 5-8 days of growth 
and tested by bioassay and MALDI-ToF. 40 µl of supernatant was applied to antibiotic 
assay discs which were laid onto a lawn of M. luteus. The plate was incubated for 36 hours 
at 30 °C before zones of inhibition were photographed (inset). The same supernatants 
were analysed by MALDI-ToF mass spectrometry. Intensity is given on the y-axis in 
arbitrary units (au) and the mass/charge ratio (m/z) on the x-axis. The monoisotopic mass 
of each m/z peak is labelled. 
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The strain constructed using pIJ12340, M1302, was used in all subsequent studies of the 
ΔpspA mutant. M1302 had a WT morphology when grown on agar and in liquid media. P. 
alba M1302 was grown for a two week period in AF/MS liquid medium and samples of 
culture supernatant taken and analysed for activity against M. luteus. No antibiotic activity 
was detected. Thus under these conditions any antibiotic compound produced by WT P. 
alba can be assumed to be planosporicin. 
 
7.3.2 pspYZ 
7.3.2.1 PCR analysis 
pIJ12328 was PCR-targeted using the P1-FRT-oriT-hyg-FRT-P2 cassette from pIJ1700 to 
replace pspYZ using the method described in Section 7.3. This resulted in 
pIJ12328ΔpspYZ::hyg, subsequently named pIJ12523, which was then conjugated into 
heat shocked P. alba spores. Five of the putative HygR exconjugants were streaked three 
times on agar plates containing 40 µg/ml hygromycin. Since the backbone of pIJ12523 
carries neo gene conferring kanamycin resistance, if pIJ12523 had been incorporated by 
single-crossover recombination, then the putative exconjugants would also be KanR; 
however if a double-crossover event had occurred, then neo as well as the WT pspYZ 
would have been removed, resulting in a KanS strain. Consequently, the HygR 
exconjugants were tested for growth in the presence of 50 µg/ml kanamycin. All five 
exconjugants had a HygR KanR phenotype.  The strains were then grown in liquid medium 
containing 40 µg/ml hygromycin but lacking kanamycin to allow for a second 
recombination event that would remove pspYZ and the remainder of the pIJ12523 
plasmid, leaving just the pIJ10700 hygromycin cassette. ISP4 agar containing hygromycin 
was spread with a sample of liquid culture. The resulting plates of single P. alba HygR 
colonies were replica-printed consecutively onto ISP4 agar plates containing kanamycin 
and then hygromycin. Figure 7.11 demonstrates that after growth in liquid medium, 
415/444 colonies (>93 %) were now the required HygR KanS double crossovers. This 
method was used to isolate four mutants P. alba ΔpspYZ::hyg_7, 11, 10 and 24. Using 
gDNA from each exconjugant, a fragment of expected size was amplified by PCR using 
one primer annealing within the pIJ10700 cassette and one annealing to the region 
flanking pspYZ (data not shown). The HygR KanS P. alba ΔpspYZ::hyg_7 mutant was 
assigned the strain number M1305, gDNA from which failed to amplify a product when 
both primers were within pspYZ (Figure 7.12).  
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Figure 7.11 : Double crossover mutants isolated after growth in liquid culture.  
A HygR KanR P. alba ΔpspYZ::hyg exconjugant was grown for 7 days in liquid ISP4 with 
hygromycin selection. 50 µl of the culture was spread onto ISP4 containing 40 µg/ml  
hygromycin and incubated for 7 days at 30 °C (top). Individual sporulating colonies were 
observed and the whole plate was replica-printed onto ISP4 agar containing 50 µg/ml  
kanamycin (middle) then 40 µg/ml  hygromycin (bottom) and incubated for a further 5 days 
at 30 °C before being photographed. 
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7.3.2.2 Bioassay and MALDI-ToF analysis 
All four P. alba ΔpspYZ::hyg exconjugants were tested for their ability to produce 
planosporicin by growing in liquid AF/MS medium. After 4 and 6 days growth, supernatant 
was sampled and used in a bioassay with M. luteus and sent for MALDI-ToF analysis. 
The WT control strain produced a bioactive compound that created a large zone of 
clearing due to the inhibition of the growth of M. luteus. P. alba ΔpspYZ::hyg clones 7, 10, 
11 and 24 induced no such zone of clearing and no masses corresponding to 
 
Figure 7.12 : PCR confirmation of four P. alba deletion mutants.  
Namely M1302 (ΔpspA::hyg), M1307 (ΔpspV::hyg), M1305 (ΔpspYZ::hyg) and M1306 
(ΔpspTU::hyg). Genomic DNAs extracted from each strain were used as a template to 
amplify pspA, (pspAF2 and pspAR2: 101 bp), pspV (pspVF and pspVR; 137 bp), pspYZ 
(pspYF and pspZR; 1218 bp) and pspTU (pspTF and pspUR; 1431 bp)  from the psp gene 
cluster. Genomic DNA from WT P. alba was used as a control. PCR products were run on 
a 2 % agarose gel by electrophoresis. The ladder is 100 bp DNA ladder (NEB) or 
Hyperladder I (Bioline) with band sizes annotated in bp. 
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planosporicin were detected in MALDI-ToF. Figures 7.13 and 7.14 depict the bioassay 
and MALDI-ToF results for P. alba ΔpspYZ::hyg_7 (assigned strain M1305) after six days 
growth in AF/MS. In subsequent repetitions of this experiment, a very small halo of M. 
luteus growth inhibition was observed in bioassays with supernatants from P. alba M1305. 
When these samples were sent for MALDI, a very small amount of the 2192 Da 
planosporicin peptide was detected (samples were spotted twice onto the MALDI plate to 
provide enough material for detection; data not shown). This observed low level of 
planosporicin production was more pronounced when using agar bioassay plates. M1305 
grown for four days on AF/MS agar medium produced a small zone of inhibition, while the 
WT strain did not (Figure 7.15). However after longer periods of growth (11 days), the halo 
from M1305 had not markedly increased, while the WT strain had produced enough 
planosporicin to create a halo that partially overlapped that of the neighbouring M1305 
patch (Figure 7.15). This phenotype was consistent for all four P. alba ΔpspYZ::hyg 
exconjugants, indicating that biosynthesis is not abolished in this mutant, and indeed 
occurs precociously when compared to the WT strain. Methanol extracts of M1305 
mycelium failed to reveal an accumulation of active planosporicin in the mycelium through 
bioassay (Figure 7.16). 
 
7.3.3 pspTU 
7.3.3.1 PCR analysis 
pIJ12321 was PCR-targeted using the P1-FRT-oriT-hyg- FRT-P2 cassette from pIJ1700 
to replace pspTU using the method described in Section 7.3. This created 
pIJ12321ΔpspTU::hyg, designated pIJ12524, which was then conjugated into heat 
shocked P. alba spores. Several hygromycin-resistant P. alba colonies were isolated, two 
of which were streaked out on agar medium containing 40 µg/ml hygromycin. One of 
these exconjugants was found to be both HygR and KanS. PCR on gDNA extracted from 
this exconjugant using one primer annealing within the pIJ10700 cassette (pspTU10700R) 
and one annealing in the region flanking pspTU (pspTUconfirmF) amplified a fragment of 
the expected size. No fragment was amplified with primers annealing within pspTU 
(Figure 7.12). This strain was designated M1306. 
  
254 
254 Chapter 7 : Mutational analysis of planosporicin biosynthesis 
 
7.3.3.2 Bioassay and MALDI-ToF analysis 
The two P. alba M1306 (ΔpspTU::hyg) clones were tested for their ability to produce 
planosporicin by bioassay against M. luteus and by MALDI-ToF analysis. The clones were 
grown alongside a WT control in liquid AF/MS medium and sampled after 4 and 6 days 
growth. Unlike the WT control, no antibiotic compound was detected from the 
supernatants of P. alba M1306 and no masses corresponding to planosporicin were 
detected in MALDI-ToF (Figure 7.13 and 7.14). This non-production phenotype was 
consistent when grown on AF/MS agar for 10 days before being overlaid with M. luteus, 
 
Figure 7.13 : Lack of production of antibiotic compounds from P. alba deletion mutants. 
The four mutants assayed were M1302 (ΔpspA::hyg), M1305 (ΔpspYZ::hyg), M1306 
(ΔpspTU::hyg) and M1307 (ΔpspV::hyg). The above P. alba strains were cultured in 
AF/MS medium for 6 days. A positive control of WT P. alba was cultured in parallel. 
Samples of culture supernatants were tested for antibiotic activity. 40 µl of supernatant 
were applied to antibiotic assay discs which were laid onto a lawn of M. luteus. The plate 
was incubated for 36 hours at 30 °C before zones of inhibition were photographed. 
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In other lantibiotic clusters, deletion of the ABC transporter responsible for lantibiotic 
export did not prevent biosynthesis, but led to accumulation of the lantibiotic in the 
cytoplasm. For example, deletion of nisT from the nisin gene cluster led to a build-up of 
processed nisin in the cytoplasm of L. lactis N8 (Qiao and Saris 1996). To determine if 
 
Figure 7.14 : Lack of production of peptides by four P. alba deletion mutants.  
M1302 (ΔpspA::hyg), M1305 (ΔpspYZ::hyg), M1306 (ΔpspTU::hyg) and M1307 ( 
ΔpspV::hyg) were cultured in AF/MS medium for 6 days. WT P. alba was grown in parallel 
as a positive control. Supernatant samples were taken after 6 days of growth and analysed 
by MALDI-ToF mass spectrometry. Intensity is given on the y-axis in arbitrary units (au) 
and the mass/charge ratio (m/z) on the x-axis. The monoisotopic mass of each m/z peak is 
labelled. 
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deletion mutations which prevent planosporicin secretion into the supernatant are simply 
preventing export, mycelial extracts were tested for antimicrobial activity by bioassay. 
However, methanol extracts of P. alba M1306 mycelium did not reveal any antibiotic 
activity (Figure 7.16). MALDI-ToF analysis of these methanol extracts did not reveal the 
presence of inactive planosporicin with the leader peptide attached. 
 
 
Figure 7.15 : Production of antibiotic compounds by P. alba M1305 in comparison to WT 
P. alba when grown on agar medium.  
10 ul of the relevant seed culture was patched onto solid AF/MS plates in duplicate and 
incubated at 30 °C. After 4 days or 11 days, plates were overlaid with SNA containing M. 
luteus. The plates were incubated for 72 hours at room temperature before zones of 
inhibition were photographed. 
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Figure 7.16 : Attempted detection of antibiotic compounds either secreted into the medium 
or accumulated in the cytoplasm.  
P. alba deletion mutants M1306 (ΔpspTU::hyg), M1307 ( ΔpspV::hyg) and M1305 
(ΔpspYZ::hyg) (as well as three other P. alba ΔpspYZ::hyg exconjugants) were cultured in 
AF/MS medium alongside M1302 (ΔpspA::hyg) as a negative control and WT P. alba as a 
positive control. Each strain was harvested after 4 or 10 days growth at 30 °C, 250 rpm. 
Samples of culture supernatants (top panel) and methanol extracts from the mycelium 
(bottom panel) were tested for antibiotic activity. 40 µl of each sample was applied to 
antibiotic assay discs and allowed to dry. A methanol only control was included to check 
for any inhibition caused by the solvent. Each disc was applied to a lawn of M. luteus 
which was incubated for 36 hours at 30 °C before zones of inhibition were photographed. 
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7.3.4 pspV 
7.3.4.1 PCR analysis 
In Chapter 4, pIJ12322 (cosmid F13-1) was sequenced and found to lack the 3’ end of 
pspV. In Chapter 6, a conjugative derivative of this construct, pIJ12325, was integrated 
into the Nonomuraea chromosome but no planosporicin was detected. Thus in a 
heterologous host pspV appears to be necessary for planosporicin production. Therefore 
it was deemed interesting to determine if pspV was also necessary for planosporicin 
production in the natural producer. To this end, a number of constructs were made. As 
pspV is located at the right hand border of the psp gene cluster, the reduced versions of 
pIJ12321, i.e. pIJ12327, pIJ12328 and pIJ12329, do not contain any sequence 
downstream of pspV thus leaving no flanking sequence for homologous recombination. It 
was anticipated that smaller constructs would be more easily mobilised into P. alba.  
Consequently, pIJ12321, which contains 7.5 kb downstream of pspV, was targeted to 
remove all genes upstream of ORF -11 (Figure 7.17). The resistance cassette was 
subsequently removed by digestion with XbaI and re-ligation of the cosmid. This reduced 
construct was further PCR-targeted using the P1-FRT-oriT-hyg-FRT-P2 cassette from 
pIJ1700 to replace pspV using the method described in Section 7.3. This created 
pIJ12321Δorf-19 to orf-12, ΔpspV::hyg, designated pIJ12527, which was then conjugated 
into heat shocked P. alba spores. Although several P. alba colonies grew on the 
conjugation plates, none grew well when restreaked on agar medium containing 40 µg/ml 
hygromycin. Consequently, an additional construct was made. Section 7.3.1.1 showed 
that recombination is possible in P. alba with just 2 kb of flanking homologous sequence. 
LongAmp polymerase was used to amplify ΔpspV::hyg from pIJ12527 along with >2 kb of 
adjacent sequence either side. The resulting 6.2 kb ΔpspV::hyg fragment, with hyg 
flanked by sequences homologous to the psp cluster, was cloned into pGEM-T, creating 
pIJ12530. Eventually, after several attempted conjugations with this construct, one 
putative exconjugant was isolated that grew well when streaked on agar medium 
containing 40 µg/ml hygromycin and which was sensitive to kanamycin.  gDNA isolated 
from a liquid culture of this clone was assessed by PCR using primers flanking pspV. This 
revealed a bandshift from the WT 1858 bp pspV to the 2125 bp ΔpspV::hyg. No 
amplification product was obtained with primers annealing within pspV (Figure 7.12). P. 
alba ΔpspV::hyg was designated M1307. 
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7.3.4.2 Bioassay and MALDI-ToF analysis 
The one P. alba ΔpspV::hyg exconjugant isolated was assayed for the ability to inhibit M. 
luteus and for the presence of peptides in the planosporicin mass range by MALDI-ToF 
analysis. P. alba M1307 grown on AF/MS agar for 10 days did not produce any 
compounds which inhibit M. luteus growth, unlike the large halo of inhibition around the 
 
Figure 7.17 : Schematic illustrating the construction of a reduced construct to use to 
generate a pspV deletion mutant in P. alba.  
In step 1, the insert DNA of cosmid pIJ12321 was PCR-targeted to remove orf-19 to orf-12. 
In step 2, PCR targeting replaced pspV with P1-FRT-oriT-hyg-FRT-P2 cassette (in red) 
from pIJ1700. 
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WT strain (data not shown). Two clones of M1307 were grown alongside a WT control in 
liquid AF/MS medium and sampled after 4, 5, 6, 7, 8 and 11 days of growth. Unlike, the 
WT control, no antibiotic activity was detected in the supernatants of P. alba M1307 and 
no masses corresponding to planosporicin were detected upon MALDI-ToF analysis 
(Figure 7.13 and 7.14). No antimicrobial activity was observed in methanol extracts of 
M1307 mycelium either (Figure 7.16).  
If PspV functions as a scaffold constraining the prepropeptide into a conformation for the 
binding of modification enzymes, these modifications may not occur in P. alba M1307. For 
every dehydration reaction, the mass of the lantibiotic precursor decreases by 18 Da 
(whereas subsequent cyclisation causes no mass change). Therefore, mass spectrometry 
can be used to distinguish between a precursor that is not dehydrated and one that is. For 
example mass spectroscopy on tryptic digests (as well as bioassay, SDS-PAGE and N-
terminal sequencing) showed that nisin precursors from a strain lacking NisC activity, but 
having NisB activity, contained dehydrated residues but no (Me)Lan bridges (Koponen et 
al. 2002). Leader peptide removal occurs after completion of the post-translational 
modifications, so may not occur if (Me)Lan formation is prohibited. The theoretical mass of 
the planosporicin prepropeptide is 5610.69 Da and the theoretical mass of the post-
translationally modified prepeptide (i.e. with seven dehydrations) is 5484.616 Da. Thus 
MALDI-ToF was also performed in a high mass range on both supernatants and methanol 
extracts. However no peptides corresponding to the planosporicin prepropeptide were 
detected. These results correspond to those obtained with Nonomuraea containing 
pIJ12325, i.e. containing the psp gene cluster but with a truncated pspV (Chapter 6).  
 
7.3.5 pspEF 
7.3.5.1 PCR analysis 
pIJ12328 has only ~750 bp of sequence upstream of pspE which is unlikely to be 
sufficient for efficient recombination. In contrast, pIJ12327, lacking the genes downstream 
of pspV, has ~15 kb of DNA upstream of pspE. Consequently, pIJ12327 was PCR-
targeted using the P1-FRT-oriT-hyg-FRT-P2 cassette from pIJ1700 to replace pspEF 
using the method described in Section 7.3. This created pIJ12321ΔpspEF::hyg, 
designated pIJ12527, which was then conjugated into heat shocked P. alba spores. 
Although several P. alba colonies grew on the conjugation plates under hygromycin 
selection, none grew well when restreaked onto selective media. An additional construct 
was therefore made. Primers pspEF_2kbF and R2 were used to amplify a single 6.5 kb 
fragment consisting of ΔpspEF::hyg with >2 kb of flanking sequence from pIJ12527. This 
PCR product was cloned into pGEM-T, creating pIJ12529, which was subsequently 
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conjugated into P. alba. One exconjugant was isolated which grew well when streaked on 
hygromycin selective medium.  gDNA was isolated from a liquid culture of the strain and 
PCR analysis revealed the presence of both pspEF and ΔpspEF::hyg, indicating the 
occurrence of a single-crossover event. However, when patched first onto kanamycin 
selective plates then onto hygromycin selective plates it was found to be HygR KanS. Thus 
it appears a deletion event had occurred that had removed the vector backbone but left 
both the WT pspEF and the disrupted ΔpspEF::hyg alleles. Despite further attempted 
conjugations, no exconjugants were obtained.  
 
7.4 Generation of ‘scar’ mutants through FLP-mediated excision of the 
disruption cassette 
The FRT sites flanking the ends of the disruptions cassettes are recognition targets for the 
FLP-recombinase. FLP-mediated recombination removes the central part of the disruption 
cassette, leaving an “in frame” (multiple of three) 81 bp ‘scar’ sequence whose reading 
frame lacks stop codons. FLP-mediated recombination enables the repeated use of the 
same resistance marker to make multiple gene replacements in the same cosmid or 
strain. In this work, FLP-mediated excision of the disruption cassette was desirable in 
order to generate non-polar, unmarked in-frame deletions in which expression of 
downstream genes was unaffected.  
The method involves the use of E. coli DH5α containing BT340, the temperature-sensitive 
FLP recombination plasmid. BT340 encodes the FLP recombinase and is temperature 
sensitive for replication (replicates at 30 °C), so FLP synthesis and loss of the plasmid are 
induced at 42 °C (Cherepanov and Wackernagel 1995). Expression of the FLP-
recombinase in E. coli removes the central part of the disruption cassette in the cosmid, 
leaving behind the ‘scar’ sequence (as described in Chapter 2) (Datsenko and Wanner 
2000). The scarred cosmid can then be used to replace resistance cassette inserts in the 
P. alba chromosome with the unmarked ‘scar’ sequence through homologous 
recombination.  
 
7.4.1 pspA 
As described in Section 7.3, P. alba M1302 was constructed by replacing pspA with the 
P1-FRT-oriT-hyg-FRT-P2 resistance cassette. This generated a replacement mutant 
marked with the hygromycin resistance cassette. It seemed likely that this mutation would 
have polar effects on the expression of pspB, pspC, pspT, pspU and pspV located 
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downstream of and co-transcribed with pspA. The original replacement primers were 
carefully designed to end in the ATG start and TGA stop codons of pspA, thus retaining 
the same reading frame after gene replacement. Thus the hygromycin cassette could be 
removed by FLP-recombination to allow in frame transcriptional read-through into 
downstream genes. It was also envisaged that this scar mutant could be complemented 
not only with pspA but also with other lanA genes and perhaps also fusion constructs 
using the leader peptide of pspA fused to the propeptide gene of other lantibiotics. 
There were two possible methods to generate the required P. alba ΔpspA::scar mutant. 
Both used the canonical method described in Chapter 2 to excise the hygromycin 
resistance cassette and oriT from between the FRT sites in pIJ12340 (pIJ12328 
∆pspA::(oriT-hyg)). For both approaches, pIJ12340 was first introduced into E. coli 
DH5α/BT340 by transformation and FLP-mediated recombination induced as described in 
Chapter 2 yielding HygS KanR clones. Removal of the hygromycin resistance cassette was 
confirmed by high-fidelity PCR using flanking primers (PspAconfirmF and PspAconfirmR) 
to generate PCR products that were then confirmed by Sanger sequencing. The resulting 
plasmid, pIJ12328 ∆pspA::(scar), was subjected to restriction analysis to ensure that no 
other gross deletions or rearrangements had occurred in the cosmid during FLP-mediated 
recombination. The methods differ in the manner in which the oriT is re-introduced to the 
pIJ12328 ∆pspA::(scar) plasmid. Usually, the construct would be re-introduced into E. coli 
BW25113/pIJ790 allowing the bla gene to be replaced with oriT and a selectable 
resistance marker not already present in the plasmid. However, as the hyg marker is 
already present in pIJ12340 (pIJ12328 ∆pspA::(oriT-hyg)) and selection for apramycin in 
conjugations is unreliable, an alternative method was used. This method was recently 
used to scar the garA gene of the actagardine cluster by introducing the scar cosmid into 
WT A. garbadiensis (Boakes et al. 2009). This work described how single-crossover 
exconjugants were obtained and subcultured through six successive rounds of growth in 
liquid media without selection to allow a second recombination event to occur. Using this 
method, it would be possible to introduce the scar cosmid into WT P. alba using 
hygromycin to select for single crossover events and then grow non-selectively to allow 
double crossovers. To this end, the bla-oriT-hyg-bla cassette from pIJ10701 was amplified 
using blaF and R primers and the 1535 bp fragment was isolated from an agarose gel. 
This fragment was used to introduce oriT and the hygromycin resistance marker into the 
backbone of pIJ12328 ∆pspA::(scar) in place of bla to create pIJ12531. This cosmid was 
checked by PCR and restriction analysis before transformation into the donor strain E. coli 
ET12567/pUZ8002 for mobilisation into WT P. alba via conjugal transfer.  
Two hygromycin-resistant P. alba colonies were isolated from the conjugation plates and 
streaked three times on ISP4 containing 25 µg/ml nalidixic acid and 40 µg/ml hygromycin. 
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Two clones from each exconjugant were inoculated into liquid ISP4 media without 
antibiotic selection and grown for 7 days before the culture was inoculated 1 in 10 into a 
second liquid culture. This method was repeated between six and eight times for each of 
the four clones before a sample of culture was plated onto solid ISP4. After 5 days growth, 
colonies from this plate were patched onto ISP4 containing 40 µg/ml hygromycin and 
ISP4 without selection. Cells sensitive to hygromycin were patched onto plates of D/seed 
media to generate mycelia for colony PCR. Out of 96 colonies patched, 30 were sensitive 
to hygromycin, of which 21 were checked by colony PCR using primers pspAconfirmF and 
pspAconfirmR; unfortunately in all 21 cases the primers amplified the 848 bp WT pspA 
and not the 719 bp scar sequence. PCR on gDNA prepared from four colonies confirmed 
this result. As an alternative assay method, nine of the hygromycin sensitive clones were 
grown in liquid AF/MS medium to screen for lack of antibiotic production. However all 
clones produced planosporicin. Therefore, although this method was reported to be 
successful in generating scar mutants in A. garbadiensis, it was unsuccessful in P. alba. 
All hygromycin sensitive colonies had reverted to WT after integration of the scarred 
cosmid. 
On reflection, these results are not particularly surprising. Growth experiments show that 
young P. alba mycelium is susceptible to planosporicin. Immunity occurs either through 
the expression of immunity genes or though age, as mature colonies no longer elongate 
through growing a new cell wall, so planosporicin is no longer effective. The double 
crossover event which leaves a scar in place of pspA likely occurs at a similar frequency 
to the excision of the entire construct. The removal of pspA would abolish production of 
planosporicin and thus prevent the self-induction of planosporicin immunity genes. Any 
mycelial compartments that instead reverted to WT would produce planosporicin which 
could kill any actively growing pspA scar mutants. Although planosporicin production in 
ISP4 is not routinely observed, a halo of inhibition is sometimes seen when P. alba is 
grown in this medium, so production is possible. In an attempt to avoid this, hygromycin 
resistant single crossovers that had been streaked three times on ISP4 containing 25 
µg/ml nalidixic acid and 40 µg/ml hygromycin were then streaked a further three times on 
ISP4 lacking any selection. Each time, well separated single colonies were selected so 
that any colonies which had reverted to WT would not be close enough to any scarred 
mutants to kill them. Forty colonies were patched onto ISP4 containing 40 µg/ml 
hygromycin then ISP4 lacking selection. Fifteen were hygromycin sensitive and patched 
onto D/seed agar for growth without selection. Once again, colony PCR revealed that all 
of the hygromycin sensitive colonies had reverted to WT instead of generating a scar 
mutant. Time limitations prevented alternative methods being pursued. 
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7.5 Complementations 
7.5.1 Complementing biosynthetic mutants 
All psp mutants were made through the targeted replacement of the gene of interest with 
the hygromycin resistance cassette. Attempts to make scar mutants failed as described in 
Section 7.4, so instead, the marked mutants were used. Attempts at complementation 
were performed in trans with the WT gene. This required the use of a second resistance 
cassette. Section 7.2.3 described how apramycin-resistant P. alba exconjugants 
containing pSET152 integrated into the chromosome were obtained if the conjugation was 
overlaid with 20 µg/ml nalidixic acid and just 20 µg/ml apramycin. Thus all 
complementation constructs made during this work were based on the vector pSET152. 
 
7.5.1.1 pspA 
To complement deletion of the gene encoding the planosporicin precursor peptide, pspA 
was introduced in trans with expression from the native promoter PpspA (defined as the 
region between pspX and pspA) through integration of pIJ12532. Chapter 2 describes the 
creation of pIJ12532 through the cloning of PpspA together with pspA into pSET152. 
pIJ12532 was conjugated into P. alba M1302 and exconjugants were selected with 20 
µg/ml apramycin.  
Three exconjugants were streaked out three times on ISP4 media containing 50 µg/ml 
apramycin and were subsequently inoculated into liquid culture from which gDNA was 
prepared. The gDNA preparations were assessed by PCR using primers which anneal 
within pIJ12532 (pSET152F2 and pSET152R2) to amplify the 727 bp band corresponding 
to pspA integrated into the P. alba chromosome. Two representative clones of each 
exconjugant were tested for planosporicin production along with WT P. alba as a positive 
control. Supernatants collected from 5, 6 and 7 day old AF/MS liquid cultures were tested 
for the ability to inhibit growth of M. luteus. While supernatants from 5 day cultures of WT 
P. alba conferred visible halos, those from P. alba M1302 carrying the complementation 
construct pIJ12532 did not  (Figure 7.18). The absence of planosporicin-related peaks 
was confirmed by MALDI-ToF analysis (Figure 7.19). Furthermore, agar-grown patches of 
P. alba M1302 carrying pIJ12532 also failed to create a halo of M. luteus inhibition. The 
genes pspABCTUV are likely to constitute one operon, with expression driven from the 
pspA promoter. A polar effect of the pspA deletion marked with the hygromycin cassette 
on the expression of downstream genes is the most likely explanation for the lack of 
complementation. The proteins encoded by pspBC are likely to be involved in (Me)Lan 
bridge formation so are very likely to be essential. Furthermore, Section 7.3.3 and Section 
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7.3.4 revealed that pspTU and pspV are both essential for planosporicin biosynthesis. 
One solution would be to complement the pspA mutation with pspABCTUV. However this 
fragment is approximately 8 kb, making the incorporation of mutations during PCR 
amplification highly likely. The absence of conveniently positioned restriction sites 
prevented the excision of the pspABCTUV fragment. However, even this approach may 
not have been successful. Recent work demonstrated that the deletion of mibA from the 
mib gene cluster in M. corallina could not be complemented. In the mib cluster, 
mibABCDTUV is likely to be transcribed as one operon. Deletion analysis revealed that 
mibTU and mibV were not essential for microbisporicin production. Thus attempts were 
made to complement the targeted M. corallina ΔmibA::aac(3)IV mutant with mibA and 
mibABCD under control of the native PmibA promoter. However neither construct restored 
microbisporicin production (Foulston 2010). 
 
Figure 7.18 : Lack of production of antibiotic compounds from P. alba deletion mutants 
complemented in trans with the WT gene.  
P. alba M1302 (ΔpspA::hyg) with integrated pIJ12532 (PpspA-pspA) and P. alba M1306 
(ΔpspTU::hyg) with integrated pIJ12535 (PpspA-pspTUV) were cultured in AF/MS medium 
for 5 days. Samples of  culture supernatants were tested for antibiotic activity. 40 µl of 
supernatant were applied to antibiotic assay discs which were laid onto a lawn of M. 
luteus. A sample containing planosporicin (+) was used as a positive control in the assay. 
The plate was incubated for 36 hours at 30 °C before zones of inhibition were 
photographed. 
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Figure 7.19 : Lack of production of peptides from P. alba deletion mutants complemented 
in trans with the WT gene.  
P. alba M1302 (ΔpspA::hyg) with integrated pIJ12532 (PpspA-pspA) and P. alba M1306 
(ΔpspTU::hyg) with integrated pIJ12535 (PpspA-pspTUV) were both cultured in AF/MS 
medium. WT P. alba was grown in parallel as a positive control. Supernatant samples 
were taken after 5 days of growth and analysed by MALDI-ToF mass spectrometry. 
Intensity is given on the y-axis in arbitrary units (au) and the mass/charge ratio (m/z) on 
the x-axis. The monoisotopic mass of each m/z peak is labelled. 
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7.5.1.2 pspTU 
To complement deletion of the ABC transporter genes pspTU, several constructs were 
introduced in trans with expression from the native promoter. pspABCTUV are likely to 
constitute one operon, with expression driven from the pspA promoter, PpspA. Chapter 2 
details the creation of pIJ12533 through the cloning of PpspA into pSET152. pspTU was 
amplified using the primers pspTUF_SpeI and pspTUR_XbaI, while pspTUV was 
amplified using the primers pspTUF_SpeI and pspTUVR_XbaI, in both cases using  a 
high-fidelity polymerase. The amplified fragments were cloned into pGEM-T. Four 
colonies from each ligation were subjected to high fidelity PCR with the primers 
pSET152F and pSET152R. The amplified fragments were subjected to Sanger 
sequencing to identify clones in which no mutations had occurred. pspTU and pspTUV 
were liberated from pGEM-T using a double digest with XbaI and SpeI. The 2066 bp 
pspTU and 3345 bp pspTUV fragments were isolated from an agarose gel and ligated 
between the SpeI and XbaI sites of pIJ12533 to create pIJ12534 and pIJ12535, 
respectively. All three complementation constructs were sequenced before transformation 
into E. coli ET12567/pUZ8002. Conjugation of these donor strains with P. alba M1306 
was attempted several times, during which the conjugation plates were overlaid with 20 
µg/ml apramycin.  
Although several P. alba colonies grew through the overlay, very few sporulated, many 
grew poorly and did not grow when streaked onto ISP4 containing a higher concentration 
of apramycin. These colonies were likely to be the recipient P. alba strain growing through 
the low level of apramycin selection. However, one of the three conjugations was 
successful. One exconjugant was obtained though conjugation of P. alba M1306 with E. 
coli ET12567/pUZ8002 harboring pIJ12535 containing the cloned pspTUV genes. This 
exconjugant was streaked three times on ISP4 media containing 50 µg/ml apramycin and 
25 µg/ml nalidixic acid before inoculation into liquid culture to grow mycelium from which 
gDNA was prepared. This gDNA was assessed by PCR using primers within pIJ12535 to 
demonstrate that the construct had integrated successfully into the P. alba M1306 
chromosome. Two clones from this exconjugant were patched onto plates of AF/MS agar 
but no halo of inhibition was observed when overlaid with M. luteus after 5, 6 or 7 days of 
growth. Likewise these clones were cultured in AF/MS liquid medium, but no antibiotic 
production was detected when 5, 6, 8 or 13 day old supernatant samples were assayed 
against M. luteus (Figure 7.18). These samples were subsequently sent for MALDI-ToF 
analysis and the absence of planosporicin-associated peaks confirmed (Figure 7.19). 
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7.5.2 Introduction of a different lanA into WT P. alba  
Section 7.4 described how attempts to make a scarred version of P. alba ΔpspA::hyg was 
not successful. It was also not possible to complement the marked mutant P. alba M1302 
in trans with the WT pspA under control of the PpspA. If either of these methods were 
successful, the logical extension would be to complement the relevant ΔpspA mutant with 
a structural peptide from a different lantibiotic cluster. The close similarity between the 
planosporicin and microbisporicin gene clusters (described in Chapter 5) made the 
structural gene from the mib cluster, mibA, the obvious choice. Microbisporicin is 
produced from a single gene cluster, containing one prepropeptide gene, mibA (Foulston 
and Bibb 2010). In addition to the introduction of (Me)Lan bridges this prepropeptide is 
subject to a number of unusual post-translational modifications. Microbisporicin refers to 
four lantibiotic-like compounds which are 107891 A1 (2246.71±0.06 Da), 107891 A2 
(2230.71±0.06 Da) (Lazzarini et al. 2005; Castiglione et al. 2008), MF-BA-1768α1 
(2214.880 Da) and MF-BA-1768β1 (2180.805 Da) (Lee 2003). The mass difference 
between these compounds corresponds to the level of modification of the prepropetide. 
107891 A1 is the fully modified peptide containing a chlorinated tryptophan and 
dihydroxyproline. 107891 A2 is 16 Da smaller than 107891 A1, due to the loss of one 
oxygen atom from Pro14. The loss of the second oxygen atom creates the non-
hydroxylated form of microbisporicin, MF-BA-1768α1. While MF-BA-1768β1 is 34 Da smaller 
than MF-BA-1768α1 due to the loss of the chlorine atom on Trp4, creating the non-
hydroxylated and non-chlorinated form of microbisporicin.  
Constructs pIJ12138 and pIJ12362 were kindly provided by L. Foulston. These plasmids 
are based on pIJ10706 in which mibA or mibABCD is under control of the native PmibA 
promoter. These constructs were mobilised by conjugal transfer into WT P. alba where 
integration into the chromosome was selected with hygromycin. Six exconjugants from 
each conjugation grew well when streaked three times on ISP4 containing 25 µg/ml 
nalidixic acid and 40 µg/ml hygromycin. Four exconjugants were moved into liquid culture 
and the resulting mycelium used to prepare gDNA for PCR analysis. Amplification of the 
115 bp mibA (primers LF025F and LF025R) from P. alba containing pIJ12138 confirmed 
integration of the construct into the chromosome. Likewise, amplification of both the 115 
bp mibA and 159 bp mibD (primers LF026F and LF026R) from P. alba containing 
pIJ12362 confirmed the integration of this construct. Four exconjugants from each 
conjugation were grown in liquid AF/MS and MV media alongside a P. alba WT control. In 
MV medium, no antibiotic compounds were produced (as assessed by failure of culture 
supernatants to inhibit a lawn of M. luteus), even by the WT control. In AF/MS medium, 
the WT control and two of the four P. alba pIJ12138 exconjugants produced an antibiotic 
compound. The other two exconjugants also failed to produce a bioactive compound in a 
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repeat assay.  Of the four P. alba pIJ12362 exconjugants, only one produced a bioactive 
compound in AF/MS medium.  
In the absence of the mib genes responsible for the hydroxylation and chlorination of 
microbisporicin, it was expected that only the MF-BA-1768β1 form of microbisporicin would 
be visible in the spectrum. This has an expected m/z peak for [M+H+] of 2181.805 Da, a 
peak for [M+Na+] of 2203.805 Da and a peak for [M+K+] of 2219.805 Da. These masses 
are similar to the mass of planosporicin. In culture supernatants from the native producer 
M. corallina, the non-hydroxylated and non-chlorinated form of microbisporicin is not 
usually detected in WT supernatant (Foulston 2010). The presence of chlorine in the other 
three forms of microbisporicin alters the isotope signature such that peak abundance is 
3rd>2nd>1st. However the anticipated absence of chlorination in microbisporicin produced 
by P. alba means that peak abundance would be 2nd>1st>3rd, the same as for 
planosporicin associated peaks. In all MALDI-ToF spectra, the 2192 Da, 2214 Da and 
2230 Da peaks of planosporicin were present while the 2181 Da, 2203 Da and 2219 Da 
peaks of non-hydroxylated, non-chlorinated microbisporicin were absent. As anticipated, 
peaks corresponding to the hydroxylated and chlorinated forms of microbisporicin were 
also absent. Thus it was not possible to produce microbisporicin in P. alba through the 
heterologous expression of mibA or mibABCD. There are many possible explanations. 
Perhaps the promoter PmibA cannot be recognised in P. alba so is not expressed. Even if 
the construct is expressed, perhaps the modification enzymes encoded by the psp gene 
cluster do not share sufficient sequence similarity with the Mib enzymes to act on both 
prepropeptides. 
 
7.6 Discussion 
The successful targeted deletion of planosporicin biosynthesis genes demonstrates that 
the intrinsic homologous recombination efficiency of P. alba is sufficient to use PCR 
targeting, which was developed based on the recombination efficiency of Streptomyces. 
Furthermore the direct isolation of double-crossover mutants demonstrated that P. alba is 
naturally quite recombinogenic. 
The deletion of pspA proved its essentiality in planosporicin production. Likewise the 
deletion of the pspTU ABC transporter genes also abolished planosporicin production. 
This was unexpected as the deletion of the equivalent mibTU genes from M. corallina did 
not stop microbisporicin production (Foulston and Bibb 2010). However, as P. alba M1306 
(ΔpspTU::hyg) could not be complemented with pspTUV, there may be a second site 
mutation which prevents production in this particular mutant. Deletion of the pspYZ ABC 
transporter genes severely reduced the amount of planosporicin secreted out of 
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mycelium. In liquid culture, often no production is observed, whereas a small halo is 
consistently observed in solid bioassays. There is no accumulation of planosporicin in the 
mycelium, suggesting this transporter is not responsible for export of the mature 
lantibiotic. The deletion of pspV indicates that it too is essential for planosporicin 
production. It is possible that PspV may act as a scaffold or chaperone for the 
prepropeptide to protect it from degradation and present the substrate to modification 
enzymes. Yet there was no indication of the planosporicin prepropeptide or smaller 
degradation products in wide-range MALDI-ToF of P. alba M1307 supernatants. In M. 
corallina, MibV has been implicated in the chlorination of microbisporicin. However 
planosporicin has a valine at this position and no chlorinated residues elsewhere on the 
peptide. These four deletion mutants of psp genes proposed to encode proteins with a 
biosynthetic function all gave a phenotype of greatly reduced or totally abolished 
planosporicin secretion. Extraction of mycelium with methanol did not reveal a significant 
accumulation of planosporicin in the mycelium of any of these mutants.  
The inability to delete pspEF could indicate that they are essential for P. alba growth. 
Bioinformatic analysis from Chapter 5 indicates that pspEF may provide an immunity 
mechanism. However the mibEF genes of the microbisporicin cluster were successfully 
deleted from M. corallina and this ΔmibEF mutant was complemented by the in trans 
expression of mibEF (Foulston and Bibb 2010). The ΔmibEF strain showed severely 
reduced and delayed microbisporicin biosynthesis. Furthermore, there was also severe 
growth inhibition when exposed to WT supernatant containing microbisporicin. Thus it 
would appear that mibEF encode an immunity mechanism and that when disrupted, a 
negative feedback loop acts to reduce production (Foulston and Bibb 2010). 
Disappointingly, a number of P. alba deletion mutants could not be complemented 
through in trans expression of the WT gene. Although PCR analysis indicated that the rest 
of the gene cluster was intact, Southern blots would be needed to be certain that no 
rearrangements had occurred in the P. alba chromosome during the construction of the 
deletion mutants. However, even a Southern blot cannot rule out the presence of a 
second site mutation introduced when the gene was deleted. This may be more likely in P. 
alba mutants generated through the introduction of ~2 kb PCR-generated fragments on 
both sides of a resistance cassette with subsequent screening for double crossover 
recombination events. As the PCR generated fragments were not sequenced, the 2 kb 
flanking fragments might have contained several mutations, which, depending on the sites 
of the crossovers, could have introduced additional mutations upstream (and/or 
downstream) of the targeted knockouts. This method was used to generate the first P. 
alba ΔpspA::hyg knockout mutant and the only P. alba  ΔpspV::hyg mutant, M1307. 
However another P. alba ΔpspA::hyg mutant was constructed using a cosmid-based 
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construct and this strain (M1302) also failed to demonstrate complementation . Time 
restrictions prevented attempts to complement the P. alba ΔpspV::hyg mutant (M1307) in 
this work. 
The lack of complementation is unlikely to be due to a polar effect on downstream genes, 
as the complementation constructs were carefully designed to include the deleted gene 
and all genes downstream in the same operon and sequenced to ensure no mutations 
were introduced during construction. However there may be other problems with the 
complementation constructs. There may be a lack of activity in the pspA and pspJ 
promoter regions which prevents transcription. One solution would be to use a constitutive 
promoter such as the promoter region of the erythromycin resistance gene (ermE) from S. 
erythraea, (Bibb et al. 1985). The upregulated variant of this promoter, ermE*p, has been 
used frequently as a strong constitutive promoter for native and heterologous genes in 
several actinomycetes. For example, the triketide lactone synthase, DEBS1- TE, was 
cloned with the strong heterologous ermE* promoter in place of the promoter for the 
activator gene. This directed highly efficient production of the PKS protein in 
Streptomyces cinnamonensis (Wilkinson et al. 2002). A recent example of a lantibiotic 
gene expressed from ermE* comes from the complementation of S. coelicolor M1146 
derivatives containing a version of cyp gene cluster in which one biosynthetic gene was 
deleted. The WT copy of each gene was cloned downstream of the constitutive ermE* 
promoter and EF-Tu RBS of pIJ10257, which integrates into the ΦBT1 phage attachment 
site. Complementation with the WT copy of the relevant gene restored heterologous 
expression (Claesen and Bibb 2010). However there is no certainty that the ermE* 
promoter would be active in P. alba. Indeed a study in which a number of promoters which 
showed high level expression in Streptomyces, such as ermE*p, were used in 
Actinoplanes friuliensis indicated that these promoters had poor expression levels in A. 
friuliensis (Wagner et al. 2009). It may be more useful to use the 454 genome scanning 
data to identify promoter sequences for P. alba genes likely to show high or constitutive 
activity, such as those for ribosomal proteins or elongation factors. It may be that the 
change in genomic context has a detrimental effect on expression levels. It is likely that 
expression of psp genes in the WT strain is coordinated in a distinct ratio which may be 
altered when expression of the complementation construct occurs at a different 
chromosomal location. This could be tested by restoring the WT gene at the original locus 
by homologous recombination. However this method could mask the involvement of a 
second site mutation which, if present near to the deleted gene, would also be replaced 
by the reparative recombination event.  
In addition, it may be that there are additional regulatory features within the cluster which 
are interrupted during in trans expression. For example in the Pep5 gene cluster of S. 
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epidermidis, there is a RNA secondary structure between pepI and pepA which stabilises 
the pepI transcript for PepI expression (Pag et al. 1999). Although a large section of the 
up and downstream regions were cloned along with the WT gene in the psp 
complementation constructs, other factors may affect mRNA stability of the in trans 
transcripts compared to the WT transcripts. Difficulties in fully complementing mutant 
phenotypes in trans may be a common problem with lantibiotic gene clusters with complex 
regulatory mechanisms, where the stoichiometry of individual gene products may be 
essential for effective regulation. For example, the ΔmibA and ΔmibV deletions in the mib 
cluster could not be complemented with the WT gene in trans (Foulston and Bibb 2010). 
Problems were also encountered when complementing deletion mutations in the 
actagardine gene cluster (Bell 2010).  
This Chapter describes the creation of four P. alba mutants through the deletion of likely 
biosynthetic genes. Each deletion completely abolished planosporicin production, 
demonstrating that the corresponding genes are essential for biosynthesis but giving little 
insight into their precise function. Chapter 8 uses the approach described in this Chapter 
to make three further P. alba deletion mutants all affected in genes likely to play a role in 
regulation, the consequence of which is then investigated further. 
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7.7 Summary 
P. alba was found to be tractable for genetic studies, and constructs were introduced by 
both (presumed) site-specific integration and homologous recombination. 
The efficiency of conjugation was negatively correlated with the size of the construct 
(however some relatively small constructs were never successfully mobilised into P. alba). 
Constructs carrying the hygromycin resistance cassette were readily mobilised into P. 
alba through conjugal transfer and exconjugants were selected with hygromycin at four 
times the MIC. Apramycin-resistant P. alba exconjugants could only be selected with 
apramycin at two times the MIC. 
The targeted deletion of pspA marked with the hygromycin resistance cassette abolished 
production of planosporicin as determined by bioassay and MALDI-ToF analysis. This 
mutant could not be complemented in trans with WT pspA.  
The generation of a ‘scar’ version of the pspA deletion mutant was not successful. 
The deletion of pspYZ abolished production of planosporicin as determined by bioassay 
and MALDI-ToF analysis. 
The deletion of pspTU abolished production of planosporicin as determined by bioassay 
and MALDI-ToF analysis. This mutant could not be complemented in trans with WT 
pspTUV. 
The deletion of pspV abolished production of planosporicin as determined by bioassay 
and MALDI-ToF analysis. 
Introduction of mibA and mibABCD into WT P. alba did not result in the detection of 
microbisporicin-related peaks when assessed by MALDI-ToF analysis. 
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Chapter 8 : Mutational analysis of 
planosporicin regulation 
 
 
8.1 Introduction  
The regulation of secondary metabolic pathways occurs at two levels; it can be pathway-
specific (e.g. SARPs and LALs), or be through pleiotropic regulatory genes (e.g. BldD 
regulates spore formation and antibiotic production) (Bibb 2005). In the latter case, 
multiple signals are integrated through different regulators to ensure that a pathway is 
expressed only under the right conditions. The regulated expression of antibiotic 
biosynthetic genes clusters may also be essential to ensure the mechanism of producer-
immunity is in place before high levels of antibiotic production commence.  
The regulation of secondary metabolite production has been characterised in a range of 
actinomycetes. Several pleiotropic regulatory factors have been identified, such as the 
stringent factor ppGpp, as well as several pathway-specific regulatory protein families, 
such as the SARPs and LALs (as discussed in Chapter 1). The use of response 
regulators to coordinate regulation is common in many lantibiotic gene clusters from low-
GC Gram-positive organisms. In L. lactis, regulation of nisin biosynthesis is mediated 
through the NisR response regulator in combination with the sensor histidine kinase NisK 
as a two-component regulatory system (Kuipers et al. 1995). In contrast, the proposed 
use of an ECF sigma factor, cognate anti-sigma factor and a transciptional regulator in the 
psp cluster represents a less common mechanism of secondary metabolite regulation, 
and form the focus of this Chapter. 
Chapter 6 demonstrated the successful heterologous production of planosporicin in 
Nonomuraea. This implied that not only were all of the essential biosynthetic enzymes 
encoded by the cloned gene cluster, but also that all of the necessary regulatory elements 
needed to synthesise planosporicin were also present. As stated in Chapter 7, conjugating 
into mycelia often results in exconjugants growing that contain a mixture of WT and 
engineered genomes. Consequently, genetic analysis of individual biosynthetic genes 
was carried out in the native producer, for which spores are available for conjugations. 
This Chapter continues the analysis of psp gene function through the specific deletion of 
putative regulatory genes to investigate the mechanism of regulation of the psp gene 
cluster. 
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8.2 Targeted deletions within the planosporicin gene cluster of P. alba 
8.2.1 pspX 
8.2.1.1 PCR analysis 
pIJ12328 was PCR-targeted using the P1-FRT-oriT-hyg- FRT-P2 cassette from pIJ1700 
to replace pspX using the method described in Chapter 7. This created 
pIJ12328ΔpspX::hyg, named pIJ12351, which was conjugated into heat shocked P. alba 
spores. 48 sporulating P. alba colonies were visible just one week after the overlay with 
antibiotic selection. Four of these putative exconjugants were streaked three times on 
ISP4 agar containing 25 µg/ml nalidixic acid and 40 µg/ml hygromycin. One colony from 
each of the four exconjugants was transferred to liquid ISP4 medium with hygromycin 
selection to grow mycelium from which gDNA was isolated. PCR with the primers 
ΔECFconfirmF and R, which anneal either side of the targeted region, amplified the 
expected 1971 bp ΔpspX fragment in all four exconjugants (data not shown). However in 
exconjugant 3, the 981 bp WT pspX fragment was also amplified, indicating that this 
exconjugant had resulted from a single crossover event. This was confirmed by the 
observed resistance to 50 µg/ml kanamycin of the clone. Indeed when the entire plate of 
48 exconjugants was replica plated onto ISP4 agar containing 50 µg/ml kanamycin and 
then ISP4 agar with 40 µg/ml hygromycin, 19 colonies were resistant to kanamycin and 29 
colonies were sensitive to kanamycin (Figure 8.1). Kanamycin sensitivity indicates that the 
neo gene on the cosmid backbone is no longer present, most likely as the result of a 
double crossover event, and that the WT pspX gene has been replaced with the pIJ10700 
cassette containing hyg and oriT. This was the largest number of exconjugants observed 
for any P. alba conjugation. On this basis it appears that 40 % of exconjugants were 
single crossovers and 60 % were double crossovers. Thus P. alba appears to be naturally 
fairly recombinogenic.  
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Figure 8.1 : Generation of P. alba ΔpspX::hyg exconjugants. 
P. alba spores were subjected to heat shock at 50 °C for 10 minutes, cooled then mixed 
with E. coli ET pUZ8002 harboring pIJ12351 and plated on ISP4 agar containing 10 mM 
MgCl2. After 20 hours at 30 °C, plates were overlaid with 1 ml H20 containing antibiotics to 
give a final concentration of 25 µg/ml nalidixic acid and 40 µg/ml hygromycin (top). After a 
further 7 days incubation at 30 °C, this conjugation plate was replica-printed using a velvet 
onto ISP4 agar containing 50 µg/ml kanamycin (middle) then onto ISP4 agar containing 40 
µg/ml hygromycin (bottom). All plates were incubated at 30 °C for a further 5 days before 
being photographed. 48 sporulating HygR P. alba colonies are visible on the conjugation 
plate (top). Replica plating onto kanamycin and then hygromycin revealed 19 are also 
KanR, while 29 are KanS. The four colonies originally picked for analysis are numbered 1-4. 
Numbers 1, 2 and 4 are HygR KanS while number 3 is HygR KanR. 
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8.2.1.2 Bioassay and MALDI-ToF analysis 
P. alba ΔpspX::hyg_1, 2 and 4, kanamycin-sensitive double crossovers with the pIJ10700 
cassette in place of pspX, were tested for planosporicin production after growth in AF/MS 
liquid medium for seven days, both by bioassay and by MALDI-ToF analysis. All three 
exconjugants had a WT morphology when grown on agar or in liquid media, but produced 
no antibiotic compounds when culture supernatants were assayed against M. luteus 
(Figure 8.2). Likewise no peptides with a mass corresponding to planosporicin were 
detected by MALDI-ToF analysis (data not shown). Thus the replacement of pspX with 
P1-FRT-oriT-hyg-FRT-P2 abolished production of planosporicin. The P. alba 
ΔpspX::hyg_1 exconjugant, named M1303, was used in all subsequent analyses of the 
ΔpspX mutant. Figure 8.3 confirms that P. alba M1303 does not produce a compound 
with antibiotic activity, while Figure 8.4 confirms the lack of detection of planosporicin-
associated peaks upon MALDI-ToF analysis of a culture supernatant. 
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Figure 8.2 : Lack of production of antibiotic compounds from three P. alba ΔpspX::hyg 
exconjugants.  
The three P. alba exconjugants were cultured in AF/MS medium for 7 days. A positive 
control of WT P. alba was cultured in parallel. Samples of culture supernatants taken after 
4, 5, 6 and 7 days were tested for antibiotic activity. 40 µl of supernatant was applied to 
each antibiotic assay disc which were allowed to dry before being applied to a lawn of M. 
luteus. The plate was incubated for 36 hours at 30 °C before zones of inhibition were 
photographed. 
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Figure 8.3 : Production of antibiotic compounds from four P. alba deletion mutants. 
Namely M1302 (ΔpspA::hyg), M1303 (ΔpspX::hyg), M1304 (ΔpspW::hyg), and M1308 
(ΔpspR::hyg). The above P. alba strains were cultured in AF/MS medium for 6 days. A 
positive control of WT P. alba was cultured in parallel. Samples of culture supernatants 
were tested for antibiotic activity. 40 µl of supernatant was applied to antibiotic assay discs 
which were laid onto a lawn of M. luteus. The plate was incubated for 36 hours at 30 °C 
before zones of inhibition were photographed. 
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Figure 8.4 : Production of peptides from three P. alba deletion mutants.  
Namely M1303 (ΔpspX::hyg), M1304 (ΔpspW::hyg), and M1308 (ΔpspR::hyg). These four 
P. alba strains were cultured in AF/MS medium for 6 days. A positive control of WT P. alba 
was cultured in parallel. Supernatant samples were taken after 6 days of growth and 
analysed by MALDI-ToF mass spectrometry. Intensity is given on the y-axis in arbitrary 
units (au) and the mass/charge ratio (m/z) on the x-axis. The monoisotopic mass of each 
m/z peak is labelled. 
  
281 
281 Chapter 8 : Mutational analysis of planosporicin regulation 
8.2.2 pspW 
8.2.2.1 PCR analysis 
pIJ12328 was PCR-targeted using the P1-FRT-oriT-hyg-FRT-P2 cassette from pIJ1700 to 
replace pspW using the method described in Chapter 7. This created 
pIJ12328ΔpspW::hyg, designated pIJ12522, which was conjugated into heat shocked P. 
alba spores. Five exconjugants were streaked three times for growth on hygromycin 
selective plates. These HygR exconjugants were tested for growth in the presence of 50 
µg/ml kanamycin. Three out of the five exconjugants were KanS; P. alba ΔpspW::hyg_3 , 
P. alba ΔpspW::hyg_5  and P. alba ΔpspW::hyg_3(2). Sensitivity to kanamycin suggested 
that they had resulted from a double-crossover recombination event that had replaced 
pspW in the P. alba chromosome with the pIJ10700 cassette. The two KanR exconjugants 
were likely to reflect single-crossover insertion of pIJ12523, containing the neo gene, into 
the P. alba chromosome. After growth in liquid medium containing hygromycin but lacking 
kanamycin, single colonies were assayed for kanamycin sensitivity. One of the KanR 
exconjugants yielded a KanS segregant, creating P. alba ΔpspW::hyg_17. PCR analysis of 
gDNA isolated from these four strains demonstrated a shift in band size from 1318 bp, 
corresponding to WT pspW, to 1917 bp, corresponding to ΔpspW::hyg, when using 
primers annealing to the regions flanking pspW (data not shown), whereas no 
amplification product was observed when both primers annealed within pspW (data not 
shown; see Figure 8.5 for analysis of one of the clones). P. alba ΔpspW::hyg_3 was 
assigned the strain number M1304. 
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8.2.2.2 Bioassay and MALDI-ToF analysis 
The four P. alba ΔpspW::hyg clones were tested for their ability to produce planosporicin. 
Supernatant samples from all four AF/MS liquid cultures inhibited the growth of M. luteus 
and MALDI-ToF analysis confirmed the presence of planosporicin. Figure 8.3 depicts the 
bioassay result for supernatant from P. alba ΔpspW::hyg_3 (strain M1304) compared to 
WT supernatant. In agar diffusion assays, antibiotic activity is correlated with the square of 
the inhibition zone radius around the antibiotic assay disc (Drugeon et al. 1987). The 
difference in zone size between the WT and M1304 sample implies that deletion of the 
anti-sigma factor gene pspW markedly enhanced planosporicin production. Figure 8.4 
shows the peaks obtained from MALDI-ToF analysis in which the y-axis scale (peak 
intensity in arbitrary units) is the same for all samples. Although not strictly quantitative, 
peak intensity is clearly much higher with the supernatant from P. alba M1304 compared 
 
Figure 8.5 : PCR confirmation of three P. alba deletion mutants.  
Namely M1303 (ΔpspX::hyg), M1304 (ΔpspW::hyg), and M1308 (ΔpspR::hyg). Genomic 
DNAs extracted from each strain were used as templates to amplify pspX, (pspXF and 
pspXR: 133 bp), pspW (pspWF and pspWR; 102 bp) and pspR (pspRF and pspRR; 93 bp) 
from the psp gene cluster. Genomic DNA from WT P. alba was used as a  positive control. 
PCR products were run on a 2 % agarose gel by electrophoresis. The ladder is 100 bp 
DNA ladder (NEB) with band sizes annotated in bp. 
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to WT P. alba. To confirm this result, approximately equivalent numbers of P. alba WT 
and M1304 spores were patched onto AF/MS agar plates. WT P. alba usually only starts 
to produce planosporicin after 5 or 6 days incubation, whereas after just 2 days, P. alba 
M1304 produced an antibiotic compound which inhibited the growth of M. luteus (Figure 
8.6). This early production of planosporicin is unlikely to be due to an enhanced rate of 
growth or development, as P. alba M1304 grew at a similar rate to the WT strain on agar 
and in and liquid medium. The early production of planosporicin in the M1304 mutant is 
investigated further in Section 8.5. 
 
 
Figure 8.6 : Production of antibiotic compounds by P. alba M1304 and the WT strain. 
Approximately 106 P. alba WT and M1304 spores were patched on AF/MS agar plates and 
incubated at 30 °C. After 2 or 3 days, plates were overlaid with SNA containing M. luteus. 
The plates were incubated for a further 36 hours at 30 °C before zones of inhibition were 
photographed. 
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8.2.3 pspR 
8.2.3.1 PCR analysis 
pspR is located towards the left hand border of the psp gene cluster. In the reduced 
cosmid pIJ12328 there is just 2.5 kb of sequence upstream of pspR. In contrast, in cosmid 
pIJ12357, there is 16 kb of sequence upstream of pspR and 13 kb downstream (the 7 kb 
downstream of pspV were removed to create pIJ12327 in Chapter 6). Consequently, to 
provide larger flanking homologous regions for recombination, pIJ12357 was chosen for 
PCR targeting of pspR, which was replaced with the P1-FRT-oriT-hyg-FRT-P2 cassette 
from pIJ10700. The resulting deleted construct, pIJ12525, was mobilised into P. alba via 
conjugation with E. coli ET12567/pUZ8002/pIJ12525. After several conjugation attempts, 
one exconjugant grew well when streaked onto ISP4 media containing hygromycin. This 
exconjugant was inoculated into ISP4 liquid medium containing hygromycin and gDNA 
was prepared. PCR amplification using primers flanking pspR amplified a 2394 bp 
fragment corresponding to ΔpspR::hyg instead of the 1569 bp WT pspR fragment (data 
not shown). Likewise, primers annealing within pspR amplified a fragment from all other 
psp mutants but not from P. alba ΔpspR::hyg, subsequently named P. alba M1308 (Figure 
8.5). In an attempt to create a second P. alba ΔpspR::hyg exconjugant, primers 
pspR_2kbF and pspR_2kbR were used to amplify ~2 kb either side of ΔpspR::hyg using 
pIJ12525 as template. The resulting 6.3 kb fragment consisted of a region of the psp 
cluster with the resistance cassette from pIJ10700 in place of pspR which was cloned into 
pGEM-T to create pIJ12528. It was thought the relatively small size of this vector 
compared to pIJ12525 would increase conjugation efficiency. Despite many attempts to 
conjugate this construct into P. alba, no further P. alba ΔpspR::hyg exconjugants were 
identified. Sequencing of the oriT cassette present in pIJ12528 confirmed the absence of 
mutations that may have prevented conjugal transfer. 
 
8.2.3.2 Bioassay and MALDI-ToF analysis 
P. alba M1308 (ΔpspR::hyg) was inoculated from a seed culture into AF/MS liquid 
medium alongside a WT control, and supernatants were sampled after 5 and 7 days. The 
M1308 supernatant did not inhibit growth of M. luteus (Figure 8.3). The absence of 
planosporicin-associated peaks was confirmed by MALDI-ToF analysis (Figure 8.4). Thus 
it would appear that pspR is a key regulator of planosporicin biosynthesis. This idea is 
discussed further in Section 8.5. 
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8.3 Complementations 
8.3.1 Complementing regulatory mutants 
All mutants were made through the targeted replacement of a psp gene with the 
hygromycin resistance cassette. Two deletion mutants in proposed regulatory genes 
abolished planosporicin production. Attempts were made to complement these mutations 
in trans through the integration of a construct containing the WT gene. As in Chapter 7, all 
complementation constructs were based on the vector pSET152, which integrates into the 
chromosome presumably at the ΦC31 site and carries aac(3)IV conferring apramycin 
resistance. Thus the HygR mutants were conjugated with complementation constructs and 
exconjugants were selected with apramycin. 
 
8.3.1.1 pspX 
The PpspX promoter (defined as the region between pspA and pspX) and pspX were 
amplified with primers to introduce a BamHI site upstream of PpspX and a XbaI site 
downstream of pspX. This fragment was cloned into pGEM-T and sequenced to check 
that no mutations had been introduced. PpspX-pspX was subsequently ligated into BamHI 
plus XbaI cleaved pSET152 to create pIJ12539. This plasmid was mobilised into P. alba 
M1303 through conjugal transfer and exconjugants selected with 20 µg/ml apramycin.  
Over 20 P. alba colonies growing through the overlay were streaked out on ISP4 agar 
medium containing 50 µg/ml apramycin and 20 µg/ml nalidixic acid. However, only one 
grew well on the higher level of apramycin and was subsequently inoculated into liquid 
medium and gDNA prepared. This gDNA was assessed by PCR using primers annealing 
within pIJ12539 (pSET152F and pSET152R2) and the expected 1122 bp band 
corresponding to PpspX-pspX was observed (data not shown). Two clones from this 
exconjugant were grown in AF/MS liquid medium and the resulting supernatants tested for 
the production of an antibiotic compound capable of inhibiting the growth of M. luteus. The 
presence of the complementation construct pIJ12539 in P. alba M1303 restored 
planosporicin production, as demonstrated in the bioassay (Figure 8.7) and by MALDI-
ToF analysis (Figure 8.8).  
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8.3.1.2 pspR 
The region between pspQ and pspR was defined as the native promoter PpspR and was 
amplified along with pspR using primers that introduced BamHI and XbaI sites at the 5’ 
and 3’ ends, respectively, of pspR. This fragment was cloned into pGEM-T, confirmed by 
sequencing, the BamHI/XbaI fragment excised and ligated into the BamHI/XbaI site of 
pSET152 to create pIJ12540. This plasmid was mobilised into P. alba M1308 by conjugal 
transfer, using 20 µg/ml apramycin to select exconjugants.  
One putative P. alba M1308 pIJ12540 exconjugant was observed to grow well when 
streaked on 50 µg/ml apramycin. Genomic DNA prepared from this exconjugant was 
assessed by PCR using primers annealing within the integrated pIJ12540 construct. 
Amplification of the 1474 bp band corresponding to pspR confirmed the presence of 
pIJ12540 in this P. alba strain. Two clones from this exconjugant were grown in AF/MS 
liquid medium alongside a positive control of WT P. alba. After 5, 6, 8, 13 and 19 days of 
incubation, samples of supernatant were tested but no antibiotic compounds were 
detected in bioassay with M. luteus. Subsequent repetitions of this assay gave the same 
result. Five day old supernatants consistently failed to yield halos of inhibition (Figure 8.7) 
and MALDI-ToF analysis failed to identify planosporicin-associated peaks (Figure 8.8). 
 
Figure 8.7 : Production of antibiotic compounds from P. alba deletion mutants 
complemented in trans with the WT gene.  
Two clones of P. alba M1308 (ΔpspR::hyg) with integrated pIJ12540 (PpspR-pspR) and P. 
alba M1303 (ΔpspX::hyg) with integrated pIJ12539 (PpspX-pspX) were cultured in AF/MS 
medium for 5 days. Samples of  culture supernatants were tested for antibiotic activity. 40 
µl of supernatant was applied to antibiotic assay discs which were laid onto a lawn of M. 
luteus. The plate was incubated for 36 hours at 30 °C before zones of inhibition were 
photographed. 
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Likewise 5, 6 and 7 day old patches of mycelium grown on AF/MS agar also failed to 
reveal a halo of inhibition when overlaid with M. luteus (data not shown). 
 
 
 
Figure 8.8 : Production of peptides from P. alba deletion mutants complemented in trans 
with the WT gene.  
P. alba M1308 (ΔpspR::hyg) with integrated pIJ12540 (PpspR-pspR) and P. alba M1303 
(ΔpspX::hyg) with integrated pIJ12539 (PpspX-pspX) were cultured in AF/MS medium. 
Supernatant samples were taken after 5 days of growth and analysed by MALDI-ToF mass 
spectrometry. Intensity is given on the y-axis in arbitrary units (au) and the mass/charge 
ratio (m/z) on the x-axis. The monoisotopic mass of each m/z peak is labelled. 
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8.4 Computational analysis 
In addition to the bioinformatic analysis of the coding regions of the psp gene cluster in 
Chapter 5, additional programs were used to identify regions that might be associated with 
biologically active sites such as promoter motifs, activator/repressor binding sites, 
attenuators or RNA processing sites, all of which may play a role in the regulation of 
planosporicin biosynthesis. 
 
8.4.1 Dyad symmetries 
Clone Manager (Sci-Ed) was used to identify two areas of DNA whose base pair 
sequences are inverted repeats of each other.  These dyad symmetries could form stable 
RNA stem-loop or hairpin structures, or act as a binding site for transcriptional regulators. 
The program first searches for sequences that are repeated in the opposite direction on 
the same strand and then uses RNA energy parameters to determine which loops would 
be most stable. 
 
8.4.1.1 Attenuators 
Clone Manager reported that the largest and most stable RNA hairpin loop structure which 
could be formed from the psp gene cluster occurred between pspA and pspB. This loop 
has the stem sequence: GCCCGUGGGGCCGGGC and has a ΔG value of -35.4 (Figure 
8.9). This putative structure is located 14 bp downstream of the pspA stop codon and is 
likely to represent a transcription terminator. The hairpin loop would form in the mRNA 
strand during transcription, causing RNA polymerase to dissociate from the DNA 
template, resulting in some level of transcription termination.  
 
 
8.4.1.2 Binding sites 
 
Figure 8.9 : The 36 bp hairpin loop located between pspA and pspB.  
Numbers correspond to the position in the pIJ12321 insert DNA sequence. pspA is located 
from 22297-22467 and pspB  is 22561-25764. 
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Chapter 5 identified PspR as a transcriptional regulator of the LuxR family. PspR may 
exist in the cell as a homodimer, in which case an inverted repeat may be evident of a 
cognate binding site(s). For example the LuxR dimer (together with RNA polymerase) 
binds the lux box, a 20 bp inverted repeat (Stevens et al. 1994). It was proposed that the 
PspR binding site could be identified as a palindromic region in the promoter regions of 
the relevant psp operons. Dyad symmetries were only observed in the promoter regions of 
pspEF and pspJYZQ. The putative PpspEF site is a 10 bp inverted repeat with the sequence 
CGCCGGGCCG, separated by 17 nucleotides with one mismatch (the underlined G at 
position 7 is a T in the repeat sequence). The putative PpspJYZQ site is an 11 bp inverted 
repeat with the sequence CGGCCGGCGGC, separated by 44 nucleotides. Thus neither 
appear likely to represent genuine binding sites for PspR. 
 
8.4.2 Promoter motifs 
As described in Chapter 5, pspX is likely to encode an ECF sigma factor. The consensus 
motif found at many ECF-dependent promoters differs from those of other σ70 proteins. 
This motif is characterised by a highly conserved ‘AA’ motif in the -35 region that induces 
a DNA geometry appropriate for sigma factor binding (Lane and Darst 2006). ECF-
dependent promoters are more generally characterised by an ‘AAC’ motif in the -35 region 
and a ‘CGT’ motif in the -10 region (Staron et al. 2009).  
The annotation of the psp gene cluster in Chapter 5 was based on a distinctive pattern of 
GC content across codons that allows the identification of protein coding regions; 
translational start sites were identified by defining an appropriate RBS upstream of a start 
codon (Bibb et al. 1984; Kieser et al. 2000). On the basis of this annotation, the psp genes 
were grouped into five operons; pspABCTUV, pspXW, pspJYZQ, pspR and pspEF. The 
five promoter regions were analysed using MEME (Multiple EM for Motif Elicitation) 
(Bailey and Elkan 1994). Figure 8.10 depicts the alignment of the consensus sequences 
identified upstream of pspE, pspJ, pspX and pspR. This consensus motif was derived by 
MEME analysing four intergenic regions from the psp gene cluster (ORF-10-pspE, pspR-
pspQ, pspJ-pspW and pspX-pspA) together with five from the mib gene cluster (orf1-mibJ, 
mibO-mibQ, mibQ-mibR, mibX-mibA and mibV-mibE). Other intergenic regions of the psp 
cluster were also analysed (e.g. pspZ-pspQ) but a consensus motif was not identified. The 
consensus motif in the mib regions had previously been identified as characteristic for 
ECF sigma factor binding with ‘GAACC’ at -35 and ‘GCTAC’ at -10 (Foulston and Bibb 
2011). Table 8.1 shows that the ‘GAACC’ at -35 is also present in four psp promoters, 
while the conserved GXXXC motif at -10 is characterised by a preference for GCT, which 
is most clearly present in the pspE and pspJ promoter regions.  
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Overall, four psp promoter regions contain a consensus motif similar to those commonly 
recognised by ECF sigma factors (Table 8.1, Figure 8.10). This is in contrast to the 
classical consensus promoter sequences of primary sigma factors, the -35 ‘TTGACA’ and 
-10 ‘TATAAT’ regions. The only operon which is entirely missing an ECF sigma factor 
binding motif is pspABCTUV. The only other regulator in the cluster is the LuxR-type 
transcriptional regulator PspR. Active PspR may be a homodimer, in which case an 
inverted repeat may be evident as a binding site. Section 8.4.1.2 failed to identify a 
binding site for the PspR homodimer upstream of pspA. In the mib cluster, a ‘GAACC’ 
motif was identified 89 nucleotides upstream of mibA. This is the same as the -35 motif for 
other mib operons. However this conservation was not extended to the ‘GCTAC’ motif 
observed at the -10 region of other mib operons. On this basis it was proposed that the 
mibABCDTUV operon is regulated by a member of the σ70 family, possibly a vegetative 
sigma factor (Foulston and Bibb 2011). In the psp cluster, the ‘GAACC’ motif was only 
observed in the promoter regions of pspE, pspR, pspJ and pspX. There was no such motif 
in the pspA promoter region. For pspEF and pspJYZQ, the motif for ECF sigma factor 
binding is conserved at both the -35 and -10 regions, whereas for pspX and pspR, only 
the -35 region is highly conserved (Figure 8.10). The variation in conservation of the ECF 
sigma factor consensus sequence could imply that operons pspEF and pspJYZQ are 
highly expressed by σPspX, while pspR and pspXW are less so. This would fit with the 
observation that many ECF sigma factors auto-regulate their own expression (Staron et 
al. 2009), and that they play a regulatory, not catalytic role, in cell physiology. 
Alternatively, the regulatory genes pspXW and pspR may be recognised by a different 
member of the σ70 family. 
 
Figure 8.10 : A sequence logo of the consensus sequence compiled by MEME.  
The motif represents four promoter regions of the planosporicin gene cluster (upstream of 
pspE, pspJ, pspX and pspR) with five regions of the microbisporicin cluster (upstream of 
mibJ, mibQ, mibR, mibX and mibE). 
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8.5 Transcriptional analysis 
The regulation of the psp gene cluster was investigated through analysis of the 
transcription of the cluster in five P. alba strains: M1302 (ΔpspA:hyg), M1303 
(ΔpspX::hyg), M1304 (ΔpspW::hyg), M1308 (ΔpspR::hyg) and the WT strain. The five 
strains were inoculated in duplicate to the same OD450 and grown in parallel in AF/MS 
liquid medium. OD450 was monitored at regular intervals to create a growth curve (Figure 
8.11). M1308 grew at approximately the same rate as the WT strain, whereas M1302, 
M1303 and M1304 grew at a faster rate. However all strains reached the same final 
optical density at stationary phase. Consequently four time points of 41, 73, 113 and 162 
hours were used in order to cover the different growth phases of all five strains. 
Culture supernatants from each time point were used to assess when production of 
planosporicin began in each strain. As observed previously, M1302, 1303 and M1308 did 
not produce planosporicin. There was no halo of M. luteus inhibition even in bioassays 
with supernatant collected after more than 11 days growth (Figure 8.11). 
 
Table 8.1 : Promoter motifs identified by MEME.  
The five psp promoter regions were entered, of which four were used in the alignment; 
PpspE, PpspJ, PpspX and PpspR. The consensus sequence identified by MEME is underlined, in 
which the -35 and -10 consensus sequences are in red. 
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Figure 8.11 : Growth and planosporicin production in five P. alba strains.  
Growth was measured by determining optical density at 450 nm averaged for two 
independent cultures of each strain at each time point; P. alba WT (dark blue diamonds), 
M1302 ΔpspA::hyg (red squares), M1303 ΔpspX::hyg (green triangles), M1304 
ΔpspW::hyg (purple crosses) and M1308 ΔpspR::hyg (light blue stars). Mycelium was 
collected after 41, 73, 114 and 162 hours for RT-PCR analysis. Supernatant was collected 
at 41, 73, 114,162 and 265 hours to be assayed for antibacterial activity. 40 µl of 
supernatant was applied to antibiotic assay discs which were laid onto a lawn of M. luteus. 
The plate was incubated for 36 hours at 30 °C before zones of inhibition were 
photographed. 
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Two methods of RNA extraction were trialled on WT P. alba mycelium grown in two 
different media and sampled at two different time points. Good quality RNA was prepared 
using either the pestle and mortar method or silica beads with FastPrep (methods 
described in Chapter 2). Gel electrophoresis of approximately 1 µg RNA revealed both the 
23S and 16S rRNA bands, and often larger mRNA aggregates (Figure 8.12). RNA was 
extracted from mycelium sampled from one of the duplicate cultures after 41, 73, 113 and 
162 hours using the pestle and mortar method. For all 20 RNA extractions, a control PCR 
experiment using primers RT_hrdBF and RT_hrdBR confirmed the absence of DNA 
contamination. Quantification by Nanodrop showed that all RNA samples gave a 260/280 
ratio between 1.9 and 2.3, and a 260/230 ratio greater than 1.8, and in most cases also 
greater than the 260/280 reading, as expected for highly purified RNA. Gel 
electrophoresis of approximately 1 µg RNA revealed in most cases the 23S rRNA band 
was larger than the 16S rRNA band, indicating that the samples have not suffered 
significant degradation. Subsequently, the RNA samples were used as templates for 
reverse transcription as detailed in Chapter 2. cDNA from each reverse transcriptase 
reaction was diluted 1 in 10 in H2O and determined by Nanodrop analysis to contain 
approximately 80-110 ng cDNA. 
 
Figure 8.12 : Appearance of RNA extracted from P. alba separated by gel electrophoresis.  
RNA was extracted from WT P. alba cultured in two different types of media (ISP4 or 
AF/MS) at two different time points (46 and 95 hours) through two different methods. One 
method used a pestle and mortar to break open cells while the other used silica beads in a 
FastPrep machine (described in Chapter 2). Both methods gave good quality RNA (with a 
260/280 ratio of 1.94-2.11 and a 260/230 ratio >1.99). Approximately 1-2 ug of RNA was 
run on a 1 % agarose gel to reveal bands of 23S and 16S rRNA as well as larger rRNA 
aggregates (labelled). 
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8.5.1 Reverse transcriptase (RT) PCR 
Analysis of psp gene expression at the four time points shown in Figure 8.11 was initially 
investigated by PCR of cDNA (Reverse Transcriptase (RT) PCR). As a positive control for 
each cDNA template, a gene with 87 % nucleotide identity across 1036 nucleotides of 3’ 
sequence of hrdB from S. coelicolor was identified from P. alba 454 sequence data. hrdB 
encodes the major vegetative sigma factor σ70 and is commonly used as a control in RT-
PCR and quantitative (q)RT- PCR experiments in Streptomyces sp. (Hesketh et al. 2009). 
Primers annealing to this constitutively expressed gene served as a positive control for 
cDNA synthesis. In addition, primers annealing to the rRNA gene set rrnD were used as 
an additional positive control. Further primers were designed to amplify short (80-150 bp) 
fragments from the transcripts of psp genes (Chapter 2). RT-PCR was performed on RNA 
from each of the four time points indicated in Figure 8.11. PCR reactions performed on 
RNA samples that had not been treated with reverse transcriptase served as controls for 
DNA contamination. To get an overview of transcription within the cluster, primers were 
used which anneal within each of the proposed psp operons (Figure 8.13).  
The expression of hrdB occurred at roughly equal levels in all five strains at each time 
point (Figure 8.13). The lower expression levels in later time points may represent the 
decrease in transcription that would generally be expected during stationary growth. All of 
the negative control samples (from cDNA synthesis reactions lacking reverse 
transcriptase) did not amplify a visible PCR product, demonstrating that the RNA samples 
were not contaminated with genomic DNA (Figure 8.13).  
Overall, the strongest level of expression of psp genes occurred in strain M1304 (Figure 
8.13). There is also a good level of expression of all psp genes in the WT after 162 hours 
growth, corresponding with the observed production of planosporicin in bioassay analysis 
(Figure 8.13). At earlier WT samples, expression of pspE, pspR, pspQ, pspY, pspJ, pspW, 
pspX and pspA is evident. The hairpin loop between pspA and pspB observed in Section 
8.4.1.1 likely acts as a transcriptional attenuator, reducing transcription of pspBCDTUV 
relative to pspA. Expression levels of pspE, pspQ, pspY, pspJ, pspT and pspV were lower 
in strains M1302, M1303 and M1308 compared to M1304 and the WT strain (Figure 8.13).  
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Figure 8.13 : RT-PCR on four P. alba strains.  
Namely M1302 (ΔpspA::hyg), M1303 (ΔpspX::hyg), M1304 (ΔpspW::hyg), M1308 
(ΔpspR::hyg) and WT. RNA extracted from each strain at four different time points was 
used as a template for cDNA synthesis. Primers annealing within pspE, pspR, pspQ, pspY, 
pspJ, pspW, pspX, pspA, pspT and pspV were used to assess the level of transcription of 
these genes at each time point. Primers annealing within hrdB and rrnD were used as 
positive controls. RNA from cDNA synthesis reactions lacking the RT enzyme was used as 
a template with primers for hrdB in a negative control reaction (marked ‘-’). Primers 
annealing within orf-10 and orf+7 were used to assess the transcription of genes flanking 
the psp cluster. PCR products were run on a 2 % agarose gel by electrophoresis. 
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As anticipated, the pspA transcript was completely absent from strain M1302, and 
appeared to decrease from a level similar to the WT at 41 and 73 hours, to a level lower 
than the WT by 113 and 162 hours in both strain M1303 and M1308. Interestingly, M1302 
also expresses pspT and pspV. It would appear that the introduction of the pIJ10700 
cassette in place of pspA does not have a polar effect on the transcription of the rest of 
the pspABCTUV operon. On the contrary, the promoter in front of the hygromycin 
resistance gene in the pIJ10700 cassette may be driving higher levels of expression than 
in the WT strain. In addition, psp transcript levels were markedly reduced in strains M1303 
and M1308. Reassuringly, the pspX transcript was not detected in strain M1303, and 
likewise M1308 did not contain a detectable level of pspR transcription, while transcription 
of pspW was detected in M1303, indicating that the introduction of the pIJ10700 cassette 
in place of pspX did not completely abolish pspW expression. Overall, it is apparent that 
pspA, pspX and pspR are all required for efficient transcription of most of the psp gene 
cluster. 
It is interesting to note that expression of orf-10 and orf+7 also appear to be coordinately 
regulated with the rest of the cluster. After 165 hours incubation expression is detectable 
in WT and M1308 but not in M1302, M1303 and M1308 (Figure 8.13). However an 
essential role in planosporicin production seems unlikely; Chapter 6 demonstrated that the 
cluster of 15 genes extending from pspE to pspV was sufficient for planosporicin 
production in Nonomuraea. 
 
8.5.2 Quantitative (q) PCR 
RT-PCR, which is at best semi-quantitative, had indicated that levels of psp transcription 
were similarly and markedly reduced in both M1303 and M1308 (Section 8.5.1), indicating 
that pspX and pspR, respectively, were both essential for expression of the psp cluster. 
However, a more quantitative analysis might reveal differences in expression levels 
between M1303 and M1308 that could indicate specific roles for each regulatory protein. 
Consequently, quantitation of psp gene expression after 73 and 162 hours of growth was 
determined by Quantitative (q) PCR. 
Primers were selected which annealed to representatives from each operon predicted in 
Section 8.4. Table 2.5 of Chapter 2 lists the primers used in RT-PCR and Section 2.20.6 
describes the qPCR protocol. Products were detected using the fluorogenic dye SYBR 
Green that upon excitation emits a strong fluorescent signal when bound to double-
stranded (ds)DNA. However, as SYBR Green will bind to any dsDNA in the reaction, 
follow up assays were used to ensure only the desired product was present. Melting curve 
analysis was used to measure the temperature-dependent dissociation between DNA 
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strands through the resultant large reduction in SYBR green fluorescence. The melting 
curves from each plate confirmed that just one product was amplified with each primer 
pair. Likewise, samples checked by gel electrophoresis revealed one band of the 
expected size for each primer pair. The quantitation graphs revealed that the three 
independent qPCR analyses of each RNA sample took off after similar numbers of qPCR 
cycles. As well as cDNA templates, each primer pair was used in reactions with different 
dilutions of P. alba genomic DNA to generate a standard curve onto which a linear 
regression line was plotted. The R2 value is a measure of goodness-of-fit of linear 
regression (where an R2 of 1.0 means all points lie exactly on a straight line with no 
scatter). The regression line for all standard curves had an R2 value >0.98, indicating the 
regression equation can be reliably used to convert threshold cycle (Ct) values into 
transcript copy number. Primer efficiency varied from 85 – 95 % for all primer pairs used. 
Occasionally some contamination with gDNA was observed in the blank controls (no 
template), however this was at a very low level, only detectable after >35 cycles.  
The raw Ct values were averaged across the triplicates to get a mean value which was 
converted into the copy number of cDNA in each sample using the appropriate regression 
equation. These values were normalised to the expression of the endogenous control 
gene, hrdB, in each sample to take account of differing cDNA concentrations in each 
sample. Initial analysis of this data revealed that the level of expression within an operon 
varied, whereas it would be expected to be consistent for all constituent genes. The one 
exception would be if an attenuator is present, for example after pspA. This unexpected 
variation is likely due to variable amplification efficiencies using different primer pairs 
during qPCR. To counteract this observed variability, the expression level of each gene in 
the different mutants was expressed as a percentage of the WT expression level.  
Figure 8.14 shows the level of transcription of 11 genes from the psp gene cluster in four 
P. alba deletion mutants. The increased expression of all psp genes in P. alba M1304 is 
immediately apparent. After 73 hours of growth, WT P. alba had not yet started to produce 
planosporicin, while M1304 exhibited 5.1 - 37.5 fold increases in expression of 10 psp 
genes (pspW is deleted from the genome so no expression is detected). These included 
representatives from each of the five proposed operons. By 162 hours of growth, 
planosporicin production had commenced in the WT strain and so the increase in 
transcription in M1304 was reduced compared to earlier time points, but was still 1.1 - 4.5 
fold higher than WT levels. The increased expression of pspT and pspV in M1302 
compared to M1303 and M1308 may be due to transcription initiation at the promoter of 
the hygromycin resistance gene used to replace pspA. All of the negative control samples 
gave values comparable to the water only control, demonstrating that the RNA samples 
were not contaminated with genomic DNA. 
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Figure 8.14 : Level of transcription from 11 genes of the psp gene cluster in four different 
P. alba strains at two different time points.  
cDNA was synthesised from RNA extracted from P. alba M1302, M1303, M1304, M1308 
and WT after 73 hours (top) and 162 hours (bottom). qPCR used primers which annealed 
to 11 different genes in the psp gene cluster. Primers for hrdB were used as a control. The 
copy number of each psp gene was normalised against the hrdB control then expressed 
as a percentage of WT expression. Standard error is displayed in error bars. 
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In the psp cluster there are two positively acting regulatory genes; pspX encodes an ECF 
sigma factor and pspR a transcriptional regulator. To analyse their individual roles in 
regulation, the expression of psp genes was compared in P. alba strains M1303 (ΔpspX) 
and M1308 (ΔpspR). Genes markedly down-regulated in one mutant compared to the 
other might imply direct regulation. Figure 8.15 shows that after 73 hours growth pspJ, 
pspZ and pspE were down-regulated 3.12-fold, 1.53-fold and 1.36-fold in M1303 
compared to M1308, potentially revealing direct regulation by σPspX. In contrast, pspA, 
pspT and pspV were down-regulated 2.17-fold, 3.57-fold and 1.18-fold in M1308 
compared to M1303, potentially revealing direct regulation by PspR. The same trend is 
observed after 162 hours growth, with the difference in expression levels even more 
pronounced with 5.89-fold lower pspZ expression and 9.32-fold lower pspE expression in 
M1303 compared to M1308. In addition, pspW is also up-regulated in M1303 compared to 
M1308. However this is likely to be read-through from the promoter of the hygromycin 
resistance gene in the pIJ10700 cassette used to replace pspX in the construction of 
M1303. 
PspX and PspR are likely to directly regulate different psp genes independently of each 
other. If they were absolutely dependent on the presence of the other protein, then 
expression levels would be the same in both mutants. Therefore, both regulators 
presumably act independently. This analysis can be summarised to form a model for the 
regulation of planosporicin biosynthesis (Figure 8.16). An unknown signal activates pspR 
transcription at an unidentified promoter to activate pspABCTUV transcription and 
planosporicin production. Once planosporicin is produced, σPspX is released from PspW to 
drive high the level expression of pspEF, pspJYZQ, pspXW and pspR (through a second 
promoter). Thus PspR is the master regulator and σPspX-PspW form an ECF sigma factor–
anti sigma factor complex that responds to sub-inhibitory concentrations of planosporicin. 
In the absence of PspR (strain M1308), pspA expression is decreased, which inhibits 
pspX induction, consequently decreasing expression of σPspX-regulated genes (pspJ, 
pspZ, pspE) but not to the same level as when σPspX is completely absent. This implies 
there is a basal level of pspXW expression even in the absence of planosporicin to trigger 
the cycle. 
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Figure 8.15 : Level of transcription from 7 genes of the psp gene cluster in two different P. 
alba strains at two different time points.  
cDNA was synthesised from RNA extracted from P. alba M1303, M1308 and WT after 73 
hours (top) and 162 hours (bottom). qPCR used primers which annealed to 7 different 
genes in the psp gene cluster. Primers for hrdB were used as a control. The copy number 
of each psp gene was normalised against the hrdB control then expressed as a 
percentage of WT expression.  Standard error is displayed in error bars. 
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8.6 Discussion 
The bioinformatic analysis of the psp cluster in Chapter 5 proposed the ECF sigma factor 
encoded by pspX and the transcriptional regulator encoded by pspR as a potential 
regulators of psp gene expression. The lack of planosporicin production in deletion 
mutants of pspX and pspR in Section 8.2 demonstrates they have an essential role in 
planosporicin biosynthesis. This is further substantiated in Section 8.5 in which PspX and 
PspR are found to have distinct roles in the regulation of different psp genes. 
The results presented in this Chapter suggest a model for the regulation of planosporicin 
biosynthesis in which PspR functions as a master regulator to promote a sub-inhibitory 
level of planosporicin production. This induces a feed-forward mechanism mediated 
through σPspX that results in high level planosporicin production (Figure 8.16). In the young 
P. alba mycelium, a basal level of expression of pspXW results in a small amount of σPspX 
sequestered in the membrane by the PspW anti-sigma factor. Transcription of pspR 
mediated through a growth rate-dependent promoter is activated through an as-yet 
 
Figure 8.16 : Model for the regulation of the psp gene cluster.  
Block arrows represent transcription and translation. Black arrows represent activation, 
whereas inhibition is indicated by a blocked line.  
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unknown signal. This results in expression of the pspABCTUV operon and low-level 
planosporicin production which is likely exported through PspTU. Extracellular 
planosporicin interacts either directly with PspW, or inhibits peptidoglycan biosynthesis at 
a low level which is perceived by PspW. Inactivation of the anti-sigma factor causes the 
release of σPspX which forms a holoenzyme with RNA polymerase to drive high level 
expression of the entire psp gene cluster.  This includes pspEF which encode an ABC 
transporter predicted to confer immunity to planosporicin.  
A strikingly similar regulatory system is proposed for the microbisporicin gene cluster of M. 
corallina (Foulston and Bibb 2011). As described in Chapter 5, the psp gene cluster bears 
a strong resemblance to the mib gene cluster, not only on the basis of percent identity 
between proteins but also of synteny within the cluster. Foulston and Bibb proposed the 
ECF sigma factor, MibX, and the transcriptional regulator, MibR, as the key activators of 
mib gene transcription in a feed-forward mechanism. This was based on qPCR data, 
bacterial two- hybrid experiments (demonstrating that σMibX and the anti-sigma factor 
MibW interact strongly in E. coli) and the identification of the transcriptional start sites of 
each mib operon. MibR was proposed as the master regulator that induces the low level 
expression of the major microbisporicin biosynthetic operon through activation of an 
unidentified promoter triggered by an unknown signal. This would result in the production 
of microbisporicin without the chlorination and dihydroxylation modifications. Interaction of 
this less active form of microbisporicin with MibW would result in inactivation of MibW, 
release of MibX and high level expression of the entire mib cluster, resulting in the 
production of fully modified microbipsoricin. 
The high level of similarity between the mib and psp clusters, combined with the qPCR 
data from M1303 and M1308 suggests that planosporicin production is regulated in a 
similar manner. To support this model the suggested σPspX binding sites would need to be 
corroborated by identifying the transcriptional start site of each psp operon by S1 
nuclease protection assays. Bacterial two-hybrid experiments could also be used to 
confirm an interaction between σPspX and PspW. Gel-shift experiments could be used to 
indicate the DNA binding site of PspR, which is presumed to lie just upstream of pspA. It 
is interesting to note that the ECF binding motif at -10 of four of the psp promoters is 
conserved as ‘GCTAC’ in pspE and pspJ but is only GXXXC in pspX and pspR, the two 
regulators. This may reflect a difference in expression level, indicating that expression is 
focused on biosynthetic enzymes rather than further expression of regulators.  
According to this model of psp regulation, pspR must have two promoters; one recognised 
by σPspX and another triggering initial expression of the cluster. It is possible that this 
second promoter is located a considerable distance upstream, and was not cloned into 
pSET152 preventing successful complementation of strain M1308. 
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8.7 Summary 
The targeted deletion of pspX marked with the pIJ10700 cassette abolished production of 
planosporicin as determined by bioassay and MALDI-ToF analysis. This mutant was 
complemented in trans with WT pspX under control of the native promoter.  
The targeted deletion of pspW marked with the pIJ10700 cassette markedly increased 
production of planosporicin as determined by bioassay and MALDI-ToF analysis. 
The targeted deletion of pspR marked with the pIJ10700 cassette abolished production of 
planosporicin as determined by bioassay and MALDI-ToF analysis. It was not possible to 
complement this mutant in trans with WT pspR using 446 bp upstream of the pspR start 
site as a promoter. 
Expression of mibA and mibABCD in WT P. alba did not result in the detection of 
microbisporicin-related peaks in MALDI-ToF analysis. 
A hairpin loop is likely formed in RNA between pspA and pspB, forming a transcriptional 
attenuator. 
An ECF sigma factor consensus binding motif ‘GAACC’ was identified in the -35 regions 
of all psp operons except pspA. The pspE and pspJ promotors also contained a 
conserved ‘GCTAC’ motif in the -10 region. 
RT-PCR demonstrated that expression of the psp gene cluster was dependent on pspA, 
pspX and pspR. 
qPCR demonstrated a 5 – 38 fold increase in transcription of the psp cluster in P. alba 
M1304 (ΔpspW::hyg) compared to the WT after 3 days growth. 
RT-PCR and qPCR demonstrate the differential control of operons within the psp cluster 
by the ECF sigma factor gene pspX and the transcriptional regulator gene pspR. 
A regulatory model is proposed for the pathway-specific regulation of the planosporicin 
biosynthetic gene cluster by a master regulator (PspR) and an ECF sigma factor–anti 
sigma factor complex (σPspX-PspW) that responds to sub-inhibitory concentrations of 
planosporicin. 
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9.1 Planosporicin structure and activity 
Lantibiotics form a distinct class of antimicrobial peptides due to their unusual post-
translational modifications. These modifications constrain the molecule into a defined 
structural conformation that provides both stability and biological activity. 
Few three-dimensional solution structures have been solved for lantibiotics produced by 
members of the order Actinomycetales. Two examples are microbisporicin, a type A 
lantibiotic produced by Microbispora sp. (Castiglione et al. 2008) and actagardine, a type 
B lantibiotic produced by Actinoplanes sp. (Zimmermann and Jung 1997). The revisions 
made to the planosporicin structure (detailed in Chapter 3) changed its classification from 
type B to type A, and revealed significant N-terminal similarity to nisin-like lantibiotics.  
A notable feature of lantibiotics is the presence of non-proteogenic amino acids. Against 
MRSA strain L1400, planosporicin has an MIC of 8 µg/ml, while microbisporicin has an 
MIC of less than 0.13 µg/ml (Castiglione et al. 2008). The lower MIC of microbisporicin 
may be due to the presence of additional modifications; a chlorinated tryptophan and 
dihydroxyproline. Yet a M. corallina knockout mutant unable to chlorinate tryptophan 
displayed an increased zone of inhibition in agar diffusion bioassays (Foulston and Bibb 
2010). The formation of the inhibition zone is affected by a number of lantibiotic 
properties, including solubility, stability, and diffusion. Therefore a difference in zone size 
in an agar diffusion assay is not necessarily indicative of a difference in potency. For 
example the lantibiotics nisin A and nisin Z differ in just a single amino acid residue and 
have identical MICs when tested on a number of Gram-positive bacteria, but at 
concentrations above the MICs, nisin Z displays a larger zone of inhibition compared to 
nisin A (de Vos et al. 1993). These nisin variants have comparable solubility and stability, 
so it was concluded that nisin Z diffuses more rapidly than nisin A (de Vos et al. 1993). 
Thus it may be that the difference in charge distribution in the non-chlorinated form 
compared to the chlorinated form of microbisporicin results in an increase in the rate of 
diffusion in agar, not necessarily an increase in potency. 
The rate of diffusion is not the only factor affecting the ease at which the compound 
reaches the target. Additional difficulties may be encountered when crossing the thick 
peptidoglycan layer due to interactions with polar, charged and hydrophobic moieties 
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present on the cell surface. An alternative explanation for the increased potency of 
microbisporicin compared to planosporicin lies in the structural differences at the C-
terminus. Planosporicin is charged at its C-terminus due to the presence of the carboxyl 
group of Cys24, while in microbisporicin the C-terminal cysteine is modified to form an 
AviCys modification that is not charged. A recent patent by Sentinella Pharmaceuticals, 
Inc. demonstrated that carboxyamide derivatives of planosporicin have enhanced 
antibacterial activity (Maffioli et al. 2010). This patent describes how the carboxyl groups 
of Cys24 and Glu14 can be modified to remove the negative charge to create variants with 
increased potency. However this is not likely to be a strategy that will apply to all 
lantibiotics. In both the solution and the crystal structure of mersacidin, the N-terminus 
folds back to interact with the carboxyl group of the glutamic acid residue at position 17 
giving a compact structure (Schneider et al. 2000). Site-directed mutagenesis exchanged 
Glu17 for Ala17 creating a derivative that was obtained in good yields but showed markedly 
reduced activity (Szekat et al. 2003). This confirmed that the biological activity of 
mersacidin relied on the carboxylic acid moiety at position 17, and thus this residue 
cannot be replaced to reduce overall negative charge with the possibility of increased 
potency. This may apply to other lantibiotics with a mersacidin-like lipid II binding motif; for 
example the site-directed mutagenesis of the equivalent Glu residue in haloduracin 
abolished bioactivity (Cooper et al. 2008). 
 
9.2 Planosporicin mode of action 
Information from a number of indirect experiments implies that planosporicin inhibits cell 
wall biosynthesis. Planosporicin severely inhibits peptidoglycan synthesis over that of 
other macromolecules, and planosporicin treatment of growing bacterial cells result in the 
accumulation of UDP-linked peptidoglycan precursors (Castiglione et al. 2007). 
Planosporicin also shows activity against VRE so is is proposed to bind lipid II through a 
moiety other than the D-Ala-D-Ala pentapeptide (Castiglione et al. 2007).  
Thus the classification of planosporicin as a type A, nisin-like molecule (as described in 
Chapter 3) allows inference into its likely mode of action. The N-terminal 11 residues of 
planosporicin are identical to those of nisin (except for positions 4 and 6). Homology 
modelling of epidermin and mutacin on the structure of nisin bound to lipid II revealed that 
the A and B rings can accommodate a variety of amino acid side-chains apart from those 
at conserved positions 3 and 7-11 (Hsu et al. 2004). Planosporicin is conserved in these 
regions, indicating that it too is likely to be able to form a cage around the pyrophosphate 
moiety of lipid II. 
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However the presence of nisin-like A and B rings is not a pre-requisite for lipid II binding. 
Mersacidin and actagardine are type B lantibiotics with a globular tertiary structure but 
they also bind to lipid II. It is thought that the ‘CTLTXEC’ motif in the C-ring of mersacidin 
and the B-ring of actagardine confers an ability to bind lipid II (Zimmermann and Jung 
1997; Brotz et al. 1998). Lacticin 3147 and haloduracin are two-component lantibiotics 
with no similarity to nisin. The mature A1 component of lacticin 3147 and the mature halα 
of haloduracin also contain the ‘CTLTXEC’ motif in the B-ring and have been proposed to 
bind lipid II (Cooper et al. 2008; Zerikly and Challis 2009). 
Thus it would appear that lantibiotics from distinct gene clusters have evolved 
convergently to act upon on the same target. Similarly the glycopeptide vancomycin also 
acts on lipid II, but through the sequestration of the D-Ala-D-Ala moiety (Barna and 
Williams 1984). In contrast the precise mechanism of action of other lipid II-targeting 
antibiotics such as the mannopeptimycins, ramoplanin, plusbacin A3 and katanosin B, is 
not yet known (Fischbach 2009). Targeting lipid II is such an effective antibacterial 
strategy, it is also targeted by antimicrobials produced by other domains of life. Plectasin 
is a fungal defensin which also binds to the pyrophosphate moiety of lipid II (Schneider et 
al. 2010).  
While a key functionality of planosporicin is likely to be the binding of lipid II by its N-
terminus, it is likely that most lantibiotics possess multiple activities that combine 
differently for individual target strains. For example, nisin has a second mode of action; 
the formation of trans-membrane pores resulting in osmotic shock and cell lysis. This is 
mediated through its C-terminus. However binding to lipid II by the N-terminus is a key 
initial step (Hasper et al. 2004). Other type A lantibiotics that bind lipid II at the N-terminus 
vary in their ability to form pores through their C-termini. Epidermin and gallidermin are 20 
Å shorter than nisin, limiting pore-formation to only the thinnest of membranes (Bonelli et 
al. 2006). 
As yet there is no evidence for the formation of pores in the plasma membrane as a 
second mode of action for planosporicin. Indeed, the characteristic inhibition of DNA, RNA 
and proteins observed upon treatment of S. aureus with nisin is not observed with 
planosporicin (Castiglione et al. 2007). The mode of action of planosporicin was not 
investigated during this work due to perceived difficulties in distinguishing specific pore 
formation with stress-induced lysis (O'Neill et al. 2004). To date, there has been little work 
undertaken to investigate the precise mode of action of planosporicin. The ability to bind 
lipid II is implied from the strong similarity of the N-terminus to that of nisin.  
The specific targeting of a key component of cell wall biosynthesis implies lantibiotics may 
yet find a niche use in the clinic. So far, only nisin has been used commercially, however 
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the observed low solubility at physiological pH prevents clinical use (Gowans et al. 1952). 
Instead nisin is widely used as a food preservative with E number E234. The success of 
other lantibiotics such as microbisporicin and actagardine in pre-clinical trials indicates 
they may soon enter Phase I clinical trials. Lantibiotics differ completely to the planar 
heterocycles currently used in the clinic, and may mark a new frontier in antimicrobials.  
One remaining concern is that treatment with a peptide may result in an immune 
response. However, there is evidence to suggest that the presence of (Me)Lan bridges 
prevents the presentation of these molecules to macrophages, preventing specific 
antibody formation (Hans-Jorg Sahl, personal communication). It is likely that lantibiotics 
will only ever be successful in treating Gram-positive infections due to the bulky (Me)Lan 
residues preventing transport across the membrane of Gram-negative bacteria. However 
there are already exceptions; a lantibiotic produced by Bifidobacterium longum has 
recently been patented due to claims that it successfully inhibits the growth of Gram-
negative bacteria under conditions in which the outer membrane is intact (O'Sullivan and 
Lee 2011). 
While many actinomycetes encode lantipeptide gene clusters, very few produce a 
corresponding compound with antimicrobial activity. Assuming that these gene clusters 
are expressed at significant levels under laboratory conditions, these lantipeptides must 
presumably have other biological functions. The vast discrepancy between the 
concentrations used to demonstrate antimicrobial activity and the concentration present in 
the soil implies that even lantibiotics that do exhibit antimicrobial activity when tested 
under laboratory conditions may have an entirely different role in the natural environment, 
for example as signalling molecules (Goh et al. 2002; Shank and Kolter 2009). 
 
9.3 The psp gene cluster 
9.3.1 Introduction of non-proteogenic amino acids  
The proteins PspB and PspC were assigned functions on the basis of their significant 
similarity to proteins whose function had been determined experimentally. PspB is likely 
the dehydratase responsible for the dehydration of five serines and two threonines to Dha 
and Dhb, respectively, while PspC is likely the cyclase responsible for the coupling of a 
cysteine to five of these dehydrated residues to form four Lans and one MeLan (Figure 
9.1). So far, lanB and lanC genes have only been found in biosynthetic operons encoding 
lantibiotics. Conversely, all lantibiotics are biosynthesised by one of four characterised 
pathways; LanB/C, LanM, RamC and LanL (as described in Chapter 1). Until recently, one 
exception was thought to be the sublancin 168 biosynthetic gene cluster from B. subtilis 
168. This lantibiotic was originally characterised as containing four bridges; one Lan, one 
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MeLan and two disulphides (Paik et al. 1998). However the sublancin 168 biosynthetic 
gene cluster encodes no recognisable lanthionine synthases and only BdBB, a thiol-
disulfide oxidoreductase, and SunT, an ABC transporter were shown to be essential for 
production (Dorenbos et al. 2002). Recently, the structure of sublancin was revised as 
tandem mass spectrometry and Q-ToF revealed there were no dehydrated residues or 
(Me)Lan bridges and therefore sublancin is not a lantibiotic (Oman et al. 2011). Instead 
two disulphide bridges and one additional modification, a glycosylation of Cys22 was 
observed. An S-glycosyl transferase adds a glucose residue to a cysteine residue, 
therefore this antibiotic was reclassified from a lantibiotic to a glycopeptide (Oman et al. 
2011). 
 
 
Figure 9.1 : Schematic representation of planosporicin post-translational modifications.  
PspB catalyses the dehydration of Ser and Thr into Dha and Dhb, respectively. PspC 
installs the four Lan bridges and one MeLan bridge by regioselective cyclisation.  Removal 
of the leader sequence (MGISSPALPQNTADLFQLDLEIGVEQSLASPA) by an unidentified 
protease liberates the active lantibiotic.  
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Over 50 % identity was observed between PspBC and MibBC. This is much higher than 
the <30 % identity commonly observed between LanBC enzymes and likely reflects the 
similar prepropeptide substrates of the psp and mib gene clusters due to a more recent 
common ancestral gene cluster. The 24 amino acid propeptides of planosporicin and 
microbisporicin are dehydrated in identical positions; 2, 3, 5, 8, 13, 18 and 21, and four 
out of the five (Me)Lan bridges in planosporicin are also present in microbisporicin. An 
even higher percent identity would likely be observed if the PspA and MibA leader 
peptides were identical (they show 43 % end-to-end identity), as is the case for subtilin 
and ericin S prepropeptides from B. subtilis. In these biosynthetic clusters EriB and SpaB 
share 83 % identity while EriC and SpaC share 80 % identity (Stein et al. 2002a). 
Consequently the EriC enzyme is able to complement a SpaC deletion mutant, restoring 
production of mature subtilin (Helfrich et al. 2007). 
 
9.3.2 ATP-binding cassette transporters 
All lantibiotic gene clusters encode at least one ABC transporter system proven or 
presumed to be responsible for transport of the lantibiotic out of the cell, and many also 
encode a second as an immunity mechanism (Chatterjee et al. 2005). Interestingly, the 
architecture of the transporter responsible for lantibiotic export differs with the producing 
organism. The NisT of low-GC Lactococcus contains fused domains while the MibTU of 
high-GC Microbispora encodes the nucleotide-binding domain (NBD) and transmembrane 
domain (TMD) domains on separate proteins. However, the dependence on these 
transporters for export of the lantibiotic differs on a case-by-case basis.  
There are several examples in which deletion of the transporter genes had no effect on 
lantibiotic production, presumably due to complementation by other transporters located in 
the same gene cluster or elsewhere on the chromosome. The single-component 
transporters SpaT and PepT, encoded in the subtilin and Pep5 gene clusters, 
respectively, were each found to be non-essential for production of the respective 
lantibiotic (Klein et al. 1992; Meyer et al. 1995). However there was some indication that 
spaT mutants accumulated subtilin intracellularly, implying that it does play a role in 
transport (Klein et al. 1992). Likewise, the deletion of PepT abolished 90 % of Pep5 
production, indicating that it can only be partially replaced by other host-encoded 
translocators (Meyer et al. 1995). Epicidin 280 produced by Staphylococcus epidermidis 
BN 280 exhibits 75 % identity to Pep5 produced by S. epidermidis 5. Interestingly, the 
epicidin 280 gene cluster encodes proteins with significant sequence similarity to those of 
the Pep5 cluster, but lacks a homologue of the PepT ABC transporter (Heidrich et al. 
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1998). The absence of an ABC transporter in the gene cluster implies export occurs 
through a transporter encoded elsewhere in genome. 
A similar phenotype has been observed in high-GC bacteria in which the two-component 
transporter responsible for lantibiotic export has been deleted. MibTU is predicted to be 
involved in the export of microbisporicin from M. corallina. Deletion of mibTU did not 
abolish microbisporicin production and so it was proposed that other transporters encoded 
by the mib gene cluster (MibYZ, MibEF and/or MibN) could compensate for this deletion 
(Foulston and Bibb 2010). Likewise, the actagardine gene cluster encodes GarTH, an 
ABC transporter thought to be involved in lantibiotic export (Boakes et al. 2009). 
Heterologous production of actagardine in S. lividans was not affected by the deletion of 
these genes (Bell 2010).  
Equally, there is precedence for the deletion of ABC transporter genes preventing 
lantibiotic production. NisT is absolutely required for export of nisin; after deletion of nisT 
from L. lactis, nisin activity could only be detected if cells were lysed (Qiao and Saris 
1996). Likewise S. cinnamoneus encodes the two-component ABC transporter CinTH. 
Deletion of the corresponding genes created a strain unable to produce cinnamycin (S. 
O’Rourke, personal communication). The ABC transporter PspTU of P. alba exhibits a 
similar phenotype; the production of planosporicin is completely abolished in a pspTU 
deletion mutant. However as only one mutant was isolated and could not be 
complemented, the existence of a second-site mutation cannot be ruled out. 
The ABC transporter PspEF was proposed to function as an immunity mechanism based 
on its significant alignment to other lantibiotic immunity transporters. In this work, time 
restrictions prevented deletion analysis of this two-component ABC transporter. Work on 
immunity mechanisms for other lantibiotics has confirmed that LanFEG transporters 
confer resistance. For example, deletion of spaEFG from B. subtilis and of nisFEG from L. 
lactis 6F3 increased susceptibility to nisin and subtilin, respectively (Klein and Entian 
1994; Siegers and Entian 1995). However viability was maintained through the continued 
expression of a second immunity mechanism, mediated through a lipoprotein. There does 
not appear to be a link between this reduction in resistance and compound production, as 
lantibiotic biosynthesis continued at near-WT levels in both deletion mutants. However, in 
some cases there appears to be a link with the regulation of lantibiotic production; in-
frame deletion of the lipoprotein gene nisI resulted in a marked reduction not only in 
immunity levels but also in the production of nisin (Ra et al. 1999). 
Many lantibiotic gene clusters rely solely on a LanFEG transporter for immunity, such as 
the epidermin biosynthetic gene cluster of S. epidermidis Tu3298. The psp gene cluster 
does not encode an obvious secondary mechanism of immunity, although PspQ may be a 
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lipoprotein and PspYZ is an ABC transporter of unknown function. Likewise the 
microbisporicin gene cluster of M. corallina encodes the immunity transporter MibFEG, but 
the lipoprotein MibQ and unknown ABC transporter MibYZ may also play a role in 
immunity. Deletion of mibEF gave a phenotype in which microbisporicin was only detected 
at very low levels after prolonged growth, possibly through cell lysis (Foulston and Bibb 
2010). 
It could be anticipated that deletion of the immunity mechanism would leave the organism 
vulnerable to its own antibiotic. However there is some evidence that immunity genes may 
regulate export from the cell or biosynthesis in some way. Alternatively the cluster may 
encode a mechanism for sensing resistance levels which, when insufficient, prevents 
lantibiotic export or production. This mechanism is likely to be located within the cluster, 
as heterologous expression of epiFEG in addition to the epidermin biosynthetic genes in 
Staphylococcus carnosus resulted in five-fold higher levels of epidermin production 
compared to S. carnosus bearing only epiABCDQP (Peschel and Gotz 1996). 
The recently characterised microbisporicin gene cluster from M. corallina encodes a third 
ABC transporter, MibYZ, whose function is as yet unknown. Similarly, the planosporicin 
gene cluster also encodes three ABC transporters, all of which are encoded as separate 
TMD and NBD proteins. Homologues of pspYZ have been observed in other gene 
clusters as part of a cluster encoding homologs of pspXWJ. However pspYZ is the first to 
undergo deletion analysis, revealing severe reduction in the amount of planosporicin 
production. Interestingly, on solid media, production begins before the WT but never 
accumulates to a very high level, implying this ABC transporter may function together with 
PspXW in a mechanism of regulation as discussed in the next Section. 
 
9.3.3 Regulatory genes 
The regulatory mechanism coordinating the expression of the planosporicin gene cluster 
appears dissimilar to most other lantibiotic gene clusters. As described in Chapter 1, most 
low-GC type AI lantibiotic gene clusters encode a sensor histidine kinase and a response 
regulator, forming a two-component system. One well characterised example is the NisRK 
system, which is induced through a basal level of nisin expression detected at the cell 
membrane by NisK, which phosphorylates NisR, which in turn activates high level 
expression of the nisin gene cluster to generate high level production (Kuipers et al. 1995; 
de Ruyter et al. 1996). This low level production of the lantibiotic may be a common 
mechanism through which gene cluster expression is induced, as many other clusters 
also encode a two-component system (Stein et al. 2002b; Schmitz et al. 2006). 
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The planosporicin and microbisporicin high-GC type AI lantibiotic gene clusters do not 
encode a two-component system. Instead there is pair of genes encoding an ECF sigma 
factor and an anti-sigma factor (σPspX-PspW) and a helix-turn-helix DNA binding protein 
(PspR). Chapter 8 described the deletion analysis of pspX, pspW and pspR which 
revealed that all play a role in planosporicin production, while RT-PCR and qPCR 
experiments revealed that all are important for psp gene expression.  
ECF sigma factors are known to play a role in the regulation of genes involved in 
antimicrobial resistance as part of the general cell envelope stress response. For example 
in B. subtilis, σW and σX respond to cell envelope stress to regulate genes that include 
those conferring antibiotic resistance (Cao and Helmann 2004; Butcher and Helmann 
2006). More recently, it has also been shown that ECF sigma factors contribute to 
antibiotic production. Sublancin 168 is an antimicrobial produced by B. subtilis 168 strains 
that are lysogenic for the SPβ phage (Luo and Helmann 2009). As well as sublancin 
resistance in nonlysogens being controlled by σW, production in lysogens is dependent on 
σX and σM. However the activation of sublancin production occurs indirectly through the 
upregulation of the transition state regulator Abh (Luo and Helmann 2009). The first 
example of the direct regulation of an antibiotic gene cluster was the regulation of 
microbisporicin biosynthesis by MibX (Foulston and Bibb 2011). 
Deletion of the ECF sigma factor pspX created a strain in which no planosporicin 
production was detected. This strain was complemented through the in trans expression 
of pspX from its own promoter to restore production, although it did not reach WT levels. 
In contrast, deletion of the anti-sigma factor pspW created a strain in which planosporicin 
production occurred earlier and at more prolific levels than the WT. On this basis, it 
appears σPspX is a positive regulator and PspW is a negative regulator of the psp gene 
cluster. The reduction in planosporicin produced from the complemented pspX mutant 
might reflect an altered level of gene expression at the presumed ΦC31 integration site 
compared to the psp cluster. Consequently the expression of pspX would be uncoupled 
from the expression of pspW potentially unbalancing the ratio of these proteins, which 
may well have an adverse effect on production levels. Similar results have been observed 
previously in the mibX mutant of M. corallina. Interestingly, mibX was better 
complemented on agar medium than in liquid (Foulston 2010). It was proposed that the 
agar prevents microbisporicin from diffusing far away, resulting in an increased local 
concentration around the M. corallina mycelium, triggering increased microbisporicin 
production in a feed-forward mechanism (Foulston and Bibb 2011). 
Deletion of the transcriptional regulator pspR created another strain in which no 
planosporicin production was detected. Similar results were also observed in the mibR 
mutant of M. corallina, and this phenotype was complemented back to WT through the in 
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trans expression of mibR from its own promoter (Foulston and Bibb 2011). Thus it would 
appear that PspR plays a role as another positive regulator of the psp gene cluster. 
PspR and MibR are not the only LuxR-family proteins that regulate an antibiotic 
biosynthetic gene cluster without the need for a cognate signal generator. The Serratia 
marcescens ATCC 39006 carR gene, encodes a LuxR-like protein which functions 
independently of a specific pheromone signal resulting in constitutive activation of 
carbapenem synthesis in S. marcescens (Cox et al. 1998). It has been proposed that 
these unpaired LuxR-family proteins could allow bacteria to respond to signals produced 
by different neighbouring species, which would not be observed when they are grown in 
laboratory monocultures (Subramoni and Venturi 2009). Thus PspR may interpret signals 
from other species or even kingdoms to regulate planosporicin production. 
 
9.3.4 Unknown genes 
Bioinformatic analysis revealed PspV to be a hypothetical protein with no defined function. 
The deletion of its closest homologue, mibV, from M. corallina, prevented chlorination of 
the tryptophan at position four of microbisporicin (Foulston and Bibb 2010). As 
planosporicin has a valine at this position and no chlorinated residues elsewhere on the 
peptide, PspV is likely to play a broader role. This is consistent with the observation that 
PspV-like proteins are encoded in both type AI (MibV) and type AII/B (Sven_0538/0540) 
lantibiotic gene clusters. One possibility is as a scaffold or chaperone to aid the binding of 
modification and processing machinery to the prepropeptide. 
Likewise, PspJ and PspQ are also hypothetical proteins. Time limitations prevented 
deletion analysis of these genes so conclusions can only be drawn from bioinformatics 
analysis. PspJ is predicted to contain TM helices, while PspQ has a predicted signal 
peptide sequence containing the conserved lipobox motif of lipoproteins. Homologues to 
PspQ occur in the microbisporicin gene cluster of M. corallina (MibQ) and Microbispora 
sp. ATCC PTA-5024 (MlbQ). Heterologous expression of mibQ, mlbQ or mlbQ with mlbEF 
in S. coelicolor did not confer increased resistance to microbisporicin (J.P. Gomez-
Escribano, personal communication). Strikingly, homologues to pspJ and pspQ always 
occur in a gene cluster that also contains pspX, pspW, pspY and pspZ homologues. This 
cluster is not always associated with a lantibiotic gene cluster, implying a more generic 
role. It could be that the PspJYZQ homologues play a role in the mechanism of ECF 
sigma factor regulation, whether that sigma factor has a pathway-specific role in one gene 
cluster or has a pleiotropic role in the transcriptional activation of a diverse regulon. The 
fact that the ECF sigma factor is a core component, implies these genes may regulate 
some aspect of cell wall physiology in response to cell wall stress. 
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9.4 The model of psp regulation 
One can imagine that there is a low basal level of pspXW transcription, giving a 
constitutive presence of σPspX-PspW at the cell membrane. PspR appears to be a master 
regulator which induces low level planosporicin production to initiate the system through 
an unidentified promoter triggered by an unknown signal, possibly nutrient limitation. 
Interaction of planosporicin with PspW (or perhaps low level peptidoglycan biosynthesis 
inhibition that is perceived by PspW) disrupts the binding interaction with σPspX. The 
release of σPspX from PspW would allow formation of the RNA polymerase holoenzyme to 
drive the high level expression of the entire psp cluster in a feed-forward mechanism 
(Figure 9.2). 
In contrast the majority of lantibiotic systems are regulated via a two-component system. 
For example nisin is able to autoregulate its own transcription, acting as a peptide 
pheromone for quorum sensing (Kleerebezem 2004). The response regulator NisR and 
the histidine kinase NisK are constitutively expressed (de Ruyter et al. 1996). Nisin 
induces the autophosphorylation of NisK, with subsequent phosphotransfer to NisR. The 
conformational change in NisR confers the ability to act as a transcriptional activator 
resulting in expression of nisin biosynthetic genes due to a nisin-responsive element in 
the promoters of nisABTCIP and nisFEG (Kleerebezem 2004). A parallel can thus be 
drawn between this system and that of planosporicin in which σPspX-PspW are analogous 
to NisRK in sensing increasing levels of planosporicin at the cell membrane.  Both 
mechanisms provide a means for the lantibiotic to reach a threshold sub-inhibitory 
concentration, leading to high level production. 
In addition to pathway-specific regulation by PspX and PspR, the psp cluster may also be 
regulated by a global regulator such as ppGpp. In streptomycetes this stringent factor is 
induced in response to amino acid starvation to favour transcription of genes for 
adaptation and survival over those for growth, essentially acting as a switch (Hesketh et 
al. 2007). The bioinformatics analysis in Chapter 5 revealed a TTA codon in pspX. In 
streptomycetes this codon is known to rely on the bldA encoded Leu-tRNA for translation 
(Leskiw et al. 1991). Although rare in high-GC organisms, the TTA codon is often present 
in pathway-specific regulatory genes for antibiotic biosynthesis (Leskiw et al. 1991). This 
implies that the initiation of planosporicin synthesis via PspX may be the point at which 
bldA exerts developmental control of production. Thus the TTA codon may link P. alba 
development to planosporicin production. However planosporicin production was 
observed on media in which P. alba does not sporulate, and a lack of planosporicin 
production was observed on media in which P. alba sporulates. Therefore the decision to 
sporulate and the decision to produce planosporicin occur through separate hubs fed by 
multiple signals and so can occur independently. 
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Figure 9.2 : A schematic depicting the model of regulation of planosporicin biosynthesis. 
The upper panel depicts the induction of transcription by the master regulator, PspR. The 
lower panel depicts the response to sub-inhibitory concentrations of planosporicin 
mediated through the σPspX-PspW complex leading to high level planosporicin production. 
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9.5 Future work  
There remain a number of deletion mutants that would be desirable for a full 
understanding of the planosporicin biosynthetic gene cluster. Most notably the mechanism 
of immunity has not been investigated, and deletion of the putative immunity transporter 
PspEF and the possible lipoprotein PspQ would indicate if they are likely to play a role in 
self-protection. In parallel, the similarity between planosporicin and microbisporicin implies 
that the M. corallina ΔmibEF deletion mutant might be complemented through the 
expression of the pspEF genes. Cross-immunity has been observed for the producing 
strains of epicidin 280 and Pep5, indicating that the immunity peptides can function to 
protect the producer from two lantibiotics (Heidrich et al. 1998). 
Another desirable deletion mutant would be for the membrane protein PspJ, a potential 
regulator of PspW. The model of planosporicin regulation proposed in Chapter 8 is based 
entirely on observed expression levels in deletion mutants of three key regulatory genes. 
The role of the regulators PspX, PspW and PspR could be substantiated through a 
number of additional experiments. The predicted interaction between PspX and PspW 
could be investigated through bacterial-two-hybrid experiments. This technique could also 
be used to see if the inactivation of PspW occurs through a direct interaction with either 
PspJ or PspYZ. The physiological transcription start site of each psp operon transcribed in 
vivo could be mapped to check whether the ECF sigma factor consensus sequences 
identified in silico have a genuine function in the regulation of the gene cluster. This 
technique validated the consensus sequences identified in the mib cluster (Foulston and 
Bibb 2011). Once established, run-off transcription assays using the holoenzyme of RNAP 
with purified PspX as a sigma factor could confirm that PspX recruits RNAP to these sites. 
Likewise, if active PspR can be overexpressed and purified then DNA-protein binding 
could be investigated through qualitative techniques such as gel-shifts and footprinting. 
The proposed direct interaction of PspX with the promoter region of the operons pspXW, 
pspJYZQ, pspR and pspEF could be investigated through Lux-reporter analysis in S. 
coelicolor. This experiment could be extended to investigate the direct interaction of PspR 
with the promoter region of the pspABCTUV operon. The production of light by luxAB 
cloned downstream of the mibX promoter provided evidence that MibX can positively 
auto-regulate its own expression (Foulston and Bibb 2011). 
The striking phenotype of the pspW deletion mutant may form a paradigm for other 
secondary metabolite clusters regulated by a sigma factor-anti sigma factor complex. It is 
tempting to mobilise the ΔpspW psp cluster into Nonomuraea to see if this mutation has 
the same effect of increased planosporicin expression levels in a heterologous host. 
However, this deletion is unlikely to solve the lack of heterologous expression in 
Streptomyces, as RT-PCR on Streptomyces with the integrated mib cluster showed some 
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level of transcription does occur (Foulston 2010), implying the problem may instead be 
with the level of immunity. Deletion of the anti-sigma factor may provide a universal 
method to enhance expression of respective secondary metabolite clusters. This could 
partly alleviate the time-consuming optimisation of culture conditions and so may be of 
great use to the pharmaceutical industry. 
The fact that lantibiotics are gene-encoded makes them amenable to engineering 
strategies, which may be employed to further enhance their activity. This initially took the 
form of rational design, a knowledge-based approach to alter residues to enhance 
bioactivity. Although this failed to result in better variants, much was learnt about the 
structure/function relationship of lantibiotics (Cortes et al. 2009). Recently we have 
entered what is sometimes referred to as a ‘golden era’ in lantibiotic bioengineering 
through the construction of randomised libraries (Field et al. 2010). Through this strategy, 
derivatives of nisin, mersacidin and nukacin ISK-1 have been identified with improved 
activity (Field et al. 2007; Field et al. 2008; Appleyard et al. 2009; Islam et al. 2009). 
However, success depends on the type and number of variants generated. The use of 
alanine scanning mutagenesis of lacticin 3147 and actagardine, and the generation of a 
small number of randomly altered lacticin 3147 variants failed to generate more potent 
forms (Cotter et al. 2006; Field et al. 2007; Boakes et al. 2009). Thus the development of 
a method to generate random planosporicin variants may reveal which features confer its 
potent bactericidal activity and might even result in the production of more potent 
compounds. The combined knowledge of microbisporicin and planosporicin gives scope 
for the rational design of planosporicin variants containing additional modifications 
observed in microbisporicin.  
The overall similarity between not only the structure of microbisporicin and planosporicin, 
but also the gene clusters directing their biosynthesis has many implications. The fusion of 
different parts of pspA and mibA could lead to the creation of mib-psp chimeras. The 
relaxed substrate specificity observed in many LanB and LanC proteins may enable 
subsequent post-translational modification as observed in nisin-subtilin chimeras. The 
expression of the leader peptide DNA sequence of subtilin fused to the sequence 
encoding pronisin Z in L. lactis (a strain that produces nisin A) led to the detection of nisin 
A and mature nisin Z with the unmodified leader peptide of subtilin still attached (Kuipers 
et al. 1993b). The reciprocal experiment expressed nisin-subtilin chimeric prepeptides in a 
B. subtilis 168 strain in which the presubtilin gene had been deleted from the spa cluster. 
The chimeras consisted of the subtilin leader peptide fused to a structural region 
composed of the N and C terminus from either nisin or subtilin. Chimeras in which the N-
terminus of nisin was fused to the C-terminus of subtilin resulted in production of the fully 
modified chimera, whereas if the chimeric structural region had a subtilin N terminus and a 
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nisin C terminus, a heterogeneous mixture of products was detected (Chakicherla and 
Hansen 1995). Clearly specific recognition between the processing machinery and the 
prelantibiotic peptide (particularly the leader peptide and the C-terminus of the structural 
region) is a prerequisite for processing to occur correctly. Exchanging the leader peptide 
sequence of the planosporicin prepropeptide with that microbisporicin may reveal which 
structural features of the leader peptide are essential for particular functions. It may also 
be possible to export these mib-psp chimeras, as the NisT exporter has demonstrated 
relaxed substrate specificity in exporting fusions of the NisA leader peptide with non-
lantibiotic peptides (Kuipers et al. 2004).  
It is interesting to speculate on the evolution of the psp and mib gene clusters. The 
absence of a nearby transposase implies they are not related through horizontal gene 
transfer, but are instead related through vertical transfer. In particular, the biosynthetic 
operons pspABCTUV and mibABCDTUV are very similar. The main difference is the 
absence of a MibD homologue in P. alba. Two scenarios can be envisaged. In one, the 
common ancestor to the mib and psp clusters did not encode a lanD, but during the 
evolution of the mib cluster, an additional enzyme was acquired resulting in AviCys 
formation at the C-terminus of microbisporicin. Alternatively, it is possible that the common 
ancestor may have encoded a lanD that was subsequently deleted during the evolution of 
the psp cluster.  The loss of the AviCys would likely be prompted by a selection pressure, 
perhaps by another mutation which further increased potency. Therefore there was a 
need to abolish AviCys formation, to restore the C-terminal negative charge to reduce 
affinity to the membrane containing the molecular target lipid II, with a consequent 
reduction in potency. Given the difference in potency between planosporicin and 
microbisporicin, there remains much scope for the improvement of planosporicin activity 
and it joins other lantibiotics as one of the arsenal of potential antibiotics required to fight 
the ever present threat posed by infectious diseases. 
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